Tailored polymeric nanoparticles for gene delivery and diagnostic by Vollrath, Antje
 
 
 Friedrich-Schiller-Universität Jena  Tailored polymeric nanoparticles for  gene delivery and diagnostic 
 Dissertation  zur Erlangung des akademischen Grades doctor rerum naturalium (Dr. rer. nat.)  
  vorgelegt dem Rat der Chemisch-Geowissenschaftlichen Fakultät der Friedrich-Schiller-Universität Jena  von Diplom-Chemikerin Antje Vollrath geboren am 12.07.1984 in Weimar
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Gutachter: 1.  
2.    Tag der öffentlichen Verteidigung:    
 
 
 
 Für meine Familie   
“Be the change that you wish to see in the world.” Mahatma Gandhi     
    
TABLE OF CONTENTS 
 
3 
 
Table of contents  Documentation of authorship          4 1. Introduction           8 2. Nanoparticles for diagnostic       10 3. Nanoprecipitation for tailored nanoparticle preparation    14 4. Advanced characterization of nanoparticles     19 5. Targeting of polymeric nanoparticles for cell internalization studies  24 6. Nanoparticles for gene delivery      30 7. Summary         37 8. Zusammenfassung        40 9. References         43 Supplementary information        46 List of abbreviations         48 Curriculum vitae         49 Publication list         50 Acknowledgement / Danksagung       54 Declaration of authorship / Selbstständigkeitserklärung    57 Publications P1 ‒ P9         59   
0. DOCUMENTATION OF AUTHORSHIP  
 
 
4  
Documentation of authorship 
 
This section contains a list of the individual authors′ contribution to the publications reprinted in this thesis.   P1) A. Vollrath, S. Schubert, U. S. Schubert, "Fluorescence imaging of cancer tissue based on metal-free polymeric nanoparticles – Review", J. Mater. Chem. B 2013, accepted.  A. Vollrath:  preparation of the manuscript, conceptual development S. Schubert, U. S. Schubert: correction of the manuscript, supervision  P2)  I. Y. Perevyazko, A. Vollrath, S. Schubert, G. M. Pavlov, U. S. Schubert, "Characterization of poly(methyl methacrylate) nanoparticles prepared by nanoprecipitation using analytical ultracentrifugation, dynamic light scattering, and scanning electron microscopy", J. Polym. Sci., Part A: Polym. Chem. 2010, 48, 
3924−3931.  I. Y. Perevyazko:  nanoparticle preparation and characterization, conceptual development, preparation of the manuscript A. Vollrath:  nanoparticle preparation and characterization, conceptual development, preparation of the manuscript G. M. Pavlov:  correction of the manuscript, supervision I. Y. Perevyazko S. Schubert, U. S. Schubert:  correction of the manuscript, supervision   P3) I. Y. Perevyazko, J. T. Jr. Delaney, A. Vollrath, G. M. Pavlov, S. Schubert, U. S. Schubert, "Examination and optimization of the self-assembly of biocompatible, polymeric nanoparticles by high-throughput nanoprecipitation", Soft Matter 2011, 7, 
5030−5035.  I. Y. Perevyazko:  nanoparticle preparation and characterization, conceptual development, preparation of the manuscript J. T. Jr. Delaney:  conceptual development, preparation of the manuscript A. Vollrath:  nanoparticle preparation and characterization, preparation of the manuscript G. M. Pavlov:  correction of the manuscript, supervision I. Y. Perevyazko S. Schubert, U. S. Schubert:  correction of the manuscript, supervision   
0. DOCUMENTATION OF AUTHORSHIP 
 
 
5  
P4)  I. Y. Perevyazko, A. Vollrath, C. Pietsch, S. Schubert, G. M. Pavlov, U. S. Schubert, "Nanoprecipitation of poly(methyl methacrylate)-based nanoparticles: Effect of the molar mass and polymer behavior",  J. Polym. Sci., Part A: Polym. Chem. 2012, 50, 
2906−2913.   I. Y. Perevyazko:  nanoparticle preparation and characterization, conceptual development, preparation of the manuscript A. Vollrath:  nanoparticle preparation and characterization, preparation of the manuscript C. Pietsch:  polymer synthesis and characterization G. M. Pavlov:  correction of the manuscript, supervision I. Y. Perevyazko S. Schubert, U. S. Schubert:  correction of the manuscript, supervision   P5) A. Vollrath, D. Pretzel, C. Pietsch, I. Y. Perevyazko, R. Menzel, S. Schubert, G. M. Pavlov D. Weiß, R. Beckert, U. S. Schubert, "Preparation, cellular internalization, and biocompatibility of highly fluorescent PMMA nanoparticles", Macromol. Rapid 
Commun. 2012, 33, 1791−1797.  A. Vollrath:   nanoparticle preparation and characterization, conceptual development, preparation of the manuscript D. Pretzel:  biological studies, preparation of the manuscript C. Pietsch:  polymer synthesis and characterization, contribution to the manuscript  I. Y. Perevyazko:  PUC studies, contribution to the manuscript  R. Menzel:  synthesis and characterization of fluorescent dye G. M. Pavlov:  supervision I. Y. Perevyazko D. Weiß, R. Beckert:  supervision R. Menzel S. Schubert, U. S. Schubert:  correction of the manuscript, supervision     
0. DOCUMENTATION OF AUTHORSHIP  
 
 
6  
P6) A. Vollrath, A. Schallon, C. Pietsch, S. Schubert, T. Nomoto, Y. Matsumoto, K. Kataoka, U. S. Schubert, "A toolbox of differently sized and labeled PMMA nanoparticles for cellular uptake investigations", Soft Matter 2013, 9, 99−108. 
 A. Vollrath:  polymer labeling, nanoparticle preparation and characterization, conceptual development, preparation of the manuscript A. Schallon:  biological studies, conceptual contribution, preparation of the manuscript C. Pietsch: polymer synthesis and characterization T. Nomoto, Y. Matsumoto:  cell studies (fluorescence microscopy), correction of manuscript K. Kataoka:  correction of the manuscript, supervision S. Schubert, U. S. Schubert:  correction of the manuscript, supervision   P7)  K. Babiuch, D. Pretzel, T. Tolstik, A. Vollrath, S. Stanca, F. Foertsch, C. R. Becer, M. Gottschaldt, C. Biskup, U. S. Schubert, "Uptake of well-defined, highly-glycosylated, pentafluorostyrene-based polymers and nanoparticles by human-heptocellular carcinoma cells", Macromol. Biosci. 2012, 12, 1190−1199.  K. Babiuch:  synthesis, characterization, conceptual development, preparation of the  manuscript D. Pretzel:   biological studies, preparation of the manuscript T. Tolstik:  cell studies (flow cytometer) A. Vollrath:  nanoparticle preparation and characterization  S. Stanca, F. Foertsch:  cell studies (fluorescence microscopy) C. R. Becer, M. Gottschaldt:  correction of the manuscript, supervision K. Babiuch C. Biskup:  cell studies (fluorescence microscopy), supervision   F. Foertsch U. S. Schubert:  correction of the manuscript, supervision          
0. DOCUMENTATION OF AUTHORSHIP 
 
 
7  
P8)  S. Ochrimenko,# A. Vollrath,# K. Kempe, L. Tauhardt, S. Schubert, U. S. Schubert, D.  Fischer, "Dextran-graft-linear poly(ethylene imine) for gene delivery ‒ influence of  linker strategies on the phyicochemical and biological properties", Bioconjug. Chem.  2013, submitted. 
 S. Ochrimenko:  biological studies, conceptual development, preparation of the manuscript A. Vollrath:  polymer synthesis and characterization, conceptual development, preparation of the manuscript K. Kempe:  synthesis and characterization of pEtOx L. Tauhardt:  synthesis and characterization of lPEI S. Schubert, U. S. Schubert:  correction of manuscript, supervision D. Fischer:  correction of manuscript, supervision S. Ochrimenko    P9)   A. C. Rinkenauer,# A. Vollrath,# A. Schallon, L. Tauhardt, K. Kempe, S. Schubert, D. Fischer, U. S. Schubert, "Parallel high-throughput screening of polymer vectors for non-viral gene delivery: Evaluation of structure-property-relationships of transfection", ACS Comb. Sci. 2013, submitted. 
 A. C. Rinkenauer:  biological and stability studies of polyplexes, conceptual development, preparation of the manuscript A. Vollrath: polyplex preparation and DLS measurements, conceptual contribution, preparation of the manuscript A. Schallon:  conceptual development, preparation of the manuscript L. Tauhardt:  synthesis and characterization of lPEI K. Kempe:  synthesis and characterization of pEtOx D. Fischer:  conceptual contribution, correction of the manuscript S. Schubert, U. S. Schubert:  correction of manuscript, supervision  
 
      Jena,  25.02.2013    ________________________________  
# Equal contribution 
1. INTRODUCTION 
 
 
8 
1. Introduction  Nanomedicine is one of the most promising fields within the area of nanotechnology and may be the answer to many intractable medical challenges. Nowadays, it benefits already from novel nanotechnologies in detection, imaging, treatment and prevention of diseases, such as cancer.[1,2] Due to the increased surface-to-volume ratio, small nanoscale objects possess unique physicochemical characteristics. They reveal a different behavior in suspension compared to their bulk material and can pass fine capillaries as well as internalize into cells. Thus, nanocarriers are able to resolve important limitations accompanied with conventional diagnostic and therapeutic devices, such as lack of water solubility, non-specific biodistribution and low therapeutic indices. With the development of 
“theragnostic” nanoparticles that combine diagnostic and therapy via integration of drug and dye molecules, the medical effectiveness was even more improved.[3]  Nanoparticles can consist of various inorganic and organic materials, whereby polymer based formulations have gained significant attention owing to their good biocompatibility, structural diversity and excellent adjustability of their resulting properties.[4,5] Synthetic polymers, like poly(lactide-co-glycolide) (PLGA) and poly(ε-caprolactone) (PCL), but also biopolymers, like dextran and chitosan, were found to be perfectly suitable matrix materials.[6-9] By utilization of top-down or bottom-up engineering, nanoparticle systems can be systematically designed with well-tuned size, shape and cargo loading.[10,11] New generations of nanoparticles are furthermore functionalized on the surface with targeting 
and “stealth” moieties to reduce or to exclude adverse effects. By utilization of the sophisticated concept of a specific surface modification an enhanced blood circulation time of the nanoparticles as well as a highly-efficient delivery of drugs and diagnostic agents can be realized.[12,13]  But despite the wide field of possible polymeric systems, preparation methods and surface modifications, until now only a few targeted polymeric nanoparticles have progressed to clinical trials demonstrating the challenges that come along with their development.[3] Limiting factors of capital importance are the controlled and reproducible production and the still existing insufficient understanding of the particle interactions and distributions in vitro and in vivo. Innumerable studies can be found in literature that investigated the characteristics and tissue interactions of nanoparticles. However, these studies are based on different materials and basically non-defined surfaces due to the use of surfactants. No final conclusion can thus be drawn about the optimal particle design for safe and efficient administration.[14-16]  In order to gain deeper insights into vital characteristics of nanoparticles, this thesis addresses the preparation of various polymeric particles in the nanoscale without using surfactants and includes their characterization as well as the biological evaluation. An overview about polymer-based nanoparticles applied for cancer detection is presented (see Chapter 2), whereby important parameters and possibilities for the design of nanocarriers for improved diagnostic applications are discussed. The formulation of several polymers 
1. INTRODUCTION 
 
 
 
9 
into nanoscaled objects by nanoprecipitation is investigated in Chapter 3, whereby an automatic high-throughput (HT) approach using pipetting robots is described that enables a systematical analysis of versatile materials and formulation process parameters. For the development of optimized particle formulations, a detailed physicochemical characterization of the nanoparticles represents a central prerequisite. In particular, parameters like the size are known to significantly influence the biodistribution and clearance of the nanoparticles; therefore, the size values should always be evaluated with great care.[17] Though many techniques are available for their characterization, the particle sizes and size distribution are frequently poorly described using mainly only one analysis technique, mostly dynamic light scattering (DLS).[18] For a sufficient characterization and detailed insight into the nanoparticle properties, orthogonal analysis methods, such as DLS, scanning electron microscopy and analytical ultracentrifugation are utilized and compared amongst each other (see Chapter 4). Admittedly, such a comprehensive investigation of the nanoparticle size is not feasible for a HT-approach, but with the application of a HT-DLS platereader device for the fast analysis of all nanoparticles and a subsequent review of selective samples by other methods, deeper insights into various nanosystems could be achieved.  However, many issues in the field of nanomedicine which come along with the application of polymeric nanoparticles, like long-time consequences or unexpected side effects, are still precarious and need to be considered carefully. To study their interactions with biological tissue more in detail, various polymeric nanoparticles with defined sizes and surfaces were prepared and utilized for cellular internalization and biocompatibility studies (Chapter 5). Furthermore, nanoparticles were targeted with different sugar molecules and investigated with regard to their specific cellular uptake. Finally, since the polymer itself plays an important role for the effective design of nanocarriers useful for diagnostic and drug delivery applications, it is of high importance to understand fundamental structure-property relationships. Hence, a range of cationic polymeric vectors useful for gene delivery were synthesized applying different linker strategies, complexed into nanoscale assemblies with negatively charged DNA and evaluated with regard to their physicochemical and biological properties (Chapter 6). Moreover, a HT-workflow for an automatic and parallel evaluation of gene vectors is presented.  
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2. Nanoparticles for diagnostic 
 
Parts of this chapter will be published: P1) A. Vollrath, S. Schubert, U.S. Schubert, J. Mater. Chem. B 2013, 
accepted.  The area of medicine and biological diagnostic is a research field of great magnitude as it enables the detection of manifold processes inside the body and forms the major basis for the understanding of disfunctionalities and the subsequent occurrence of diseases. In particular for cancer treatment, an early diagnosis is of vital importance and decides about the success of the therapy. Since the development of nanoparticle-based technologies has revolutionized the diagnostic area, tremendous effort was set on the investigation of new, suitable nanomaterials and detection systems.[2] A diagnostic technique that utilizes nanoimaging agents is fluorescence imaging. It is easy applicable and provides high spatial and temporal resolution, superb sensitivity as well as good selectivity.[19,20] This imaging technique allows insights into living organisms with high sensitivity without the need of dissection, e.g., by usage of endoscopes.[21,22] The examinations of vascular networks and sentinel lymph node mapping are only two examples of the successful application of fluorescence imaging.[23] Besides an early detection, the surgical removal of the tumor is mostly efficient for cancer therapy, but it is a demanding task for the surgeon to remove the tumor tissue completely without damaging healthy tissue. In order to visualize tumors while surgery and to improve its radical resection, new systems were developed that enable the intraoperative identification of tumors. It was preclinically validated that by using specific fluorescent nanoagents and image guided surgery, tumors can be detected and removed very efficiently with reduced complications.[24] At the moment, fluorescence image guided surgery is in the transit to clinical practice.[3,20] However, in order to enable a fast clinical realization, new fluorescence probes need to be established and approved for in vivo application. The use of dye containing polymeric nanoparticles represents an excellent opportunity since the concept to incorporate fluorophores into a polymer shell provides a protection of the dye against external influences. Further benefits associated with the usage of fluorescent nanoparticles are: (1) Enhanced fluorescence intensities owing to a potential multiple loading of fluorophores into the particle, (2) increased surface area of the nanoparticle, which is perfectly suited for the attachment of targeting moieties or stealth polymers and (3) enhanced in vivo distribution as well as prolonged blood circulation time of the nanoagents compared to single dye molecules. Moreover, if two or more different chromophores are embedded in the polymer, it is also possible to obtain systems with switchable emission and/or stimuli-responsive fluorescent nanoparticles.[25] Nevertheless, for a realistic in vivo application of fluorescent nanoparticles the agents have to fulfill a couple of prerequisites: (1) Fluorescent nanoparticles have to exhibit high purity and must be non-toxic to ensure a safe administration; (2) superior colloidal stability must be given in biological systems in order to avoid degradation or agglomeration and to prolong the blood circulation time, (3) carriers should be targetable for a controlled imaging, (4) complete 
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clearance from biological systems must be warranted after the imaging process is completed and (5) dye containing nanoparticles should posses a high and stable fluorescence to ensure the long-term imaging as well as a good signal-to-noise ratio. In order to realize the development of nanocarriers that fulfill all prerequisites mentioned above, the polymers used as matrix material should offer excellent biocompatibility, low or non-toxicity and the ability to form stable particles that persist over a long time also in biological environments.  To this end, a significant amount of effort was devoted to the synthesis and characterization of biocompatible polymers as matrix material. By utilizing living and controlled polymerization techniques, the architecture, composition and constitution as well as molar mass of the polymer can be easily adjusted resulting in defined chemical and physical properties. Polymers such as poly(lactide-co-glycolide) (PLGA)  and poly(ε-caprolactone) (PCL) and poly(methyl methacrylate) (PMMA) derivatives are often used (Scheme 2.1).[26] PLGA is thereby most extensively investigated as matrix material for nanoparticle based diagnostic and drug delivery owing to its outstanding characteristics, such as excellent biocompatibility, biodegradability into metabolizable moieties, and good manufacturing abilities.[27] PCL represents a good alternative that shows comparable properties and is also widely applied for particle-based drug delivery and imaging application.[28] Although nanoparticles consisting of PMMA are not biodegradable, their proven biocompatibility and high stability in vitro and in vivo declare them suitable for in 
vivo applications.[29,30]  PMMA is a FDA approved polymer for some in vivo applications (contact and intraocular lenses, filler for bone cavities) and can be combined with versatile polymers to obtained functional copolymers with fine-tuned properties.[29,30] Beside the synthetic compounds, which can be tailored with regard to their desired properties, biopolymers are well-suited for nanoparticle preparation as they offer excellent biocompatibility, good biodegradability as well as multiple functional groups for conjugation with dyes or drugs. Important representatives amongst others are polysaccharides, such as dextran and chitosan.[8,31]  
 
Scheme 2.1. Schematic representation of synthetic and natural polymers applied for the synthesis of nanoparticles.  To prepare fluorescent nanoparticles, two different techniques can be applied to embed the fluorophore in a polymer matrix. The non-covalent procedure is characterized by physical entrapment of the dye molecules in the matrix material, either by encapsulation during the particle formation or by diffusion of the dye molecules into the nanoparticle core. The physical inclusion method has the advantage that changes in the optical properties evoked by the attachment of the dye to the polymer backbone do not occur. Additionally, the 
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manner of possible dyes is much less limited as no functionality on the chromophore is required for a chemical attachment. However, the dye may leak out of the nanoparticle shell. Such a leakage can be prevented by covalent attachment of the dye to the polymer scaffold. Several techniques can be utilized for the preparation of fluorescent nanoparticles. In detail, 
in situ polymerization of monomers in an emulsion polymerization can be performed.[32] In addition, particles are fabricated by forcing the polymer material into nanostructures. Therefore, single or double emulsification, solvent-displacement/ nanoprecipitation, electro spraying, salting out, supercritical- and microfluidic processes as well as the inkjet printing of nanoparticles were developed.[10,11]  In order to predict the particles fate in vivo, their physicochemical characteristics as well as target unit should be adjusted very carefully with regard to the final application (Figure 2.1). By implementation of passive (size, shape, charge) and active (targeting moieties) targeting concepts, nanoparticles can be directed to desired active sites (tumors) without adverse effects such as fast blood clearance by the macrophagocytotic system or accumulation in healthy tissue.[3,12] For an improved diagnostic application, it is essential that the fluorescent particles accumulate, but to a great extend only in the target site to avoid interferences and will achieve high signal-to-background ratios for, e.g., refined tumor detection. The most important passive targeting parameter of the nanoparticles is their size. In literature, controversial size specifications are found to be used for in vitro and in vivo applications.[17] Although the data range thereby from small particles below 10 nm up to a size of 500 nm, the optimal particle diameter is expected to be in the range of 30 nm to 200 nm, since nanoparticles in that size range benefit from the enhanced permeation and retention (EPR) effect.[33] The influence of the shape was also determined to be considerable. In detail, rod-like nanoparticles with high aspect-ratios were internalized faster into cells in comparison to spherical ones with similar volume.[13] Furthermore, it was predicted that prolate ellipsoids and discoidal shapes possess prolonged blood circulation times in comparison to spherical nanoparticles and are internalized most effectively into cells.[34] Likewise controversially discussed as the size, the surface charge has an explicit impact on the particle stability and their interactions in suspension with cells and proteins. 
In vitro studies suggest that positively charged particles reveal a high cellular uptake through endocytosis because of the attraction for the negatively charged cell membrane (due to the presence of phospholipid groups and proteins).[17,35] But as a result of this sticking, they display also highly non-specific internalization rates. Contrary, it was remarked that strong negatively charged nanoparticles exhibited lower cellular uptake efficiencies, but also decreased plasma protein absorption as well as non-specific interactions.[35] For in vivo applications, a neutral charge was found to be more beneficial due to the fact that charged nanoparticles are recognized by the macrophagocytotic system and rapidly cleared from the body.[35] To this end, the nanocarriers are often surface-functionalized with non-charged hydrophilic polymers, such as poly(ethylene glycol) (PEG), in order to minimize nonspecific protein binding and to enable prolonged blood circulation.[36,37]  
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Figure 2.1. Important parameters for the design of polymeric nanoparticles.  Moreover, for in vivo applications an active targeting strategy of the nanoparticles is beneficial to ensure a controlled accumulation in the desired tissue.[38] The idea is to conjugate ligands, such as antibodies, peptides, nucleic acids and other small molecules to the nanoparticle surface, which bind specifically to antigens or receptors that are only expressed on the target cells.[39] Manifold studies demonstrated that the attachment of targeting units, in particular in combination with a PEG surface modification, significantly increased the accumulation of the nanoparticles in the tumor tissue.[40,41] The undesired accumulation in healthy organs, such as liver, spleen, heart and lung was thereby decreased, which is beneficial in terms of enhanced cancer detection and unknown long-time consequences that might be accompanied with the application of fluorescent nanoparticles. In the past few years a great progress in the development of polymer based nanoscale agents could be observed and many promising studies demonstrated the large potential of targeted fluorescent particles for selective imaging. However, in order to realize the usage of polymeric nanoparticles in clinical applications it is certainly required to gain deeper knowledge about their production and design, in vivo stability, circulation behavior and their interactions with blood, proteins and cells as well as their definite faith.    
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3.  Nanoprecipitation for tailored nanoparticle preparation 
 
Parts of this chapter have been published: P2) I. Y. Perevyazko, A. Vollrath, S. Schubert, G. M. Pavlov, U. S. 
Schubert, J. Polym. Sci., Part A: Polym. Chem. 2010, 48, 3924-3931. P3) I. Y. Perevyazko, J. T. Jr. Delaney, 
A. Vollrath, G. M. Pavlov, S. Schubert, U. S. Schubert,  Soft Matter 2011, 7, 5030-5035. P4) I. Y. 
Perevyazko, A. Vollrath, C. Pietsch, S. Schubert, G. M. Pavlov, U. S. Schubert,  J. Polym. Sci., Part A: 
Polym. Chem. 2012, 50, 2906-2913.  
 As mentioned in the last chapter, nanoparticles were investigated with great effort in the last years as a result of their enormous potential in diagnostic and therapy, but their controlled and reproducible production and their specific design still remain a demanding process. One straightforward methodology that gained significant attention for the construction of nanoparticles, by both industry and academia, is nanoprecipitation.[42-44] This method describes the formation of nanoparticles if a dissolved polymer is exposed to a non-solvent and is known as a facile and time efficient as well as inexpensive preparation technique. Nanoprecipitation offers a remarkable and unique advantage over alternative techniques, meaning no surfactants are required, which is of high relevance for biological studies. Furthermore, since for preparation of the nanoparticles no washing step is necessary, the concentration of the polymeric particles in the suspensions remains constant and must not be determined in subsequent time-consuming lyophilization and weighing procedures. The term nanoprecipitation encompasses the dialysis and the dropping technique (Figure 3.1a, b). Dialysis describes the exchange of the solvent against the non-solvent molecules through membranes, while the dropping technique specifies the dropwise addition of a polymer solution to the non-solvent while stirring (or vice versa).  Both methods allow the manipulation of the nanoparticle sizes by alteration of the initial polymer concentration, while the dropping technique additionally convinces with low costs (non-necessity of a membrane) and the ability to fine-tune the size and shape of the nanoparticles by the way of dropping (Figure 3.1c). While the dropwise addition of the polymer solution into water yields small but irregularly formed nanoparticles as a results of the rapid replacement of the solvent to the non-solvent, the addition of water into the polymer solution tends to result in more defined, spherical nanoparticles due to the stepwise change of the solvent environment (Figure 3.1d). Due to the great applicability of the nanoprecipitation methodology for manifold materials, versatile synthetic polymers were tested with regard to their potential to form nanoparticles. To this end, the polymers were dissolved in suitable solvents, e.g., acetone or tetrahydrofuran (THF), with a concentration of 1 to 10 mg ∙ mL-1 and added dropwise into water or water was added to the polymer solutions, respectively. It could be shown that almost all polymers were able to form stable particles on the nanoscale by applying nanoprecipitation for particle formulation (Table S.1 and Figure S.1, supporting information).   
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Figure 3.1. Left: Overview about the nanoprecipitation methods (a) of dialysis and (b) dropping technique. Right: Tuning possibilities of the size and shape of the nanoparticles by variation of (c) initial polymer concentration and (d) dropping method.  Stimulated by the successful application of nanoprecipitation for various synthetic polymers, the dropping technique was accomplished in a high-throughput (HT) manner via utilization of pipetting robots, in order to facilitate a faster, reproducible, and more in-depth exploration of process-property relationships of the materials. In particular, for the development of improved particle formulations for drug delivery or systematic biotechnological studies, the HT-nanoprecipitation represents a highly suitable tool. In a first set of experiments, the biocompatible polymers poly(methyl methacrylate-stat-methylacrylic acid) (p(MMA-stat-MAA)0.66:0.33), poly(lactide-co-glycolide)0.5:0.5 (PLGA) and acetal-derivatized dextran (ac-dex) were chosen to be processed via HT-nanoprecipitation (Figure 3.2a). The interplay of the manufacture process and the resulting characteristics of the nanoparticles was thereby investigated by alteration of the initial polymer concentration and the solvent-to-non-solvent ratio (Figure 3.2b). For this purpose, a dilution series of the respective polymer solution with concentrations ranging from 1 mg · mL-1 up to 12 mg · mL-1 was created and combined with different proportions of water, in a way that the solvent (acetone) to non-solvent (water) ratios varied from 0.1 to 0.5 (v/v). After each polymer solution was added dropwise into water, the net result was an array of 96 different formulations, which exhibits a visually observable trend in appearance, following the changes made in the nanoprecipitation process (Figure 3.2b).  The fabricated plates of the different nanoparticle formulations were subsequently characterized with regard to their particle size distribution in an automated manner using a high-throughput dynamic light scattering (HT-DLS) device (Figure 3.2c). The HT-DLS measurements confirmed the dependency of the final average particle sizes on the polymer concentration (Figure 3.3a-c). At diluted polymer concentrations, the nanoprecipitation process yielded small nanoparticle sizes below 100 nm with monomodal and narrow size distributions for all polymers. But with rising concentration, the particle diameters 
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increased, which was indicated before by the increased turbidity of the suspensions. In detail, 60 nm to 290 nm sized nanoparticles were obtained by nanoprecipitation of the p(MMA-stat-MAA)0.66:0.33 polymer within a concentration range from 1 mg · mL-1 to 12 mg · mL-1 (Figure 3.3a). The sizes of the PLGA nanoparticles varied from 40 nm for 1 mg · mL-1 to 170 nm for 10 mg · mL-1, while ac-dex particles revealed increasing sizes from 80 nm to 140 nm for the same range of concentrations (Figure 3.2b,c).  
Figure 3.2.  HT-experimental set-up: (a) HT-nanoprecipitation of polymers a pipetting robot. (b) Layout of a 96 well plate after nanoprecipitation. The concentration of the polymer is varied along the x-axis and the ratio of solvent/non-solvent solution along the y-axis. (c) The final well plates of different nanoparticle formulations were characterized using HT-DLS. For all examined polymers the tendency of a growth of the mean particle diameter as a function of initial polymer concentration was detected. This effect was expected since with higher concentration of the polymer in the organic phase more polymer molecules per unit volume of solvent are present. A comparatively small effect on the nanoparticle sizes exhibited the solvent to non-solvent ratio in the studied region. Merely a slight decline in the mean nanoparticle diameter with increasing solvent/non-solvent ratio was observed. Furthermore, the polymer characteristics itself revealed a high impact on the nanoparticle size as well. Regarding to its hydrophobicity and molar mass, a difference in the particle formation for the different polymers is the consequence. By HT-DLS investigations, an exponential growing in the particle size was observed for the p(MMA-stat-MAA)0.66:0.33 copolymer, while the sizes of the ac-dex particles increase less considerably, and the concentration dependence tends to play a minor role (Figure 3.3d). The tendency obtained for PLGA-nanoparticles is located between the p(MMA-stat-MAA)0.66:0.33 and ac-dex, and it also tends to show a linear correlation between concentration and size, contrary to the exponential one of the p(MMA-stat-MAA)0.66:0.33 copolymer. To evaluate the influence of the polymers and the manufacturing parameters on the resulting surface charge of the nanoparticles, zeta potential (ζ) measurements were performed of selected samples. As mentioned in Chapter 2, the zeta potential provides vital information about the nanoparticle stability and affects the cellular internalization as well as the biodistribution in vivo.[17,45] p(MMA-stat-MAA)0.66:0.33 particles revealed values between ζ = ‒17  to ‒65 mV, while a lower 
surface charge of ζ = ‒14  to ‒22 mV was obtained for ac-dex and PLGA particles. A correlation of the zeta potential and particle size was evident due to the fact that the surface charge was increasing with higher polymer concentrations, whereas with varying solvent/non-solvent ratio the measured zeta potential remained unchanged. 
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Figure 3.3. (a) P(MMA-stat-MAA)0.66:0.33, PLGA, and ac-dex applied for HT-nanoprecipitation and (b) corresponding 3-D representation of the size distribution obtained by HT-DLS as a function of initial polymer concentration and solvent to non-solvent ratio. The particle suspensions were prepared by dropping the polymer acetone solution into water.   Additional studies were addressed to extend the understanding of the effect of the molar mass of the polymer on the nanoparticle formation. For this purpose, a homologous series of a poly(methyl methacrylate) (PMMA) polymer with molar masses ranging from 3,000 g · mol-1 to 278,000 g · mol-1 was applied for the HT-nanoprecipitation process. In first studies identical to previous experiments, the polymer concentration and the solvent to non-solvent ratio were altered. HT-DLS measurements revealed that with increasing molar mass of the PMMA polymer the range of particle sizes was rising as well, while the critical polymer concentration for aggregation was decreased (Figure 3.4). For instance, PMMA with a molar mass of 38,000 g · mol-1 showed an aggregation of the particles already at an initial concentration above 10 mg · mL-1, whereas PMMA with a molar mass of 6,000 g · mol-1 formed stable nanoparticles up to a concentration of c = 30 mg · mL-1.   
Figure 3.4. 3D-Representation of a size distribution obtained by DLS of PMMA polymers with different molar masses: (a) Mw = 6,000 g · mol-1, (b) Mw = 18,000 g · mol-1, and (c) Mw = 38,000 g · mol-1.  The particles were prepared by dropping polymer acetone solution in water. 
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However, to allow a reliable conclusion about the influence of the molar mass of the polymer it is crucial to maintain the same initial conditions for each nanoprecipitation process. But since polymers with various molar mass will occupy different volumes owing to the altered length of a polymer chain, the equality of the initial polymer concentration will not reflect the same conditions for the nanoprecipitation process. Thus, a approximation of the volume fraction of the macromolecular coils in the solution represented by the product of the polymer concentration (c) and the intrinsic viscosity [ ], the so-called Debye parameter (c ∙ [ ]) was introduced. If c ∙ [ ] << 1, the polymer solution can be considered as diluted and overlapping of the macromolecular coils can be excluded. Therefore, in further HT-experiments the nanoparticle suspensions of the different PMMA polymers were prepared with a degree of dilution ranging from 0.004 < c ∙ [ ] < 0.12. As expected, the particle size increased with increasing Debye parameter. The detected growth of the particle size was thereby more rapidly for higher molar mass polymers and reached a plateau. Furthermore, it was investigated that generally stable nanosuspensions were only observed when c ∙ [ ] < 0.1 was applied. For c ∙ [ ] > 0.1 the nanoparticle suspensions were found to be highly polydisperse with diameters larger than 500 nm. Thus, it could proven that not only the polymer concentration, but rather the volume fraction occupied by the polymer macromolecular coil and, related to this, the molar mass, are key factors for the production of well-defined particles on the basis of a certain polymer.  In conclusion, it was demonstrated that nanoprecipitation represents a well-suitable methodology for the preparation of polymeric nanoparticles with desired size and polydispersity. In order to allow the preparation of particle suspensions in large numbers in an automated, reproducible manner, a HT-nanoprecipitation technology was developed for a highly efficient particle formulation screening. With the assistance of the HT-nanoprecipitation set-up, it was verified that the properties of polymeric nanoparticles primarily depend on the initial polymer characteristics and concentration used for nanoprecipitation process. 
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4. Advanced characterization of nanoparticles 
 
Parts of this chapter have been published: P2) I. Y. Perevyazko, A. Vollrath, S. Schubert, G. M. Pavlov, U. S. 
Schubert, J. Polym. Sci., Part A: Polym. Chem. 2010, 48, 3924−3931. P5) A. Vollrath, D. Pretzel, C. Pietsch, 
I. Y. Perevyazko, R. Menzel, S. Schubert, G. M. Pavlov, D. Weiß, R. Beckert, U. S. Schubert, Macromol. 
Rapid Commun. 2012, 33, 1791−1797. 
 For future applications of nanoparticle dispersions in biomedical fields the tailoring of the main particle parameters like mean size, size distribution and shape is extremely important.[13,17,18] To optimize nanosuspensions and to prevent undesired side effects like aggregation (e.g., of drug-containing particles in the blood stream), a detailed analysis of the nanoparticle characteristics with regard to their preparation procedure must be ensured. A frequently used technique to characterize nanoparticles is dynamic light scattering (DLS).[46,47] Based on the detection of the fluctuation of scattered light caused by the Brownian motion of particles in the sub micron region, the translational diffusion coefficient (D) is determined and used to calculate the average hydrodynamic diameter (dh, Z average) 
via the Einstein-Stokes equation (4.1) and the polydispersity.[48,49] The calculated particle size is thereby assumed to be the size of a sphere that reveals the same diffusion coefficient as the scatterer.         
        
                           (4.1)  In general, DLS is a rapid, facile and well adapted method for routine measurements of nanoparticles. However, for very polydisperse samples or high concentrated suspensions the accurate data analysis and interpretation becomes demanding due to the occurrence of multi scattering.[50] Multiangle DLS analysis offers here more detailed insights into the nanoparticle size and provides further information about the shape. But accordingly the measurement time and data analysis becomes more complex and time-consuming. Adversely, DLS is very sensitive against the presence of small amounts of aggregates, larger particles or dust.[18] Hence, the intensity distribution can be somewhat misleading (e.g., due to an enormous increase in mean calculated size) since the scattering intensity of spherical particles is proportional to the power of six of the diameter or the square of the molar mass (I ~ d6 ~ M2). Although the intensity weighted distribution can be transformed into volume and number weighted distributions based on the Mie theory, all results obtained by DLS investigations should be advisedly evaluated.[49] In addition, a couple of parameters like viscosity of the medium, refractive index and concentration of the suspension as well as temperature may also affect the data and should be considered very carefully. Thus, for a reliable conclusion about the particle size and size distribution the application of additional analysis methods such as scanning electron microscopy (SEM) or analytical ultracentrifugation (AUC) are required.[51,52]   
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SEM offers the advantage that an image of the particles is obtained, and, hence, also detailed information about the nanoparticle shape and surface (roughness) can be achieved. In comparison to DLS, the particles are investigated in a dried status. This is beneficial because once the sample is prepared it is less sensitive against measurement artifacts. But during the drying process particle shrinking appears, which frequently results in underestimated particle sizes.[52,53] However, resolution problems may arise with particles well below 100 nm, depending on the instrument. The sample preparation, measurement and analysis are additionally more elaborating for the microscopy method than for the DLS investigations. Furthermore, SEM images provide only information about a small fraction of nanoparticles, whereas DLS enables a more statistical size analysis of many nanoparticles in the suspension.[52,53] Likewise DLS, AUC measurements are performed in solution and no further sample preparation is necessary. AUC detects the sedimentation of objects in solution during the centrifugation with different optical systems and provides information about size, size distribution, shape and molar mass of nanoparticles in a range of 1 nm to 100 μm.[54,55] Although providing many information about the nanoparticle suspension, AUC requires a complex and time-intensive data analysis and various parameters, such as viscosity and density of the solvent as well as density of the particles, need to be considered.  Consequently, in order to obtain an all-embracing insight into the particle size and size distributions for a reliable conclusion, all polymeric nanoparticles fabricated by nanoprecipitation were investigated by at least two of the before mentioned analysis methods.  In a first study, different poly(methyl methacrylate) (PMMA) copolymers, like a poly(methyl methacrylate)-stat-(methacrylic acid)  (p(MMA-stat-MAA)0.66:0.33) and a fluorescence labeled poly(methyl methacrylate)-stat-(pyrene-methacrylic acid) (p(MMA-
stat-PyMAA)0.95:0.05)  polymer were precipitated by dialysis and the dropping method, and the nanoparticles obtained were characterized by DLS, SEM and AUC (Table 4.1).   
Table 4.1. Weight average diameters of p(MMA-stat-PyMAA)0.95:0.05 and p(MMA-stat-MAA)0.66:0.33 nanoparticles determined by DLS, SEM and AUC. Polymer Nanoprecipitation method dDLS [nm] PDIP dSEM [nm] dAUC [nm] 
p(MMA-stat-PyMAA)0.95:0.05 Dialysis 480 0.35 280 570 Dropping AW 100 0.23 75 65 Dropping WA 680 0.32 490 380 
p(MMA-stat-MAA)0.66:0.33 Dialysis 46 0.31 36 28 Dropping AW 41 0.30 43 35 Dropping WA 190 0.13 110 104 AW = polymer acetone solution was dropped into water, WA = water was dropped into polymer acetone solution.  
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For a facile comparison of the size distribution measured by SEM with the values obtained by DLS and AUC, the weight average diameters were calculated from the SEM images, whereby the number of individual particles N considered in the calculations varied between 100 and 300. A satisfactorily good agreement of the three analysis techniques was identified for small nanoparticles below 100 nm (Table 4.1). But with rising diameters of the nanoparticles, the sizes obtained by the different techniques vary incremental. Often DLS revealed the largest values, which was expected due to the before mentioned sensitivity against the presence of aggregates and dust as well as the overrepresentation of larger particles. In return, SEM provided in most cases the smallest size values, which was likewise 
expected due to the “dried state” investigation. For a closer look, the size distributions for p(MMA-stat-MAA)0.66:0.33  particles measured by DLS, SEM, and AUC are shown as a typical example in Figure 4.1. The shapes of the distributions obtained from the different techniques had a similar appearance (i.e., similar modalities of distribution). But the DLS size distribution clearly exceeded the sizes obtained by AUC and SEM, which were found to be in a good agreement. The observed considerable discrepancies in the sizes and size distributions proved the necessity of different characterization techniques for a final conclusion about the nanoparticle size.  
0 100 200 300 400 500 600
0,0
0,2
0,4
0,6
0,8
1,0
c(
d)
, ¶


¶
d
d, nm  
Figure 4.1. Size distribution of nanoparticles (prepared from an acetone solution of p(MMA-stat-MAA)0.66:0.33   by dropping water into it) as analyzed by SEM (in bars), AUC (    ) and DLS (---). 
  In another study, a PMMA copolymer that contained methacrylate units functionalized with a thiazole chromophore (MAy) (p(MMA-stat-MAy)0.97:0.03) was utilized.  Differently sized nanoparticles were prepared by nanoprecipitation and separated using the preparative ultracentrifugation (PUC). PUC is a technique that can be used to fractionate nanoparticles and provides another degree of physical control of the size distribution of particles on the nanoscale compared to nanoprecipitation.[56-60] In the following, the particles were characterized by DLS, SEM and AUC to evaluate the dimensions of the nanoprecipitation method as well as of the characterization techniques. However, by means of the two techniques a small (S) and a large (L) nanoparticle batch was prepared, respectively, whereby S1 and L1 were produced by the dropping method and S2 and L2 were obtained by PUC fractionation of an initially polydisperse sample. The resulting diameters observed by DLS, SEM and AUC are displayed in Table 4.2.  
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 It was explored that the small p(MMA-stat-MAy)0.97:0.03 particle batches (S1 and S2) revealed similar average sizes and size distributions proving the superior qualification of the nanoprecipitation to prepare narrow, defined nanoparticles in a straightforward manner. Contrary, for the larger particles (L1 and L2) diverging sizes were obtained ranging from 400 up to 600 nm, depending on the characterization method applied. Although no remarkable discrepancy in the size plots of the differently prepared particle suspensions could be observed by DLS (Figure 4.2a), the distributions obtained by AUC already illustrate broader size distribution for the samples prepared by nanoprecipitation (Figure 4.2b). This was further confirmed by a detailed analysis of the SEM images, in which the fractionated samples were obviously more uniform in their size than the initial, non-fractionated samples (Figure 4.2c). Yet, it is difficult to predict if a fractionation process by PUC is actually more efficient than using a defined nanoprecipitation process. The precipitation method convinces due to its fast and easy applicability. Furthermore, it already led to monomodal and narrow size distributions for the small nanoparticles. In contrast, for the large particles prepared by nanoprecipitation a broader size distribution was observed (as revealed by AUC and SEM measurements) indicating that the effort to use PUC for more distinct size distribution might be profitable.  
 
Figure 4.2. Characterization of small and large nanoparticles of p(MMA-stat-MAy)0.97:0.03 prepared by nanoprecipitation and fractionation via PUC. Size distributions of the particles in water determined by DLS (a) and AUC (b) as well as SEM images of the particle suspensions (c). 
Table 4.2. Summary of the size distributions of the nanoparticles based on p(MMA-stat-MAy)0.97:0.03.  Sample Preparation method dDLS [nm] PDIP dSEM [nm] dAUC [nm] 
S1  Nanoprecipitation 118 0.10 111 120 
L1 Nanoprecipitation 488 0.03 696 503 
S2 PUC fractionation 120 0.26 131 97 
L2 PUC  fractionation 597 0.19 502 381 
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In conclusion, for a detailed characterization of nanoparticles orthogonal analysis techniques are required. Certainly, all mentioned characterization methods have their advantages as well as their limitations and none of the techniques provides ultimate information about the size and shape as well as flow behavior of nanoparticle systems. Only a combination of these techniques can lead to satisfying characterization results. Therefore, all prepared suspensions were characterized with at least two analysis techniques, mostly DLS and SEM.   
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5. Targeting of polymeric nanoparticles for cell internalization 
studies  
Parts of this chapter have been published: P5) A. Vollrath, D. Pretzel, C. Pietsch, I. Y. Perevyazko, R. 
Menzel, S. Schubert, G. M. Pavlov, D. Weiß, R. Beckert, U. S. Schubert, Macromol. Rapid Commun. 2012, 
33, 1791−1797. P6) A. Vollrath, A. Schallon, C. Pietsch, S. Schubert, T. Nomoto, Y. Matsumoto, K. Kataoka, 
U. S. Schubert, Soft Matter 2013, 9, 99−108. P7) K. Babiuch, D. Pretzel, T. Tolstik, A. Vollrath, S. Stanca, F. 
Foertsch, C. R. Becer, M. Gottschaldt, C. Biskup, U. S. Schubert, Macromol. Biosci. 2012, 12, 1190–1199.  
 For an efficient utilization of nanoparticles in diagnostic and therapy with low or non-adverse side effects, it is crucial to address them specifically to the target side of action. Nowadays, different strategies for a controlled nanoparticle application are available, encompassing passive and active targeting concepts.     
5.1 Passive targeting As already discussed in Chapter 1, the most important passive targeting parameter is the size since it certainly influences the biodistribution and cellular internalization of nanoparticles significantly.[13,17] While for large particles up to the range of 10 µm a cellular uptake via phagocytosis and macropinocytosis is assumed, smaller particles below 300 nm most likely internalize into cells by clathrin- and caveolin-dependent endocytosis.[61-64] Although plenty of investigations focused on the understanding of the cellular internalization process of nanoparticles, no final conclusion regarding the size dependency can be drawn, due to the fact that the studies are based on different materials and cells.[14,17] Furthermore, the nanoparticles were frequently prepared by techniques that require the use of surfactants, which were found to influence the cellular uptake as well.[65]  To achieve well-defined nanoparticles with different sizes for cellular uptake studies in the absence of any surfactants, poly(methyl methacrylate) (PMMA) copolymers were formulated into nanoparticles via the nanoprecipitation method. The intracellular detection of the particles was thereby enabled by incooperation of various fluorescent dyes into the copolymers used as matrix material. The fluorophores were either covalently introduced during the polymerization reaction or chemically attached in a post-modification reaction to the polymer. A thiazole chromophore functionalized poly(methyl methacrylate)-stat-(methacrylic acid)  (p(MMA-stat-MAy)0.97:0.03) copolymer was applied for nanoprecipitation, whereby small particles were obtained by dropping the polymer acetone solution with a concentration of 4 mg · mL-1 into water. Larger particles were achieved if water was added to a polymer acetone solution with a concentration of 3 mg · mL-1. In addition, small and large particles were furthermore prepared by fractionation of a polydisperse nanosuspension via preparative ultracentrifugation (PUC). The comprehensive characterization of the prepared nanoparticles via orthogonal analytical techniques, such as dynamic light scattering (DLS), scanning electron microscopy (SEM) and analytical ultracentrifugation (AUC), was already discussed in Chapter 4. All suspensions revealed 
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monomodal particle size distributions in the range of 120 nm (small) or 500 nm (large), respectively.  In order to ensure that the nanoparticles would be applicable for biological studies, the occurrence of adverse side effects, e.g., bulk precipitation and Ostwald ripening during storage or at subsequent manufacturing processes, such as autoclavation and lyophilization, must be excluded. For this purpose, stability studies of the nanoparticles were performed. In detail, samples of the initial nanosuspensions were analyzed by DLS and SEM after storage for 6 months at 5 °C, incubation with cell culture media (DMEM), centrifugation at 24.650 g for 20 minutes, autoclavation and lyophilization with subsequent resuspension. Since no signs of instability in terms of agglomeration or creaming up and no changes in the size distributions were observed, the nanoparticles were declared as highly stable and well-suitable for in vitro studies.  To investigate the biocompatibility and cell internalization of the nanoparticles, mouse fibroblasts L929 cells were incubated with the suspensions. The particles revealed excellent biocompatibility, since no cytotoxicity, hemolytic activity and no red blood cell aggregation was observed. Furthermore, a concentration dependent internalization of the particles was proven by CLSM, whereby a clear discrimination of small and large particles was possible regarding the amount of cells with internalized nanoparticles (Figure 5.1). Next to the size and the concentration, the preparation method exhibited a significant influence on the resulting nanoparticle-cell interaction. The particles prepared by fractionation via PUC were internalized to a much higher degree compared to the suspensions prepared by simple nanoprecipitation. This unexpected difference is presumably caused by the presence of sugar molecules on the surface of the fractionated nanoparticles since sucrose was used as concentration gradient during the PUC treatment.[45] Even after purification by extensive dialysis, some sucrose moieties might still be attached on the particle surface leading to enhanced cellular recognition and internalization.[66-68]  
 
Figure 5.1. Confocal fluorescence images of L929 cells after 24 h incubation with polymeric p(MMA-stat-MAy) nanoparticles (green). Cells incubated with polymer free culture medium served as control (not shown). All images were obtained with identical instrument settings (scale bars 10 µm). 
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Continuative studies aimed to explore the size dependent internalization of particles into cells in more detail. To this end, p(MMA-stat-MAA)0.91:0.09 was post-functionalized with various fluorescent dyes (DY-495, DY-547 and DY-647) to obtain differently labeled copolymers for the preparation of nanoparticles (Scheme 5.1). For the labeling reaction (1-ethyl-3-(3-dimethylamino-propyl)carbodiimide (EDC) was used as coupling reagent. A low degree of labeling was sufficient due to the superior fluorescent properties of the selected dyes, and ensures similar properties for all copolymers as well as minimizes the influence of the dyes on the nanoprecipitation procedure. The fluorescence emission spectra of the purified copolymers p(MMA-stat-MAgreen), p(MMA-stat-MAorange), and p(MMA-
stat-MAred) revealed distinct peaks at 525 nm, 568 nm, and 668 nm, respectively. In comparison to the initial emission of the pure dyes, no significant change in the fluorescence behavior was obtained. SEC measurements exhibited a minor change of the elution volume of the labeled copolymers in comparison to unmodified p(MMA-stat-MAA)0.91:0.09, which indicated a slight increase of the molar mass as a result of the dye conjugation and supported the assumption that the polymer was not degraded or cross-linked during the labeling procedure. The overlay of the diode array detector and refractive index traces of the labeled samples further confirmed the successful covalent attachment of the dyes.  
 
 
Scheme 5.1. Schematic representation of the reaction of p(MMA-stat-MAA)0.91:0.09 with the DY-495 (green excitation), DY-547 (orange excitation), and DY-647 (red excitation) using EDC as coupling reagent. After detailed characterization of the fluorescent copolymers, the nanoparticles were prepared only via nanoprecipitation in order to avoid any possible influence of other parameters (such as the presence of sugars on the surface). To achieve differently sized nanoparticles, the initial polymer concentration in the organic phase and the dropping method (polymer acetone solution into water or water into polymer acetone solution) were altered. The conditions used for the preparation of small, medium and large nanoparticles as well as their resulting sizes investigated by DLS are displayed in Table 5.1. 
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AW = Polymer acetone solution was dropped into water, WA = water was dropped into polymer acetone solution. In detail, small nanoparticles in the range of 80 nm, medium particles with diameters of 170 nm and large nanospheres with an average size of 360 nm were obtained. Low PDIP values indicated narrow size distribution, in particular for the medium and large particles, which were further verified by SEM investigations (Figure 5.2). Repetitive zeta potential measurements ascertained similar charge values in the range of 30 ± 10 mV for all nanoparticles indicating a good stability of the suspensions. Similar zeta potential values are furthemore essential since the focus was set on the influence of the size and not on the surface charge. To confirm the nanoparticles stability, the suspensions were centrifuged at 24.650 g for 20 min, autoclaved, incubated in PBS or cell culture media as well as titrated in a pH range of 4 to 10. Subsequent analysis by DLS, zeta potential measurements and SEM revealed that neither the size distributions nor the zeta potential values changed proving the high stability of the p(MMA-stat-MAdye) nanoparticles as well as their eligibility to be used for further biological studies.  
 
Figure 5.2. Representative SEM images and DLS intensity size distribution with corresponding Z average value and PDIP of the small, medium and large particles of the p(MMA-stat-MAdye) copolymer.  In first internalization studies with HeLa cells, a rapid uptake of medium sized particles was detected by flow cytometry investigations, whereas the large and small nanoparticles exhibited a slower internalization. In subsequent localization studies, mixtures of the various sized nanoparticles bearing different labels were applied simultaneously. Confocal 
Table 5.1. Summary of the nanoprecipitation conditions as well as resulting Z average value (dDLS) and polydispersity index (PDIP) of representative nanoparticles prepared using p(MMA-stat-MAdye). The solvent/non-solvent ratio was 0.25. 
 Polymer Nanoprecipitation method Polymer concentration [mg ∙ mL-1] dDLS [nm] PDIp p(MMA-stat-MAgreen) Dropping AW 1 80 0.26 p(MMA-stat-MAorange) Dropping AW 10 170 0.06 p(MMA-stat-MAred) Dropping WA 4 360 0.07 
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laser scanning microscopy measurements revealed the same cellular distribution of small and medium sized nanoparticles as both were detected in the late endosomes/lysosomes, whereas the large nanoparticles showed marginal co-localization with them. In additional experiments, different inhibitors for clathrin-dependent (chlorpromazine) and caveolin-dependent (filipin III) endocytosis as well as macropinocytosis (EIPA) were applied to confirm that small and medium nanoparticles with d < 200 nm were internalized via clathrin-dependent endocytosis, whereas larger nanoparticles with d > 300 nm were internalized via macropinocytosis.  In summary, highly fluorescent nanoparticles with different sizes were obtained via nanoprecipitation and PUC from various p(MMA-stat-MAdye) copolymers that were labeled with a range of different fluorophores. It was evaluated that the nanoprecipitation technique is more suitable for the preparation of nanoparticles with defined surfaces, since the PUC samples might carry sugar moieties at the surface. Furthermore, it was proven that p(MMA-stat-MAdye) copolymers represent excellent well-defined materials for the preparation of biocompatible nanoparticles: The size of the particles was easily tunable, the suspensions showed excellent stability without the usage of any surfactants and all particles were internalized into cellular compartments without any cytotoxic effects. Moreover, a size as well as a concentration dependent internalization of the particles was proven.  
5.2 Active targeting Although the adjustment of passive targeting parameters, e.g., the size and charge, is of vital importance, an active targeting of the nanoparticles via surface functionalization with ligands that bind selectively to specific cells represents the most promising concept for defined diagnostic and drug delivery applications.[17] As mentioned in Chapter 2, sugar moieties are popular targeting units, which are broadly available and known to enhance the specific cellular uptake of nanoparticles.[12,39] To explore the relationship between the sugar type attached to the particle and the resulting biorecognition and internalization, nanoparticles were prepared of fluorescence labeled poly(styrene-block-pentafluorostyrene)54:33 (PS-b-PTFS) copolymers that either contain β-D-thioglucose (PS-b-PTFSGlcOH) or β-D-thiogalactose (PS-b-PTFSGalOH) as different sugar moieties. The nanoparticles prepared were subsequently incubated with a human hepatocellular carcinoma cell line (HepG2 HCC) that expresses selective receptors for galactose. For the nanoparticle preparation, the glycopolymers PS-b-PTFSGlcOH and PS-b-PTFSGalOH were dissolved in a mixture of tetrahydrofuran (THF) and distilled water (1:1) with a concentration of 4 mg ∙ mL-1 and water was added dropwise to cause nanoprecipitation of the polystyrene block. After evaporation of the THF, both particle suspensions revealed final hydrodynamic diameters of 20 nm (Figure 5.3a), which was further confirmed by investigations via electron microscopy techniques, such as scanning electron microscopy (SEM) and cryo transmission electron microscopy (cryo-TEM) (Figure 5.3b). The similarity of the average 
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diameter and size distribution for both glycopolymers was essential in order to exclude an influence of the size on the cell internalization.[64] DLS measurements furthermore confirmed a high stability of the glycosylated nanoparticles in suspension since storage at 5 °C in the dark for 12 months did not influence the size distribution. Moreover, no aggregation or sedimentation occurred. In subsequent biological studies, a carbohydrate specific biorecognition and cellular uptake of the galactose carrying nanoparticles into the HepG2 HCC cell line was detected. The nanoparticles internalized thereby in a concentration dependent manner with accumulation in the cytoplasm, most probably within lysosomal compartment, without any noticeable cytotoxic effect. 
 
 
Figure 5.3. (a) Volume size distributions of the fluorescent glycosylated nanoparticles obtained by DLS and (b) cryo-TEM microscopy images of the glycosylated nanoparticles (bGlc =  PS-b-PTFSGlcOH and bGal =  PS-b-PTFSGalOH).  In conclusion, polymeric nanoparticles with specific targeted sugar moieties were prepared by nanoprecipitation from PS-b-PTFS that contain β-D-thioglucose or 
β-D-thiogalactose. The bioactivity of the carbohydrates remained after attachment to the polymer and led to a preferential internalization of galactosylated targeted nanoparticles by hepatocarcinoma cell line.  
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6. Nanoparticles for gene delivery 
 
Parts of this chapter will been published: P8) S. Ochrimenko, A. Vollrath, K. Kempe, L. Tauhardt, S. 
Schubert, U. S. Schubert, D. Fischer, Bioconjug. Chem. 2013, submitted.  P9)  A. Rinkenauer, A. Vollrath, A. 
Schallon, L. Tauhardt, K. Kempe, S. Schubert, D. Fischer, U. S. Schubert, ACS Comb. Sci. 2013, submitted. A new era in the field of pharmacotherapy began with the application of non-viral carrier vectors for gene delivery. Among cationic lipids or peptides which can be utilized as non-viral vectors, particularly cationic polymers like poly(ethylene imine) (PEI) and poly-(2-dimethylaminoethyl methacrylate) emerged as promising vector systems.[69] Cationic polymers are able to compact the negatively charged nucleotides by counter charge complexation into nanoparticles. With implementation of such polymer based gene carriers, severe side effects accompanied with the usage of viruses, such as toxicity, immunogenic response or manufacturing limitations, can be avoided.[70] However, for the evaluation and design of cationic polymers useful as transfection vectors two main aspects must be addressed: Optimal gene delivery with efficient protein expression as well as low cytotoxicity for safe administration. Unfortunately, it was investigated that many polycations (e.g., PEI) achieve high transfection rates only with rising positive charge which, in turn, effectuates high cytotoxicity. On the other hand, alternative polymer systems with lower charge density (e.g., chitosan) revealed indeed lower acute toxicity, but adversely also decreased transfection efficiency.[69,71,72] Hence, continuative effort to understand the chemical nature and biological function of polymeric vectors is of vital importance, since researchers are still on the prospect of safe gene delivery agents with useful transfection levels.  
6.1 Dextran-graft-linear poly(ethylene imine) synthesis In the last decades, dextrans functionalized with cationic moieties were evaluated as promising gene delivery systems in various studies. Dextran is a natural, hydrophilic, 
biodegradable polysaccharide based of mainly α-1-6-linked D-glucose units and represents a well suitable material for the development of non-viral vectors. It offers the possibility of various chemical modifications with cationic moieties and captivates with a well-defined structure, excellent water-solubility, and perfect biocompatibility. Several attempts have been made to selectively modify dextran with cationic molecules such as PEI, diethylaminoethyl, spermine, protamine, or poly(L-lysine).[73-77] Although different strategies for conjugation were followed and several linking strategies have been reported to covalently bind PEI to dextrans, the influence of the different linker strategies on biocompatibility, transgene expression, and DNA binding characteristics have received only little attention.[73,78-82]  Thus, in order to directly study the influence of the different linker strategies, dextran with a molar mass of 60,000 g · mol-1 was functionalized with low molar mass linear PEI (lPEI) via altered synthesis routes. In detail, three synthesis strategies were applied to 
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synthesize a range of dextran-graft-linear poly(ethylene imine)s (dex-g-lPEI): (1) Reductive amination of aldehyde functionalized dextran (CHO-dex), (2) 1-ethyl-3-(3-dimethylamino-propyl) carbodiimide (EDC) coupling of carboxymethylated dextran (CM-dex) and (3) carbamate formation via reaction of 4-nitrophenyl carbonate-substituted dextran (NPC-dex) (Scheme 6.1).[31,80,83] 
 
Scheme 6.1. Schematic representation of the functionalization of dextran by (a) oxidation, (b) carboxymethylation and (c) 4-nitrophenyl carbonate-activation with subsequent reaction with lPEIs 
via (a) reductive amination, (b) EDC coupling and (c) carbamate formation. 
 To study further the impact of the degree of substitution (DS) of the dextran with lPEI as well as the lPEI chain length, two lPEIs consisting of n = 20 and 40 monomer units (lPEI20 and lPEI40) were allowed to react in various ratios with the different dextran precursors. For the grafting of lPEI to the dextran via reductive amination, aldehyde enriched dextrans were prepared by oxidation of dextran from Leuconostoc mesenteroides with different amounts of potassium periodate (KIO4). Subsequently, the aldehyde containing precursors were each converted with the lPEI20 and lPEI40, whereas the DS of conjugated lPEIs per AGU was aimed to be at maximum 0.5. After subsequent reduction with sodium borohydride (NaBH4) and purification by dialysis, the successful binding of the lPEI to the CHO-dex was confirmed by 1H NMR spectroscopy measurements. The resulting DS of lPEI was calculated from the nitrogen content observed in the elemental analysis and determined to be between 0.13 to 0.38 per AGU (A series, A1-A4, Table 6.1).  For the EDC coupling strategy, dextran was first derivatized to CM-dex to introduce carboxylic moieties into the polymer. The carboxymethylation was performed under basic conditions using altered ratios of monochloroacetic acid (CH2ClCOOH) and altered reaction times.[84] The final degree of functionalization was determined according to the HPLC procedure described by Heinze et al. (Table 6.1).[85] The subsequent grafting of lPEI20 and lPEI40 to the carboxymethylated carbohydrates was performed with usage of 
N-hydroxysulfosuccinimide (sulfo-NHS) and EDC owing to their well-known coupling 
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efficiency.[73] The successful binding of the lPEIs to the CM-dextrans was confirmed by 1H NMR spectroscopy measurements of the purified products (B series, B1-B6, Table 6.1). The coupling efficiency of lPEI per AGU was again calculated from the nitrogen content measured in the elemental analysis and found to be in the range of 0.06 to 0.18 (Table 6.1). In contrast to the previously described synthesis routes, the carbamate formation via reaction of 4-nitrophenyl carbonate-substituted dextran with the lPEIs was not qualified for the preparation of dex-g-lPEIs, due to the fact that adverse crosslinking occurred and led to insoluble products.  
a Determined by elemental analysis measurements; b calculated from nitrogen content. 
 To evaluate the potential of the prepared dex-g-lPEI polymers to be useful as vectors for gene delivery applications, crucial characteristics such as the interaction with DNA, the complex formation, and the cell- and hemocompatibility as well as transgene expression were examined. Briefly, it could be shown that all cationic dextrans spontaneously formed interpolyelectrolyte complexes with the DNA as a result of cooperative electrostatic interactions depending on the N/P ratio. The efficiency to complex and stabilize the DNA was thereby increasing for both linker strategies with increasing N/P ratio, higher molar masses and DS of lPEI. In comparison to the CHO-dex-g-lPEIs synthesized by reductive amination, a weaker DNA complexation and stabilization ability was detected for the CM-dex-g-lPEIs. This may be attributed to the lower content of lPEI within the samples prepared by EDC coupling and to the presence of anionic charges, which presumably interfere with the positively charged amines of the lPEI polymer and lead to decreased DNA interactions. dynamic light scattering (DLS) measurements of the dex-g-lPEI/DNA nanoparticles revealed sizes in water in the range of 70 to 113 nm with monomodal size distributions (polydispersity indices (PDI) 0.13 to 0.31), which were comparable to the sizes obtained for the DNA complexes with lPEI20 and lPEI40. Moreover, all complexes were positively charged 
Table 6.1. Overview about the DS and nitrogen content of the synthesized dex-g-lPEI samples. Samples dex-g-lPEIs CHO/COOH:NH2-lPEI [mol] Na [%] DSb [lPEI/AGU] A Reductive amination    
A1 CHO0.5-dex-g-lPEI20 1:0.5 15.78 0.18 
A2 CHO0.5-dex-g-lPEI40 1:0.5 19.12 0.13 
A3 CHO1.0-dex-g-lPEI20 1:0.5 21.45 0.38 
A4 CHO1.0-dex-g-lPEI40 1:0.5 21.73 0.19 B EDC coupling    
B1 CM0.3-dex-g-lPEI20 1:1.2 6.73 0.06 
B2 CM0.3-dex-g-lPEI40 1:1.2 12.80 0.07 
B3 CM0.5-dex-g-lPEI20 1:1.2 7.96 0.07 
B4 CM0.5-dex-g-lPEI40 1:1.2 14.83 0.1 
B5 CM1.6-dex-g-lPEI20 3:1 8.16 0.11 
B6 CM1.6-dex-g-lPEI40 3:1 18.38 0.18 
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with zeta potentials between +15 and +35 mV due to the excess of the cationic component with comparable results for N/P ratios 25 and 50. In comparison to the lPEI/DNA nanoparticles, the zeta potential values decreased indicating a shielding effect of the neutral dextran polymer. The shielding effect of the dextran was further supported by the observation that the zeta potential was rising with increasing DS and molar mass of lPEI grafted onto dextran. While the physicochemical properties were affected only marginal by the linker strategy, a remarkable difference between the A and B series was detected in the transfection efficiency as well as the cell- and hemocompatibility studies. The transfection efficiency obtained for the samples prepared by reductive amination (A1-A4) was higher than for the corresponding free lPEIs, but lower than for the cationized dextrans prepared by EDC coupling (B1-B4), which demonstrated the highest activity. The lower efficiency of the dextrans of the A series may be attributed to the higher DNA complexation efficiency of the polymer and, therefore, lower ability to release DNA from the complexes compared to the polymers of the B series. However, for the CHO-dex-g-lPEI polymers the transgene expression increased with higher molar mass of the lPEIs and N/P ratio, which was in agreement with literature.[81] Contrary, the CM-dex-g-lPEI40 conjugates revealed an approximately 1/3 lower transfection for B4 at the N/P ratio 25 and B2 at the N/P ratio 50 compared to their lPEI20 counterparts. This could be due to higher interactions between the longer lPEI chain and COOH groups of the CM-dex than with the DNA. In conclusion, the best gene delivery properties at both N/P ratios in this study were provided by B3. Moreover, all dex-g-lPEIs/DNA complexes were examined concerning their cytotoxicity and were found to be highly compatible under the transfection conditions applied.[86] The compatibility was thereby independent of the linker technique, the DS, and the selected N/P ratios. In addition, no hemolytic potential of the dex-g-lPEIs was observed under the chosen conditions.[87] Both polymer series induced higher red blood cell aggregation compared to free lPEIs, whereby the interactions with negatively charged cell membranes of the red blood cells were found to increase with the molar mass of lPEI. In general, the conjugates synthesized by reductive amination demonstrated a higher red blood cell aggregation potential compared to the modified dextrans prepared by EDC. The better compatibility of the B series polymers compared to the A series may be ascribed to the polyelectrolyte nature of the CM-dex-g-lPEIs, since polymers that contain both positive and negative charges revealed prolonged half life time in blood circulation experiments.[88] In conclusion, a library of several dex-g-lPEIs with varied linker units, different DS of lPEI as well as a range of cationic polymer chain length was synthesized. It was investigated that the variation of the linking strategy of cationic polymers to dextran affects particularly the biological properties. Although the reductive amination method achieved higher DS values of lPEI compared to the EDC coupling reaction, the latter synthesis route was more suitable as linking strategy since the conjugates showed improved hemocompatibility and enhanced transfection efficiencies.  
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6.2 High-throughput preparation and screening of nanoparticles for DNA delivery Highly efficient cationic polymers suitable for gene delivery should provide (1) excellent binding and protection of genetic material during delivery, (2) enhanced cellular uptake, (3) superior biocompatibility and (4) high transfection efficiency. However, general synthesis rules for the construction of such efficient polymers are missing as a result of too diverse methods and polymer classes applied in the published studies. With the aim to realize a straightforward but comprehensive characterization of gene vectors that supports to understand how the polymers should be designed specifically to their task, an automatical combinatorial high-throughput (HT) workflow was developed that starts with the automated polyplex preparation via pipetting robots and continues with a parallel and HT-analysis of the size, binding affinity, stability, transfection efficiency, and toxicity (Scheme 6.2). Therefore, lPEI and branched PEI (bPEI) with a degree of polymerization (DP) of 20, 200 and 600 (Mw = 860, 8,600 and 25,800 g ∙ mol-1, respectively) were chosen as model transfection agents to be complexed with plasmid DNA. For an automated preparation of complexes, liquid handling robots were used in a similar manner to the previously described HT-nanoprecipitation approach of synthetic polymers in Chapter 2. The benefit of such pipetting systems is the ability to systematically alter different parameters individually, such as polymer concentration, pH value, or buffer system. The HT-complex preparation was realized by automatic deposition of a buffered DNA solution to wells that contain various buffered cationic polymer solutions with the desired concentrations. Although this approach differs from conventional polymer/DNA complex preparation methods, where the polymer is pipetted to DNA solution with subsequent vortexing,[89] previous experiments reveal similar results. 
 
Scheme 6.2: HT-workflow for structure-property evaluation of cationic polymers/DNA nanocomplexes concerning molar ratio, size, binding, stability, release, transfection efficiency as well as cytotoxicity. 
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In order to investigate the dependency of the nanoparticle properties on different polymers and preparation conditions, several N/P ratios (2.5, 5, 10 and 20) were applied next to various PEIs. To this end, a dilution series ranging of previously produced polymer stock solutions was provided by using the pipetting robot. Afterwards, a DNA solution was added to each polymer solution, and the resulting suspensions were directly mixed by repetitive suction and release. After the nanoparticle formation, the nanosuspensions were distributed automatically into different well plates for subsequent parallel characterization studies (Scheme 6.2).  Since the complex size allows a first conclusion regarding the polymer capability to be used as transfection agent, DLS was applied as first analysis technique to determine the dependency of aggregation of the PEI/DNA assemblies on the conditions used for the complex formation.[62] In order to realize the analysis of the complex size in an automatic HT-manner, a DLS platereader was used. As displayed in Figure 6.1, all PEI/DNA nanoassemblies revealed diameters less than 600 nm. The smallest diameter of 140 nm was obtained for the bPEI200. In comparison to previously performed manual size measurements, where complex sizes in a range of 80 to 200 nm were obtained, larger diameters with increased standard deviations were detected by the HT-DLS device. This could be explained by the different devices and settings for the DLS measurements. Although the HT-DLS results should be always considered with care, by application of the HT-DLS device information about the tendency of the polyplexes to aggregate can be obtained and conclusions about the polyplex stability in comparison to standard polymer controls are possible. According to these data, three tendencies were found: (i) With increasing N/P ratio, smaller complexes were formed; (ii) the bPEI revealed a stronger size dependency with higher molar masses in comparison to the lPEI, and (iii) the bPEI condensed the DNA into smaller particles compared to the lPEI (as also reported in literature).[90] An influence of the degree of polymerization or the molar mass could not be observed under the chosen conditions. 
 
Figure 6.1 Hydrodynamic diameters of PEI/DNA complexes prepared by the pipetting robot. Values represent the mean, n ≥ 3. 
0 
200 
400 
600 
800 
1000 
20 200 600 20 200 600 
lPEI  bPEI  
d,
 n
m
 
NP 2.5 NP 5  NP 10  NP 20  
6. NANOPARTICLES FOR GENE DELIVERY
 
 
 
36 
Afterwards, the DNA binding affinity of the polymers as well as the DNA release were evaluated via ethidium bromide and heparin assays, respectively. A proportional increase of the binding affinity was observed with increasing molar mass of the polymer. Furthermore, a higher binding affinity of branched structures (bPEI) was detected in comparison to linear architectures.[90,91] In the case of lPEI20, it can further be seen that the DNA binding affinity correlates with the N/P ratio until a plateau is reached (here at N/P 10). Simultaneous with the increased binding affinity, a decreased DNA release dependent on the N/P ratio, the architecture, and the molar masses of the various polymers was observed. These trends were also reported in literature and confirm that a rapid relationship analysis of polymer structure and conditions with respect to the DNA binding and release can be performed in an automated way within two hours by this HT-assay.[92,93]  To allow conclusions about the transfection efficiency of the polymeric vectors, the expression of reporter genes was visualized by fluorescence using an EGFP reporter encoded plasmid (pEGFP-N1). Usually, this expression system is analyzed by flow cytometry analysis. But as this technique is not suitable for the HT-screening approach presented here, the transfection efficiency was studied using a microscope and a fluorescence plate reader. The following order of high to low transfection efficiency was obtained: lPEI600 > bPEI200 > lPEI200 > bPEI600 > bPEI20 > lPEI20. Since the results observed from the screening of the EGFP expression were comparable with non HT-transfection procedures, which use vortexed polymer/DNA complexes and flow cytometry, this observation confirms the potential of such a HT-screening of the transfection efficiencies of polymers.  Furthermore, the cytotoxicity of the nanosuspensions was studied in human embryonic kidney (HEK) cells in 96-well plates after 24 h incubation with the nanoparticles. The viability of the cells was explored after staining with Hoechst 33324 and detection of the fluorescence utilizing again the fluorescence plate reader device. After the HT-screening of the nanoparticles prepared from various PEIs with different molar masses and architectures, it was confirmed that lPEI20 and bPEI20 are non-cytotoxic at the investigated concentrations. However, with rising molar mass, the cytotoxic effect was increasing. The polymeric architecture itself showed no influence on the cell viability, but certainly on the DNA binding capability, since bPEI20 revealed stronger DNA binding than lPEI20. Although having relatively high binding affinities, the best transfection results were obtained for lPEI600 and the bPEI200. In conclusion, the obtained results indicated in agreement with literature that PEIs with branched architectures and small molar masses have the highest potential to be used as gene vectors, as they offer the advantage of low cytotoxicity combined with high DNA binding affinity. It could be proven that the developed HT-workflow is applicable for different polymer systems as well as conditions enabling a fast and efficient analysis of polymer vectors in an automated way with respect to important polymer characteristics, such as molar mass, architecture, and N/P ratio used for the DNA binding and release. Then it is possible to identify and evaluate reams of polymers with regard to their capability to realize an efficient complexation, protection, and transfection of DNA. 
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7. Summary  In recent years, polymeric nanoparticles had their breakthrough within the area of nanotechnology and represent nowadays a new class of therapeutics with impressive potential. The straightforward encapsulation of multiple drug and dye molecules with high loading capacities as well as the possible introduction of additional functionalities for targeted delivery and controlled cargo release, are only a selection of the exquisite properties provided by polymeric nanoparticles. In particular, by combining the drug 
delivery with diagnostic application, multifunctional “theragnostic” agents for an improved medical treatment can be obtained. Although a couple of challenges associated with the development of polymeric nanoparticles for drug delivery and diagnostic are still unsolved, e.g., the reliable evaluation of their interaction with the environment and attended long-time consequences as well as their controlled and reproducible production, it is incontrovertible that nanomedicine is on the right path. Continuous effort on polymeric nanoparticles will thus represent an important scientific field in the future. The presented thesis addresses the systematic formulation of polymeric nanoparticles, their physicochemical characterization, and the study of their resultant interaction with cells (Figure 7.1). Biocompatible polymers, such as poly(methyl methacrylate) (PMMA), poly(saccharides) and poly(lactic acid) derivatives were investigated with regard to their nanoparticle formation using the nanoprecipitation approach. This method is cost and time-efficient and provides the key benefit that no surfactants are required leading to more defined nanoparticles. The nanoprecipitation of the polymers was manually performed, but also in a high-throughput (HT) manner by the application of pipetting robots. In combination with the subsequent dynamic light scattering (DLS) platereader analysis, the HT approach enabled an efficient screening of various polymer systems with regard to their precipitation behavior and crucial influencing parameters, such as concentration of the initial polymer solution or the solvent/non-solvent ratio in a 96-well plate format. It was investigated that almost all applied polymer systems were able to be formulated into nanoscale particles under distinct nanoprecipitation conditions. A vital contribution to the final size and size distribution revealed thereby the polymer characteristic itself (molar mass, hydrophobicity) as well as the route of adding the non-solvent (addition of the polymer solution to the non-solvent or vice versa). After evaluation of important formulation parameters, well-defined nanoparticles were prepared from selected copolymers for cellular internalization studies. First, the fluorescent copolymer (p(MMA-stat-MAy)0.97:0.03), which already contained a thiazole chromophore in the backbone, was selected. Furthermore, a p(MMA-stat-MAA)0.91:0.09 copolymer was chosen to be post-functionalized with various fluorescent dyes yielding three polymers (p(MMA-
stat-MAgreen), p(MMA-stat-MAorange), and p(MMA-stat-MAred)) with comparable properties, but different fluorescence. Nanoparticles with various sizes and altered fluorescent properties were also achieved by using diverse nanoprecipitation conditions for the differently labeled PMMA copolymers. After comprehensive characterization of the obtained 
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nanoparticles via orthogonal analysis techniques, e.g., DLS, scanning electron microscopy (SEM) and analytical ultracentrifugation (AUC), and ensurance of the nanosuspensions stability under various conditions (cell culture media, autoclavation, freeze drying, etc.), cellular uptake studies revealed an internalization of all particles examined into intracellular compartments without causing any adverse effects (cytoxicity). This finding represents a crucial requirement for the utilization of the particles in vitro and in vivo. In subsequent studies by application of confocal microscopy, a concentration- as well as size dependent internalization of particles was proven. Furthermore, nanoparticles with specific targeted sugar moieties were prepared by nanoprecipitation from PS-b-PTFS copolymers that contain β-D-thioglucose or β-D-thiogalactose. The sugar-targeted nanoparticles were subsequently studied with regard to their cellular uptake by a hepatocarcinoma cell line. A preferential internalization of galactosylated targeted nanoparticles was detected proving the capability to actively targeted nanocarriers to reach a specific uptake.  
 
Figure 7.1 Overview of the thesis strategies: From preparation and characterization of polymeric nanoparticles to their application in diagnostic and therapy.  In addition to the formulation and characterization of polymeric nanoparticles for diagnostic purposes, the focus was also set on the investigation of the nanocarriers suitable for efficient gene delivery. In order to gain deeper insights into the structure-property relationships of polycations and their resulting nanoparticle formation, dextran, which is a 
water soluble, α-(1→6) glycosidically linked polysaccharide that is characterized by superior biocompatibility and good availability, was functionalized with different linear poly(ethylene imine)s (lPEI) introducing the cationic charge into the dextran structure. The different cationic polymers were studied in terms of their nanoscale complexation with nucleic acids and their biophysicochemical properties. To evaluate the impact of the coupling strategies between dextran and the cationic polymers next to the influence of the molar mass and the degree of substitution of lPEI, different derivatives were synthesized via altered synthesis routes. The amidation reaction of carboxymethylated dextran and the reductive amination of previously oxidized dextrans are hereby noteworthy, since they enabled an efficient synthesis of several cationic dextrans with variable degree of substitution of lPEI. In subsequent studies, the capability of the synthesized polymer vectors to bind DNA into stable complexes in the nanoscale was proven. Moreover, the transfection efficiencies as well as the resulting toxicities were determined. Although the reductive amination method resulted in a higher degree of grafting of lPEI, the amidation reaction was 
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more suitable as linking strategy owing to the improved hemocompatibilites and enhanced transfection efficiencies of the obtained dextran-graft-lPEI conjugates. In addition, a facile combinatorial HT-workflow that enables a straightforward but comprehensive characterization of cationic polymers as gene vectors was developed. As model polymers, well-known PEI derivatives were used. The complex formation between the cationic polymer and the plasmid DNA was realized via pipetting robots in an automated way. By subsequent parallel HT-analysis using a DLS platereader as well as biological assays, the size, the binding affinity, the complex stability as well as transfection and toxicity of the prepared nanoparticles were rapidly and efficiently explored. In summary, within this thesis, well-defined nanoparticles based on a range of bio-compatible polymers were synthesized and studied with regard to their resulting characteristics as well as interactions with biological systems. The presented results will contribute to the development and understanding of polymeric nanoparticle formulations and will support their future applications in the medical field.   
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8. Zusammenfassung 
 In den vergangenen Jahren erlebten polymerbasierte Nanopartikel im Bereich der Nanotechnology ihren wissenschaftlichen Aufschwung und stellen heutezutage eine neue Klasse von Therapeutika mit eindruckvollem Potenzial dar. Die unkomplizierte Einkapselung von Wirkstoff- und Farbstoffmolekülen mit hohen Ladungskapazitäten, sowie die Möglichkeit der Einführung von zusätzlichen Funktionalitäten für eine zielgerichtete Wirkstoffabgabe, sind nur eine Auswahl der herausragenden Eigenschaften, die diese Systeme aufweisen. Besonders die Kombination von kontrollierter Wirkstoffabgabe und Diagnostik führte zur Entwicklung von ersten multifunktionalen „Theragnostik“-Partikeln und ermöglichte eine verbesserte medizinische Behandlung. Obwohl einige Herausforderungen, die mit der Entwicklung von geeigneten polymeren Nanopartikeln zur Anwendung in Therapie und Diagnostik einhergehen, noch ungelöst sind (wie zum Beispiel die sichere Einschätzung der Interaktionen der Nanopartikel mit ihrer Umgebung und der damit verbundene Langzeitfolgen sowie ihre kontrollierte und reproduzierbare Herstellung), ist es unbestreitbar, dass die Nanomedizin sich auf dem richtigen Weg befindet. Weiterführende Bemühungen in Bezug auf polymerbasierte Nanopartikel stellen daher für die Zukunft ein entscheidenes Forschungsfeld dar. Die vorliegende Schrift befasst sich mit der gezielten Formulierung polymerer Nanopartikel durch Nanofällung, deren biophysikochemischen Charakterisierung und der Untersuchung ihrer Wechselwirkung mit Zellen (Abbildung 8.1). Biokompatible Polymere, wie zum Beispiel Polysaccharidderivate, Polymilchsäurederivate oder Poly(methyl methacrylat) (PMMA)-Copolymere wurden hinsichtlich ihrer Nanopartikelbildung mittels Nanofällung untersucht. Diese Fällungsmethode ist kostengünstig, zeiteffizient und bietet den entscheidenden Vorteil, dass keine oberflächenaktiven Substanzen notwendig sind. Dies führt zu definierten Nanopartikeloberflächen und ist von zentraler Bedeutung für biologische Studien. Die Nanofällung wurde sowohl manuell als auch im Hochdurchsatzverfahren mit Hilfe von Pipettierrobotern realisiert. In Kombination mit der automatisierten dynamischen Lichstreuanalyse konnten verschiedene Polymersysteme sehr effizient hinsichtlich ihrer Fällungseigenschaften und entscheidende beeinflussenden Parameter, wie zum Beispiel die Konzentration der anfänglichen Polymerlösung oder die Fällbedingungen im 96-Plattenformat, untersucht werden. Dabei wurde festgestellt, dass nahezu alle verwendeten Polymere unter bestimmten Fällbedingungen zu nanoskaligen Partikeln formuliert werden können. Entscheidend zur resultierenden Größe und Größenverteilung der Partikel tragen dabei die Eigenschaften der Polymere (molare Masse, Hydrophobität) sowie die Art der Zugabe des Nichtlösungsmittels bei (Zugabe der Polymerlösung zu dem Nichtlösungsmittel oder vice versa).  Nach Evaluierung der wichtigsten Formulierungsparameter wurden wohldefinierte Nanopartikel zur Untersuchung von Zellaufnahmemechanismen von ausgewählten Copolymeren hergestellt. Zunächst wurde das fluoreszierende Copolymer P(MMA-stat-MAy)0.97:0.03, welches bereits ein Thiazolchromophor im Polymerrückrat 
8. ZUSAMMENFASSUNG
 
 
 
41 
auswies, verwendet. Weiterhin wurde ein  P(MMA-stat-MAA)0.91:0.09 Copolymer mit unterschiedlichen Fluoreszenzfarbstoffen funktionalisiert und so drei verschiedene Polymere  (P(MMA-stat-MAgreen), P(MMA-stat-MAorange), and P(MMA-stat-MAred)) mit ähnlichen Eigenschaften, aber unterschiedlicher Fluoreszenz erhalten. Im Folgenden konnten Nanopartikel verschiedener Größe mit divergenter Fluoreszenz durch den Einsatz von unterschiedlichen Fluoreszenzfarbstoff-markierten PMMA Copolymeren und Anwendung verschiedenartiger Fällbedingungen erhalten werden. Nach umfassender Charakterisierung der erhaltenen Nanopartikel mit Hilfe orthogonaler Techniken, wie zum Beispiel der dynamischer Lichtstreuung, Rasterelektronenmikroskopie und der analytischen Ultrazentrifugation, sowie der Gewährleistung der Stabilität der Nanosuspensionen unter verschiedenen Bedinungen (Zellkulturmedium, Autoklavierung, Lyophilization, etc.), konnte in Zellexperimenten eine Aufnahme aller Partikel in intrazelluläre Kompartimente ohne toxische Nebenwirkungen (Zytotoxizität) nachgewiesen werden. Dies stellt eine notwendige Voraussetzung für den Einsatz der Partikel in vitro und 
in vivo dar. Mit Hilfe der konfokalen Fluoreszenzmikroskopie wurde in weiteren Studien neben einer konzentrationsabhängigen Aufnahme auch eine größenabhängige Partikelinternalisierung nachgewiesen. Desweiteren wurden Nanopartikel mit spezifischen Zuckermolekülen durch Nanofällung eines β-D-Thioglukose- oder β-D-Thiogalaktose-funktionalisierten Polystyrol-Copolymers hergestellt. Die mit Zucker funktionalisierten Nanopartikel wurden anschließend in Bezug auf ihre Aufnahme in Leberkrebszelllinien untersucht. Eine bevorzugte Aufnahme der Galaktose-funktionalisierten Nanopartikel bestätigte die Möglichkeit, Nanopartikel aktiv zu steuern und eine spezifische Zellaufnahme zu erhalten. 
 
 
Figure 8.1 Übersicht über zentralen Themen der Dissertation: Von der Herstellung und Charakterisierung polymerer Nanopartikel zu deren Anwendung in Diagnostik und Therapie.  Im Fokus der Arbeit stand neben der Herstellung und Charakterisierung von polymeren Nanoobjekten für die Diagnostik auch die Untersuchung von Nanopartikeln zum therapeutischen Einsatz. Zu diesem Zweck wurden verschiedene kationische Polymere hergestellt und ihre nanoskalige Komplexbildung mit Nukleinsäuren erforscht. Zur genauen Analyse von Struktur-Eigenschaftsbeziehungen von Polykationen und ihrer Nanopartikelbildung wurde Dextran, ein wasserlösliches, α-(1→6) glycosidisch verknüpftes Polysaccharid, welches sich durch eine hohe Biokompatibilität und gute Verfügbarkeit 
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auszeichnet, gezielt mit verschiedenen linearen Polyethyleniminen (lPEI) funktionalisiert, um kationische Ladungen in die Dextran-Struktur einzuführen.  Um den Einfluss der molaren Masse und des Substitutionsgrades der lPEIs, aber auch die Bedeutung der verschiedenen Kopplungsstrategien zwischen Dextran und PEI zu studieren, wurde eine Reihe von Derivaten auf unterschiedlichen Syntheserouten hergestellt. Die Amidierung mit carboxymethyliertem Dextran sowie die reduktive Aminierung von zusätzlich oxidierten Dextranen sind hierbei hervorzuheben, da sie am effizientesten zur Herstellung verschiedener kationischer Dextranderivate mit variablen Substitutionsgraden führten. In anschließenden physikochemischen und biologischen Studien konnte gezeigt werden, dass die synthetisierten Polykationen mit Plasmid-DNS stabile Komplexe im Nanometerbereich bilden. Darüber hinaus wurden die Transfektionseffizienzen und Toxiziäten der jeweiligen Nanokomplexe bestimmt und die erfolgreichsten kationischen Polymere ermittelt. Obwohl mit der reduktiven Aminierung höhere Substitutionsgrade von lPEI an Dextran erhalten wurden, ist die Amidierungsreaktion die favorisierte Kopplungsstrategie, da die resutlierenden Dextran-graft-lPEI Konjugate eine verbesserte Blutverträglichkeit als auch gesteigerte Transfektionseffizienten aufwiesen. Zur schnellen und umfassenden Analyse von kationischen Polymeren als Genvektoren wurde weiterhin ein automatisierter Arbeitsablauf entwickelt. Als Modelpolymere wurden dazu bekannte PEI-Derivate verwendet. Die automatisierte Formulierung der Nanopartikel zwischen dem kationischen Polymer und der Plasmid-DNS wurde mit Hilfe eines Pipettierroboters realisiert. Anschließende parallele Hochdurchsatzanalysen unter Zuhilfenahme von DLS Plattenlesern und biologischen Testverfahren ermöglichten eine zügige und effiziente Untersuchung der Komplexgröße, der Bindungsaffinität, der Komplexstabilität, sowie der Tranfektionseffizienzen und der Toxizitäten. Zusammenfassend konnten im Rahmen dieser Arbeit eine Vielzahl an maßgeschneiderten Nanopartikeln auf Basis verschiedener biokompatibler Polymere hergestellt und ihre Eigenschaften und Interaktion mit biologischen Systemen evaluiert werden. Die beschriebenen Ergebnisse werden zum tieferen Verständnis und zur Weiterentwicklung von polymeren Nanopartikeln beitragen und so deren zukünftigen Einsatz in medizinischen Anwendungsbereichen unterstützen. 
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Supplementary information 
A in W = Polymer acetone solution was dropped into water, W in A = water was dropped into polymer acetone solution.  W in T = Polymer THF solution was dropped into water.  Abbreviations: PLGA = poly(lactic-co-glycolic acid); EUDRAGIT S100 = poly(methyl methacrylate-
stat-methyl methacrylate); PMMA = poly(methyl methacrylate); P2VP = p(2-vinylpyridine); P(BuMA-
stat-MMA)= poly(butyl methacrylate-stat-methylacrylic acid); PS = poly(styrene); P(iPOx-stat-MMA)18:44 = poly(iso-propyloxazoline-stat-methyl methacrylate)18:44; P(EtOx-stat-Dec-GlcAc) = glucosylated poly((2-ethyl-2-oxazoline)-stat-poly(dec-9-enyl)-2-oxazoline); P(EtOx-stat-Dec-GalAc)10:10  = galactosylated poly((2-ethyl-2-oxazoline)-stat-poly(dec-9-enyl)-2-oxazoline).  
Table S.1. Summary nanoprecipitation conditions and size distributions of representative nanoparticles prepared from various synthetic polymers. Solvent/non-solvent ratio was kept constant at 0.25. Polymer Schematic representation  of the chemical structure Nanoprec. method cpolymer [mg ∙ mL-1] dDLS [nm] PDIp  [mV] PLGA   (Mw ≈ 7,000 ‒ 17,000 g ∙ moL-1)  
A in W 0.25 30 0.28 ‒9 
W in A 4 242 0.11 ‒22 
EUDRAGIT S100 (Mw ≈ 25.000  g ∙ moL-1)  
A in W 0.25 64 0.20 ‒22 
W in A 4 89 0.43 ‒19 PMMA  n = 50 
 
W in A 4 453 0.30 ‒27 PMMA  n = 120 W in A 4 731 0.24 ‒22 P(BuMA-stat-MMA)    (Mw ≈ 150.000  g ∙ moL-1)  W in A 4 191 0.05 ‒26 PS  n = 33 
 
W in T 4 453 0.30 ‒26 PS  n = 66 W in T 4 731 0.24 ‒22 
P2VP  n = 28  W in A 4 616 0.39 / P(iPOx-stat-MMA)18:44   W in A 4 578 0.23 ‒8 P(EtOx-stat- Dec-GlcAc)16:4  
 
W in A 4 610 0.45 +17 
P(EtOx-stat- Dec-GalAc)10:10  W in A 4 590 0.19 ‒6 
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Figure S.1. Overview about nanoparticles prepared by nanoprecipitation using thiazole-functionalized PMMA copolymers: Intensity weighted size distribution, diameter and PDIP values obtained by DLS measurements as well as representative SEM images. The particles were prepared by the dropping technique, applying a polymer acetone solution with c = 3 mg ∙ mL-1 and a solvent-non-solvent ratio of 0.25. A in W = polymer acetone solution was dropped into water, W in A = water was dropped into polymer acetone solution.    
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List of abbreviations     AGU    anhydroglucose unit AUC    analytical ultracentrifugation CLSM    confocal laser scanning microscopy TEM    transmission electron microscopy   d     diameter D     diffusion coefficient dh     hydrodynamic diameter DLS    dynamic light scattering DMEM    Dulbecco's modified Eagle's Medium DS    degree of substitution EDC     1-ethyl-3-(3-dimethylamino-propyl) carbodiimide 
g    gravity HBG    HEPES-buffered glucose HEK    human embryonic kidney HepG2 HCC    hepatocellular carcinoma cell line HT     high-throughput I     intensity kB    Boltzmann constant mg    milligram mL    milliliter Mn    number average molar mass Mw    weight average molar mass N/P ratio   nitrogen (cationic polymer) to phosphate ratio (DNA) NaBH4    sodium borohydride NMR    nuclear magnetic resonance PBS    phosphate buffered saline PDI    polydispersity index PDIP    polydispersity index particle (DLS) PUC     preparative ultracentrifugation RAFT    reversible addition-fragmentation chain tranfser SEC    size exclusion chromatography SEM    scanning electron microscopy THF    tetrahydrofuran v/v    volume to volume  
ζ     zeta potential 
 0    viscosity
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Fluorescence imaging of cancer tissue based on metal-free polymeric 
nanoparticles - Review
Antje Vollrath,a Stephanie Schubert,b,c Ulrich S. Schuberta,b* 
 
Abstract  5 
 
The utilization of fluorescent nanoparticles (FNPs), which consist of organic fluorophores embeded into a polymer matrix, seems to be 
a promising concept for in vivo cancer imaging showing good biocompatibility, biodegradability, and low toxicity of the agents. 
Polymeric nanoparticles as fluorescent nanocarriers can be systematically designed with regard to the requested task, i.e., specific 
accumulation in the tumor tissue. Versatile organic fluorophores can be entrapped into polymers with fine-tuned properties, which 10 
were synthesized via polymerization techniques. Moreover, the formulation of the nanoparticles can be adjusted, and passive as well as 
active targeting strategies can be employed. Despite their evident benefits, fluorescent polymeric nanoparticles are still not in clinical 
application for cancer detection due to a still existing lack in the understanding of their in vivo interactions as well as their reproducible 
production. This review focuses on cancer imaging based on organic dyes and metal-free polymeric fluorescent nanoparticles 
highlighting recent interesting reports about their design and application as well as their limitations.  15 
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1 Introduction  
 
Nanomedicine is an ever-growing scientific field within the 
multidisciplinary area of nanotechnology that addresses the 
design of novel nanosized therapeutics, which facilitates a target 5 
delivery of active species for an improved treatment of 
diseases.[1-3] Likewise aspired in the nanomedicine area, is the 
development of diagnostic agents that enable the detection of 
manifold processes inside the body and form the major basis for 
the understanding of disfunctionalities and their subsequent 10 
occurrence of diseases.[4] In particular for cancer treatment, an 
early detection of growing tumor cells is of vital importance and 
decides about the success of the therapy. A diagnostic technique 
that utilizes nanoimaging agents is fluorescence imaging. It is 
easy applicable and provide high spatial and temporal 15 
resolution, superb sensitivity as well as good selectivity.[5-11] 
Thus, fluorescence imaging allows insights into living 
organisms with high sensitivity without the need of dissection, 
e.g. by usage of endoscopes or miniaturized fiber-based 
catheters.[12-17] The examinations of vascular networks and 20 
sentinel lymph node mapping are only two examples of the 
successful application of fluorescence imaging.[18] Besides an 
early detection, the surgical removal of the tumor is mostly 
efficient for cancer therapy, but it is a demanding task for the 
surgeon to remove the tumor tissue completely without 25 
damaging healthy tissue.[19-21] In order to visualize tumors while 
surgery and to improve its radical resection, new systems were 
developed that enable the intraoperative identification of tumors. 
It was preclinically validated that by using specific fluorescent 
agents and image guided surgery, tumors can be detected and 30 
removed very efficiently with reduced complications.[22]  
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At the moment fluorescence image guided surgery is in transit to 
clinical practice. However, in order to enable a fast clinical 
realization, new fluorescence probes need to be established and 
approved for in vivo application. As the detection of light of 
fluorescence dyes emitted from the body is limited by tissue 60 
induced light absorption and reflection that decreases 
tremendously the fluorescence signals as well as signal-to-
background ratios, researchers focused on the synthesis of stable 
near-infrared (NIR) fluorescent dyes that emit light between 650 
to 900 nm, a range where the autofluorescene of tissue 65 
(hemoglobin) is reduced.[21,23-25] In recent years, efficient 
fluorescent probes providing high quantum yields and 
absorption/emission spectra in regions beyond the physiological 
autofluorescence were developed.[21] Suitable and preferred 
agents applied in fluorescence imaging are semiconductor 70 
nanocrystals (quantum dots, QD) and organic fluorophores due 
to their straightforward application compared to genetically 
engineered molecules (fluorescent proteins, 
bioluminescence).[26-28] QD possess excellent fluorescent 
properties including broad excitation spectra, sharp 75 
fluorescence, and a bright emission with a high signal to noise 
ratio.[29] Additionally, QD are stable against photobleaching due 
to the inorganic composition, and they possess long fluorescence 
lifetimes. Nevertheless, they are discussed controversially in 
terms of their health risks including cytotoxicity, induced 80 
apoptosis, and peroxidative stress.[30] Significant effort was 
performed with the aim to enhance the biocompatibility of QD 
by coating with polymers like poly(ethylene glycol) (PEG) or 
polysaccharides.[31] However, there are still open questions 
about their toxicity, and their future application in clinical 85 
settings is ambiguous. Contrary, new organic fluorophores 
exhibit similar fluorescent properties, but are established to be 
biocompatible and less toxic.[15,19,32] Still, some problems come 
along with the application of free dyes, such as low 
photostability and low stability in the physiological 90 
environment.  
With the objective to improve the fluorophore-based diagnostic 
and to develop new promising fluorescent agents suitable for 
clinical applications, dyes were entrapped into polymeric 
nanoparticles (NPs).[28,33-36] The benefits of using polymeric 95 
particles as templates for dye encapsulation are thereby 
apparent: (1) Potential multiple loading of fluorophores into the 
NP leads to enhanced fluorescence intensities; (2) protection of 
the dye inside the NP core against the biological environment 
avoids undesired side effects such as reduced fluorescence 100 
because of interaction with proteins; (3) increased surface area 
for attachment of functional groups and targeting moieties.[28] 
Furthermore, several polymeric NPs are already in clinical trials 
for drug delivery applications (without the use of any 
fluorescent label). Thus, the concept to encapsulate fluorophores 105 
into a polymeric NP that can be used as diagnostic agent seems 
promising in term of future clinical realization.[37-41] This 
contribution reviews the design and application of organic dyes 
and fluorescent metal-free nanoparticles for cancer imaging. 
Thereby, advantages, challenges and available methods to 110 
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overcome some limitations are discussed in order to evaluate if 
metal-free imaging based on polymers is realistic for clinical 
application. 
 
2 Organic fluorophores for in vivo imaging 5 
applications 
 
As efficient imaging relies on the good detection of 
fluorophores, its final application depends on the properties of 
the chromophores. Desirable characteristics are high 10 
fluorescence quantum yields, high molar extinction coefficients, 
broad absorption ranges in visible field and a good tolerance to 
photobleaching.[6,42] Scheme 1 represents a selection of 
fluorophores commonly used for in vivo imaging.  
Fluorescein-5-isothiocyanate (FITC) and rhodamine B are 15 
members of the xanthene group and probably the most well-
known and used dyes for cell, molecule or particle labelling. 
Besides its application in vitro, a fluorescein water based 
injection (10%) is approved by the Food and Drug 
Administration (FDA) to be used in diagnostic fluorescein 20 
angiography for blood flow examinations in surgical resections 
or in the ophthalmology for angioscopy of the retina and iris 
vasculature.[17,43,44] However, the common xanthene members 
still suffer from low photostability and rapid photobleaching, 
which limits their utilization for diagnostic application. Though, 25 
it was found that the optical properties of common fluorophores 
can be enhanced and fine-tuned by introducing versatile 
substituents to the initial dye scaffold. [45-47] For instance, Alexa 
fluorophores and DyLight Fluors are established derivatives of 
rhodamine, coumarin, cyanine and xanthene and were obtained, 30 
e.g., by the introduction of sulfonate groups at the 
chromophore.[48-51] As a result of the sulfonation, the negatively 
charged dyes show an increased hydrophilic character and 
possess improved fluorescent properties in terms of emission 
intensity, photobleaching, pH stability and aggregation behavior 35 
of the dye molecules. Furthermore, these dyes cover a wide 
range of the fluorescence spectra including a good emission 
within the NIR range that was identified as ideal region for in 
vivo imaging owing to the ability of deeper penetration into 
tissue and decreased tissue autofluorescence. Most currently 40 
applied in diagnostic applications is the polymethine (cyanine) 
dye family. The spectra of available polymethine dyes ranges 
from 400 to 800 nm (and above) as a result of the ability to fine-
tune the absorption via introduction of further vinylen units to 
the polymethine bridge that link the two aromatic nitrogen-45 
containing heterocycles. A well-known representative of the 
polymethine class is the indocyanine green (ICG). ICG is 
approved by the FDA for intravenous administration and applied 
since several years in ophthalmic angiography and cardiac 
output determination. Recently, it is also used in the field of 50 
surgical oncology for sentinel lymph node mapping, for the 
imaging of vascular networks, demarcations of liver segments as 
well as intra operative staining.[18,19,52] Other cyanine 
derivatives, such as 1,1’-dioctadecyltetramethyl 
indotricarbocyanine iodide (DiR), cyanine 5.5 (Cy5.5) and 55 
cyanine 7 (Cy-7) are further utilized for fluorescence labelling 
of peptides or particles for in vivo imaging applications.[6,15,34,42]  
Besides the cyanines, new NIR fluorophores based on 
difluoroboron dipyrromethene (Bodipy, 4-bora-3a,4a-diaza-s-
indacene) have gained significant attention for diagnostic 60 
application due to their robustness against light and chemicals, 
the good solubility, and their outstanding optical 
properties.[45,53-55] Furthermore, the very inexpensive methylene 
blue (MB) fluorophore is utilized, e.g. in fluorescence-guided 
surgery for tissue staining, such as identification of bile ducts 65 
and ureters.[56] MB is characterized by excellent water-
solubility, low toxicity and emission wavelengths in the NIR 
range (600 to 900 nm).[57,58]  
Besides the synthesis of fluorophores with superb molar 
absorptions and quantum yields for high fluorescence intensity 70 
in the NIR spectral range was realized, the preferential 
accumulation in specific cells was requested for defined 
diagnostic and challenged researchers within the last years. The 
primary concentration of the fluorophores in specific cells can  
be achieved by attachment of targeting moieties. For instance, 75 
cancer specific NIR derivatives were synthesized by conjugation 
with cancer specific ligands, such as folate (FL), cyclic arginine-
glycine-aspartic acid (cRGD) peptides, and various antibodies 
(AB).[24,42,59-67] Surprisingly, two classes of heptamethine based 
dyes already prefer the accumulation in tumors. The so-called 80 
IR-808 and IR-783 dyes exhibit a favored tumor accumulation 
without the need of chemical conjugation with tumor specific 
ligands.[68,69]  
 
An alternative strategy for a defined imaging relies on imaging 85 
agents that only emit light via interaction and chemical reaction 
with the targeted tissue.[23,70] For the synthesis of such “optically 
silent” NIR dyes, the quenching effect is often exploited. This 
effect of decreased fluorescence (due to the loss of absorption or 
decreasing quantum yield) occurs either if two or more of the 90 
same or different chromophores are linked close to each other or 
if they are coupled to a non-fluorescent quencher.[71-73] By 
enzymatic cleavage of the linker, e.g. by a specific proteolytic 
enzyme that is mainly present in tumor tissue, the dyes are 
released and activated. As the fluorescence occurs only in the 95 
target site, interference and low signal-to-background ratios are 
avoided.[74,75] One example is a protease activatable Cy5.5-based 
fluorochrome, so-called ProSense-680.[27] The fluorophore/non-
fluorescent quencher approach offers the advantage to utilize a 
target moiety as quencher and combine two superior properties: 100 
fluorescence activation as well as the targeting effect. To this 
end, responsive NIR optical probes were synthesized based on 
conjugation of various monoclonal antibodies (mABs) to ICG, 
AlexaFluor680 and others.[60,61,76,77] 
 105 
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Although the synthesis of versatile “smart” NIR dyes already 
improved the platform of in vivo fluorescent imaging 
applications, some limitations remain. For one, by shifting the 
fluorescence of the chromophore agents to the NIR region to 
enable deeper tissue imaging a decrease in the fluorescence 5 
intensities is observed due to the resultant higher degree of 
vibrations that increases the numbers of non-radioactive decay 
pathways. Moreover, these approaches still suffer from 
relatively low long-term photostability and low stability in the 
physiological environment, which can provoke aggregation of 10 
the dyes with a subsequent decrease in fluorescence. For some 
fluorophores, solubility issues in water are still not resolved. 
Though the water solubility of the fluorophores can be enhanced 
by attachment of biological molecules and/or polar groups, it 
should be mentioned that with conjugation of biomolecules or 15 
other ligands the chemical structure of the dyes might change 
leading to different fluorescence properties. Furthermore, it is 
challenging to adjust the dye-biomolecule conjugation. It should 
be sensitive enough to achieve a cleavage and subsequently a 
fluorescence signal in the targeted region, but not too sensitive 20 
against the biological environment to avoid a premature release 
of the dye from the conjugate.  
 
3 Polymeric fluorescent nanoparticles (FNPs) 
 25 
A promising way to amplify the fluorescence of dyes and to 
overcome the above mentioned limitations is to enclose dye 
molecules into NPs.[28,33-36] Within this article, the term 
fluorescent nanoparticles (FNPs) refers to polymer-based 
particle systems that contain common organic dyes for optical 30 
imaging applications. Inorganic based particle systems will not 
be in the scope since there are excellent reviews discussing 
versatile systems based on inorganic (nano)materials, such as 
silica particles.[85-88] 
 35 
3.1 Opportunities and challenges 
 
Manifold benefits are associated with the usage of FNPs.[6] The 
particle formation on the nanoscale increases the in vivo 
distribution as well as the retention time of the dyes. Moreover, 40 
hundreds of dye molecules can be entrapped into the NP core 
that significantly enhances the fluorescence brightness in a 
single spot. The amount of fluorophores entrapped into the NP 
core is thereby only limited by the quenching effect which can 
occur if too many fluorophores are too close too each other. 45 
Thus, by application of NPs that contain fluorophores, a lower 
 
   
 
FITC[44] ICG[19] Cy-5[78] DiR[34] 
em = 520 nm em = > 800 nm em = 660 nm em = 780 nm 
 
 
 
 
Rhodamine 800[79] 5-TAMRA[80] Bodipy 6RG[54] Methylene blue[58,81] 
em = 705 nm em = 570 nm em = 550 nm em = 600–900 nm 
 
 
 
 
Naphtho-fluorescein[82] IRdye800CW [83] LS479[84] IR-783[69] 
em = 665 nm em = 790 nm em = 690 nm em = 780 nm 
 
Scheme 1. Schematic representation of the structures and approximated emission wavelengths of organic fluorophores used for in vivo 
imaging. 
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amount of dye molecules encapsulated into the NP might be 
more beneficial since it can lead to an enhanced detection 
ability. It was also observed that some fluorophores exhibit an 
increased quantum yield within the hydrophobic environment 
inside the particle core. Aside from that, the particle surface can 5 
be used for further reaction with functional groups, such as 
target moieties or stealth polymers. If two or more different 
chromophores are embedded in the polymer, it is also possible 
to obtain FRET systems, e.g. switchable emission and/or 
stimuli-responsive FNPs.[34,89-91] Another important benefit of 10 
encapsulation of the dyes into a matrix material is the protection 
of the dye against the biological enviroment.  
However, for the realistic application of FNPs for in vivo 
surgery practice, the agents have to fullfill a number of 
prerequisites. (1) FNPs have to exhibit high purity and must be 15 
non-toxic to ensure a safe administration. (2) Superior colloidal 
stability must be given in biological systems in order to avoid 
degradation or agglomeration and to enhance the blood 
circulation time. (3) Carriers should be targetable for a 
controlled imaging. (4) Complete clearance from biological 20 
systems must be warranted after the imaging process is 
completed. (5) Dye containing NPs should posses a high and 
stable fluorescence to ensure the long-term imaging and a good 
signal-to-noice ratio.  
 25 
3.2 Polymer systems 
 
In order to realize the development of nanocarriers that fulfill all 
prerequisites mentioned above, the polymers used as matrix 
material should offer excellent biocompatibility, low or non-30 
toxicity and the ability to form stable particles that persist over a 
long time also in biological enviroments. To this end, a variety 
of formulations were tested, and a lot of effort was dedicated to 
the synthesis and characterization of biocompatible polymers as 
matrix material. Living and controlled polymerization 35 
techniques are applied for the preparation of polymers with a 
defined architecture, composition and constitution as well as 
molar mass.[92-97] Thus, the chemical and physical properties of 
polymers can be easily adjusted. For the preparation of NPs, 
hydrophobic polymers such as poly(lactic-co-glycolic acid) 40 
(PLGA), poly(-caprolactone) (PCL) and poly(methyl 
methacrylate) (PMMA) derivatives are often used 
(Scheme 2).[98-103] PLGA is the most extensively investigated 
matrix material for NP based diagnostic and drug delivery 
applications owing to its outstanding characteristics, such as 45 
excellent biocompatibility, biodegradability into metabolizable 
moieties, and good manufacturing abilities.[104] PCL represents a 
good alternative that shows comparable properties and is also 
widely applied for NP-based drug delivery and imaging.[99] 
Although NPs consisting of PMMA and its derivatives are not 50 
biodegradable, their proven biocompatibility and stability in 
vitro and in vivo declare them useful for in vivo applications.[105-
108] PMMA is a FDA approved polymer for some in vivo 
applications (contact and intraocular lenses, filler for bone 
cavities) and can be combined with versatile polymers to 55 
obtained functional copolymers with fine-tuned 
properties.[89,90] Besides synthetic compounds, biopolymers are 
also well-suited for the preparation of NPs as they offer 
excellent biocompatibility, good biodegradability as well as 
multiple functional groups for further conjugation with dyes or 60 
drugs. Important representatives amongst others are 
polysaccharides, such as dextran and chitosan.[91-94] 
 
 
Scheme 2. Synthetic and natural polymers applied for the 65 
synthesis of NPs.  
 
3.3 FNPs preparation 
 
For the preparation of FNPs, two different techniques can be 70 
applied to embed the fluorophore in a polymer matrix 
(Figure 1). The non-covalent procedure is characterized by 
physical entrapment of the dye molecules in the matrix material, 
either by encapsulation during the particle formation or by 
diffusion of the dye molecules into the NP core. The physical 75 
inclusion method has the advantage that changes in the optical 
properties evoked by the attachment of the dye to the polymer 
backbone do not occur. Additionally, the manner of possible 
dyes is not limited as no functionality on the chromophore is 
necessary for chemical attachment. However, the dye may leak 80 
out of the nanoparticle shell. Such a leakage can be prevented by 
covalent attachment of the dye to the polymer scaffold.  
The fabrication of FNPs is accomplished either by in situ 
polymerization of monomers in an emulsion polymerization or 
by forcing the polymer material to build nanostructures. For the 85 
latter method, single or double emulsification, solvent-
displacement/nanoprecipitation, electro spraying, salting out, 
supercritical- and microfluidic processes as well as the inkjet 
printing of NPs were developed;[95-99] thereby emulsion and 
nanoprecipitation technique are most frequently used. Emulsion 90 
polymerization relies on the formation of oil droplets containing 
the monomer units that are stabilized in water by surfactants.[100] 
After the (nano-)emulsion is formed and homogenized, a 
polymerization reaction occurs within the existing nanodroplets 
leading to the formation of nanoparticles. Using this preparation 95 
technique, different particle sizes with narrow size-distributions 
can be achieved by controlling various parameters such as the 
type of surfactants, the solvent/non-solvent ratio, and the 
reaction time. Dye molecules can be mixed with monomer 
molecules leading to the entrapment of the dye into the 100 
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emerging matrix. The covalent attachment can be realized by 
copolymerization of original and dye-functionalized monomers. 
 
Figure 1. Common preparation techniques of polymeric FNPs. 5 
 
To obtain FNPs via the single emulsion technique, the labeled 
polymer units (covalent method) or a mixture of the polymer 
and the hydrophobic dye molecules (non-covalent method) are 
dissolved in a water-immiscible organic solvent (e.g. ethyl 10 
acetate, dichloromethane). Subsequently, the organic phase is 
emulsified in water with usage of appropriate surfactants 
(poly(vinylalcohol), polysorbate 20) to stabilize the particles, 
following the evaporation of the organic solvent. Hydrophilic 
dyes can be encapsulated by the double emulsion process.[101,102] 15 
In this approach, the dye is dissolved in a small volume of an 
aqueous phase and emulsified in an organic phase that contains 
the polymer. The mixture is emulsified again in a larger amount 
of aqueous media. Comparable to emulsion polymerization, the 
particle size and degree of dye loading can be influenced by the 20 
type of polymer and solvents, concentrations, surfactants, 
emulsification time, and other formulation conditions.  
Polymeric NPs are further produced by the nanoprecipitation 
method (also called solvent displacement) (Figure 1).[97,103-105] 
This method presents an alternative, easy, low cost as well as 25 
time efficient way to produce polymeric NPs and can be realized 
in a high-throughput manner.[106,107] Thereby, particles are 
readily constructed by exposure of a polymer solution (organic 
phase) to a non-solvent (water). The major advantages of the 
nanoprecipitation process over the emulsification procedures are 30 
the non-requirement of surfactants and that no additional energy 
for sonification is required. Moreover, by variation of the initial 
conditions, such as the solvent/non-solvent ratio and the 
concentration of the polymer solution, the NP sizes can be tuned 
from a few nanometers up to 1 µm.[106] For the dye labeling, the 35 
dye molecules are mixed with the polymer in the organic phase 
prior precipitation, and the dyes are encapsulated during the 
collapse or arrangement of the polymer molecules; not included 
dyes can be removed by washing procedures.   
To achieve FNPs via a covalent procedure, active groups, such 40 
as carboxylic groups, amine functionalities or entities that may 
perform click reactions, are introduced into the polymer 
backbone for reaction with the dye molecules. Likewise, the 
dyes also have to provide at least one functionality that can react 
with the polymer without changing the fluorescence properties. 45 
By usage of coupling agents, high conversions can be reached, 
though very often a low degree of dye substitution (e.g. few dye 
molecules per polymer chain) is sufficient as the particles 
contain multitudes of polymer molecules. 
 50 
3.4 Design of smart NPs 
 
Manifold biophysicochemical parameters are the key for NPs 
fate in vivo, which emphasizes that NP characteristics, such as 
size, shape, surface properties, and target unit, should be 55 
adjusted very carefully with regard to the final application of the 
nanocarriers.[108-111] By implementation of targeting concepts, 
NPs can be directed to desired active sites (tumors) without 
adverse effects such as fast clearance by the macrophagocytotic 
system (MPS) or accumulation in healthy tissue. For improved 60 
diagnostic it is essential that the FNPs accumulate, but to a great 
extend, only in the target site to avoid interferences and to 
achieve high signal-to-background ratios for refined tumor 
detection. 
 65 
 
Figure 2. Important parameters for the design of polymeric NPs.  
 
3.4.1 Passive targeting 
 70 
 Size 
One of the most important parameters in the NP design is the 
size. It is evident that particles aimed for intravenous injection 
should be in a size range not larger than 1 m in order to ensure 
long-term in vivo circulation without causing any thrombolytic 75 
reactions.[1] In contrast, particles administered to the lung by 
aspiration of an aerosol can be in the range of several 
micrometers, and for GI tract imaging the particle size is 
supposed to be even less important.[112] In literature, 
controversial size specifications are found for NPs to be used for 80 
in vitro and in vivo applications.[107,110-114] The data range 
thereby from small particles below 10 nm up to 500 nm sized 
NPs. While NP with a diameter approximately below 30 nm 
show an efficient cell uptake, they are also rapidly cleared by 
glomerular filtration in the kidney. Contrary, larger NPs 85 
(> 200 nm) show a decreased internalization into cells and 
increased accumulation in spleen and liver.[110] The optimal NP 
diameter is expected to be in the range of 30 to 200 nm, since 
NPs in that size range benefit from the enhanced permeation and 
retention (EPR) effect.[115] The EPR effect exploits that the 90 
tumor tissue exhibits different structural features compared to 
normal cells, such as leaky vessels with enlarged gap functions 
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due to rapid angiogenesis.[116] These features enable an 
enhanced extravasation of particulate material from the 
surrounding vessel into the tumor. Due to the lack of a 
lymphatic system, the retention time of NPs in tumors is 
prolonged, which further increases the preferential NPs 5 
accumulation. However, there is no general admitted optimum 
dimension for all NPs systems as the size dependent uptake also 
relies on other physicochemical properties and the tumor 
characteristics itself. Tumor tissue can be very heterogen, and 
the vascular permeability can be limited in a range of 100 nm up 10 
to 2 m sized particles. Some tumor types show no EPR effect 
at all, and, accordingly, an active targeting is essential.[117]  
 
Shape 
De Simone and co-workers studied the internalization of 15 
differently shaped NPs produced by the PRINT technology.[118] 
Thereby, it was investigated that rod-like NPs with high aspect-
ratios were internalized faster in comparison to spherical once 
with similar volume.[108]  Caruso et al. used the “surface-area to-
volume ratio” (SAV) as parameter to describe all geometric 20 
features (size, shape, surface area) in one value. It was found 
that the SAV affects the biodistribution and cellular uptake of 
the NPs significantly.[119] In detail, with increasing SAV the 
phagocytotic uptake tends to decrease (due to flow alignment 
effects) whereas the cellular uptake increases (due to improved 25 
surface interaction).[119] It was predicted that prolate ellipsoids 
and discoidal shapes possess prolonged circulation times in 
comparison to spherical NPs and are internalized most 
effectively. For the final conclusion, which SAV ratio is most 
beneficial for enhanced NP uptake, further studies are 30 
indespensible. 
 
Surface charge and chemistry 
In addition to the size and shape, the characteristics of the NPs 
surface greatly influences the retention time and cell recognition 35 
of the NP.[120] Qualities, such as the surface charge, the surface 
hydrophobicity and further functionalization with ligands and 
polymers can significantly affect the interactions of the particles 
in suspension with cells and proteins. It was explored that 
positively charged particles reveal a high cellular uptake through 40 
endocytosis as a result of the intensified attraction with the 
negatively charged cell membrane (due to the presence of 
phospholipid groups). But, simultanously, they also show 
increased non-specific interactions and non-desired 
internalization.[110,111] Contrary, strong negatively charged NPs 45 
reveal decreased plasma protein absorbtion as well as non-
specific interactions, but also lower cellular uptake 
efficiencies.[111] Thus, for prolonged blood circulation times and 
an efficient cellular uptake, a neutral NP charge is 
recommended.[109-111,114] For the influence of the hydrophilicity 50 
and hydrophobicity it was remarked that hydrophobic NPs 
revealed enhanced cellular uptake, but also an increased 
absorption of proteins that leads to a fast blood clearance.[121] In 
order to achieve prolonged blood circulation times and to 
minimize the nonspecific protein binding, very often NPs are 55 
surface-functionalized with additional ligands or polymers. 
Reactive groups, such as carboxylic acids and amino moieties, 
which are present at the surface, can be used for the ligand 
conjugation. Thereby, carbodiimide-mediated amide and 
maleimide coupling reactions as well as click chemistry 60 
represent exquisite techniques. Most frequently applied in the 
field of NPs surface functionalization is the attachment of 
poly(ethylene glycol) (PEG). The effect of PEGylation is 
nowadays well-known, intensively reviewed, and will be 
therefore not further discussed.[122,123]  65 
 
3.4.2 Active targeting 
 
In cell culture experiments reproducible internalization rates at 
specific sites due to defined physical parameters of the NPs is 70 
possible, but for in vivo applications an active targeting of the 
NPs is essential to ensure a controlled accumulation in the 
desired tissue.[41,124,125] The idea is to conjugate ligands to the 
NPs surface, which bind specifically to antigens or receptors 
that are only expressed on the target cells.[126] By utilization of 75 
such ligand-receptor interactions, a specific tumor accumulation 
can be achieved.[127,128] Although this concept seems simple, it 
has to be considered that the NPs are aimed for clinical usage. 
Hence, they should be manufactured in a reproducible manner 
with a controlled and defined ligand conjugation. Furthermore, 80 
the stability in biological environment, including also 
consistency against pH changes and hydrolysis must be 
guaranteed. At the same time, the bioactivity of the target unit 
after the conjugation to the particle should remain unchanged. 
The active targeting approach is realized most frequently via 85 
simple and efficient covalent bioconjugation techniques, or by 
electrostatic interactions of the ligands to the particle 
surface.[124] Still, obstacles of weak reproducibility and poor 
control about the ligand density remain. To overcome these 
hurdles, a pre-targeting of the polymer with subsequent particle 90 
formation is feasible, and the number of target moieties can be 
tuned very efficiently.[129] 
 
Antibodies 
As targeting ligands, often antibodies (AB), peptides, nucleic 95 
acids and other small molecules are used.[128] Antibodies are 
large molecules, which are able to bind highly selectively to 
antigens, which are unique parts of each cell line. Common 
FDA approved representatives are the chimeric AB (rituximab) 
that binds to a CD20 antigen and is applied in the treatment of 100 
non-Hodgkins lymphoma as well as the humanized AB 
(trastuzumab) that is used in breast cancer therapy due to its 
selectivity to the HER2/neu antigen.[130-132] Unfortunately, apart 
from their high selectivity, ABs are large (~150 kDa), expensive 
and potentially immunogenic. To lower the side effects of the 105 
AB, recently antibody fragments (Fab, nanobodies) including 
antigen-binding fragments or small antibody mimetics, such as 
affibodies, are applied as target units.[133,134]  
 
Peptides 110 
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The conjugation of peptides is convincing as they are of smaller 
size, increased stability with subsequent decreased 
immunogenicity, and easy to manufacture.[131,135] Well-known 
members are the cyclo(arginine-glycine–aspartate) (cRGD) 
peptides that displays a selectivity to 3 integrin receptors in 5 
tumor cells.[136] The commercial derivative Cilengitide is tested 
in clinical phase III for lung cancer as well as pancreas treatment 
and in phase II for several other tumors.[131,137] The drawback of 
peptides is their relatively low affinity for the aimed site and the 
subsequent occurrence of non-specific adhesion to normal 10 
tissue. Multiple peptide conjugation on the particle surface 
might reduce this problem, but still more effort is necessary to 
develop new derivatives with improved selectivity.  
 
Aptamers 15 
A high target specificity, owing to their unique conformations, is 
warranted by the usage of nucleic acids segments 
(aptamers).[138,139] Aptamers are short single-stranded DNA or 
RNA oligonucleotides consisting of 15 to 40 base pairs and are 
low immunogenic as well as easy to manufacture and scale 20 
up.[140] The 2´-fluoro-pyridine-RNA aptamer is known to 
targeted the prostate specific membrane antigen (PSMA) and is 
currently in clinical phase II.[124]  
 
Sugars and vitamins 25 
Small molecules, such as sugars and vitamins, are also utilized 
as target moities. For instance, folic acid (FA), a member of 
vitamin B family, participates in the biosynthesis of nucleic and 
amino acids and shows a high selectivity to folate receptors that 
are overexpressed in tumor cells.[141] Important folate 30 
derivatives in clinical trails are the indium-111-labeled 
diethylenetriamine pentaacetic acid (DTPA)-folate and the 
vintafolide (EC145). EC145 is a FA-drug conjugate, which 
consists of FA attached to the vinca alkaloid 
desacetylvinblastine monohydrazide and showed a high anti-35 
tumor effect against subcutaneous FR-positive tumor 
xenografts.[124,142] Moreover, it was investigated that tumors 
show a high affinity to sugar units (glucose, mannose or 
galactose).[143] The preferential accumulation of sugars is further 
supported by the presence of special carbohydrate-binding 40 
proteins (membrane lectins) on the cell surface. As a result, 
sugars are profitable targets, which are convincing with easy 
synthesis, good biocompatibility and high affinity. Despite the 
wide field of possible target moieties and the manifold reaction 
paths for their attachment, until now only three targeted 45 
polymeric NPs have progressed to clinical trials for drug 
delivery application.[37-41] For one, a PEGylated cyclodextrin-
based NP that contains human transferrin as a targeting ligand 
for binding to transferrin receptors, which are typically 
upregulated on cancer cells, is utilized to deliver siRNA.[37] In 50 
addition, a PLGA-PEG based nanoparticle containing the anti-
cancer drug docetaxel and a ligand that targets the prostate-
specific membrane antigen (PSMA) is now in clinical trials in 
people (BIND-014).[38] Moreover, a polymer based NP 
functionalized with nicotine and PEG containing a synthetic 55 
TLR agonist, a novel universal T cell helper peptide, is applied 
against nicotine for smoking cessation (SEL-068).[40] The low 
number of clinically applied targeted polymeric NPs clearly 
demonstrates the challenges that come along with the 
development of such designed nanocarriers.  60 
A limiting factor of capital importance accompanied with the 
targeting concept is the controlled and reproducible production 
of NPs that fulfill the good manufacture practice (GMP) 
guidelines. Aside from that, there is still an insufficient 
understanding of the NP interactions and distributions in vivo. In 65 
order to realize the usage of targeted NPs in clinical 
applications, it is required to gain more knowledge about their in 
vivo stability, circulation behavior, their interactions with blood, 
proteins and cells as well as their definite faith. The 
development of new screening methods, which enable the study 70 
of various NPs systems, might help to gain more insights into 
the NP and their interplay with the biological environment.[41] 
Nevertheless, in the past few years a great progress in the 
development of targeted nanosystems was observed, and many 
promising studies demonstrate the huge potential of targeted 75 
polymeric NPs for selective imaging as well as controlled drug 
delivery. A selection of recently performed in vivo studies of 
fluorescent NPs for cancer imaging applications are presented in 
Table 1 and reviewed in the following. 
 80 
4. Recent in vivo studies of fluorescent NP 
systems 
 
4.1 PLGA/PLA and PCL based NPs 
 85 
Due to the well-known biocompatibility and biodegradability, 
many studies utilize PLGA as matrix material for the NP 
preparation and encapsulation of cyanine dyes, such as ICG and 
Cy-5 to investigate the NP detection ability, biodistribution and 
circulation behavior in vivo in comparison to free fluorescent 90 
dye molecules (Table 1).[144,145] Thereby, two major benefits of 
the FNPs were found: The particles could be nicely detected in 
vivo and the resulting dye concentrations in all organs (liver, 
spleen, lung, heart and kidney) were significantly increased 
compared to free dye molecules.[145] The results clearly 95 
demonstrate the potential of polymeric NP for diagnostic 
application, though the accumulation of NPs was not specific. 
Since this is a fundamental requirement for excellent disease 
diagnostic, it becomes obvious that a targeting strategy is 
essential. As mentioned before a passive targeting can be 100 
realized via size dependent accumulation. To study the size 
effect in tumors, PEGylated fluorescent PLGA NPs with three 
different sizes were prepared by co-nanoprecipitation of the 
polymer with DiR fluorophores.[146] The in vivo fate of the 
resulting NPs was studied in two different xenograft tumor 105 
types, the HT29 (colorectal carcinoma) and the A2780 (ovarian 
carcinoma) cell lines. It was observed that small NP batches 
(d = 111 and 141 nm) accumulated efficiently in the human 
xenograft tumor tissue, while slightly larger NPs (d  = 166 nm) 
were rapidly eliminated by the liver. Nevertheless, passive 110 
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targeting does not solve the drawback of undesired 
accumulation of the NP in other organs.  
To obtain a more tumor specific uptake, FA was attached to 
PLGA and FNPs were obtained via co-nanoprecipitation of the 
PLGA and ICG. The tagged nanocarriers (FA-ICG-PLGA) were 5 
evaluated in vitro with regard to their targeting characteristics 
using a human mammary gland adenocarcinoma cell line 
(MCF-7), which overexpresses the folate (FA) receptor.[147] The 
fluorescence imaging properties and biodistribution of the FA-
ICG-PLGA NPs were studied in nude mice bearing MCF-7 cell 10 
tumors. As expected, a prolonged circulation time in comparison 
to free ICG was obtained and uptake experiments proved the 
higher targeting efficiency of the FA-ICG-PLGA NPs in folate 
receptor overexpressing MCF-7 cells compared to folate 
receptor negative A549 cells. Furthermore, it was proven 15 
(Figure 3) that 24 h after injection no detectable signal of free 
ICG and ICG-PLGA NPs was recorded in the tumor. In contrast, 
the FA-ICG-PLGA NPs provided a significant fluorescence 
signal in the tumor. Similar PEGylated NPs consisting also of 
FA-targeted PLGA particles containing ICG were further 20 
studied in mice xenografted with MDA-MB-231 human breast 
cancer cells.[148] The study demonstrated that the dual surface 
modification with PEG and FA significantly helped targeting 
and accumulating the nanoparticles in the tumor tissue. 
 25 
Figure 3.  In vivo imaging of FA-ICG-PLGA NPs compared 
with ICG-PLGA NPs and free ICG as controls after injections in 
nude mice implanted with human breast tumors (MCF-7). (A) 
In vivo images taken at 0.5, 8, 24 h time point. (B) Fluorescence 
images of organs and tumors 24 h after injection. Reprinted with 30 
permission from ref 152. Copyright 2012 Elsevier. 
In another example, NPs were obtained by nanoprecipitation of 
a PLA-PEG copolymer with covalently attached Cy-5 and 
aptamer.[149] The resulting Cy-5-PLA-PEG-aptamer NPs 
revealed a size of 157 nm and high tumor specificity by in vitro 35 
measurements in PSMA-positive LNCaP cells. The in vivo 
detection was proven with the non-targeted and non-PEG 
functionalized Cy5-PLA NPs. Other studies with PEG-PLGA 
based NP systems that utilized cRGD as target moiety examined 
the specific accumulation in breast cancer cells as well as 40 
pancreatic cancer in mouse models.[150,151] In detail, 180 nm 
sized mPEG-PLGA-PLL-cRGD NPs with encapsulated 
rhodamine and the anti-tumor drug mitoxanthrone were 
prepared by nanoprecipitation and showed a preferentially tumor 
accumulation with decreased accretion in the heart.[150] 45 
Furthermore, PLGA-4-arm-PEG NPs were loaded with the IR-
140 dye, revealing sizes in the range of 150 to 180 nm.[151]  
Similar to the previously mentioned study, an increased NP 
accumulation in the tumor in comparison to the controls was 
observed even after 1 h. The biodistribution of the NPs was 50 
studied ex vivo after 48 h and revealed primary accumulation in 
the tumor. Accumulation in liver and spleen was significantly 
reduced after one week of treatment, which proves the great 
potential of polymeric NP as imaging agents for cancer 
detection.  55 
Figure 4. In vivo images of tumor-bearing mice after injection 
of ICG-PMMA-PEG NPs. Targeting concept: (A) Non-targeted, 
(B) folate (C), RGD, (D) GA. Color code: low intensity black, 
high intensity yellow, and tumor site red circle. Reprinted with 60 
permission from ref 160. Copyright 2012 John Wiley and Sons. 
 
4.2 PS, PMMA and chitosan based NPs 
 
Poly(acrylate-co-styrene) based imaging agents with entrapped 65 
coumarin 6 as fluorophore were prepared via 
nanoprecipitation.[152-154] The PS nanospheres were targeted with 
peanut agglutinin (PNA) that binds to the glycoprotein 
Gal-β(1-3) GalNAc, which is over-expressed on tumor cells. As 
proven in a human colorectal cancer orthotropic mouse model, 70 
the PNA-PS-NPs recognize millimeter-sized tumors on the 
mucosal surface with high affinity and specificity.  
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Detailed biological studies also revealed good stability and no 
cytotoxicity. Also a high targeting efficiency to malignant 
cancer tissue compared to other organs was found for 
poly(chloromethyl-styrene) (PCMS) NPs (d = 86 nm) that were 
functionalized with a naphthalimide derivative (NA) as ligand 5 
and FA as target units.[155] To study the specific tumor uptake, 
various targeting units, such as folic acid, glucose amine (GA) 
and RGD, were conjugated to an PMMA-PEG copolymer with 
covalently attached ICG.[156] After assembly in water, the 
different NPs posses a size of 200 nm and were intravenously 10 
injected to mice with subcutanous tumor xenograft. Non-
targeted and FA tagged NPs showed accumulation in the tumor, 
liver, spleen, heart and lung (Figure 4). In contrast, the 
copolymers that were targeted with GA and RGD showed rapid 
and more efficient accumulation in tumor tissues with only low 15 
side accumulation in the liver. This effect was explained by the 
10 times higher hydrophilicity of RGD and GA in comparison to 
folate molecules that might prefer to hide inside the more 
hydrophobic environment.[156] Although the difference of the 
folate targeted copolymer is not yet fully understood, the study 20 
proved that stable NP systems combined with efficient targeting 
strategies enable selective tumor detection.  
Furthermore, cancer-specific chitosan particles (CNPs) with an 
average diameter of about 260 nm were prepared from glycol 
chitosan that was chemically modified with hydrophobic 5β-25 
cholanic acid and labelled with Cy5.5. The NPs were also 
loaded with a drug for combined cancer detection and treatment 
(Figure 5).[157] The Cy5.5-labeled CNPs exhibited significantly 
increased tumor accumulation in brain tumors, liver tumors, and 
metastasis tumor models with low nonspecific uptake by other 30 
tissues in tumor-bearing mice proving their great potential in 
both cancer imaging and therapy.[158] 
 
 
Figure 5. (A) In vivo biodistribution of Cy5.5-CNPs in SCC7 35 
tumor-bearing mice after intravenously injection. (B) Time-
dependent tumor contrast after administration of Cy5.5-labeled 
CNPs into tumor-bearing mice. (C) Ex vivo imaging of SCC7 
xenograft tumor showed higher NIRF signal than other organs at 
all time points. Reprinted with permission from ref 162. 40 
Copyright 2012 Elsevier.  
 
 
 
 45 
 
Table 1. Selected studies of fluorescent NP systems prepared by nanoprecipitation for cancer detection in vivo.   
 Polymer Dye Active target Dye ligation Size [nm] Detection/ application Ref 
1 PLGA ICG - Physical 300  Increased  organ  accumulation [145] 
2 PLGA Cy-5 - Chemical  
Study of lymphatic biodistribution   
for detection of metastatic cancer 
[144] 
3 PLGA-PEG DiR - Physical 110 – 160 
Size-dependent passive tumor 
accumulation studies 
[146] 
4 PLGA ICG Folate Physical 105 Breast cancer [147] 
5 PEG-PLGA ICG Folate Physical 200 – 300 Breast cancer [148] 
6 PLA-mPEG Cy-5 Aptamer Chemical 157 Prostate carcinoma [149] 
7 mPEG-PLGA-PLL Rhodamine B cRGD Chemical 180 Breast cancer [150] 
8 PLGA-4-arm-PEG IR-140/nile red cRGD Physical 170 Pancreas carcinoma [151] 
9 PS-PNVA-PMMA Coumarin 6 PNA Chemical 180 – 300 Colorectal carcinoma [152,153] 
10 PCMS Naphthalimide Folate Chemical 86 Breast cancer [155] 
11 PMMA-PEG ICG cRGD, GA Chemical 200  Epithelial carcinoma [156] 
12 Chitosan Cy-5.5 5β-Cholanic acid Chemical 260 
Brain tumors, liver tumors, metastasis 
tumor models 
[157,158] 
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5 Conclusion and prospective 
 
Within the last few years, a variety of novel fluorophores with 
emission in the NIR range were synthesized that enable a 
superior detection in vivo, and relieved the fluorescence imaging 5 
from the limitation to be only applied for thin sections. Besides 
the development of cancer targeted dyes, the concept of the 
encapsulation of dye molecules into a polymeric matrix seems 
advantageous, in particular in terms of fluorophores that are 
already approved by the FDA, e.g., ICG and MB. These dyes 10 
were not developed to be used as contrast agents for image-
guided surgery and reveal only a low photostability. By using 
NPs as templates, multiple fluorophores can be loaded into the 
NPs and the dye molecules are protected against the biological 
environment leading to smart and tailor-made particles with 15 
enhanced fluorescence intensity and improved in vivo imaging. 
Another advantage of FNPs is the ability to precisely engineer 
them to their specific applications by variation of the polymer, 
the preparation method, and the kind of surface funtionalization. 
Complementary to the passive targeting effect, which is mainly 20 
based on the size, shape, surface charge and chemistry of the 
NPs, also active targeting with ligands can be exploited to reach 
a high circulation time and tumor specificity. In all reviewed 
studies, an enhanced tumor accumulation of NPs compared to 
free dye molecules was reported. Furthermore, the ability to 25 
overcome various mentioned drawbacks of single dye molecules 
(instability, interaction with proteins, low signal-to-background 
ratios) by usage of targeted polymeric NPs as matrix for 
fluorescent dyes was proven. Although the results are difficult to 
interpret as various parameters affect the efficiency of the NPs, 30 
it was demonstrated that the targeting unit is one of the most 
important factors to affect the particle faith in vivo and is a 
prerequsite for improved diagnostic. The most promising 
systems seem to be PLGA-PEG copolymer based NPs that 
contain ICG dye molecules. Owing to the existing FDA 35 
approval for the polymers and the dye, these might be the first 
systems used in clinical studies. As targeting moieties, cRGD or 
aptamers seem convincing in terms of their high tumor 
specificity. Although folate is also often utilized as target 
moiety, it appears that folate receptors are also keenly expressed 40 
in other organs leading to increased accumulation in the non-
target site.  
However, to become a clinical reality, the controlled and 
reproducible production of FNPs must be guaranteed. 
Fortunately, significant progress was made within the last years 45 
in the preparation of well-defined NPs. Nowadays, manifold 
advanced polymerization methods can be used to obtain 
(co-)polymers with distinct properties.[159,160] For the fabrication 
of safe FNPs, it becomes obvious that the labelling of the 
polymers should be realized via chemical attachment to the 50 
polymer backbone in order to prevent adverse leackage of the 
fluorophores and to ensure a reproducible dye loading. Today, 
the labelling of multifuntional polymers with desired dyes can 
be performed using non-toxic coupling agents as well as click 
chemistry, and the resulting fluorescent polymers can be 55 
comprehensively characterized by sophisticated techniques, 
such as multidimensional chromatography and modern mass 
spectrometry.[107,161-163] Furthermore, with the application of 
high-troughput approaches, such as nanoprecipitation performed 
via pipetting robots, the reproducible and controlled prepration 60 
of NPs with adjustable properties could be realized.[106] 
Since there is still an insufficient understanding how NPs 
interact and distribute in vivo, the major goal within the next 
years will be the systematical study of promising systems with 
regard to their distribution and interaction within the body, in 65 
order to explore the optimal parameters in terms of dye loading, 
core/shell ratio, and specific target unit. While the theory 
appears very straightforward, reams of in vitro and in vivo 
studies remember consistently that the major problem remains: 
How can the knowledge be transfered from the cuvette to the 70 
cell to the mice and, finally, to the human body? 
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ABSTRACT: Nanoprecipitation represents an effective method
for the production of polymeric nanoparticles. This technique
was used to prepare nanoparticles from solutions of poly-
(methyl methacrylate) and its copolymers. Since the regulation
of main parameters like particle size, particle size distribution,
and molar particle mass is very important for future applica-
tions, the stable nanoparticle dispersions were examined by
scanning electron microscopy, velocity sedimentation, and
dynamic light scattering, whereby advantages and disadvan-
tages of each characterization techniques are discussed. Poly-
dispersities of particle size distributions are determined by the
ratio of dw/dn, where dw and dn are weight- and number-aver-
age diameters, respectively. The particle characteristics
strongly depend on the chemical structure of the polymers and
the way of preparation and, therefore, vary in the studied cases
in the range of 6 < dw < 680 nm, whereas the polydispersity
index dw/dn changes in the range of 1.02 to 1.40. It is shown
that nanoparticles in a desirable size range can be prepared by
solvent–nonsolvent methods (dialysis technique or dropping
technique). VC 2010 Wiley Periodicals, Inc. J Polym Sci Part A:
Polym Chem 48: 3924–3931, 2010
KEYWORDS: dynamic light scattering; nanoparticles; SEM; ultra-
centrifugation; velocity sedimentation
INTRODUCTION The development of functional nanoparticles
is of major interest because it was found that the unique
properties of such nanoscale materials allow breakthroughs
in technology, bioengineering, life sciences, and many others.
To tune the properties of the nanoparticles for specific appli-
cations, not only the molecular structure but also the size of
the systems needs to be well investigated. Therefore, imaging
techniques such as atomic force microscopy and scanning
and transmission electron microscopy (SEM and TEM) were
used to investigate the nanoscale dimensions and morpholo-
gies up to the molecular level. In addition, dynamic light
scattering (DLS) was applied because it provides more statis-
tical information about the average size and size distribution
of the particles in suspension. A further and less commonly
used method is analytical ultracentrifugation (AUC), which
allows a closer look on the flow characteristics of the nano-
particles. In the early 20th century, Svedberg already used
AUC for the determination of the size and the size distribu-
tion of colloids.1 None of the techniques mentioned provides
ultimate information about the size, shape, morphology, and
flow behavior of nanoparticular systems. However, a combi-
nation of these techniques can lead to a satisfying characteri-
zation that is necessary for further improvements and pre-
vention of undesired side effects, like aggregation (e.g., of
drug-containing particles in the blood stream).
Synthetic polymers are widely used materials for the design
of functional nanoparticles because they provide unique
structural diversity and functionality. In this study, poly
(methacrylate) nanoparticles were prepared and analyzed by
SEM, DLS, and AUC. Poly(methacrylic acid)-co-(methyl meth-
acrylate)s [poly(MAA-co-MMA)] show a pH-dependent solu-
bility behavior, which makes it possible to use them as drug
delivery systems both able to protect the drug and to release
it at the targeted side.2 In addition, the functionalization of
the polymers with dyes allows the localization of the par-
ticles for cell studies or tissue examinations.3,4
To prepare well-defined poly(methacrylate) nanoparticle sus-
pensions, nanoprecipitation was applied as alternative tech-
nique besides emulsion techniques and spray drying proc-
esses usually used for polymers.5 The nanoprecipitation
technique is based on precipitation of polymer molecules
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into nanoscale particles during displacement of a solvent
with a nonsolvent.6,7 Till now, nanoprecipitation is mainly
used for poly(lactides) and its copolymers; however, it is, ap-
plicable in principle for all polymers under certain condi-
tions.8–10 The latter could be shown not only for example for
diverse polysaccharide derivatives, namely cellulose11 and
dextran esters,12 several industrially prepared polymers13
but also highly functional pentafluorostyrenes.14 In this
work, copolymers of MMA with MAA and ethylacrylate (EA),
in particular poly(MMA-stat-MAA)1:2 and poly(MMA-stat-
EA)1:4, a homopolymer of poly(methyl metharcrylate)
(PMMA) and a fluorescence-labeled poly(MMA-stat-PyMMA)
were formed into nanoscale particles, applying a dialysis and
a dropping technique. The particle formation and, conse-
quently, the resulting size and shape of the particles strongly
depend on the concentration of the polymer solutions, the
solvent, the solvent to nonsolvent ratio, and the course of
the reaction. All these factors influence the self-assembly of
the polymer molecules from the dissolved state into defined
nanoparticular systems. The nanoparticle suspensions
formed were characterized extensively by SEM, TEM, and
AUC including storage stability, to evaluate their ability as
possible carries for drug delivery and diagnostics.
EXPERIMENTAL
Materials
Poly(MMA-stat-MAA)1:2 and poly(MMA-stat-EA)1:4 were
kindly provided by Evonik Ro¨hm GmbH (Darmstadt, Ger-
many). Pyren-1-ylmethylmethacrylate (PyMMA), P(MMA-stat-
PyMMA), and PMMA were prepared by a reversible addition-
fragmentation chain-transfer polymerization.15–17 Purified
N,N-dimethylacetamide (DMA) was purchased from VWR
(West Chester, PA).
METHODS
Size Exclusion Chromatography (SEC)
SEC was performed on a Shimadzu system, equipped with a
SCL-10A VP system controller, a LC-10AD VP pump, a RID-
10A refractive index detector, and a PSS SDV linear S column,
with a mixture of chloroform:triethyl-amine:2-propanol
(94:4:2) as eluent at 1 mL/min flow rate at 40 C. Additional
SEC measurements were performed on an Agilent 1200 series
LC system (isocratic pump G1310A, refractive index detector
G1362A) with a PSS Gram30 and a PSS Gram1000 column in
series. DMA containing 0.21% LiCl (m/v) was used as eluent
at a flow rate of 1 mL/min at 40 C. As calibration standard,
PMMA was used.
SEM
The nanoparticle suspensions were diluted with demineral-
ized filtered water to a final concentration of 1 mg/mL. The
suspensions were characterized by SEM using the system
LEO-1450 VP (Leo, Oberkochen, Germany) operating at 10 kV.
For this, one droplet (15–20 lL) of the suspension was placed
on a mica surface, lyophilized for 3 h and finally covered with
gold using a sputter coating device BAL-TEC SCD005 (Balzers,
Lichtenstein; 60 mA, 80 s). The diameter of the nanoparticle
was measured using the ImageJ software.18
Sedimentation Velocity Experiments
Sedimentation velocity experiments were performed with a
Beckman XLI analytical ultracentrifuge (ProteomeLab XLI Pro-
tein Characterization System). They were carried out in con-
ventional double-sector Epon centerpieces of 12-mm optical
path length in a four holes rotor. Cells were filled with
420 lL of suspension and 440 lL of solvent (H2O or D2O). A
rotor speed of 3,000 to 40,000 rpm was used depending on
the sample. The nanoparticle suspensions were used without
further purification. The rotor was equilibrated for 2 h at
20 C in the centrifuge. Sedimentation profiles were obtained
every 15 s by interference optics, and the sedimentation data
were evaluated by the program Sedfit.19
Particle Characterization by DLS
DLS was performed on a Zetasizer Nano ZS (Malvern instru-
ments, Malvern, United Kingdom) equipped with a 10 mW
He–Ne laser (633 nm) and operating at an angle of 173 . The
nanoparticle suspensions were diluted with demineralized, fil-
tered water to a final concentration of 0.02 mg/mL, and
measured three times at 25 C for 150 s. From the experi-
mental data (autocorrelation function), the size information
can be obtained by using the method of cumulants.20–22 In
the cumulants method, the logarithm of the correlation func-
tion is given as:
ln½g2ðsÞ ¼ K1sþ K2s2=2þ   
where K1 and K2 are the cumulants and s is a delay time.
This method provides z-average size; the width of the distri-
bution is related to the polydispersity index (PDIDLS), which
is defined as relation
PDIDLS ¼
ﬃﬃﬃﬃﬃﬃ
K2
K21
s
where K1 and K2 are the first- and the second-order cumu-
lant of the light scattered intensity, respectively. It should be
noted that the PDIDLS cannot be related with the particle
size ratio in a simple way.
Preparation of the Nanoparticles
Nanoparticles of different PMMA homopolymers and copoly-
mers were obtained via nanoprecipitation.7,23 Two techniques
were applied for the nanoparticle formation: dialysis and a
dropping technique.13,24 For the dialysis process, 10 mg of
the polymer was dissolved in 2.5 mL purified DMA as organic
solvent, transferred into a regenerated cellulose membrane
(Spectra/PorV
R
, Rancho Dominguez, CA, molar mass cutoff
6,000–8,000 g/mol), and dialyzed against 500 mL distilled
water. The surrounding water was exchanged five times in a
period of 12 h until all DMA was replaced. As a typical exam-
ple for the dropping technique, 10 mg of the polymer was
dissolved in 2.5 mL acetone, and the solution was added
dropwise under stirring to 10 mL distilled water or deuter-
ated water, respectively, or vice versa water was dropped into
the polymer solution. The acetone was removed by evapora-
tion at 40 C overnight. The nanoparticle suspensions pre-
pared were stored at 4 C.
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RESULTS AND DISCUSSION
A homopolymer of PMMA and the copolymers poly(MMA-
stat-MAA)1:2, poly(MMA-stat-EA)1:4, as well as poly(MMA-
stat-PyMMA) were transformed into nanoscale materials by
applying different nanoprecipitation techniques. The molar
mass of the MMA-based polymers and their PDIs were esti-
mated by size-exclusion chromatography (SEC) (Table 1). In
the following, the particle suspensions of the synthetic poly-
mers will be characterized and compared applying SEM,
AUC, and DLS.
Distributions and Size Average Values
Because of the use of different methods for characterizing
the nanoparticle suspensions, also different size distributions
were obtained. SEM investigations yield number distribu-
tions. From velocity sedimentation, a weight-average distri-
bution can be obtained. In addition, the translational diffu-
sion coefficients Dz resulting from DLS represent z-averages.
Usually, the weight-average distribution is shifted to higher
values when compared with the number average distribu-
tion. However, at the same time, corresponding average val-
ues calculated from different kinds of distributions must
coincide:
dn ¼ 1P wi
di
¼
X
vidi and dw ¼
X
widi ¼
P
vid2i
dn
;
with vi ¼ niN being the number fraction and wi ¼ ndiP ndi being
the weight fraction. For polydisperse samples, the relation
dw > dn can be applied. The heterogeneity of an ensemble of
nanoparticles can further be characterized by the ratio of dif-
ferent size average values PDId ¼ dwdn . For particles with
spherical shape, PDId is related by a simple way to the molar
mass distribution PDIM ¼ MwMn ¼

dw
dn
3
.
Particle Characterization by SEM
The morphology and size distribution of the PMMA nanopar-
ticles was first investigated by SEM. Typical images of nano-
particles from poly(MMA-stat-MAA)1:2 and poly(MMA-stat-
PyMMA) prepared by different precipitation techniques are
shown in Figure 1. In all images, spherical-shaped particles
in the nanoscale range can be observed. In some cases, adhe-
sion of the particles is detected (dropping acetone solution
of poly(MMA-stat-MAA)1:2 into water). The corresponding
histograms are presented in Figure 2. Based on these num-
ber of histograms, the average values dn and dw were calcu-
lated. Weight-average diameters are listed in Table 2, and
dw/dn values are presented in Table 3. The number of indi-
vidual particles N considered in the calculations varies
between 100 and 300.
Particle Characterization by AUC
In an ultracentrifuge, nanoparticles will be fractionated
according to their size, density, and shape. Therefore, sedi-
mentation analysis in combination with Sedfit software gives
a reliable and adequate analysis of the nanoparticles includ-
ing size and size distribution. A typical image obtained from
the Sedfit program is shown in Figure 3. The data were
TABLE 1 Characterization of PMMA and PMMA Copolymers
Sample Ratio Mn (g/mol) Mw (g/mol) PDI
Poly(MMA) – 10,100a 11,200a 1.11a
Poly(MAA-stat-MMA)1:2 1:2 10,000
b 19,600b 1.96b
Poly(MMA-stat-EA)1:4 1:4 10,000
b 23,800b 2.38b
Poly(MMA-stat-PyMMA) 95:5 9,100a 10,600a 1.16a
a Calculated from SEC (CHCl3) with PMMA standards.
b Calculated from SEC (DMA/LiCl) with PMMA standards.
FIGURE 1 SEM images of PMMA nanoparticles prepared by various techniques.
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modeled using two different analysis methods implemented in
Sedfit: (1) c(s) analysis, which is based on a numerical solution
of the Lamm equation; it allows to estimate the weight-average
frictional ratio of all particles, and (2) the least-squares bound-
ary modeling ls-g*(s), which describes sedimentation of a non-
diffusing species.25 A parameter necessary for the quantitative
interpretation of sedimentation data is the partial specific vol-
ume u, which was determined by the ‘‘density variation
method’’: by sedimentation velocity experiments on the nano-
particle suspensions using H2O and D2O,
26,27 assuming that the
nanoparticles have the same size and molar mass in each sol-
vent (which is equivalent to the assumption of a constancy of
the intrinsic sedimentation coefficients ½s  s0g0ð1vq0Þ). Applying
this method, the partial specific volume value u of the particles
can be obtained from the following equation:
v ¼ s2g2  s1g1
s2g2q1  s1g1q2
where s1, g1, q1, and s2, g2, q2 are sedimentation coefficients,
dynamic viscosity, and solvent density measured in H2O and
D2O, respectively. The partial specific volume of the particles
was found as u ¼ 0.78 cm3/g with maximum deviation 0.01.
The nanoparticle suspensions were also investigated at dif-
ferent concentrations, to check for a possible concentration
dependence of the sedimentation and frictional coefficient.
However, no concentration dependence of s and f/fsph could
be observed in the concentration range of 0.025 to 0.10 
102 g/cm3. The fitted frictional ratio (f/fsph)0 obtained by
c(s) analysis is virtually equal to 1, which confirms the
spherical shape of the nanoparticles and supports the inves-
tigations by SEM. By combining Svedberg’s equation,
s ¼ Mð1 vq0Þ
NAf
;
where f ¼ 3pgd is the translational friction coefficient, and
the hard sphere approximation M ¼ NApd36v , where NA is Avo-
gadro number. The diameter d of the particles can be easily
calculated from the following expression28:
d ¼ 3
ﬃﬃﬃ
2
p ﬃﬃﬃﬃﬃﬃﬃ
½sv
p
(  )
Based on equation (*), the c(s) and/or ls-g*(s) distributions
can be converted to the distributions by sizes. The corre-
sponding distributions are shown in Figure 4. Molar masses
of the particles were estimated by applying the modified
Svedberg’s equation
Ms ¼ 9p
ﬃﬃﬃ
2
p
NA
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½s3v
q
Based on these mass distributions, the average values dw
were calculated and listed in Table 2 with the Ms
estimations.
Particle Characterization by DLS
DLS is a commonly used technique to determine the size dis-
tribution profile of particles in suspension or of polymers in
solution.29–31 The raw experimental data obtained in a DLS
FIGURE 2 Size distribution, determined by SEM, of poly(MMA-
stat-PyMMA) nanoparticles prepared by different nanoprecipita-
tion techniques: (1) dropping a solution of the polymer in ace-
tone into water, (2) dialysis of a solution in DMA against water,
and (3) dropping water into the acetone/polymer solution.
TABLE 2 Weight-Average Sizes of Nanoparticles Determined by SEM, AUC, and DLS and Their Molar Masses Determined by AUC
N Sample Preparation SEM, dw (nm) AUC, dw (nm) Msf  106 (g/mol) DLS, dw (nm)
1 poly(MMA) Da 310 300 12,000 480
2 poly(MMA-stat-PyMMA) D 280 570 73,000 480
3 A!Wb 75 65 120 100
4 W!Ac 490 380 22,500 680
5 poly(MMA-stat-MAA)1:2 D 36 28 9.5 46
6 A!W 43 35 18 41
7 W!A 110 104 420 190
8 poly(MMA-stat-EA)1:4 D 135 106 425 150
9 A!W – 6.6 0.04 5.8
10 W!A – 105 420 270
a Dialysis preparation technique.
b Dropping acetone solution of a polymer into water.
c Dropping water into acetone solution of a polymer.
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experiment is the intensity autocorrelation curve. For small
particles, when d 	 k, the Rayleigh scattering approximation
is valid. The intensity I of light scattered by a single small
particle from a beam of unpolarized light of wavelength k
and intensity I0 is given by:
I ¼ I0 1þ cos
2h
2R2
 2p
k
4 n2  1
n2 þ 2
2 d
2
6
with R being the distance to the particle, y being the scatter-
ing angle, n being the refractive index of the particle, and d
being its diameter. The scattering intensity of spherical par-
ticles is proportional to the sixth power of the diameter or
the square of the molar mass: I  d6  M2. Thus, a small
amount of aggregates or larger particles can dominate the
distribution, with the consequence that the intensity distri-
bution can be somewhat misleading. The software of the
Zetasizer Nano ZS transforms the intensity distribution into
volume and number distributions of the particles, with cor-
responding differential distribution qV/qd and qN/qd, respec-
tively, based on the Mie theory.32 In contrast to Rayleigh
scattering, the Mie solution of the scattering problem is valid
for all possible ratios of diameter to wavelength, although it
results in a numerical summation of infinite sums.
For particles with d 	 k, the Rayleigh approximation allows
the following scaling of the intensity: I0.5  d3  M. There-
fore, the integral distribution I ¼ f(d) can be transformed
into the corresponding I0.5 ¼ f1(d) distribution, from which
the differential distribution q(I0.5)/qd was obtained. The dis-
tribution q(I0.5)/qd may be close to qV/qd. A comparison of
the three types of distributions is presented in Figure 5 for
the examined poly(MMA-stat-MAA)1:2. In an ideal case, the
numerical size distribution shifts to smaller values in com-
parison with the weight distribution. In the majority of sys-
tems studied, this trend was observed; unexpectedly how-
ever, in some cases, the opposite of this trend was observed,
where the weight distribution values were smaller than
those of the corresponding numerical size distributions. The
values of the weight-average diameter dw obtained by DLS
are presented in Table 2. In general, they are in acceptable
(but in some cases only in rough) agreement with those
obtained by the other methods applied. Values obtained
from DLS using different distributions are listed in Table 4.
Comparison of Sizes and Distributions
It is obvious from Figures 1 and 4 as well as Table 2 that
different preparation techniques lead to different particle
sizes and size distributions (by comparing data of the same
characterization technique; otherwise it is somewhat
obscured due to the differences in the measuring principles
applied). Apparently, what matters is the way of exchanging
the solvent: The exchange of the solvent to the nonsolvent is
either fast, in case of the dropwise addition of the polymer
TABLE 3 Calculated PDI Values Obtained from DLS, AUC, and
SEM
N PDIDLS DLS, dw/dn AUC, dw/dn SEM, dw/dn
1 0.291 1.30 1.20 1.29
2 0.346 1.26 1.24 1.40
3 0.228 1.05 1.07 1.04
4 0.321 1.09 1.12 1.04
5 0.312 1.05 1.12 1.09
6 0.300 1.05 1.13 1.10
7 0.132 1.12 1.06 1.10
8 0.194 1.03 1.06 1.12
9 0.543 1.02 1.20 –
10 0.237 1.08 1.06 –
FIGURE 3 Sedimentation velocity
experiments on poly(MMA-stat-
MAA)1:2. The experiment was car-
ried out at 12,000 rpm, scans were
collected every 15 s. Top panel:
superposition of sedimentation
profiles obtained with interference
optics at 20 C. Middle: corre-
sponding residual plots. Bottom:
differential distribution c(s) of the
sedimentation coefficients. The dis-
tributions were obtained with a
regularization procedure with a
confidence level of 0.9.
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solution to water, or very slow, for the dialysis method as
well as for dropping the water into acetone.
Considering all data obtained for the PMMA particle suspen-
sions, some qualitative conclusions can be drawn. By drop-
ping the acetone/polymer solution into water, the polymer
precipitates rapidly in the surplus of water. As a result, the
formation of comparatively small nanoparticles (less than
100 nm in diameter) could be observed. On the other hand,
the successive dropping of water into the polymer/acetone
solution leads to a more defined precipitation of the polymer
molecules into nanoparticles. However, significantly larger
particles are formed. The slow exchange of DMA as polymer
solvent against water applying dialysis yields particles with
sizes in between the two dropping techniques, though with a
broad size distribution.
As a typical example, the size distributions for poly(MMA-
stat-MAA)1:2 particles obtained by DLS, SEM, and AUC are
shown in Figure 6. The shapes of the distributions obtained
from the different techniques have a similar appearance (i.e.,
similar modalities of distribution). In Figure 7, the average
measured weight diameter values of nanoparticles from cor-
responding distributions are compared from the different
techniques, where the dotted straight line represents parity
between the two measurements. In the size range below 150
nm, a satisfactory correlation between the measurements
from the different methods is observed. However, at larger
sizes (> 300 nm) the measurement values collected by DLS
exceed those of dSEMw . To understand this disparity in the
measurements for this size domain, more data must be
obtained. The parameter dw/dn, which characterizes the
FIGURE 4 Size distributions, determined by DLS, of poly(MMA-
stat-MAA)1:2 nanoparticles prepared by different nanoprecipita-
tion techniques: (1: solid line) by dropping an acetone solution
of the polymer into water, (2: dashed line) by dialysis of a
DMA solution against water, (3: solid line) by dropping water
to the acetone/polymer solution.
FIGURE 5 Comparison of different size distributions of a poly-
(MMA-stat-MAA)1:2 sample (prepared by dropping an acetone
solution into water), all determined from DLS data: (1) number
distribution, (2) volume distribution, and (3) square root of
scattered intensity. Number and volume distributions were
automatically calculated from the intensity distribution by
using the Mie theory.
TABLE 4 Weight-Average Diameters Calculated from DLS Data
Using Different Distributions
N
dw (nm)
davw (nm)Square Root of Intensity Volume Number
1 484 406 344 410 6 50
2 476 455 451 460 6 10
3 100 105 85 97 6 8
4 684 661 637 650 6 10
5 46 41 45 44 6 2
6 41 40 40 40 6 1
7 187 177 179 181 6 4
8 150 149 150 150 6 1
9 5.83 5.81 5.89 5.8 6 0.1
10 269 267 261 266 6 3
FIGURE 6 Size distribution of nanoparticles (prepared from an
acetone solution of poly(MMA-stat-MAA)1:2 by dropping water
into it) as analyzed by (1) SEM (in bars), (2) AUC, and (3) DLS.
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dimensional polydispersity of the ensemble of nanoparticles,
changes in the limits 1.02 
 dw/dn 
 1.40, which means
that the corresponding molar mass polydispersity Mw/Mn
will change in the limits 1.06 
 Mw/Mn 
 2.75. Figure 8
demonstrates the slight increase of the dw/dn values with
increasing diameter of the particles. The corresponding PDI
values are listed in a Table 3.
Analysis of Storage Stability
The effect of storage of the dispersions (in the refrigerator at
þ4 C) on particle diameters and size distributions was
investigated by velocity sedimentation runs. Figure 9A
shows the distributions of the sedimentation coefficient of
poly(MMA-stat-PyMMA) nanoparticles after different periods
of time (1, 2, 4, 7, and 26 weeks, respectively). The shapes
of the distribution remain virtually the same, whereas the
peak position fluctuates around 500 S. The area under the
distribution curve is related to the total number of fringes
which, in turn, is directly related to the concentration of the
dispersed species by the following equation:
J ¼ c kl Dn=Dc
k
 
;
where k is the light wavelength, k the magnifying coefficient,
and l the optical path.33 After 6 months, the particle concen-
tration in suspension decreased only by 20% (see Fig. 9B),
which could also be confirmed by monitoring the small
amounts of sediment in the bottom of the flasks.
CONCLUSIONS
Nanoparticles of homopolymers and copolymers of PMMA
were obtained by nanoprecipitation using three different
methods. The characteristics of the particle suspensions
were investigated by applying SEM, AUC, and DLS measure-
ments. Each of these analysis tools provides information
about the characteristics of the particles, however, also com-
ing along with some benefits and disadvantages. SEM imag-
ing shows the approximate shape of the particles but only
for a comparatively small section. AUC and DLS measure-
ments provide more statistical information about nanopar-
ticles in suspensions and do not require any drying proc-
esses. However, only a few larger aggregates are necessary
to influence the DLS results yielding misleading data.
Although requiring longer preparation and measurement
times, AUC provides information about multimodal size dis-
tributions over a wide range of sizes. In this study, the diam-
eters of the nanoparticles obtained by the nanoprecipitation
method were in the range of 6 
 d 
 600 nm as revealed
and discussed by various measuring principles. The PMMA-
based polymers form dispersions of spherical-shaped
FIGURE 7 A comparison of particle weight-average sizes
obtained by different methods. Values obtained by AUC (1–3)
and DLS (4–6) plotted against measurements taken using SEM.
Particles obtained by the dialysis technique (1,4), by dropping
polymer solution into water (2,5), and by dropping water into
the polymer solution (3,6), were compared. The dashed line
slope is equal to measurement parity.
FIGURE 8 Correlation between the PDI values calculated from
(1) AUC, (2) DLS, and (3) SEM data and the weight-average
sizes estimated from AUC.
FIGURE 9 Effect of storage on the distribution of the sedimen-
tation coefficients (A) and on the number of interference
fringes (B) of a poly(MMA-stat-PyMMA) suspension after (1) 1,
(2) 2, (3) 4, (4) 7, and (5) 26 weeks of storage.
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particles in the nanoscale range, which are stable for at least
6 months.
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View Article Online / Journal Homepage / Table of Contents for this issueExamination and optimization of the self-assembly of biocompatible,
polymeric nanoparticles by high-throughput nanoprecipitation†
Igor Y. Perevyazko,ab Joseph T. Delaney, Jr.,abc Antje Vollrath,ab Georges M. Pavlov,abc Stephanie Schubertabd
and Ulrich S. Schubert*abc
Received 17th January 2011, Accepted 21st March 2011
DOI: 10.1039/c1sm05079fIn recent years, the development of polymer nanoparticle suspensions by nanoprecipitation has gained
increased attention both by industry and academia. However, the process by which such formulations
are prepared is a highly empirically driven enterprise, whereby developing optimized formulations
remains an iterative process. In this contribution, a new approach towards exploration of the materials
space for these systems is reported, based on systematically varying processing and formulation to
understand their influence on the characteristics of the resulting materials. Taking advantage of the
tools and techniques that have already been standardized by informatics-driven life sciences disciplines,
we have prepared libraries of nanoparticle formulations of poly(methyl methacrylate-stat-acrylate),
poly(lactic-co-glycolic acid), and acetal-derivatized dextran by using a pipetting robot. They were
subsequently characterized using a dynamic light scattering plate reader, analytical ultracentrifugation,
and scanning electron microscopy. With this high-throughput nanoprecipitation approach, large
numbers of materials can be prepared, screened, and the formulation rationally optimized.Introduction
Polymer-based nanoparticle dispersions offer tremendous
opportunities for tailoring biologically active materials, such as
drugs,1,2 transfection agents,3 and agrochemicals, with respect to
improved bioavailability and specificity of delivering.4,5 Several
techniques like emulsification–solvent diffusion, salting out, and
nanoprecipitation (solvent shifting) are established for the
production of the polymeric particles.6 Nanoprecipitation is
a very mild and common method and represents the process of
nanoparticle formation by self-assembly of polymer molecules
during an exchange of a solvent against a non-solvent that is
miscible with the solvent.7 For this approach, various synthetic
polymers as well as biopolymers can be used.8–10
Besides its application for completely hydrophobic polymers,
nanoprecipitation is also used for the preparation of nanovesicles
and micelles on the basis of amphiphilic block copolymers.11,12
The process and mechanism of the nanoparticle formation wereaLaboratory of Organic and Macromolecular Chemistry (IOMC),
Friedrich-Schiller-University, Humboldtstrasse 10, D-07743 Jena,
Germany. E-mail: ulrich.schubert@uni-jena.de
bJena Center for Soft Matter (JCSM), Friedrich-Schiller-University,
Humboldtstrasse 10, D-07743 Jena, Germany
cDutch Polymer Institute (DPI), Post Office Box 902, Eindhoven, 5600
AX, The Netherlands
dLaboratory of Pharmaceutical Technology, Friedrich-Schiller-University,
Otto-Schott-Strasse 41, D-07743 Jena, Germany
† Electronic supplementary information (ESI) available. See DOI:
10.1039/c1sm05079f
5030 | Soft Matter, 2011, 7, 5030–5035intensively investigated in the last decades.13–15 Recent publica-
tions on this topic come up with the theory of the ‘‘Ouzo
effect’’.16–19 The ‘‘Ouzo effect’’ or the spontaneous emulsification
effect is a phenomenon observed when water is added to Ouzo
(Greek liquor) forming a milky and highly stable oil-in-water
microemulsion. This effect also occurs if a solution of the
hydrophobic polymer is rapidly brought into a metastable region
by the addition of a non-solvent.16
However, in order to identify suitable nanoparticle formula-
tions with predictable performance as well as the process
parameters leading to them, knowledge and understanding of the
relationships between formulation, process parameters, and
properties of the end product are beneficial. While many publi-
cations are available in this area, there is still no ‘‘unified theory’’
for predicting particle size, size distribution, and dispersion
stability ab initio for complex systems.20–24 Thus, even if signifi-
cant efforts are spent in order to create a manageable workflow,
large numbers of samples are required to explore a particular
materials space. To elucidate the material relationships more
rigorously, the nanoprecipitation technique was applied as a tool
of high-throughput experimentation. In this study, we applied
nanoprecipitation on poly(methyl methacrylate-stat-acrylate)
(p(MMA-stat-MAA)2:1), poly(lactic-co-glycolic acid) (PLGA)
and a hydrophobic dextran derivative. These biocompatible and
biodegradable polymers have been widely used in the biomedical
industry (p(MMA-stat-MAA)2:1, PLGA), but also in basic
research (dextran), e.g. as nanoparticles for sustained-release
formulations.25–30 When preparing nanoparticles from theseThis journal is ª The Royal Society of Chemistry 2011
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View Article Onlinecompounds, a number of questions immediately emerge related
to the processing conditions, e.g., concerning the influence of the
initial polymer concentration and the solvent-to-non-solvent
ratio.13,20 In order to investigate such an influence directly, we
have systematically prepared nanoparticle populations of
various polymers under varied conditions using liquid handling
robots, and we have characterized plates of different formula-
tions in an automated manner using high-throughput dynamic
light scattering (HT-DLS). Such systems are usually applied for
the characterization of proteins and other nanostructured bio-
logical samples, but surprisingly only few reports can be found
that deal with non-biological nanoparticles.31–33 Selected samples
were further characterized using different analytical techniques,
including analytical ultracentrifugation (AUC) and scanning
electron microscopy (SEM). This side-by-side comparison allows
for the general evaluation of the reliability of the HT measure-
ment and supplies additional opportunities for the analysis of the
process–property relationships.34–37 This high-throughput
approach may lead to improved particle formulations, e.g. for
drug delivery; it may also be useful for systematic biotechno-
logical screenings.
Experimental section
Materials
The statistical copolymer p(MMA-stat-MAA)2:1 (Eudragit
S100), with Mw ¼ 25 000 g mol1 and PDI ¼ 1.96, was kindly
provided by Evonik R€ohm GmbH (Darmstadt, Germany).
PLGA (50 : 50, acid terminated, Mw ¼ 13 900 g mol1 and
PDI ¼ 2.03) was purchased from Sigma Aldrich and used
without further treatment. Dextran acetal (ac-dex) was prepared
as previously described38 from pharma grade dextran
(Leuconostoc mesenteroides strain no. NRRL B-512(F) with
Mw ¼ 61 600 g mol1), as purchased from Pharmacosmos. The
reaction time was 20 minutes, leading to degrees of substitution
(DS) with cyclic acetals of 1.37 and with acyclic acetals of 0.80, as
confirmed by 1H NMR spectroscopy in DCl/D2O. The molar
mass was determined to be Mw ¼ 45 000 g mol1 (PDI ¼ 1.98).
Molar masses and PDI indexes were estimated by size exclusion
chromatography (SEC) (performed on a Shimadzu system
equipped with a SCL-10A VP system controller, a LC-10AD VP
pump, and a RID-10A refractive index detector). DMA con-
taining 0.21% LiCl (m/v) was used as eluent, at a flow rate of
1 mL min1 at 40 C. The calibration standard used during SEC
was polystyrene. The chemical structures of the polymers are
presented in the ESI†.
Preparation of the nanoparticle suspensions
Nanoparticles were prepared by the nanoprecipitation method
from a stock polymer solution in acetone, with solute concen-
trations of 10 mg mL1 and 16 mg mL1. The initial polymer
solutions were filtered via a 0.45 mm filter. In order to formulate
the particles in a 96 well microtiter plate, a pipetting robot
(FasTrans, Analytik Jena GmbH, Jena, Germany) was used.
Nanoparticles can be prepared by nanoprecipitation in two
general ways: (1) by addition of the non-solvent into the polymer
solution, or (2) by adding the polymer solution to the non-
solvent. In general, due to fast evaporation of the acetone, it wasThis journal is ª The Royal Society of Chemistry 2011much more convenient to add the polymer solution to water,
rather than vice versa. Nevertheless, particle preparation was
done in both ways. Nanoprecipitation was performed in an
automated way by the fast injection of the polymer solution (or
the non-solvent water) to a well containing water (or the polymer
solution). The effective final volume of the well was 300 mL. The
formed nanosuspension was then mixed three times by suction,
using 200 mL tips. Subsequently, the plate was placed in a fume
hood where the acetone was completely removed from the
suspension by evaporation. For the ac-dex nanoparticles, water
adjusted to pH > 7 with triethylamine was used, to prevent
deacetalization.38
Scanning electron microscopy (SEM)
The nanoparticle suspensions were diluted with filtered deionized
water to a final concentration of 1 mg mL1. They were char-
acterized using a LEO-1450 VP SEM (Leo, Oberkochen,
Germany), operating at 10 kV. One droplet (15 to 20 mL) of the
suspension was placed on a mica surface and lyophilized for 3 h.
Finally, the sample was coated with gold, using a BAL-TEC
SCD005 sputtering device (Balzers, Lichtenstein) and applying
a current of 60 mA for 80 s.
Sedimentation velocity experiments
Sedimentation velocity experiments were performed with a Pro-
teomeLab XLI Protein Characterization System analytical
ultracentrifuge (Beckman Coulter, Brea, CA), using conven-
tional double-sector Epon centerpieces of 12 mm optical path
length and a four hole rotor. Rotor speed was 3000 to
40 000 rpm, depending on the sample. Cells were filled with
420 mL of nanoparticle suspension at initial concentration
and 440 mL of solvent (H2O). The nanoparticle suspensions were
used without further purification. Before the run, the rotor was
equilibrated for approximately 2 h at 20 C in the centrifuge.
Sedimentation profiles were obtained every 15 s at the same
temperature by interference optics.
Particle characterization by DLS
DLS was performed on the DynaPro Plate Reader Plus (Wyatt
Technology Corporation, Santa Barbara, CA) equipped with a
60 mV linearly polarized gallium arsenide (GaAs) laser of
l ¼ 832.5 nm and operating at an angle of 156. The data were
analyzed with the Dynamics software ver. 6.10 by the method of
cumulants.39 The percent of polydispersity is given by,
%Pd ¼ 100 m2
m21
; (1)
where m1 and m2 are the first and the second order cumulant,
respectively. The level of homogeneity is considered high when
the percent polydispersity is less than 15%. If the level of
homogeneity is low (percent polydispersity larger than 30%), the
particle population can be considered as being polydisperse.
For selected samples, the determination of the particles size
and z potential measurements were performed using a Zetasizer
Nano ZS (Malvern instruments, Malvern, UK). In these
measurements, a laser beam at 633 nm was used and a scattering
angle of 173. Each sample was measured in triplicate at 25 CSoft Matter, 2011, 7, 5030–5035 | 5031
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View Article Onlinefor 30 s in a low volume polycarbonate cell. For this purpose,
20 mL nanoparticle suspensions were diluted with 1 mL demin-
eralized, filtered water. The mean particle size was approximated
as the effective (Z average) diameter obtained by the cumulant
method.Fig. 2 3D-Representation of a size distribution as a function of initial
concentration of the polymer and solvent to non-solvent ratio obtained
by DLS. Particle suspensions of p(MMA-stat-MAA)2:1 prepared by (A)
dropping the polymer solution into water and (B) by dropping water into
the polymer solution.Results and discussions
In a first set of experiments, the pipetting robot was used to
create a dilution series of p(MMA-stat-MAA)2:1 ranging from 1
to 16 mg mL1 (12 different solutions in acetone with logarith-
mically scattered concentrations). These samples were then each
combined with eight different proportions of water, in a way that
the acetone solution/water ratios varied from 0.099 to 0.500
(again scattered logarithmically). To ensure the reproducibility
of the preparation procedure, particles were formulated three
times under the same conditions. The net result were three arrays
of each 96 different formulations, which exhibited a visually
observable trend in appearance, following the changes made in
the nanoprecipitation process (Fig. 1). At the lowest concentra-
tions, a faintly opalescent suspension was obtained; as the
concentration increased, the opalescence became more apparent.
At the highest concentrations, macroscopic precipitates were
evident. In terms of solvent/non-solvent ratios, a similar trend
could be observed, though only at higher polymer concentra-
tions. By taking a closer look at the instrumental analysis data,
one can identify trends and try to account for the visual obser-
vations in the array.
Initially, a DLS plate reader was used to measure the mean
particle size. In Fig. 2, the average particle size of the p(MMA-
stat-MAA)2:1 samples is presented as a function of the polymer
concentration and the solvent/non-solvent ratio (A—particles
prepared by adding the polymer solution into water; B—particles
prepared by adding water into the polymer solution). The
p(MMA-stat-MAA)2:1 particles of A have sizes between 60 nm
and 290 nm, whereas those of B vary from 30 nm to 180 nm.
At dilute polymer concentrations, the nanoprecipitation process
yields a single particle population with narrowly distributedFig. 1 Layout of a nanoprecipitation experiment: the concentration of
copolymer p(MMA-stat-MAA)2:1 is varied along the x-axis and the ratio
of solvent/non-solvent solution along the y-axis. The polymer concen-
tration in each well is a product of the initial concentration of the polymer
and the solvent/non-solvent ratio.
5032 | Soft Matter, 2011, 7, 5030–5035diameters. For both preparation techniques, the mean particle
diameter increases as a function of the initial polymer concen-
tration. Fig. 3A shows the double logarithmic plot of the average
size on the initial polymer concentration at different solvent/non-
solvent ratios. It is worth noting that two distinct areas can be
distinguished: low and intermediate concentration of the
polymer (1–6 mg mL1) can correspond to the Ouzo region.16
This region is located between the binodal (miscibility limit
curve) and spinodal (stability limit curve) on a three component
phase diagram based on hydrophobic solute, solvent, and non-
solvent.16 It was previously claimed that the volume of the
particle is proportional to the initial concentration of the poly-
mer, based on the fact that the slopes of the resulting lines are
close to 1/3 (for PMMA; use of surfactants).18 The slope of the
linear fit in our case is 0.44  0.01, whereas for higher concen-
trations, the slope of the linear fit is increasing to 1.01  0.08. In
combination with higher particle polydispersity indexes observed
in this range, such a behavior may testify a shift beyond the Ouzo
region. After exceeding the concentration of 10 mg mL1,
nanoprecipitation additionally produces particles with diameters
larger than 300 nm as well as macroscopic aggregates with
diameters >1000 nm; the latter are immediately apparent uponFig. 3 (A) Double logarithmic plot of the average diameters of p(MMA-
stat-MAA)2:1 nanoparticles as a function of the initial polymer concen-
tration at solvent/non-solvent ratios of 0.1 and 0.5. The particles were
prepared by addition of the polymer acetone solution to water (AW) or
by addition of water to the polymer acetone solution (WA). Straight lines
are the linear fits. (B) Dependence of the mean sizes of the formed
particles on the solvent/non-solvent ratio where (1) the initial polymer
concentration was kept constant at 3.57 mg mL1, (2) polymer concen-
tration in the final mixture was kept constant at 0.1 mg mL1, and (3)
amount of the polymer in the final mixture was kept constant at 0.1 mg.
The particles were prepared by adding polymer solution to water.
This journal is ª The Royal Society of Chemistry 2011
Fig. 4 Normalized size distributions obtained by analytical ultracen-
trifugation of the p(MMA-stat-MAA)2:1 nanoparticle suspensions
prepared by dropping polymer solution into water at various concen-
trations: A—1.00 mg mL1, B—3.53 mg mL1, C—5.84 mg mL1,
D—7.51 mg mL1, E—9.67 mg mL1. The corresponding weight average
sizes are: 25, 45, 52, 73 and 130 nm. The value of the solvent/non-solvent
ratio was kept constant at 0.157.
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View Article Onlinevisual inspection. In the set of three experiments performed in
parallel, the reproducibility was found to be good: average
diameters differ from the mean by less than 10%.
Interestingly, the solvent/non-solvent ratio had a compara-
tively small effect on the sizes of the formed particles in the
studied region. Therefore, another set of nanoparticle suspen-
sions representing a broader range of the solvent ratio was
prepared and analyzed by DLS. Since the amount of the polymer
in the final solution will increase with the solvent/non-solvent
ratio, the size of the particles may also be affected. Thus, the
experiment was prepared at different conditions: at constant
initial concentration (1), at constant final polymer concentration
(2), and at constant amount of the polymer in the final mixture
(3). The dependence of the mean particles diameter on the ratio is
shown in Fig. 3B, where various regions can be distinguished. At
low solvent/non-solvent ratios (0.01 to 0.1), the particle diameter
is decreasing with increasing solvent/non-solvent ratio. Since the
particle formation occurs through nucleation, such a behaviorFig. 5 (A) SEM images of p(MMA-stat-MAA)2:1 nanoparticles at different
SEM (bars) and by AUC (—). The particles were prepared by dropping the
This journal is ª The Royal Society of Chemistry 2011can apparently be interpreted as an increase in nucleation sites,
which leads to the formation of smaller particles.18 The minimum
size was reached in all cases at ratio values from 0.3 to 0.4, which
corresponds to the maximum number of nucleation sites. At
a higher solvent content with ratios from 1.44 to 3.3, the nucle-
ation process is more difficult, thus, less nuclei will be formed.18
As a consequence, a sharp increase in the mean size of the
particles is observed. The formation of microparticles and large
aggregates was detected at ratios starting from 2.5. The poly-
dispersity of the nanoparticle suspensions was also found to
be affected by the solute concentration: From c ¼ 1 mg mL1 to
c ¼ 10 mg mL1, the polydispersity increased from (15  1)% to
(35  4)%, as found by HT-DLS measurements (Table S1†).
The mean size of the particles and the polydispersity do not
provide full information on the size-distribution. In an effort to
evaluate the applicability and reliability of HT-DLS measure-
ments for the latter problem, a selected subset of samples was
also characterized using SEM and AUC. For the AUC experi-
ments, series of nanoparticle samples were prepared from the
stock p(MMA-stat-MAA)2:1 solution with concentrations of
1, 3.57, 5.84, 7.51, and 9.67 mg mL1 and solvent/non-solvent
ratios of 0.099, 0.157, and 0.280, respectively. The resulting size
distributions obtained as a function of polymer concentration for
a solvent/non-solvent ratio of 0.157 are presented in Fig. 4. The
mean diameter increases with the polymer concentration of the
polymer while the distribution becomes broader, which corre-
sponds to an increase in the polydispersity of the particles.40 The
polydispersity index in this case can be calculated as a ratio of the
weight average size of the particles, dw, to the number average
size of the particles, dn, and can be considered as the PDI index in
its classical sense;37 dw and dn were calculated from the initial size
distribution obtained by AUC. The calculated values of the
polydispersity indexes are ranging from 1.05 up to 1.20.
The morphology and size distribution of the same nano-
particle suspensions were further investigated by SEM and
compared to the DLS and AUC results. In Fig. 5, SEM images
and size distributions obtained by SEM and AUC are presented.concentrations and (B) the corresponding size-distributions obtained by
polymer solution into water.
Soft Matter, 2011, 7, 5030–5035 | 5033
Fig. 6 3D-Representation of a size distribution as a function of initial
concentration of PLGA (A) and ac-dex (B) and solvent to non-solvent
ratio obtained by DLS. The particle suspensions were prepared by
dropping the polymer solution into water.
Fig. 7 (1) Ac-dex, (2) PLGA, and (3) p(MMA-stat-MAA)2:1 nano-
particle sizes as a function of the initial polymer concentration on
a double logarithmic dependence. The plotted sizes of p(MMA-stat-
MAA)2:1 particles are average diameters of three formulations under the
same conditions. Straight lines represent a linear fit of the experimental
data. The solvent/non-solvent ratio was kept constant at 0.157.
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View Article OnlineIn the case of low and intermediate polymer concentrations, the
SEM results only show nanoparticles with smooth surfaces,
regular shapes, and narrow size distribution. The number of
individual particles considered for calculating the size distribu-
tions was 260 40. The calculated weight average sizes are 27, 49
and 141 nm, respectively. Polydispersity values were estimated to
be 1.02, 1.09, and 1.18 by the same manner as for AUC. It is
apparent that a satisfactory correlation exists between the sizes
and polydispersity indexes obtained from either AUC or SEM,
whereas the size values collected by DLS exceed those from both
AUC and SEM. A detailed comparison of the various charac-
terization techniques for polymeric nanoparticles, performed on
the same p(MMA-stat-MAA)2:1 samples, was published
recently.37
Surface charge is another important characteristic of poly-
meric nanoparticles. It provides information about the stability
and is also a significant factor affecting cellular uptake.41,42 The
charge distribution is typically quantified by the z (zeta) poten-
tial. In this study, a correlation between the z potential and the
mean size of the particles was identified. z Potential measure-
ments were performed for the same series of samples as for the
AUC experiments. It was found that the surface charge increased
with increasing polymer concentration. On the other hand, the
measured z potential remained unchanged when the solvent/non-
solvent ratio was varied, indicating a correlation between
z potential and particle size. The value of the z potential changed
from 17  7 mV for the particles prepared from dilute
polymer solution (c ¼ 1 mg mL1, solvent/non-solvent
ratio: 0.099) to 63  1 mV for the highest concentration used
(c ¼ 9.67 mg mL1, solvent/non-solvent ratio: 0.099).
In order to present additional examples on the feasibility of
high-throughput nanoprecipitation, nanoparticles were also
prepared from two other biocompatible polymers, namely poly
(lactic-co-glycolic acid) (PLGA) spheres and an acetylated
dextran (ac-dex). These polymers are suitable as medical delivery
devices in the form of nano- or microparticles.27,38 PLGA and ac-
dex were nanoprecipitated by adding the polymer dissolved in
acetone in the non-solvent water. The concentration of the
polymer/acetone solutions ranged logarithmically from 1 to
10 mg mL1. Fig. 6(A and B) show the dependence of the particle
size on the solute concentration and on the solvent/non-solvent
ratio for particles based on PLGA (A) and ac-dex (B). Again,
a concentration dependency is clearly shown. The sizes of
PLGA particles vary from 40 nm for c ¼ 1 mg mL1 to 170 nm5034 | Soft Matter, 2011, 7, 5030–5035for c¼ 10 mg mL1, whereas ac-dex particles show the formation
of particles from 80 nm to 140 nm for the same range of
concentrations. On the other hand, the particle size is only
weakly dependent on the solvent/non-solvent ratio.
By comparing the dependencies of nanoparticle size on the
polymer concentration (Fig. 7), different trends can be revealed.
As mentioned before, the size dependence of p(MMA-stat-
MAA)2:1 changes at different concentration ranges. In contrast,
the sizes of the ac-dex and PLGA particles increase linearly in the
whole interval of concentration examined. The slopes of the
resulting lines for the ac-dex and PLGA are 0.21 and 0.44,
respectively (an overview of slopes is presented in Table S3† in
the ESI). These differences could be due to the differences in
hydrophobicity of the two polymers: ac-dex contains a certain
amount of OH groups (0.83 mol hydroxyls per mol anhy-
droglucose unit), which are assumed to be preferentially located
at the particle surface and might stabilize the particle in addition
to the surface charge, thus, preventing their further growth and
aggregation. PLGA nanoparticles follow a trend between the
two other polymers. This may imply a hydrophobicity of PLGA
in between p(MMA-stat-MAA)2:1 and ac-dex. Recently, the
effect of hydrophobic–hydrophilic interactions on the formation
and properties of nanoparticles was discussed in the litera-
ture.43,44 However, additional studies seem to be necessary to
settle this problem, whereas using the present HT approach
might be the appropriate tool.
Selected samples of PLGA and ac-dex were also investigated
by a second DLS equipment (Zetasizer Malvern instruments)
and compared to the data obtained by HT-DLS. The resulting
values are in satisfactory agreement (Table S2†). For an accurate
size and molar mass estimation by AUC, complementary
experiments were carried out in order to determine the dynamic
viscosities and densities of the nanoparticle suspensions.
Viscosity and density of the suspensions are very close to water
values at ambient conditions and only at high concentrations
a slight increase is detected. More detailed information about the
size, polydispersity, and z potential of the different polymers are
presented in the ESI†.This journal is ª The Royal Society of Chemistry 2011
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View Article OnlineConclusions
We have presented a new approach for the production of
nanoparticles using nanoprecipitation technology. This
approach allows the automated, reproducible preparation of
nanoparticle suspensions in large numbers and thus identifying
the optimal conditions for the preparation of particles with
desired size and polydispersity. The work presents the formula-
tion of p(MMA-stat-MAA)2:1, PLGA and a dextran acetal
including fast characterization of the suspensions by high-
throughput dynamic light scattering. More detailed information
were obtained by using additional analysis techniques, like
analytical ultracentrifugation and scanning electron microscopy,
in order to evaluate and prove the results. For selected polymer/
solvent/non-solvent systems, the influence of the polymer
concentration and the solvent/non-solvent ratio as well as the
polymer structure on the particle formation was studied. The
appropriate conditions were found to ‘‘dial in’’ particle sizes from
20 to 300 nm, depending on the way of preparation and initial
conditions. The stability of the particles was confirmed in terms
of z potential measurements. In summary, the formulation of
different nanosuspensions can be performed in an automatic,
reproducible manner, which opens an easy and efficient way for
exploring various compositions. In the future, structure–prop-
erty relationship will be elucidated using this high-throughput
approach in order to prepare tailor-made particle formulations
with desired sizes and loadings.Acknowledgements
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Electronic supplementary information 
Instrumentation 
Sedimentation velocity experiments. 
The raw sedimentation data were evaluated by the program Sedfit using continuous c(s), which is based on the numerical resolution of 
the Lamm equation. It allows the least-squares boundary modeling ls – g*(s), which describes sedimentation of a non–diffusing species, 5 
and to determine the average frictional ratio (f/fsph) of the particles.
1,2 The partial specific volume υ was determined by the density 
variation method, i.e., by sedimentation velocity experiments on the nanoparticle suspensions, using in parallel H2O and D2O. The partial 
specific volume was found to be υ = (0.78 ± 0.01) cm3·g-1. Molar masses of the particles were estimated applying the modified Svedberg 
equation: 
  10 
where NA is the Avogadro’s number, υ the partial specific volume and [s] is the intrinsic sedimentation coefficient which is 
defined as:  
 
where s0 is the sedimentation coefficient at zero concentration, η0 the dynamic viscosity of the solvent, and ρ0 the density of 
the solvent. The diameters were calculated from the Stokes approximation for a sphere: 15 
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Fig. 1 Chemical structure of the polymers. A - p(MMA-stat-MAA)2:1, B - poly(lactic-co-glycolic acid) (50:50), C - dextran acetal (DS = 2.17). 
 
Fig. 2 Size distributions of the nanoparticles at different solvent/non-solvent ratios. The distributions were obtained by sedimentation velocity analysis. 
The values of the solvent/non-solvent ratio were 0.280 (A), 0.157 (B), and 0.099 (C). The polymer concentration was 3.57 mg·mL-1. The particles were 5 
prepared by dropping the polymer solution into water. 
 
Electronic Supplementary Material (ESI) for Soft Matter
This journal is © The Royal Society of Chemistry 2011
 
Fig. 3 SEM images of nanoparticles prepared from A) ac-dex and B) PLGA at different polymer concentrations. The particles were prepared by dropping 
the polymer solution into water. 
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Table 1 Summary of analytical data for p(MMA-stat-MAA)2:1 particles 
 
C, sol/n-sol dDLS, dAUC, PDIAUC %PdDLS Ms×10
-6
, ξ, ρ, η, 
mg·mL-1 ratio nm nm   g·mol-1 mV g·cm-3 cP 
1 
0.099 46 25 1.05 14.1 
6.2 
-(17±7) 0.9979 1.0218 
0.157 44 25 1.06 16.0 -(22±4) 0.9978 1.0236 
0.280 42 25 1.04 15.1 -(31±7) 0.9978 1.0220 
3.53 
0.099 71 43 1.12 25.6 
37 
-(44±5) 0.9979 1.0234 
0.157 74 45 1.11 26.0 -(59±6) 0.9979 1.0238 
0.280 70 45 1.11 25.2 -(49±3) 0.9980 1.0230 
9.67 
0.099 240 130 1.19 31.0 
1300 
-(63±1) 0.9981 1.0292 
0.157 240 130 1.18 35.4 -(62±1) 0.9980 1.0312 
0.280 260 150 1.20 38.9 -(65±1) 0.9983 1.0468 
* ρ denotes the density and η the viscosity of the nanoparticle suspensions 
 
Table 2 Summary of analytical data for ac-dex and PLGA particles
 5 
 
 
 
 
 10 
 
Table 3 Slope and best fit coefficient obtained from the linear fit of the mean particle size vs initial concentration plots 
Sample slope* slope** slope*** r2 
p(MMA-stat-MAA)2:1 0.44a 1.01a 0.66b 
0.98a 
0.94b 
PLGA – – 0.44 0.99 
ac-dex – – 0.21 0.93 
 
*Linear fit for the data in the 1 – 6 mg·mL-1 range of concentration.**Linear fit for the data in the 6 – 10 mg·mL-1 range of concentration. Linear fit through 
all data points. 
 
 15 
 
Polymer C, 
d
DLS
, 
Platereader  
%Pd
DLS
 
Platereader  
d
DLS
, 
Zetasizer  
%Pd
DLS
 
Zetasizer  
ξ, 
 mg·mL-1 nm   nm   mV 
ac-dex 
1 78 14.3 112  22.5 -(16±11) 
3.5 108 17.8 138  20.2 -(16±14) 
10 142 25.2 172  22.2 -(22±10) 
PLGA 
1 52 14.9 78  18.2 -(14±14) 
3.5 88 16.9 89  16.4 -(22±12) 
10 148 22.2 132  23.5 -(22±12) 
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ABSTRACT: The current investigation describes in detail the
influence of the polymer molar mass as well as polymer-sol-
vent interactions on the formation of nanoparticles using the
nanoprecipitation methodology. For this purpose, a homolo-
gous series of poly(methyl methacrylate)s with molar masses
ranging from 7,700 to 274,000 g mol1 was prepared. Subse-
quently nanoprecipitation was performed in an automated and
systematic manner using liquid handling robots and a variation
of different initial concentrations of the polymers and solvent/
nonsolvent ratios. To elucidate information about the polymer
behavior in the solvents used for the nanoprecipitation proce-
dure (acetone, tetrahydrofuran), intrinsic viscosity measure-
ments were performed. The nanoparticle formulations were
examined in terms of particle size and size distribution, particle
shape as well as zeta-potential. The conditions for the prepara-
tion of stable and uniform nanoparticles, regardless of molar
mass and hydrodynamic volume of the initial polymer, were
determined. VC 2012 Wiley Periodicals, Inc. J Polym Sci Part A:
Polym Chem 50: 2906–2913, 2012
KEYWORDS: nanoparticles; nanoprecipitation; molar mass; PMMA;
synthetic polymers; ultracentrifugation; viscosity
INTRODUCTION Polymeric nanoparticles have been exten-
sively studied in the last decades as potential drug delivery
devices. Nanoparticle formation using the nanoprecipitation
method1 is nowadays a commonly used technique. Among
the numerous other manufacturing methods, it is known to
be a very simple and convenient way for the production of
polymeric nanoparticles with desired sizes.2,3 A variety of
different polymers can be used, such as poly(lactide-co-glyco-
lide),4 poly(e-caprolactone),5 poly(acrylics), poly(styrene),
poly(methyl methacrylat) (PMMA), and its different copoly-
mers as well as various amphiphilic block copolymers.6–9
Nanoprecipitation represents a process based on the diffu-
sion of the organic solution (i.e., polymer solvent) into an
aqueous phase leading to the precipitation of the polymer
into small colloidal particles. The formation of nanoparticles
by the process complies with the nucleation theory and con-
sists of several steps like particle nucleation, molecular
growing, and aggregation.10,11 Stable nanoparticle suspen-
sions are only formed applying specific conditions, which
promote a supersaturation of polymer molecules in a ternary
polymer/solvent/nonsolvent system and shifts it into a
metastable region (Ouzo region).9,11–13 This region is located
between the binodal (miscibility limit curve) and spinodal
(stability limit curve) on a three component phase diagram
based on the hydrophobic solute, the solvent, and the non-
solvent. The resulting properties of the particles primarily
depend on the polymer behavior in the organic phase but
also on the nature and ratio of the external phase as well as
on concentration and nature of the used surfactants.14–18 It
could be shown repeatedly that the particle size is strongly
affected by the initial polymer concentration: higher concen-
trations lead to an increasing number of molecules per vol-
ume of the solvent, which, in turn, leads to the formation of
larger particles. At the same time, the ratio between solvent
and nonsolvent was found to have a more complex, nonlin-
ear influence on the size of the particles.9,18,19 Thorough
investigation of the molar mass influence on the production
of biodegradable nanoparticles based on poly(lactic acid)
was first presented by Legrand et al.16 This study was
designed to determine in detail and to extend the under-
standing of the effect of the polymer characteristics, in par-
ticular the molar mass, on the nanoprecipitation results of
synthetic polymers. For this purpose, PMMA samples were
investigated in a wide range of molar masses (between Mw
VC 2012 Wiley Periodicals, Inc.
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¼ 7,700 and 274,000 g mol1) to obtain information about
the polymer-solvent interactions and the size of the particles
formed. The investigations were carried out in two solvents,
namely acetone and tetrahydrofuran (THF). Nanoparticles
were prepared in a reproducible and systematic manner by
using a liquid handling robot.19 All formulations were subse-
quently characterized using dynamic light scattering (DLS)
for a fast size determination. In addition, selected samples
were studied by analytical ultracentrifugation (AUC) and
scanning electron microscopy (SEM).
EXPERIMENTAL
Synthesis of the PMMA Polymers
Methyl methacrylate (MMA) and 2-cyano-2-propyl dithioben-
zoate (CPDB) were purchased from Sigma-Aldrich. MMA was
purified by treating the monomer with inhibitor-remover
(Aldrich). The initiator 2,20-azobisisobutyronitrile (AIBN)
was recrystallized from methanol prior to use. All analytical
grade solvents were purchased from commercial sources
(Fluka, Aldrich, Alfa Caesar and Acros Organics).
The following procedure illustrates the standard conditions
for the reversible addition-fragmentation chain transfer
(RAFT) polymerization of MMA.20,21 The desired amount of
MMA (3.0 mL, 28.12 mmol) was transferred into a reaction
vial and dissolved in ethanol (1 mL). Thereafter, the calcu-
lated volumes of stock solutions of CPDB (5.19 mg, 0.023
mmol) as well as AIBN (1.92 mg, 0.012 mmol) in ethanol
were added. Before closing the vial, the reaction solution
was purged with a flow of argon for at least 30 min. Subse-
quently, the reaction was performed in an oil bath at 70 C
(see Table 1 for exact reaction times, MMA concentration
and [M]/[chain transfer agent, CTA] ratios). After the poly-
merization, acetone was added to the final mixtures, and the
polymers were then manually precipitated in cold methanol.
The polymers were dried under reduced pressure at 40 C.
Size-Exclusion Chromatography
Size-exclusion chromatography (SEC) was performed using
an Agilent1200 series system, a G1310A pump, a G1362A re-
fractive index detector and both a PSS Gram30 and a PSS
Gram1000 column in series, whereby N,N-dimethylacetamide
with 5 mmol lithium chloride was used as an eluent at 1 mL
min1 flow rate. The column oven was set to 40 C. The sys-
tem was calibrated with PMMA standards of narrow
dispersity.
Sedimentation Velocity Experiments
Sedimentation velocity experiments were performed with a
ProteomeLab XLI Protein Characterization System analytical
ultracentrifuge (Beckman Coulter, Brea, CA), using conven-
tional double-sector Epon centerpieces of 12-mm optical
path length and a four hole rotor. Rotor speed was 3,000 to
20,000 rpm, depending on the sample. Cells were filled with
420 lL of nanoparticle suspension at the initial concentra-
tion and 440 lL of solvent (H2O). The nanoparticle suspen-
sions were used without further purification. Before the run,
the rotor was equilibrated for 2 h at 20 C in the centri-
fuge. Sedimentation profiles were obtained every 15 s by in-
terference optics. For the analysis of the particle size distri-
bution, the sedimentation velocity data were treated by ls-
g*(s) analysis with a Tikhonov–Phillips regularization proce-
dure (confidence level of 0.9 was used) implemented into
the Sedfit program. This method is based on a boundary
modeling of a superposition of sedimentation profiles of
ideal nondiffusing particles.22 For the appropriate size deter-
mination by sedimentation velocity, the knowledge of the
partial specific volume is essential. A value of m ¼ 0.78 6
0.01 cm3 g1 was used, which was determined previously
for PMMA and its copolymers.8
DLS and Zeta Potential
DLS was performed on the DynaPro Plate Reader Plus
(Wyatt Technology Corporation, Santa Barbara, CA) equipped
with a 60 mV linearly polarized gallium arsenide (GaAs)
laser at 832.5 nm and operating at an angle of 156. The
data were analyzed with the Dynamics software ver. 6.10 by
the method of cumulants. The percent of polydispersity is
given by,
% Pd ¼ 100l2
l21
(1)
where l1 and l2 are the first and the second order cumu-
lant, respectively.
For selected samples, the determination of the particles size
and zeta potential measurements was performed using a
Zetasizer Nano ZS (Malvern instruments, Malvern, UK). In
these measurements, a laser beam at 633 nm was used and
a scattering angle of 173. Each sample was measured in
triplicate at 25 C for 30 s in a low volume polycarbonate
cell. For this purpose, 20 lL nanoparticle suspensions were
diluted with 1 mL demineralized, filtered water. The mean
particle size was approximated as the effective (Z average)
diameter obtained by the cumulant method.
SEM
The nanoparticle suspensions were diluted with filtered,
deionized water to a final concentration of 1 mg mL1. They
were characterized using a LEO-1450 VP SEM (Leo, Oberko-
chen, Germany), operating at 10 kV. One droplet (15–20 lL)
of the suspension was placed on a mica surface and lyophi-
lized for 3 h. Finally, the sample was coated with platinum,
TABLE 1 Selected Characterization Data of the Obtained PMMA
Polymers
Sample
[M]:[CTA]:
[AIBN]
Conc.
mol L1
Time,
h
Mw, SEC
g mol1 PDISEC DPSEC
1 40:1:0.25 2.0 13 7,700 1.13 66
2 200:1:0.25 2.0 13 20,200 1.17 170
3 400:1:0.25 2.0 20.5 39,700 1.26 312
4 1,200:1:0.5 7.03 16 106,000 1.25 846
5 4,000:1:0.5 7.03 16 274,000 1.34 2,035
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using a BAL-TEC SCD005 sputtering device (Balzers, Lichten-
stein) and applying a current of 60 mA for 80 s.
Viscosity Measurements
Viscosity measurements were conducted using a AMVn
(Anton Paar, Graz, Austria) rolling ball viscometer with a
manually filled capillary with an internal diameter of 0.9
mm. The viscosities of the solution, g, and of the solvent, g0,
were obtained from the rolling times of the steel ball, meas-
ured at three inclination angles (30, 50, and 70) of the
capillary. The viscosity of each solution was calculated from
the average of six measurements; the measurements were
conducted at 20 C.
Preparation of the Nanoparticle Suspensions
Nanoparticles were prepared by the nanoprecipitation
method from a stock polymer solution in acetone or THF at
different concentrations of the polymers. The initial polymer
solutions were filtered via a 0.45 lm filter. To formulate the
particles in a 96-well microtiter plate, a pipetting robot (Fas-
Trans, Analytik Jena GmbH, Jena, Germany) was used. Nano-
precipitation was performed in an automated way by the
fast injection of the polymer solution into a well containing
different amounts of water depending on the solvent/nonsol-
vent ratio. The effective final volume of the well was 300 lL.
The nanosuspension formed was then mixed three times by
aspiration and release of a volume of 200 lL. Subsequently,
the plate was placed in a fume hood, where the organic
solvent was completely removed from the suspension by
evaporation.
RESULTS AND DISCUSSION
Synthesis and Characterization of the Polymers
A range of PMMA samples were synthesized using the RAFT
polymerization technique. The RAFT polymerization was car-
ried out using AIBN as radical initiator, ethanol as solvent,
and CPDB as CTA. Different molar masses of PMMA were
obtained by changing the polymerization time, the MMA con-
centration and the [M]:[CTA] ratio (see Table 1 for detailed
reaction conditions). High molar masses up to Mw ¼
274,000 g mol1 could be realized via the RAFT process. All
PMMA samples are well-defined with polydispersity indices
ranging from 1.13 to 1.34. The SEC chromatographs of the
different PMMAs are depicted in Figure 1.
Intrinsic Viscosity Measurements
Prior to compare the influence of various PMMA samples on
the nanoparticle formation, intrinsic viscosity measurements
of polymer solutions were performed. The knowledge of the
intrinsic viscosity is essential to evaluate the interaction
between the polymer and solvent molecules at various poly-
mer molar masses. The intrinsic viscosities were obtained by
applying Huggins extrapolation to zero concentration proce-
dure:
gsp
c
¼ ½g þ k0½g2cþ    (2)
where [g] and gsp are the intrinsic and specific viscosity
respectively, k’ is the Huggins dimensionless parameter
(interaction parameter), and c is the polymer concentration.
The resulting plot of the reduced viscosity and the concen-
tration for the samples investigated in acetone and THF is
presented in Figure 2. As expected, solutions of PMMA in ac-
etone have a lower viscosity in comparison to THF. Accord-
ing to Flory’s equation,23 this can indicate that the volume of
the polymer coil in acetone is lower than in THF solutions.
The corresponding values of the intrinsic viscosity are listed
in Table 2. It is also well known that for a homologous series
of macromolecules the intrinsic viscosity can be related to
the molar mass through scaling relations of the Kuhn-Mark-
Houwink-Sakurada type (KMHS relations):23
½g ¼ Kg Ma (3)
FIGURE 1 SEC chromatograms of the obtained PMMA poly-
mers used. 1 – (Mw ¼ 7,700 g mol1), 2 – (Mw ¼ 20,200 g
mol1), 3 – (Mw ¼ 39,700 g mol1), 4  (Mw ¼ 106,000 g
mol1), and 5  (Mw ¼ 274,000 g mol1).
FIGURE 2 Dependence of the reduced viscosity on the polymer
concentration for PMMA samples in acetone (A) and THF (B),
respectively. Lines represent linear fitting procedures.
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The parameters of this equation are characteristic for the
polymer-solvent system. They can be evaluated from the log-
log dependence of the [g] versus Mw. The exponent in the
KMHS equation varies in the range of 0.5 < a < 0.85 for
random coils. A value of 0.5 is indicating theta solvent condi-
tions, which means that the polymer coil behaves as an
undisturbed Gaussian coil. In this study, the following values:
Kg ¼ 1.33102, a ¼ 0.63 and Kg ¼ 0.70102, a ¼ 0.74
were found for the polymer solution in acetone and THF,
respectively. This, in turn, testifies a good affinity of the poly-
mer to the solvents. However, according to the collected data
THF seems to be a thermodynamically better solvent for the
PMMA than acetone.
Nanoparticle Formation
To study the influence of the polymer molar mass on the
nanoparticle formation via nanoprecipitation, it is crucial to
maintain the same initial conditions for each nanoprecipita-
tion process. The characteristic ‘‘degree of dilution’’ assesses
the contribution of the different intrinsic viscosities of poly-
mer solutions, which were introduced and represented by
the Debye parameter: c[g], where c is the polymer concen-
tration and [g] is the intrinsic viscosity of the polymer. The
degree of dilution evaluates the volume fraction of the mac-
romolecular coils in the solution. If the value of c[g] << 1,
the solution can be considered as diluted, and no overlap-
ping of the macromolecular coils occurs.
In detail, the nanoparticles were precipitated from 12 differ-
ent initial polymer solutions with concentrations (logarithmi-
cally scattered) corresponding to the following range of c[g]
values: 0.004–0.120. Each solution was then combined with
eight different proportions of water in a way that the sol-
vent/nonsolvent ratio was ranged from 0.1 to 0.5 (again
scattered logarithmically) representing in total 96 different
populations of nanoparticles. The same procedure was
applied for each PMMA sample. After preparation, one can
notice a visually observable trend in appearance following
the changes made in the nanoprecipitation process. At the
lowest concentrations, a faintly opalescent suspension was
obtained; with increasing concentration, the opalescence
became more apparent. The particles suspensions were ana-
lyzed after complete evaporation of acetone or THF, respec-
tively. Initially, the DLS plate reader was used for the particle
characterization. Figure 3 shows a size distribution as a
function of initial polymer concentration and solvent/nonsol-
vent ratio of nanoparticles based on PMMA 1. The size of
the particles is increasing from around 70 to 180 nm
depending on the concentration (degree of dilution) and sol-
vent/nonsolvent ratio. The polydispersity of the nanopar-
ticles based on PMMA 1 to PMMA 3 increases from 5 6 2%
to 20 6 5% for the lowest and highest concentration,
respectively. In the case of particles based on PMMA 4 and
PMMA 5, the nanoparticle suspensions were found to be
more polydisperse; the polydispersity constitutes 12 6 3%
and 30 6 16% for the lowest and highest concentration,
respectively.
Morphology Study
In Figure 4, the SEM micrographs and the corresponding
size-distributions, determined by ImageJ analysis, are shown
for nanoparticles based on PMMA 1, 3, and 5 prepared in
acetone and THF, respectively, at a degree of dilution c[g] ¼
0.01 and a solvent/nonsolvent ratio of 0.1. The sizes of the
particles of PMMA 1, 3, and 5 were virtually the same. The
calculated weight average particle size constitutes 74 6 4
nm for the preparation procedure in acetone and 100 6 20
nm for the THF preparations. However, particles prepared
from acetone solution are only uniform and spherically
shaped for the low molar mass PMMA 1 (Mw ¼ 7,700 g
mol1), whereas with increasing molar mass less spherical
particles with rough surfaces appeared. In contrast, particles
prepared from THF solution are spherical and uniform
within the whole molar mass range.
Sedimentation Velocity Experiments
Sedimentation velocity analyses were performed for various
nanoparticle suspensions in water to gain detailed informa-
tion about the size distribution of the particles. In Figure
5(A) typical size-distributions obtained by AUC are shown
for PMMA 1 and PMMA 5 particles. The differential distribu-
tion of sedimentation coefficients were subsequently
TABLE 2 Intrinsic Viscosity Data for the PMMA Polymers
Sample [g]acetone, cm
3 g1 [g]THF, cm
3 g1
1 4.1 6 0.5 6 6 1
2 6.2 6 0.6 10.6 6 0.5
3 9.2 6 0.6 16.3 6 0.6
4 19 6 1 33.2 6 0.5
5 37 6 1 71.8 6 0.5
FIGURE 3 3D representation of the nanoprecipitation experi-
ment using a PMMA with Mw ¼ 7,700 g mol1: an average par-
ticle size (Z-axis) as function of initial polymer concentration
(X-axis) and solvent/nonsolvent ratio (Y-axis). Sizes were
obtained by DLS measurements. The nanoparticles were pre-
pared by dropping a polymer acetone solution into water.
JOURNAL OF
POLYMER SCIENCE WWW.POLYMERCHEMISTRY.ORG ARTICLE
WWW.MATERIALSVIEWS.COM JOURNAL OF POLYMER SCIENCE PART A: POLYMER CHEMISTRY 2012, 50, 2906–2913 2909
FIGURE 4 SEM images and corresponding size-distributions of nanoparticles prepared from polymer solutions of PMMA with dif-
ferent molar masses in acetone and THF. The particles were prepared by dropping a polymer solution into water. The initial poly-
mer concentration was adjusted to obtain the same degree of dilution (c[g] ¼ 0.01) of all polymer solutions. Solvent/nonsolvent
ratio was kept constant at 0.1.
FIGURE 5 A: Comparison of normalized size-distributions obtained by sedimentation velocity experiment for the nanoparticles
based on PMMA 1 (Mw ¼ 7,700 g mol1) and PMMA 5 (Mw ¼ 274,000 g mol1) in acetone and THF. The initial polymer concentra-
tion corresponds to the degree of dilution c[g] ¼ 0.01 at a solvent/nonsolvent ratio of 0.1. B: Example of sedimentation velocity
experiments for nanoparticles based on PMMA 1 in acetone. The experiment was carried out at 3,000 rpm, scans were collected
every 15 s. Top panel: superposition of sedimentation profiles obtained with interference optics at 20 C. Middle: corresponding
residual plots. Bottom: differential distribution ls–g(s) of the sedimentation coefficients. The distributions were obtained with a reg-
ularization procedure at a confidence level of 0.9.
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transformed into the size distribution, and an average diame-
ter was calculated according to the Stokes-Einstein equation
assuming a spherical shape of the particles. Particles pre-
pared from acetone solution are slightly smaller comparing
to the THF preparation. The majority of the particles pre-
pared from the different molar mass samples at similar
degree of dilution c[g] ¼ 0.01 have virtually the same sizes:
74 6 5 nm and 100 6 20 nm for the particles prepared
from acetone and THF polymer solution, respectively. How-
ever, it should be noted that the distributions of high molar
mass samples are slightly shifted to larger diameters.
Zeta-Potential Measurements
The surface charge of particles represents an additional im-
portant parameter for the characteristics of nanoparticles
besides size and shape. In particular, the stability of nano-
particle suspensions as well as the cellular uptake are
strongly affected by the zeta-potential. The correlation
between zeta-potential and initial polymer molar mass is
presented in Figure 6. The magnitude of the zeta-potential
decreases with increasing molar mass of the initial polymer.
The maximum value was observed for the nanoparticles
based on PMMA 1 and constitutes 33 and 37 mV for the
acetone and THF preparations, respectively. The minimum
values were observed for the particles based on PMMA 3,
which do not change significantly at larger molar mass:
(13 6 1) mV and (20 6 3) mV for the acetone and THF
preparations, respectively.
DISCUSSION
Many factors have to be taken into account to obtain stable
nanoparticle suspension with desired size and properties
during the nanoprecipitation process. It was shown before
that one of the key-factors, which define the particle size, is
the initial polymer concentration: the higher the concentra-
tion of the polymer in the organic phase, the lower the ve-
locity of diffusion owing to the increasing viscosity of the
polymer solution; consequently, more polymer molecules per
unit volume of solvent are present, and the resulting par-
ticles will have a larger size.13,15,16 However, equality of the
initial polymer concentration will not reflect the same condi-
tions for the nanoprecipitation process in case of polymers
with various molar mass or different chemical structure,
since macromolecular coils will occupy different volumes
owing to the different length of a polymer chain. Further-
more, the volume of the macromolecular coil of a polymer
depends on the equilibrium rigidity of the chain and on the
nature of the polymer-solvent interaction. A physical quan-
tity, which reflects the volume occupied by the polymer mol-
ecule, is the intrinsic viscosity.
½g ¼ / ðh
2Þ3=2
M
(4)
where <h2> is the mean square end-to-end distance of the
coil, F is the Flory hydrodynamic parameter, and M is the
molar mass of the polymer. The product of the intrinsic vis-
cosity [g] and the concentration of the solution (Debye pa-
rameter) represents a good approximation of the volume
fraction of the macromolecular coils in the solution u and
can be specified as follows:
u  nv
V
¼ mvNA
VM
¼ c 0:36 < h
2 >3=2 NA
M
¼ 0:36NA
/
 
c½g  c½g (5)
v ¼ 0:36 < h2 >3=2 (6)
Therein, m is the volume occupied by the macromolecular
coil in solution, m is the mass of the polymer in volume V,
NA is the Avogadro number. If c[g] << 1, the polymer solu-
tion can be considered as diluted-then, no overlapping of
macromolecular coils occurs.
Based on these data, nanoparticle suspensions were pre-
pared with a degree of dilution from 0.004 < c[g] < 0.12. In
Figure 7, the size of the nanoparticles as a function of the
Debye parameter is presented in a double logarithmic scale.
A comparison is made for particles prepared from the poly-
mer solutions of PMMA 1 and PMMA 5 in acetone and THF,
respectively. As expected, the particles size increases as the
solution becomes more concentrated-corresponding to the
higher values of the Debye parameter. However, the slopes of
the regression lines (0.20 and 0.32 for PMMA 1 and PMMA
5, respectively) show that the size increases more rapidly for
the nanoparticles on the basis of high molar mass polymer.
It is further obvious that higher molar mass polymers lead
to the formation of the particles with larger diameters,
which actually contradicts data obtained from SEM and AUC.
Such a difference in sizes can be related to the fact that, in
accordance with the measured values of zeta-potential, nano-
particles on the basis of high molar mass polymers (PMMA
FIGURE 6 Zeta-potential of the nanoparticles as a function of
initial polymer molar mass. The nanoparticles were obtained
by nanoprecipitation of polymers dissolved in acetone and
THF. The initial polymer concentration corresponds to the
degree of dilution c[g] ¼ 0.01 at a solvent/nonsolvent ratio
of 0.1.
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4, PMMA 5) were found to have low values of surface
charge. This, in turn, can provoke formation of agglomerates,
which will influence the final particle distribution. The
resulting comparison of the particles sizes (an average from
the AUC, DLS, and SEM data) as a function of the polymer
molar mass is presented in Figure 8(A). Indeed, a slight
increase of the particle sizes with the molar mass is noticea-
ble. This effect is more evident when the particles were
nanoprecipitated from the polymer solution in acetone. It
can also be concluded that, regardless to the solvent used,
the increase in particle size is followed by a plateau. A maxi-
mum size could be observed for the particles based on
PMMA 2 with Mw ¼ 20,200 g mol1. Figure 8(B) represents
the semi logarithmic dependence of the particle size on the
product of molar mass M on the intrinsic viscosity [g] for
two values of c[g]: 1, 2  0.01 and 3, 4  0.1. Since this
work was generally performed using dilute polymer solu-
tions, the parameter M[g] will reflect the volume of the mac-
romolecular coils in the initial solution. It is clear that in
both cases an increase of the volume of the macromolecular
coil leads to the formation of nanoparticles with larger sizes.
The magnitude of the particle size increases 2.5–3 times
compared to the first data point. With further increase of the
macromolecular volume, the size of the nanoparticles
remains constant within the experimental error. It is also
clear that in case of more concentrated solutions (c[g] ¼
0.1) the final nanoparticle size is larger. It was generally
observed that stable nanoparticle suspensions were only
produced when c[g] 	 0.1. Applying concentrations corre-
sponding to the values of c[g] > 0.1, nanoparticle suspen-
sions were found to be highly polydisperse, with diameters
larger than 500 nm. Such a behavior may testify to the shift
beyond the Ouzo region. Regardless to concentration and
molar mass, the particles obtained from the polymer solution
in acetone are relatively smaller than those prepared from
THF solution. This size difference can simply be related to
the lower viscosity of the acetone polymer solution in com-
parison to THF. SEM micrographs showed the formation of
more uniform nanoparticles if THF was used as solvent. This
is in agreement with the viscosity data, which show higher
values of the exponent in the KMHS equation for the poly-
mer in THF solution resulting in the higher affinity of the
polymer to the solvent. When acetone was used as solvent,
uniform nanoparticles with smooth surfaces were only
observed in case of PMMA 1 based nanoparticles.
CONCLUSION
To obtain well-defined particles on the basis of a certain
polymer, it is crucial to work with highly diluted polymer
solutions. Regardless to the polymer molar mass,
FIGURE 7 Double logarithmic dependence of the particle diam-
eters on the degree of dilution (Debay parameter) obtained by
DLS measurements. Nanoparticles based on PMMA 1 (Mw ¼
7,700 g mol1) and PMMA 5 (Mw ¼ 274,000 g mol1) in acetone
and THF.
FIGURE 8 A: Dependence of the resulting weight average sizes on the initial polymer molar mass for the nanoparticles obtained
by nanoprecipitation of polymers dissolved in acetone and THF. Initial polymer concentrations correspond to the degree of dilu-
tion c[g] ¼ 0.01. B: Semi logarithmic dependence of the particle size on the product of polymer molar mass and intrinsic viscosity.
Initial polymer concentrations correspond to the degree of dilution c[g] ¼ 0.01 and c[g] ¼ 0.1 in acetone and THF. Deviations are
related to the difference in the nanoparticle sizes obtained from various characterization techniques (AUC, DLS, and SEM).
ARTICLE WWW.POLYMERCHEMISTRY.ORG
JOURNAL OF
POLYMER SCIENCE
2912 JOURNAL OF POLYMER SCIENCE PART A: POLYMER CHEMISTRY 2012, 50, 2906–2913
hydrodynamic volume and solvent quality, the formation of
stable nanoparticle suspensions could only be observed at a
Debye parameter c[g] << 0.1. According to this, it could be
shown that the key factor during the particle preparation is
the volume fraction occupied by the polymer macromolecular
coil in the initial solution instead of the polymer concentration.
The morphology of the nanoparticles depends on the affinity
of the polymer molecules to the solvent. It appeared that
‘‘good’’ solvents are preferable to formulate uniform nanopar-
ticles with smooth surfaces. Taking together these findings, it
can be concluded that knowledge of the hydrodynamic proper-
ties of the initial polymer solution is essential for tuning and
optimizing conditions for the nanoprecipitation process.
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PMMA Nanoparticles 
 Antje  Vollrath ,  David  Pretzel ,  Christian  Pietsch ,  Igor  Perevyazko , 
 Stephanie  Schubert ,  George M.  Pavlov ,  Ulrich S.  Schubert *  Methacrylate monomers were functionalized with a 4-hydroxythiazole chromophore and copo-
lymerized with methyl methacrylate via RAFT. Nanoparticles of 120 and 500 nm in size were 
prepared without using stabilizers/surfactants. For comparative studies, preparative ultracen-
trifugation was applied for the separation into small and large 
particle fractions. All suspensions were characterized by DLS, 
AUC, and SEM and tested regarding their stability during cen-
trifugation and re-suspension, autoclavation, and incubation 
in cell culture media. In vitro studies with mouse ﬁ broblast 
cell line and differently sized NP showed a particle uptake into 
cells. Biocompatibility, non-toxicity, and hemocompatibility 
were demonstrated using a XTT assay, a live/dead staining, 
and an erythrocyte aggregation and hemolysis assay.  1. Introduction 
 Recent progress in the area of nanosciences enabled the 
development of various nanoparticle (NP) devices as pow-
erful tools in the pharmaceutical area for drug delivery wileyonline
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© 2012  WILEY-VCH Verlag GmbH &  Co.  KGaA, Weinheimsystems, but also in other scientiﬁ c ﬁ elds, for example, 
chemistry, biology, and electronics. [ 1–3 ] In particular for 
diagnostic applications, like live cell imaging, the inves-
tigation of labeled nanosystems (1 to 1000 nm) is rapidly 
expanding. [ 4–8 ] Such nanodevices can consist of various 
materials, such as silica, carbon, metal oxides, pure metals, 
and polymers. [ 6 , 9,10 ] In particular, quantum dots have revo-
lutionized the biological research with their fascinating 
light-emitting properties, though still having safety issues 
due to the liberation of heavy metals. [ 2 , 11 ] The use of ﬂ uo-
rescent polymeric NP represents a suitable alternative 
to avoid the obstacle of the potential toxicity of metal-
based NP. A diversity of biocompatible polymers, such as 
poly(lactide- co -glycolide) and poly( ε -caprolactone), are used 
for formulation. [ 12–14 ] The incorporation of dyes into the 
polymer shell during NP preparation or the use of labeled 
polymer systems provides a protection against external 
inﬂ uences while keeping their spectral properties, which 
are essential for the subsequent analysis of particle–cell 
interactions via confocal laser scanning microscopy. [ 7 , 13 , 15 ] 
A further beneﬁ t of polymeric NP is the variety of formu-
lation techniques such as emulsiﬁ cation–solvent diffusion, library.com 1791
 DOI: 10.1002/marc.201200329 
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179nanoprecipitation, spray drying, salting out, and milling 
processes. [ 16–18 ] By using the appropriate conditions for 
formulation, speciﬁ c drugs can be encapsulated resulting 
in labeled drug carriers of desired sizes and with suitable 
charges. [ 16 , 18,19 ] 
 In the herein presented study, polymethylmethacrylate 
(PMMA) copolymers were chosen as a model system to 
demonstrate that functional PMMA-based nanoparticles 
are well suitable for diagnostic applications such as the 
imaging of cells. The biocompatibility of PMMA micro-
spheres enables their use in many biomedical applica-
tions, for example, as injectable dermal ﬁ llers, as PMMA-
based NPs for in vitro gene delivery approaches, and also 
for orthopedic bone reconstruction. [ 20–28 ] For the design 
of labeled nanosystems, a luciferin-based 4-hydrox-
ythiazole derivative was incorporated into the PMMA 
polymer backbone, showing beneﬁ ts as high ﬂ uores-
cence at room temperature with high quantum yields, 
easy adjustment of the ﬂ uorescent properties, and excel-
lent stability. [ 29,30 ] For this purpose, methacrylates were 
functionalized with the thiazole chromophore (MA y ) and 
then copolymerized with methyl methacrylate (MMA) 
using the reversible addition–fragmentation chain 
transfer (RAFT) polymerization technique. [ 29 , 31–33 ] For the 
NP preparation, nanoprecipitation (solvent-evaporation) 
was chosen as a simple, fast, reliable, and cost-effective 
method. [ 34–36 ] Different particle sizes were obtained by 
varying the initial conditions of the formulation. Addi-
tionally, preparative ultracentrifugation (pUC) was uti-
lized for the fractionation of particles into discretely 
sized NP suspensions. It provides another dimension of 
physical control of the size distribution of particles on 
the nanoscale. [ 14 , 37–39 ] 
 Since the size strongly inﬂ uences the biodistribution 
of NPs and the way of internalization into target cells, it 
is imperative to have well-deﬁ ned particles with narrow 
size distributions. Unfortunately, it is a matter of fact 
that in literature the accuracy of particle size determina-
tion is disputable. [ 40–42 ] Consequently, in this distribution, 2
 Scheme  1 .  Schematic representation of the synthesis of p(MMA- stat -
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dynamic light scattering (DLS), scanning electron micro-
scopy (SEM), and analytical ultracentrifugation (AUC) to 
allow a detailed characterization of the NPs. [ 43 ] The sta-
bility of the resulting nanosuspensions after long-time 
storage, autoclavation, and incubation in cell culture 
media was studied by measurements of size and zeta 
potential. The internalization of the differently sized nan-
oparticles into adherent cells was monitored by confocal 
laser scanning microscopy (CLSM). The biocompatibility 
of the particle suspensions in terms of their non-toxicity 
was proven by XTT cytotoxicity assay and microscopic 
evaluation of viability after a live/dead staining. Compat-
ibility with blood was analyzed by checking the induction 
of hemolysis and aggregation of erythrocytes. 
 2. Results and Discussion 
 2.1. Synthesis of P(MMA- stat -MA Y ) 
 The yellow light-emitting thiazole-dye 3-((5-(4-(dimethyl-
amino)phenyl)-2-(pyridin-3-yl)thiazol-4-yl)oxy)propan-1-ol 
was attached to the methacrylate monomer by an esteri-
ﬁ cation reaction. The non-classical 4-hydroxy-1,3-thiazole 
chromophore structure is similar to the luciferin dye of 
ﬁ reﬂ ies and shows excellent ﬂ uorescent properties. [ 44 ] The 
resulting dye-functionalized methacrylate MA y was copo-
lymerized statistically with MMAs using the RAFT polym-
erization methodology (Scheme  1 ). [ 31–33 ] The reaction was 
carried out using AIBN as a radical initiator, toluene as a 
solvent, and 2-cyano-2-propyl dithiobenzoate (CPDB) as 
a chain transfer agent. The ratio of MMA to the dye-func-
tionalized monomers was 69:1, leading to a ﬁ nal conver-
sion rate of 70% of the copolymers with a DP of 100. The 
dye-functionalized methacrylates were statistically distrib-
uted in the polymer backbone due to the same reactivity 
of both monomers. [ 29 ] The low degree of labeling (1 to 3%) 
ensured the preservation of the properties of the PMMA  
www.MaterialsViews.com
MA y ). 
. 2012,  33,  1791−1797
bH &  Co.  KGaA, Weinheim
Macromolecular
Rapid CommunicationsPreparation, Cellular Internalization, and Biocompatibility  .  .  .
www.mrc-journal.de
 Table  1.  Summary of the size distributions of the nanoparticles 
based on p(MMA- stat -MA y ). 
Sample  d DLS 
[nm]
PDI particle  d SEM 
[nm]
 d AUC 
[nm]
 ξ 
[mV]
 S1 118 0.10 111 120  − 36
 L1 488 0.03 696 503  − 35
 S2 120 0.26 131 97  − 32
 L2 597 0.19 502 381  − 33homopolymer. As determined by SEC, the ﬁ nal p(MMA-
 stat -MA y ) revealed a molar mass ( M— n ) of 8500 g mol  − 1 with 
a polydispersity index value of 1.19 (Table S1, Supporting 
Information). Similar molar mass distributions recorded by 
both RI and UV detector clearly demonstrate that the thia-
zole dye was incorporated into the copolymer. The ratio of 
the MMA units and the thiazole dye in the copolymer was 
determined to be 2.9 mol% by  1 H NMR spectroscopy. The 
ﬁ nal copolymer showed the same absorbance and emis-
sion behavior like the monomeric thiazole chromophore 
(solvent acetonitrile;  λ Abs  = 413 nm,  λ Em  = 557 nm, Stoke-
shift 6259 cm  − 1 , Figure S1, Supporting Information) with a 
quantum yield of  Φ PL  = 0.29. 
 2.2. Nanoparticle Preparation and Characterization 
 The so-called nanoprecipitation or solvent evaporation 
process was found to be a suitable method for the prepa-
ration of differently sized NPs. Therefore, this simple, fast, 
and cost effective technique was applied for the prepara-
tion of p(MMA- stat -MA y ) NPs. [ 34 , 45 ] The ﬁ nal particle size 
was tuned by variation of the initial polymer concentra-
tion in the organic phase and/or by changing the drop-
ping method (polymer solution into water or water into 
polymer solution). [ 46 ] In order to obtain small particles ( S1 ), 
a polymer solution with a concentration of 4 mg mL  − 1 was 
dropped into water. For larger particles ( L1 ), water was 
dropped into the polymer solution with a concentration 
of 3 mg mL  − 1 . In general, a solvent/non-solvent ratio of 
0.25 was used and continuous stirring was applied. After 
evaporation of the acetone, the particle sizes were exam-
ined by DLS. The Z-average diameter for the nanoparticles 
suspensions  S1 and  L1 was determined to be  d S1  = 118 nm 
(PDI P  = 0.10) and  d L1  = 488 nm (PDI P  = 0.03), respectively 
(Table  1 ). The resulting size distributions were monomodal 
(Figure  1 ). In addition to nanoprecipitation, preparative 
ultracentrifugation (pUC) [ 47 ] in a density gradient was used 
for the separation of deﬁ ned NP. For pUC, a thin layer of 
a particle suspension to be fractionated is layered on the 
top of a solution containing the density gradient. When a 
centrifugal ﬁ eld is applied, the various components move 
through the gradient at different rates depending on their 
sizes, densities, and shapes. [ 37–39 , 48 ] In this respect, a particle  
www.MaterialsViews.com
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pUC into fractions  S2 and  L2 . DLS and AUC measurements 
indicated particle sizes of  d S2  = 120 nm (PDI P  = 0.29) and  d L2  = 
600 nm (PDI P  = 0.19, Table  1 ). The small increase of the 
PDI P values of  S2 and  L2 compared with  S1 and  L1 might 
be caused by a slight agglomeration of the NP during the 
pUC treatment. The zeta potential of all suspensions were 
in the same range ( ζ  =  − 32 to  − 36 mV) and thereby testiﬁ ed 
a good stability of the NP in suspension. SEM investiga-
tions were performed to obtain further information about 
the size and shape of the particles (Figure  1 ). The small 
particles  S1 and  S2 revealed more irregular shapes than 
the larger ones ( L1 and  L2 ), which might be caused by the 
preparation technique, that is, dropping acetone in water, 
which is characterized by the fast exchange of the solvent 
against the non-solvent environment. [ 34,35 ] For the small 
particles, the calculated diameters were in good agreement 
with the DLS results ( d S1  = 111 nm,  d S2  = 131 nm), whereas 
the large particle samples were characterized by slightly 
increased sizes in the particle fractions ( d L1  = 696 nm,  d L2  = 
502 nm, Table  1 ). Complementary, the analysis of the sam-
ples by AUC revealed diameters of  d S1  = 120 nm and  d L1  = 
503 nm as well as  d S2  = 97 nm and  d L2  = 381 nm, respec-
tively. In order to exclude the occurrence of bulk precipita-
tion and Ostwald ripening even over a long period of time, 
the nanosuspensions were stored at 5  ° C for 6 months and 
examined again regarding their zeta potential and size dis-
tribution. No signs of instability of the initial nanosuspen-
sions were found in terms of agglomeration or creaming 
up. It should be mentioned that no surfactants were added 
to inhibit particle aggregation. In addition, samples of the 
initial NP suspension were analyzed by DLS and SEM after 
centrifugation at 24.650 g for 20 min, autoclavation, lyophi-
lization, and subsequent resuspension. Neither the size 
distributions nor the zeta potential values changed, which 
ensured the high stability of the p(MMA- stat -MA y ) nano-
particles. The absorption and emission spectra of the nano-
suspensions in comparison to the monomer were equal 
within the range of the measurement errors ( ± 5 nm). This 
implies that the ﬂ uorescence properties of the monomers 
were unaffected by polymerization and NP formation. 
 2.3. Biological Experiments 
 In order to prove the efﬁ cient internalization of the par-
ticles into cells, mouse ﬁ broblasts L929 were incubated 
with 120 and 500 nm sized nanosuspensions prepared 
by nanoprecipitation and pUC separation, respectively. 
The internalization of the NP into the cells was moni-
tored by CLSM (representative micrographs are shown in 
Figure  2 ). On the basis of the relative size distribution of 
their corresponding ﬂ uorescence signal, a clear discrimi-
nation of small and large particles was possible. Further-
more, a concentration-dependent internalization of all 1793
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 Figure  1 .  Size distributions of the particles in water ( c  = 0. 5 mg mL  − 1 ) obtained by DLS and AUC as well as SEM images of the particle 
suspensions. ﬂ uorescent NP into the cytoplasm in the range of  c  = 
0.1 to 10  μ g mL  − 1 was observed. The more particles added 
for incubation with adherent cells, the more particles 
were consequently found in the cytoplasm. It was further 
obvious that the pUC prepared samples  S2 and  L2 were 
internalized to a higher degree than the particles  S1 and 
 L1 . This might be due to traces of sucrose attached to the 
particle surface. As described in literature, carbohydrate 
moieties can act as ligands for diverse receptors. Hence, 
their appearance on the particle surface could lead to an 
enhanced cellular recognition and internalization of the 
particle  S2 and  L2 . [ 49–51 ] Macromol. Rapid Commu
© 2012  WILEY-VCH Verlag Gm It is known that PMMA particles are phagocytosable 
and it can be assumed that the cellular uptake of PMMA 
particles in the size range studied is presumable medi-
ated in a similar fashion via an endocytotic pathway. [ 27 ] 
The negative surface charge of the PMMA NP does not 
alter the cellular uptake and most probably yields to a 
reduction of the non speciﬁ c binding of anionic proteins 
present in the cell culture medium and also in the body 
ﬂ uid, for example, in the blood, thus rendering opportuni-
ties for in vivo administration of NP. [ 26 ] 
 For diagnostic applications, the biocompatibility and 
non-toxicity of the nanosuspensions are important  
www.MaterialsViews.com
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 Figure  2 .  Confocal ﬂ uorescence images of L929 cells after 24 h incubation with polymeric p(MMA- stat -MA y ) nanoparticles. Cells 
incubated with polymer free culture medium served as control (not shown). All images were obtained with identical instrument settings 
(scale bars 10  μ m). prerequisites. The in vitro cytotoxicity experiment was 
performed on the basis of the XTT assay using L929 mouse 
ﬁ broblasts, according to the German standard institution 
guideline DIN ISO 10993-5 as a reference for biomaterial 
testing. After 24 h of incubation with different NP concen-
trations ( c  = 0.1–10  μ g mL  − 1 ), the metabolic activity of cells 
treated with test-samples was found to be on the level of 
untreated controls, which proves the absence of a toxic 
effect mediated by the NPs (Figure S2, Supporting Infor-
mation). A detailed live/dead microscopy study of cells 
that were treated with NP conﬁ rmed the cell-membrane 
integrity (exclusion of red ﬂ uorescent PI from cell nuclei) 
and their excellent viability (strong green ﬂ uorescence  
www.MaterialsViews.com
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tion). In addition, the interaction of NP suspensions with 
blood cells was investigated in terms of their potential 
to induce hemolysis (membrane damage and cell dis-
ruption) and/or aggregation of erythrocytes, one of the 
major cellular blood components. Whereas the treatment 
of erythrocytes with 1% Triton X-100 as positive control 
led to a complete disruption of the erythrocytes and sub-
sequent release of the incorporated hemoglobin, none of 
the NP suspensions nor the PBS-treated negative control 
showed any hemolytic activity, indicating the absence of 
any harmful effect on the erythrocyte membrane integ-
rity (Figure S4, Supporting Information). Furthermore, 1795
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1796the capability of NP suspensions to induce a formation 
of erythrocyte aggregates as an unwanted sign of blood 
incompatibility was studied microscopically and photo-
metrically. None of the NP suspensions induced any red 
blood cell aggregation, even at the highest concentration 
of 10  μ g mL  − 1 (Figure S5 and S6, Supporting Information). 
In contrast, the treatment with 25 kDa bPEI as positive 
control caused the clear formation of aggregates, whereas 
PBS-treated samples used as negative control did not 
yield in any aggregate formation. This observed absence 
of any nanoparticle-mediated blood incompatibility is 
in line with clinical evaluations of PMMA membranes 
dedicated for the use in blood dialysis. [ 26 ] It is reported 
that due to their relatively hydrophobic and anionic sur-
face PMMA particles show less nonspeciﬁ c protein and 
peptide binding, and, thereby reduce the initial steps of 
opsonization leading to cell recognition/binding and pos-
sible immunological reactions. [ 52 ] It is known that PMMA 
NP may be ingested and most probably can pass through 
the epithelial barrier and will likely end up in the blood-
stream. Large particles are usually trapped by the liver, [ 53 ] 
while smaller pass on and are captured by the kidneys. [ 54 ] 
However, because of the very low toxicity documented for 
PMMA NPs, even in view of a chronic/continuous disease 
treatment in,vivo, the possibility of obtaining sustain-
able effects by using PMMA NPs is presumably realistic. 
In addition, the good stability of the nanoparticles during 
autoclavation, centrifugation, and lyophilization/resus-
pension is basic requirements for the possible adminis-
tration of lyophilized, resuspended/reconstituted, and 
autoclaved particles. 
 3. Conclusion 
 Consequently, the 4-hydroxythiazole-functionalized PMMA 
NPs are suitable for ﬂ uorescence-based long-term studies of 
biological processes at the molecular level. On the contrary 
to traditional ﬂ uorophores, the PMMA NPs combine small 
size and high photostability, and, in contrast to widely used 
quantum dots, they do not contain hazardous components, 
which need to be shielded by protective layers. The bio-
analytical applications based on functionalized polymeric 
PMMA NPs are of emerging interest and provide oppor-
tunities like minimal-invasive intracellular monitoring 
of key components like pH value and oxygen content as 
well as ions like calcium, potassium or sodium. They can 
be combined with state-of-the-art imaging techniques 
like ﬂ ow cytometry, ﬂ uorescence microscopy, and sophis-
ticated imaging approaches, such as confocal imaging 
providing the opportunity for 3D analysis. In combination 
with dyes emitting in the near-infrared wavelength range, 
it offers an optical window for in vivo tissue imaging into 
several mm depth. By the immobilization of ligands to the Macromol. Rapid Comm
© 2012  WILEY-VCH Verlag GPMMA particles surface, also a speciﬁ c binding to biomol-
ecules can be mediated, thereby enabling approaches like 
speciﬁ c cell targeting. [ 55 ] 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library 
or from the author. 
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Materials  
All reagents were purchased from commercial sources (Fluka, Aldrich, Alfa Aesar and Acros 
Organics). MMA was purchased from Sigma-Aldrich and purified with an inhibitor-remover 
before use. 2,2’-Azobis(iso-butyronitrile) (AIBN) was recrystallized from methanol prior to 
use. The RAFT agent 2-cyano-2-propyl dithiobenzoate (CPDB) was purchased from Sigma-
Aldrich. The thiazol functionalized methacrylate monomer was synthesized according to the 
2 
 
literature.[1,2] Purified N,N-dimethylacetamide (DMA) was purchased from VWR. Unless 
otherwise stated, the chemicals were used without further purifications. 
Synthesis of p(MMA-stat-MAy) The RAFT polymerization technique was used according to 
already established methods.[3-5] The desired amounts of MMA (592 mg, 0.63 mL) and dye-
functionalized methacrylate (MAy, 37.0 mg) were transferred into 5 mL reaction vials and 
dissolved in toluene. Thereafter, the calculated amounts of CPDB (9.5 mg) as well as AIBN 
(1.8 mg) dissolved in toluene (in total 2.07 mL) and anisole (0.3 mL), respectively, were 
added. The ratio of [CPDB] to [AIBN] was 4/1 using a monomer concentration of 2 mol · L-1. 
Before closing the vial, the reaction solution was purged with a flow of argon for at least 
30 min. Subsequently, the reaction solution was placed in a preheated oil bath at 70 °C for 
14 h. The polymers obtained were purified by precipitation into cold methanol and dried 
under reduced pressure. Conversion was measured by 1H NMR spectroscopy using anisole as 
internal standard.  
p(MMA-stat-MAy) 1H NMR (CDCl3, 300 MHz): δ = 8.57, 8.11 (Ar-H pyridine), 7.89, 7.78, 
7.62, 7.51, 6.77 (Ar-H), 4.57 (OCH2), 4.20 (OCH2), 3.60 (OCH3), 3.00 (NCH3), 2.21 – 0.63 
(backbone) ppm. SEC (CHCl3, PMMA standard): Mn = 8,500 g · mol
-1, PDI = 1.19 
(Mn,theo = 9,900 g · mol
-1). UV/Vis (acetonitrile) λmax = 413 nm, emission (acetonitrile) 
λmax = 557 nm.  
Preparation of the nanoparticle suspensions NP were prepared by the nanoprecipitation 
method from a stock polymer solution in acetone.[6,7] The polymer solution was filtered 
through a 2 µm filter before use. Since the route of nanoprecipitation has an influence on the 
size of the particles, the technique was performed in two ways: By dropping the acetone 
polymer solution into water (AW) or by dropping water in the polymer solution (WA). For 
route AW, the polymer was dissolved in acetone at a concentration of 4 mg · mL-1. For route 
WA, the concentration was 3 mg · mL-1. The solvent/non-solvent ratio was chosen to be 0.25. 
Subsequently, the acetone was completely removed from the suspensions by evaporation. The 
nanoparticle suspensions were diluted to a final concentration of 1.5 mg · mL-1 and stored at 
4 °C until further use.  
Density gradient centrifugation The linear density gradients were prepared in 14 mm 
diameter, 13.2 mL capacity ultracentrifuge tubes (ultra clear tubes, Beckman) using a gradient 
maker consisting of two chambers connected via a channel with a stopcock; final gradient 
volume was 11.7 mL. In order to create a border for pelleting particles, 0.5 mL of 60% w/w 
sucrose solution was placed on the bottom of the tube before the main gradient solution was 
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loaded. The main gradient was obtained by mixing 5.6 mL of 20% w/w and 5.6 mL of 40% 
w/w sucrose solution in a mixing chamber by the way that the lower density solution was 
loaded first into the centrifugal tube. The gradient prepared was then stored for an hour at 
room temperature. The initial particle solution (0.5 mL) with a concentration of 
1.5 mg · mL-1was placed on top of the gradient. The centrifugal tube was then placed in a 
swinging bucket rotor and centrifuged at 10,000 rpm for 40 minutes. After centrifugation, the 
solution was collected by using a peristaltic pump and a narrow tube, inserted from above to 
the bottom of the centrifuge vial. Depending on the sample each 0.5 mL or 1 mL of the 
solution was collected. The fractions containing nanoparticles were then dialyzed against pure 
water and analyzed by AUC, DLS and SEM. 
 
Instrumentation 
Size Exclusion chromatograms (SEC) were recorded using a SEC Shimadzu SCL-10A 
system controller, a LC-10AD pump, a RID-10A refractive index detector and a PSS SDV 
column with chloroform:triethylamine:2-propanol (94:4:2) as eluent. The column oven was 
set to 40 °C with a flow rate of 1 mL · min-1. The system was calibrated with narrow 
polydispersity PMMA standards.   
1H NMR and 13C NMR spectra were recorded in CDCl3 on a Bruker Avance 250 MHz or 
300 MHz spectrometer. Chemical shifts are given in ppm relative to signals from the NMR 
solvents. Conversions were calculated from 1H NMR spectra using anisole as an internal 
standard.  
Elemental analysis (EA) was carried out at an Elementaranalysator Vario EL III CHNS from 
Elementar Analysensysteme GmbH, Hanau.  
UV/VIS spectroscopy measurements were set out on a Specord 250, Analytik Jena GmbH. 
The emission spectra were recorded using the FP 6500, Jasco. The polymers were dissolved 
in acetonitrile and measured in a quartz cuvette.  
Dynamic light scattering (DLS) and zeta potential were recorded on a Zetasizer Nano ZS 
(Malvern Instruments, Malvern, U.K.) operating with a laser beam at 633 nm and a scattering 
angle of 173°. Each sample was measured in triplicate at 25 °C in a polycarbonate zeta cell. 
For size measurements, 3 runs for 30 s were chosen, and for the zeta potential, 3 runs for 10 s. 
For this purpose, 20 µL nanoparticle suspensions were diluted with 1 mL demineralized, 
filtered water. The mean particle size was approximated as the effective (Z average) diameter 
obtained by the cumulant method, and the particle polydispersity index (PDIp) was calculated 
as a square root of the ratio of the second order cumulant to the first order cumulant 
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PDIp = (K2/K1)
1/2.[8] Furthermore, the intensity and the volume distribution of the particle 
size were calculated applying the NNLS mode.  
Scanning electron microscopy (SEM) was performed on a LEO-1450 VP (Leo 
Elektronenmikroskopie GmbH, Oberkochen, Germany). One droplet (20 µL) of the 
nanoparticle suspension (1 mg mL-1) was placed on a mica surface, lyophilized for 3 h, and, 
covered with platinum or gold using a sputter coating device BAL-TEC SCD005 (Balzers, 
Lichtenstein; 60 mA, 80 s). The system was operating from 8 to 10 kV. The average size of 
the particles was determined using the software Image J.  
Analytic Ultracentrifugation (AUC): A ProteomeLab XLI Protein Characterization system 
analytical ultracentrifuge (Beckman Instruments, Palo Alto, USA) was used for sedimentation 
velocity runs. Experiments were carried out in conventional double-sector Epon centerpieces 
of 12 mm optical path length in a four holes rotor. Cells were filled with 400 μL of suspension 
(c = 1.2 mg · mL-1) and 420 μL of solvent (H2O). The rotor speed was set to 6,000 rpm. The 
rotor temperature was equilibrated for approximately 2 h at 20 °C in the chamber of the 
centrifuge. Sedimentation profiles were obtained every 15 s by interference optics, and the 
sedimentation runs were evaluated by the program Sedfit.[9] As partial specific volume, 
ν = 0.832 cm3 g-1 was used.  
Density gradient centrifugation was set up in a Beckman Optima L-XP ultracentrifuge 
(Beckman Instruments, Palo Alto, USA) using the swinging bucket rotor SW 41 Ti rotor. 
Laser scanning microscopy: For the analysis of the uptake of particles by L929 cells, 
fluorescence images were obtained with a confocal laser-scanning microscope (LSM 510 
Meta, Carl Zeiss, Jena, Germany), using a Plan-Apochromat 63× oil immersion objective (NA 
1.4, Zeiss). The thiazole dye was excited with a 458 nm laser. The emitted fluorescence was 
collected with a 505 nm longpass filter. To facilitate a comparison between the images, all 
images of a series were captured under identical conditions and instrument settings (e.g. laser 
power, pinhole diameter and detector gain).  
Fluorescence microscopy: To visualize the viability of L929 cells after incubation with 
different particle suspensions, the blue/red/green fluorescence signal of cells cultured in 96 
well plate and stained with Hoechst/PI/FDA was observed on a fluorescence microscope (Cell 
Observer Z1, Carl Zeiss, Jena, Germany) equipped with a mercury arc UV lamp and the 
appropriate filter combinations for excitation and detection of emission. Images of a series 
were captured with a 10× objective using identical instrument settings (e.g. UV lamp power, 
integration time, camera gain) and spots of the 96-well plate were addressed using an 
automated XY table.  
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Photometric absorbance measurement: A TECAN Infinite M200 PRO platereader 
(TECAN, Crailsheim, Germany) was used to measure the absorbtion of samples from a) the 
XTT cytotoxicity assay (570 nm with a background correction of the OD at 690 nm) b) the 
hemolysis of erythrocytes (540 nm with a background correction of the OD at 690 nm) and c) 
the photometric evaluation of erythrocyte aggregation (645 nm). Each well containing the 
sample was measured in 4 different spots each with 10 flashes per scan.   
 
Biological studies  
Cell line: The mouse fibroblast cell line L929 used in the biological experiments was 
purchased from the German Collection of Microorganisms and Cell Cultures (DSMZ, 
Braunschweig, Germany). Cells were cultured in Dulbecco's modified eagle's medium 
(DMEM) supplemented with 10% FCS, 100 U · mL-1 penicillin, and 100 µg · mL-1 
streptomycin (all components from Biochrom, Berlin, Germany) at 37 °C in a humidified 
atmosphere with 5% (v/v) CO2.  
Uptake study: To assess the particle uptake in adherent L929 cell monolayers by CLSM, 
8 × 104 cells were initially seeded onto sterile glass coverslips placed into 6 well plates. The 
cells were grown for 48 hours until 75% confluency was reached and then incubated 
separately with different concentrations (0.1, 1.0, and 10.0 g · mL-1, respectively) of particle 
suspensions for 24 h. Control cells were incubated with fresh culture medium. After 
incubation, the solutions were aspirated from the wells, and any unbound conjugates were 
removed by washing the cell layer three times with PBS. Subsequently, the cells were fixed 
directly on the glass coverslips for 10 minutes at room temperature using 4% 
paraformaldehyde dissolved in PBS followed by 2 times washing with PBS. The glass 
coverslips were mounted on glass slides using 25 µL Moviol 4-88 solution containing 625 µg 
1.4-diazabicyclo-(2,2,2) octane. Samples were then characterized by CLSM.  
Cytotoxicity test: In order to assess the short-term cytotoxicity of the polymeric 
nanoparticles, the XTT cytotoxicity test was used, according to ISO/EN 10993 part 5 
guidelines: For the XTT test, L929 cells were seeded in 96-well plates at a density of 
1 × 104 cells/well and were grown as monolayer cultures for 24 h. The cells were then 
incubated separately with different concentrations (0.01, 0.1, 1.00 and 10.00 g · mL-1 
(n = 6)) for 24 h.  Control cells were incubated with fresh culture medium. After incubation, 
50 µL of a XTT solution prepared according to the manufacturer’s instructions were added to 
each well. After 4 h at 37 °C 100 µL of each solution were transferred to a new microtiter 
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plate and the optical density (OD) was measured photometrically. The negative control was 
standardized as 0% of metabolism inhibition and referred as 100% viability.  
Cytotoxicity test: In order to assess the short-term cytotoxicity of the polymeric 
nanoparticles, the XTT cytotoxicity test was used, according to ISO/EN 10993 part 5 
guidelines: For the XTT test, L929 cells were seeded in 96-well plates at a density of 
1 × 104 cells/well and were grown as monolayer cultures for 24 h. The cells were then 
incubated separately with different concentrations (0.01, 0.1, 1.0 and 10.0 µg · mL-1 (n = 6)) 
for 24 h.  Control cells were incubated with fresh culture medium. After incubation, 50 µL of 
a XTT solution prepared according to the manufacturer’s instructions was added to each well. 
After 4 h at 37 °C, 100 µL of each solution were transferred into a new microtiter plate, and 
the optical density (OD) was measured photometrically. The negative control was 
standardized as 0% of metabolism inhibition and referred to 100% viability.  
Viability staining with FDA/PI/Hoechst: In addition to the XTT assay as a method for 
determination of metabolic activity, the influence of the particle suspensions on viability of 
L929 mouse fibroblasts was examined microscopically by using the fluorescein diacetate 
(FDA)/propidium iodide (PI) viability assay. The cell line was treated with particle 
suspensions as described for the XTT assay. After incubation for 24 h a viability staining was 
performed. For that, cells were covered for 10 min with a solution of cell culture medium 
containing Hoechst 33342 dye (1 g · mL-1), PI (1 µg mL-1) and FDA (1 g · mL-1). After 
removal of the staining solution, cells were washed twice and finally covered with PBS. The 
blue, red and green fluorescence was observed within 10 min after staining using a 
fluorescence microscope.  
Hemolysis of erythrocytes and erythrocyte aggregation: For testing the hemolytic activity 
of the particle suspensions, blood from sheep, collected in heparinized-tubes, was centrifuged 
at 4.500 × g for 5 min and the pellet was washed three times with cold PBS. The suspension 
of red blood cells was always freshly prepared and used within 24 h after collection. The 
stock solutions were diluted with PBS to a final erythrocyte-concentration of approx. 3 × 
106/mL. Polymer solutions with concentrations of 0.01, 0.1, 1.00 and 10.00 µg mL-1 were 
prepared in PBS buffer, added to the erythrocytes in a ratio of 1:1 and were then incubated for 
60 min at 37 °C. The release of hemoglobin was determined after centrifugation (2,400 g for 5 
min) by measurement of absorption. Complete hemolysis was achieved using 1% Triton X-
100 reflecting the 100% value. PBS served as negative control. Less than 5% hemolysis rate 
were taken as non-hemolytic. For the analysis of erythrocyte aggregation, 100 µL of polymers 
with concentrations of 0.01, 0.1, 1.00 and 10.00 g · mL-1were dissolved in PBS buffer, 
7 
 
incubated at 37 °C for 2 h with 100 µL of erythrocytes isolated as described above for the 
hemolysis assay. PBS served as negative control and 50 g · mL-1 25 kDa branched 
poly(ethylene imine) displayed the positive control. Erythrocyte aggregation was measured 
photometrically at λ = 645 nm.[10] Additionally, a microscopic evaluation was performed with 
samples that were diluted after photometric measurement 1:10 with PBS.  Experiments for 
hemolysis and erythrocyte aggregation were run in triplicate from 3 different donor sheep and 
were repeated once. 
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Polymer characterization 
Table S1. Characterization data of the copolymer p(MMA-stat-MAy).  
[MMA]: 
[dye] 
[M]: 
[CTA]: 
[AIBN] 
Conv.  
MMAa 
(%) 
Mn, theo 
(g/mol) 
Mn, SEC  
(RI)b 
(g/mol) 
PDISEC  
(RI)b 
DPSEC  
(RI)b 
Dye content  
(NMR)c 
(%) 
138:2 140:1:0.25 68 9,900 8,500 1.19 81 2.9 
a) Calculated from vinyl integrals of 1H NMR spectra using anisole as internal standard. 
b) Calculated from SEC (CHCl3), PMMA calibration. 
c) Calculated from integrated areas of aromatic dye signals and the methyl signals of MMA. 
 
 
A) B) 
  
Figure S1. A) Fluorescence emission spectra of p(MMA-stat-MAy) in acetonitrile (excited at 
 = 418 nm). B) SEC measurements (CHCl3) of p(MMA-stat-MA
y). The refractive index 
trace (--) and the UV trace at 310 nm (-) of the labeled polymer occur at the same retention 
time confirming the covalent attachment. 
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Biological experiments 
 
S1 L1 S2 L2
0
20
40
60
80
100
120
V
ia
bi
lit
y 
in
 %
Particle fraction
 0 µg mL-1
 0.01 µg mL-1
 0.1 µg mL-1
 1 µg mL-1
 10 µg mL-1
 
Figure S2. Cell viability of L929 mouse fibroblasts after incubation with small (S1/S2) and 
large (L1/L2) polymeric p(MMA-stat-MAy) nanoparticles up to 10 µg · mL-1 for 24 hours. 
Cells incubated with polymer free culture medium served as control. The cell viability was 
determined by XTT assay according to ISO 10993-5, where values below 70% viability were 
regarded as cytotoxic. Data are expressed as mean ±SD of six determinations.  
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Figure S3. Representative fluorescence microscopy micrographs of Hoechst 33342/FDA/PI 
stained L929 mouse fibroblast cells cultured for 24 hours in the presence of the small (S1/S2) 
and large (L1/L2) polymeric p(MMA-stat-MAy) nanoparticles up to 10 g · mL-1 for 24 
hours. Blue fluorescent Hoechst dye labels nuclei of all cells present, green fluorescent FDA 
dye indicates cytoplasm of vital cells, red fluorescent PI signals tag nuclei of dead cells. Left: 
10 g · mL-1particle suspension added (small (S1); same results for small (S2) and large 
(L1/L2) particle suspensions), right: control culture without particles. 
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Figure S4. Representative micrographs of red blood cell aggregation after 2 h incubation at 
37 °C with small polymeric p(MMA-stat-MAy) nanoparticles (S1, 10 g · mL-1). Same results 
as for S1 were obtained for S2/L1/L2. 25 kDa bPEI (50 g · mL-1) served as positive and PBS 
as negative control. Magnification 320 ×.  
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Figure S5: Photometric determination of hemolytic activity after 1 h incubation at 37 °C with 
small (S1/S2) and large (L1/L2) polymeric p(MMA-stat-MAy) nanoparticles. Triton X-100 
(1%) served as positive and PBS as negative control. Data are presented as the mean 
percentage ± SD of hemolytic activity compared to the positive control set as 100%. 
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Figure S6: Photometric determination of erythrocyte aggregation after 2 h incubation at 
37 °C with small (S1/S2) and large (L1/L2) polymeric p(MMA-stat-MAy) nanoparticles. 
25 kDa bPEI (50 g · mL-1) served as positive and PBS as negative control. Data are 
presented as the mean measured absorbance ± SD. 
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thiazole-dye 3-((5-(4-(dimethylamino) phenyl)-2-(pyridin-3-yl)thiazol-4-yl)oxy)propan-1-ol as well as the corresponding 
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were both investigated – however, due to the non-visibility of the blue polymer only the yellow one was continued in the 
published study. In order to allow an exact reproduction of the monomer synthesis, a detailed description has been added 
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Materials  
The hydrazinium hydroxide solution and the Raney nickel were purchased from Sigma-Aldrich. The educt 
5-(4-nitrophenyl)-2-(pyridin-2-yl)thiazol-4-ol (1) for the synthesis of the thiazol-functionalized 
methacrylate monomer was prepared according to the literature.[1]  
 
[1] Arylamine-Modified Thiazoles as Donor-Acceptor Dyes: Quantum Chemical Evaluation of the Charge-
Transfer Process and Testing as Ligands in Ruthenium(II) Complexes, R. Menzel, S. Kupfer, R. Mede, D. 
Weiss, H. Goerls, L. Gonzalez, R. Beckert, Eur. J. Org. Chem. 2012, 5231. 
 
 
 
 
Synthesis of the monomer used for the polymerization. 
 
Synthesis of 3-((5-(4-nitrophenyl)-2-(pyridin-2-yl)thiazol-4-yl)oxy)propan-1-ol (2). Fine 
ground K2CO3 (1.44 g, 10.4 mmol, 1.2 equiv) was added to a suspension of 5-(4-nitrophenyl)-
2-(pyridin-2-yl)thiazol-4-ol (2.60 g, 8.69 mmol) and 3-bromopropane-1-ol (1.33 g, 
9.56 mmol, 1.1 equiv) in DMSO (100 mL). The deep blue mixture was stirred for four days at 
room temperature followed by the addition of H2O (400 mL). The product was extracted with 
CHCl3 (3 · 100 mL). The combined organic phases were washed additionally with H2O 
(3 · 100 mL) to remove the DMSO, dried over MgSO4 and concentrated in vacuo. The brown 
solid was purified with a short gel filtration (silica, CHCl3/EtOAc 3:1) to yield the pure ether. 
The product can also be recrystallized from n-heptane/CHCl3 by slow evaporation of the 
CHCl3 and addition of a seed crystal; yield: 2.85 g (7.97 mmol, 92%). 1H NMR (250 MHz, 
CDCl3): δ = 8.62 (ddd, J = 4.8, 1.6, 0.9 Hz, 1H), 8.28 - 8.18 (m, 2H), 8.08 (dt, J = 8.0, 0.9 Hz, 
1H), 7.95 - 7.86 (m, 2H), 7.81 (td, J = 7.7, 1.7 Hz, 1H), 7.35 (ddd, J = 7.5, 4.8, 1.1 Hz, 1H), 
4.76 (t, J = 6.0 Hz, 2H), 3.88 (t, J = 5.9 Hz, 2H), 2.40 (s, 1H), 2.14 ppm (p, J = 6.0 Hz, 2H). 
13C NMR (63 MHz, CDCl3): δ = 163.89, 161.18, 150.52, 149.81, 145.71, 138.64, 137.31, 
126.86, 125.13, 124.31, 119.40, 112.21, 68.08, 59.29, 32.81 ppm. MS (Micro-ESI): 380.2 [M 
+ Na]+. Anal. Calcd for C17H15N3O4S: C, 57.13; H, 4.23; N, 11.76; S, 8.97. Found: C, 57.01; 
H, 4.35; N, 11.90; S, 8.91. 
Synthesis of 3-((5-(4-aminophenyl)-2-(pyridin-2-yl)thiazol-4-yl)oxy)propan-1-ol (3). A 
suspension of 3-((5-(4-nitrophenyl)-2-(pyridin-2-yl)thiazol-4-yl)oxy)propan-1-ol (1.90 g, 
5.32 mmol) in MeOH (100 mL) was heated to 50 °C. An 80% solution N2H5OH in H2O and 
freshly prepared Raney nickel (catalytic amounts) were added till no educt was left as 
indicated by TLC. The reaction mixture was filtered through a frit, on which a two centimeter 
thick silica bed was applied to remove the Raney nickel after the reaction was finished. The 
silica bed was washed with a mixture of EtOH/CHCl3 1:1 and the two fractions were 
combined and concentrated. The product was purified using gradient gel filtration (silica, 
CHCl3 to CHCl3/EtOAc 1:1) yielding the amine almost quantitatively as a yellow solid; yield: 
1.72 g (5.52 mmol, 98%). 1H NMR (250 MHz, CDCl3): δ = 8.56 (d, J = 4.2 Hz, 1H), 8.01 (d, 
J = 8.0 Hz, 1H), 7.74 (td, J = 7.8, 1.7 Hz, 1H), 7.60 - 7.52 (m, 2H), 7.25 (ddd, J = 8.7, 4.7, 
1.0 Hz, 1H), 6.74 - 6.66 (m, 2H), 4.63 (t, J = 5.9 Hz, 2H), 3.85 (t, J = 5.9 Hz, 2H), 3.77 (s, 
2H), 3.03 (s, 1H), 2.14 - 1.99 ppm (m, 2H). 13C NMR (63 MHz, CDCl3): δ = 159.02, 158.21, 
151.24, 149.58, 145.83, 137.12, 128.47, 124.05, 121.79, 118.82, 116.34, 115.34, 67.86, 59.37, 
33.02 ppm. MS (Micro-ESI): 350.2 [M + Na]+. Anal. Calcd for C17H17N3O2S: C, 62.36; H, 
5.23; N, 12.83; S, 9.79. Found: C, 62.21; H, 5.35; N, 12.90; S, 9.86. 
Synthesis of 3-((5-(4-(dimethylamino)phenyl)-2-(pyridin-2-yl)thiazol-4-yl)oxy)propan-1-
ol (4). To a solution of 37% CH2O in H2O (1.80 g, approx. 22.1 mmol, 7 equiv.) and 3 M 
H2SO4 (15 mL), a mixture of 3-((5-(4-aminophenyl)-2-(pyridin-2-yl)thiazol-4-yl)oxy)propan-
1-ol (1.03 g, 3.15 mmol) and NaBH4 (600 mg, approx. 15.8 mmol, 5 equiv.) suspended in 
THF (30 mL) was added successively in small portions over a period of one hour. The 
resulting deep orange mixture was diluted with CHCl3 (50 mL) and washed with water 
(3 · 50 mL) after neutralization with a saturated K2CO3 solution. The organic phase was dried 
over MgSO4, filtered and concentrated in vacuo. Gel filtration (silica, CHCl3/EtOAc 4:1) 
yielded the product as brownish yellow oil, which solidifies after a few minutes to form a 
yellow solid; yield: 730 mg (2.06 mmol, 65%). 
Synthesis of 3-((5-(4-(dimethylamino)phenyl)-2-(pyridin-2-yl)thiazol-4-yl)oxy)propyl 
methacrylate (5). To a solution of 3-((5-(4-(dimethylamino)phenyl)-2-(pyridin-2-yl)thiazol-
4-yl)oxy)propan-1-ol (480 mg, 1.35 mmol) and TEA (180 mg, 1.6 mmol, 1.2 equiv.) in dry 
CH2Cl2 (20 mL), methacryloyl chloride (170 mg, 1.6 mmol, 1.2 equiv.) were added. The 
reaction was stirred under a nitrogen atmosphere at room temperature and was monitored by 
TLC. After the reaction was finished (typically after 24 h), the organic phase was washed 
thoroughly with a saturated NaHCO3 solution and H2O (3 · 20 mL), dried over MgSO4 and 
evaporated to dryness at T < 40 °C to give a yellow oil. The crude product was purified using 
column chromatography (silica, CHCl3) affording the pure methacrylate as a yellow oil, 
which solidifies at T < 0 °C; yield: 540 mg (1.28 mmol, 94%). 1H NMR (250 MHz, CDCl3): δ 
= 8.57 (d, J = 4.7 Hz, 1H), 8.00 (d, J = 7.8 Hz, 1H), 7.91 (t, J = 7.6 Hz, 1H), 7.57 (d, J = 
8.7 Hz, 2H), 7.48 - 7.37 (m, 1H), 6.75 (d, J = 8.8 Hz, 2H), 6.03 (s, 1H), 5.65 (s, 1H), 4.53 (t, J 
= 6.2 Hz, 2H), 4.29 (t, J = 6.3 Hz, 2H), 2.92 (s, 6H), 2.16 (p, J = 6.2 Hz, 2H), 1.86 ppm (s, 
3H). 13C NMR (63 MHz, CDCl3): δ = 167.53, 158.16, 157.75, 151.68, 149.61, 149.49, 
136.88, 136.50, 128.17, 125.59, 123.74, 119.76, 118.83, 116.54, 112.62, 67.04, 61.93, 40.54, 
29.20, 18.45 ppm. MS (EI): 423 (60) [M+], 296 (10), 164 (100). Anal. Calcd for 
C23H25N3O3S: C, 65.23; H, 5.95; N, 9.92; S, 7.57. Found: C, 65.20; H, 5.99; N, 10.13; S, 7.73. 
UV/Vis (acetonitrile) λmax (log ε): 226 (4.192), 283 (4.058), 413 (4.302). 
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The cellular internalization of deﬁned PMMA nanoparticles was investigated. For this purpose, the
biocompatible copolymer p(MMA-stat-MAA)0.91:0.09 was synthesized by RAFT polymerization and
labeled with three diﬀerent ﬂuorescent dyes (lEx ¼ 493, 557, and 653 nm). Nanoparticles were
formulated from the diﬀerently labeled copolymers into samples with relatively narrow size distribution
(diameter d < 100 nm, 100 to 200 nm, >300 nm) under appropriate conditions of nanoprecipitation and
were subsequently characterized by DLS and SEM. Mixtures of the diﬀerently sized nanoparticle samples
were applied for internalization studies using monolayer cultured HeLa cells. The localization of the
nanoparticles was detected after certain time points up to 24 h by CLSM, using LysoTracker as a marker
for late endosomes and lysosomes. In investigations by ﬂow cytometry, a fast uptake of medium sized
nanoparticles was found, whereas the large and small nanoparticles exhibited a slower internalization.
However, small and medium sized nanoparticles were detected in the late endosomes/lysosomes,
whereas the large nanoparticles exhibit little co-localization with LysoTracker. Moreover, it could be
shown by using diﬀerent inhibitors for clathrin-dependent (chlorpromazine), caveolin-dependent (ﬁlipin
III) endocytosis and macropinocytosis (EIPA) that nanoparticles with d < 200 nm were internalized via
clathrin-dependent endocytosis, whereas those with d > 300 nm were internalized via macropinocytosis.Introduction
Polymeric nanoparticles (NPs) can provide manifold opportu-
nities for drug and gene delivery,1,2 because molecules and
particles at the nanometer scale oﬀer important benets like an
enhanced permeability and retention eﬀect (EPR), resulting in
an improved bioavailability and fewer side eﬀects. In addition,
NPs oﬀer the possibility of delivering nucleic acids (siRNA,
DNA), proteins or other active substances into targeted organs
or cells.1–6 However, many points in the eld of nanotechnologyar Chemistry (IOMC), Friedrich Schiller
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tion (ESI) available: See DOI:
Chemistry 2013still need to be considered very carefully with regard to
unknown long-time consequences such as the accumulation of
the particles in the vessels/liver, the uptake through skin and
lungs, and the removal by the reticuloendothelial system.7
Hence, a detailed understanding of the interaction of NPs with
their environment is essential for the development of dened
drug delivery systems as well as for specic diagnostic
applications.
Since the last decade, a number of studies have been pub-
lished investigating the cellular uptake mechanisms of NPs
with respect to various physical, chemical, and biological
parameters.8–13 The size of the NPs was found to play the key role
in the nal particle–cell interaction.14–16 In detail, depending on
their size, particles can enter cells either by phagocytosis or
pinocytosis; the latter mechanism can be further subdivided
into clathrin- and caveolin-dependent endocytosis as well as
clathrin/caveolin-independent endocytosis such as macro-
pinocytosis.17–20 Phagocytosis and macropinocytosis are
processes to engulf large particles up to the range of 10 mm,
whereas the clathrin- and caveolin-dependent endocytosis are
the main processes for the internalization of smaller particles
below 500 nm.18 In addition, the shape of the NPs signicantly
inuences uptake of NPs by phagocytosis. Rod-like and oblate
ellipsoidal NPs with a high aspect ratio were taken up more
eﬃciently in comparison to their spherical counterparts, due to
their higher surface area and, therefore, a better attachment toSoft Matter, 2013, 9, 99–108 | 99
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View Article Onlinethe cell membrane.13,16,21,22 In addition, the internalization of
particles into the cells is inuenced by their surface charge: an
increased positive charge leads to a higher cellular uptake due
to electrostatic interactions with the negatively charged cell
membrane.23 As the surface of NPs can be further functional-
ized with diﬀerent reactive groups (COOH and NH2), amino
acids, sugar units, antibodies, or peptides, cellular uptake of
NPs can be inhibited or advanced.24–26 Nevertheless, no nal
conclusion can be drawn about the size, shape and charge
dependency of cellular uptake of NPs, as the studies published
so far are all based on diﬀerent materials. Inorganic (gold,27,28
silica particles,29,30 and quantum dots31) and organic (poly-
(lactic-co-glycolic acid) (PLGA),15 polystyrene (PS),32,33 and chi-
tosan34,35) materials were studied and many contradictory
results were reported by diﬀerent investigators.36 Furthermore,
cell internalization studies frequently used NP beads with non-
dened surfaces because conventional preparation techniques
(e.g. the emulsion technique) require the use of surfactants,
which also inuence cellular uptake.37 Hence, further studies
on NP–cell-interactions with well-dened NPs, in the absence of
any surfactants, would be helpful to gain a better insight into
the involved parameters and structure–property relationships.
The present study aims at investigating the cell interaction of
polymeric NPs with well-dened characteristics based on poly-
(methyl methacrylate) (PMMA) derivatives, poly(methyl methac-
rylate)-stat-poly(methacrylic acid) (p(MMA-stat-MAA)) copolymer.
Thep(MMA-stat-MAA) copolymer isbasedon the samemonomers
as the pharmaceutically important coating material EUDRAGIT
S100, which is applied for pH-dependent drug release.31 Recently,
it has been demonstrated that PMMA systems are suitable for
diagnostic applications in cell imagingandasa genecarrier due to
their non-toxicity and good biocompatibility.38–41 Here, the poly-
(methacrylic acid) segment of p(MMA-stat-MAA) was labeled with
various dyes (DY-495 (green), DY-547 (orange), and DY-647 (red))
for tracking of the NPs.42 NPs of the labeled p(MMA-stat-MAA)
copolymers (p(MMA-stat-MAdye (green, orange, or red))) were prepared
by the solvent-evaporation (nanoprecipitation) method43 and
characterized comprehensively by dynamic light scattering (DLS)
andscanningelectronmicroscopy (SEM).44Thestability of theNPs
was demonstrated by DLS measurements aer autoclave treat-
ment, aer incubation in cell culture media, and during pH
titration studies, respectively. Cytotoxicity assays were performed
to prove the biocompatibility and non-toxicity of the NPs. The
cellular uptake studies usedHeLa cells and three diﬀerently sized
and individually labeled NPs. Flow cytometry was applied for
studies on time- and concentration-dependent cellular uptake
and confocal laser scanning microscopy (CLSM) for cellular
distribution and co-localization studies. In addition, cellular
internalization was investigated by inhibitors of clathrin- and
caveolin-dependent endocytosis as well as of macropinocytosis.Experimental
Materials
All reagents were purchased from commercial sources (Fluka
and Sigma Aldrich). MMA andMAA were purchased from Sigma
Aldrich and puried with an inhibitor-remover before use. 2,20-100 | Soft Matter, 2013, 9, 99–108Azobis(iso-butyronitrile) (AIBN) was recrystallized from meth-
anol prior to use. 2-Cyano-2-propyl dithiobenzoate (CPDB) was
purchased from Sigma Aldrich. Puried N,N-dimethylaceta-
mide (DMA) and dimethylformamide (DMF) were obtained
from VWR. The uorescent dyes l ¼ 495 nm (DY-495), l ¼ 557
nm (DY-547), and l ¼ 653 nm (DY-647) were purchased from
DYOMICS GmbH. AlamarBlue, LysoTracker Green, and Opti-
MEM were obtained from Life Technologies. Hoechst 33342,
5-(N-ethyl-N-isopropyl)amiloride (EIPA), lipin III, and chlor-
promazine were purchased from Sigma Aldrich. Cell culture
materials were received from Greiner Bio One, cell culture
media and solutions from Biochrome, Greiner, and PAA. Unless
otherwise stated, the chemicals were used without further
purication.
Synthesis of p(MMA-stat-MAA)
P(MMA-stat-MAA) was prepared by copolymerization of MMA
with MAA using the reversible addition–fragmentation chain
transfer (RAFT) polymerization method.37,38 In a typical RAFT
copolymerization experiment, 4.325 g of MMA monomer (43.2 
103 mol), 0.413 g of MAAmonomer (4.8 103 mol), 19.7 mg of
AIBN initiator (0.12  103 mol), 106.3 mg of CPDB RAFT agent
(0.48  103 mol) and 5.8 mL of ethanol were mixed together
with anisole as the internal standard (1.2 mL) in a 25 mL reaction
vial. The monomer concentration was kept at 4 mol L1. Subse-
quently, the reaction solution was placed in a preheated oil bath
at 70 C for 10 hours. The copolymer was puried by precipitation
into a large volume of cold diethyl ether and dried under reduced
pressure. Conversion was measured by 1H NMR spectroscopy
using anisole as the internal standard. 1H NMR (DMSO-d6, 300
MHz): d ¼ 12.5 (–OH), 7.83, 7.64, and 6.46 (Ar–H, CPDB), 3.55
(OCH3), 2.25–0.3 (backbone) ppm. SEC (DMA, LiCl, and PMMA
standard): Mn ¼ 16 000 g mol1 and PDI ¼ 1.19. Elemental
analysis: p(MMA-stat-MAA) C: 58.18 and H: 7.91%.
Labeling of p(MMA-stat-MAA)
500 mg of the p(MMA-stat-MAA) polymer (3.1  104 mol) were
dissolved in 2 mL of dried DMF, and 50 mL (3.0  104 mol) of
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) was added
as well as 500 mL of a stock solution (c ¼ 0.1 mg mL1 in DMF) of
the desired dye DY-495 (green, 8.5  108 mol), DY-547 (orange,
7.5  108 mol), or DY-647 (red, 7.1  108 mol). The labeled
polymers were puried by repeated precipitation in water and
extensive dialysis aerwards. The products were obtained by
freeze drying in 70% overall yield. SEC (DMA, LiCl, and PMMA
standard): p(MMA-stat-MAgreen): Mn ¼ 23 500 g mol1 and PDI ¼
1.21; p(MMA-stat-MAorange):Mn¼ 21 800 g mol1 and PDI¼ 1.22;
p(MMA-stat-MAred): Mn ¼ 23 800 g mol1 and PDI ¼ 1.22;
elemental analysis: p(MMA-stat-MAgreen) C: 56.85, H: 8.18, and
N: 2.43; p(MMA-stat-MAorange) C: 58.51, H: 8.12, and N: 2.40;
p(MMA-stat-MAred) C: 58.17, H: 8.08, and N: 2.46.
Preparation of the NP suspension
NPs were prepared by nanoprecipitation with subsequent
solvent evaporation. For this purpose, the polymers were dis-
solved in acetone and ltered through a 2 mm lter prior to use.This journal is ª The Royal Society of Chemistry 2013
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View Article OnlineNP suspensions with diﬀerent sizes were prepared by variation
of the initial conditions of the formulation. For the small
(diameter d < 100 nm) and medium (100 to 200 nm) sized NPs,
the acetone solution was dropped into deionized water (AW)
with a concentration of 1 mg mL1 and 10 mg mL1, respec-
tively. By dropping water to the polymer solution (WA) with a
concentration of 4 mg mL1, large NPs (d > 300 nm) were
prepared. For all suspensions, the acetone–water ratio was
chosen to be 0.25. Furthermore, the dropping speed was
approximately 50 mL per second, and the stirring speed was set
to 1000 rpm (Magnetic Stirrer MR Hei-Standard). Aerwards,
the acetone was evaporated from the solution by stirring over-
night at room temperature, the suspensions were ltered
using a lter paper and diluted to a nal concentration of
0.5 mg mL1. The suspensions were stored in a fridge at 4 C
and before further usage they were vortexed to ensure a
homogenous particle suspension.Dynamic light scattering (DLS) and zeta potential
measurements
For DLS investigations, a Zetasizer Nano ZS (Malvern Instru-
ments, Malvern, UK) operating with a laser beam at 633 nm and
a scattering angle of 173 was used. Each sample was analyzed
in triplicate at 25 C in a polycarbonate zeta cell. For size
measurements, three runs were applied for 30 s; for the zeta
potential measurements, three runs were applied for 10 s. The
intensity, volume and number distribution of the NPs were
calculated applying the NNLS mode.Scanning electron microscopy (SEM)
SEM images were obtained using a LEO-1450 VP, Leo Elek-
tronenmikroskopie GmbH, Oberkochen, Germany. The sputter
coating device BAL-TEC SCD005 (Balzers, Liechtenstein; 60 mA,
80 s) was used. The system was operated from 8 to 10 kV.Cell lines and culture conditions
The HeLa (CCL-2, ATCC) and L929 (CCL-1, ATCC) cell lines used
in the uptake and cytotoxicity experiments were maintained in
suitable cell culture media supplemented with 10% fetal calf
serum (FCS), 100 mgmL1 streptomycin, 100 IUmL1 penicillin,
and 2 mM L-glutamine (4 mM for L929). The cells were cultured
at 37 C in a humidied 5% CO2 atmosphere.Flow cytometry analysis
For the determination of cellular uptake of NPs via ow
cytometry, 105 cells per well were seeded in 12-well plates and
incubated for 24 h. Thirty minutes prior to the incubation with
the NPs, the cells were rinsed with PBS and supplemented with
OptiMEM. The NPs were added to the cells and the plates were
incubated for the indicated time. Aerwards, the cells were
harvested by trypsinization and resuspended in PBS supple-
mented with 10% FCS. To determine the relative uptake of NPs,
10 000 cells were quantied by ow cytometry using a Cytomics
FC 500 (Beckman Coulter).This journal is ª The Royal Society of Chemistry 2013Microscopy studies
HeLa cells were cultured on 35 mm glass dishes (Iwaki, Japan)
at 2  105 cells per dish. Aer 24 h, the medium was exchanged
with OptiMEM, and the cells were incubated for 30 min before
the addition of the NP suspensions. The nuclei and the late
endosomes/lysosomes were stained with Hoechst 33342 and
LysoTracker Green, respectively, before CLSM imaging. CLSM
images were acquired 24 h aer the administration of NPs,
using a Zeiss LSM 780 (Carl Zeiss). Excitation wavelengths were
405 nm, 488 nm, 561 nm and 633 nm for Hoechst 33342,
LysoTracker Green or DY-495 stained NPs, DY-547 stained NPs,
and DY-647 stained NPs, respectively. Co-localization was
quantied, using Imaris soware (Bitplane AG, Zurich,
Switzerland).
Inhibition of endosomal pathways
The cells were seeded as described before. The growth media
were changed to OptiMEM and incubated for 30 min before
10 mg mL1 chlorpromazine, 1 mg mL1 lipin III, or 100 mM
EIPA were added and incubated for a further 30 min. Aer-
wards, the NPs were added, and the cells were incubated for the
indicated time.
Cell viability
For L929 cells, the cytotoxicity assay was performed according to
ISO10993-5. In detail, the cells were seeded at 10 000 cells per
well in a 96-well plate and incubated for 24 h. No cells were
seeded in the outer wells. The growth media were replaced by
OptiMEM. Aerwards, NP dilutions in the concentration range
from 78 to 254 mg mL1 were added, and the cells were incu-
bated at 37 C for further 24 h. Subsequently, the medium was
replaced by DPBS and AlamarBlue, as recommended by the
supplier. Aer incubation for 4 h, the uorescence was
measured at Ex 570/Em 610 nm in a microplate reader (Genios
Pro, Tecan GmbH), with untreated cells serving as controls.
Results and discussions
Polymer preparation and characterization
To provide the possibility of functionalization aer the poly-
merization, carboxylic acid groups were introduced into the
PMMA chain. Therefore, MMA was copolymerized with MAA
using the RAFT polymerization method.37,38 This technique
allows the synthesis of tailored polymers with control over
molar mass and the composition of the copolymer, i.e., the ratio
between MAA and MMA.
In the copolymerization reaction, a nal conversion of 87%
(both monomers) was reached. MMA and MAA are statistically
distributed in the polymer backbone due to the same reactivity
ratio of the MMA andMAA units.45 The ratio between both MMA
and MAA in p(MMA-stat-MAA) was determined by 1H NMR
spectroscopy. The observed ratio of 91 to 9% agrees well with
the theoretical value of 90 to 10%. The low content of MAA
ensures the stability at pH > 7 of the NPs and seems to be
benecial for a well-dened NP formation in aqueous systems.
A molar mass of Mn ¼ 16 000 g mol1 with a polydispersitySoft Matter, 2013, 9, 99–108 | 101
Table 1 Selected characterization data of the p(MMA-stat-MAA)0.91:0.09 poly-
mer and the ﬂuorescent labeled p(MMA-stat-MAdye) copolymers
Sample
Mn
a
[g mol1]
PDISEC
(RI)a C [%] H [%] N [%]
P(MMA-stat-MAA)0.91:0.09 16 000 1.15 58.18 7.91 —
P(MMA-stat-MAgreen) 23 500 1.21 56.85 8.18 2.43
P(MMA-stat-MAorange) 21 800 1.22 58.51 8.12 2.40
P(MMA-stat-MAred) 23 800 1.22 58.17 8.08 2.46
a Calculated from SEC (DMA and LiCl) and PMMA calibration.
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View Article Onlineindex of 1.15 (DMA, LiCl) was determined by size exclusion
chromatography (SEC) for the nal copolymer p(MMA-stat-
MAA)0.91:0.09 (Table 1).
In order to obtain diﬀerently labeled polymers, three
diﬀerent dyes (DY-495, DY-547 and DY-647) were chosen,
because the dyes provide high quantum yields, good photo-
stability, and are available with diﬀerent functional groups
(Scheme 1).42 The labeling procedure was performed by the
reaction of the COOH groups with the NH2-functionalized dyes
using EDC as the coupling reagent. The absence of free dye was
proven by uorescence measurements of the washing water
aer purication. The uorescence emission spectra of the
labeled copolymers p(MMA-stat-MAgreen), p(MMA-stat-MAorange),
and p(MMA-stat-MAred) are displayed in the ESI, Fig. S1.† All
the copolymers show distinct peaks at 525 nm, 568 nm, and
668 nm, respectively. In comparison to the initial emission of
the pure dyes, no signicant change in the uorescence
behavior was obtained even aer conjugation into the
copolymer segments. A comparison of the SEC graphs of the
unmodied p(MMA-stat-MAA) and the labeled copolymers
revealed a slight change in the elution volume, indicating
that the molar mass slightly increased due to dye conjuga-
tion and that the polymer was not degraded or cross-linked
during the labeling procedure. The overlay of the diode array
detector (DAD) and refractive index (RI) traces of the labeled
samples conrm the covalent attachment of the dyes (ESI,
Fig. S2†). Furthermore, the elemental analysis revealed an
increase in the nitrogen content, which also indicates the
attachment of the dyes in the polymer backbone.Scheme 1 Schematic representation of the reaction of p(MMA-stat-
MAA)0.91:0.09 with the DY-495, DY-547, and DY-647 using EDC as a coupling
reagent.
102 | Soft Matter, 2013, 9, 99–108Preparation and characterization of NPs
Diﬀerently sized NPs were prepared by nanoprecipitation with
subsequent solvent evaporation, a technique, which is not only
simple and cost-eﬀective but also fast and easy.43 By variation of
the initial conditions of the formulation, such as the solvent/
non-solvent ratio and the concentration of the polymer solu-
tion, well-dened NPs with diﬀerent sizes can be prepared. In
comparison to other procedures commonly used, e.g., the
emulsication technique, no surfactants are necessary for the
NP preparation. This represents an important benet of the
nanoprecipitation technique. It was proven that surfactants
signicantly aﬀect the interaction of NPs with cells as well as
their cellular uptake.37Using nanoprecipitation, it is known that
the nal NP sizes can be tuned from 50 nm up to 1 mm by
varying the initial polymer concentration in the organic phase
and/or by changing the dropping method (polymer solution
into water or water into polymer solution). In order to yield
small (S; d < 100 nm), medium (M; d between 100 and 200 nm),
and large (L, d > 300 nm) NPs, diﬀerent nanoprecipitation
conditions were applied. By dropping the acetone–polymer
solution into water, smaller NPs were obtained in comparison
to the reverse technique. For the preparation of the small NPs,
polymer acetone solutions with a concentration of 1 mg mL1
were dropped into water. For the medium sized NPs the same
procedure with an increased concentration of 10 mg mL1 was
used. The large NPs were generated by dropping water into
polymer solutions with a concentration of 4 mg mL1. For all
suspensions, a solvent/non-solvent ratio of 0.25 and no surfac-
tants were used. Aer subsequent removal of the acetone by
overnight evaporation, the NPs were ltered, diluted to a
concentration of 0.5 mg mL1, and characterized by DLS and
SEM. These complementary techniques give suﬃcient infor-
mation about the size, shape, and surface characteristics of the
particle systems.44 For the small NPs, a size of 80 (10) nm was
measured by DLS in water. The medium NPs revealed a size of
150 (10) nm, whereas for the large NPs a size of 400 (50) nm
was obtained. Low PDIP values conrm a narrow size distribu-
tion of the NPs, which was further veried by the SEM investi-
gations. A detailed analysis of a representative small, medium
and large NP batch is displayed in Fig. 1. As the major focus of
this research was set on the inuence of the size on the cell
internalization, a charge eﬀect needs to be excluded. Thus, only
a low degree of labeling was performed in order to keep the
charge density similar. The zeta potential of the NP was
measured in water (pH ¼ 6), resulting in comparable values
with 30  10 mV for all nanoparticle suspensions. The zeta
potential values larger than 20 mV further indicate high repul-
sion forces and colloidal stability of the NPs in suspension.
However, the stability of the NPs should also be conrmed
under diﬀerent conditions, and, therefore, a NP suspension
with medium sized NPs was investigated inmore detail. For this
purpose, all NPs were centrifuged at 15 000 rpm for 20 min,
autoclaved, or incubated in PBS or cell culture media as well as
titrated in the pH range of 4 to 10. The resulting suspensions
were analyzed again by DLS and SEM. Neither the size distri-
bution nor the zeta potential value changed, which proves theThis journal is ª The Royal Society of Chemistry 2013
Fig. 1 Representative SEM images and DLS intensity size distribution with corresponding Z average value and polydispersity PDIP of the small, medium and large
particles of the p(MMA-stat-MAdye) copolymer.
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View Article Onlinehigh stability of the p(MMA-stat-MAdye) NPs (ESI, Fig. S3†). In
combination with the easily tunable NP size, the absence of
surfactants, and the variety on possible modications/labels of
the original polymers, the NPs represent excellent and well-
dened materials for further cell internalization experiments.
Cytotoxicity of the polymers in L929 cells
To evaluate the cytotoxicity of the NPs, we used L929 cells, because
they were commonly used for the investigation of cytotoxicity, as
they are sensitive and recommended by ISO10993-5. For the cell
experiments, the NPs (which originally were in distilled water)
were buﬀered with DPBS before being added to the cells. In
preliminary experiments, cytotoxicity tests with AlamarBlue were
performed for 24 h, to evaluate the metabolic activity of L929 cells
exposed to the NPs. Small (<100 nm) and large (>300 nm) labeled
NPs were investigated. As shown in Fig. S4 (ESI†), all types of NPs
did not cause a signicant cytotoxicity aer 24 h of incubation at
the investigated concentrations up to 260 mg NPs per mL (p > 0.01;
ANOVA). Moreover, neither size nor labeling of the NPs showed an
inuence on the cytotoxicity. This is in agreement with studies of
other groups using EUDRAGIT S100.38–40 Thus, the NPs used here
are not toxic even at the maximum concentration of 150 mg mL1.
Validation of cellular uptake measurement by ow cytometry
via uorescence and side scatter
To investigate cellular uptake of the NPs into HeLa cells by ow
cytometry, we rst conrmed the validation of cellular uptake
measurement by ow cytometry. The uorescence channel as
well as the side scatter (SSC) and forward scatter (FSC) channels
were used. The SSC is directly related to the cell granularity and
was used as an indicator of cellular uptake.46On the other hand,
the FSC is correlated with the cell size and was used as an
additional factor. Aer overnight incubation with the NPs, the
cells showed a high cellular uptake that was detected by theThis journal is ª The Royal Society of Chemistry 2013uorescence intensity measurements. This result was also
conrmed by an increase in the SSC channel (ESI, Fig. S5†): the
SSC signal increased with the increase of the incubation time,
whereas the FSC signal did not change. Moreover, a strong
correlation between uorescence and SSC was detected when
HeLa cells were incubated with increasing sizes of DY-547
labeled NPs. To exclude a high inuence of NPs on the cell
surface, the outer uorescence was quenched with trypan. No
diﬀerences in the non-quenched ones could be observed.
Therefore, the uptake of NPs can be detected by uorescence
and SSC measurements.Dependency of cellular uptake on the NP concentration
A concentration-dependent cellular uptake was investigated
aer 24 h using four diﬀerent NP concentrations (25, 50, 100,
and 150 mg mL1, respectively). The cellular uptake was quan-
tied using ow cytometry. It should be noted that larger NPs
contain a higher content of labeled polymers leading to an
increased uorescence signal compared to smaller NPs. To
suppress the inuence of the cell size on granularity, the SSC
was measured relative to the FSC as the cofactor. For analysis,
the uorescence (mean uorescence intensity ¼ MFI) and SSC/
FSC of the treated cells were plotted relative to untreated cells
(Fig. 2). It was observed that higher NP concentrations lead to
an increase in MFI and SSC/FSC (Fig. 2A). In particular, for the
medium and large sized NPs, a clear concentration-dependent
cellular uptake was observed. In detail, for incubation with 150
mg mL1, a three times higher relative SSC/FSC value was
obtained for the medium and large sized NPs (3.4  0.2 and 3
0.4, respectively) in comparison to the control cells. For the
small NPs only a relative SSC/FSC value of 2.6  0.4 was
detected. The uorescence measurement also conrmed these
results, but is inuenced by the amount of uorescent polymer
per particle. The number of “positive cells” (cells thatSoft Matter, 2013, 9, 99–108 | 103
Fig. 2 Cellular uptake of NPs into HeLa cells measured by ﬂow cytometry: the cells were seeded at a concentration of 105 cells per mL 24 h before particle incubation
with NPs. The uptake of NPs was investigated in serum-reduced media and measured by two methods: the relative change of ﬂuorescence (MFI) and granularity (SSC/
FSC) compared to non-treated cells. (A) Diﬀerent concentrations of diﬀerently sized particles were analyzed after 24 h of incubation. (B) Time-dependent uptake of 50
mg NPs per mL. Data represent mean  SD, n $ 3.
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View Article Onlineinternalize NPs) was increased with higher NP concentration:
95% positive cells were found for c ¼ 150 mg mL1 and 75% for
50 mg mL1, respectively (data not shown). Furthermore, the
relative SSC/FSC as well as the relative MFI showed no signi-
cant diﬀerences between small, medium and large NPs at 50
mg mL1 (p > 0.05). It could be shown that all NPs were taken up
by HeLa cells at the used concentrations.
Cultivation conditions – inuence on the NP uptake by HeLa
cells
The majority of experiments were performed with serum-reduced
media (OptiMEM), but additionally the cellular uptake of NPs was
further investigated in growth media to exclude an inuence of
serum proteins on the uptake. No signicant diﬀerences could be
obtained between serum-reduced and serum-containing (growth
media) conditions for 50 mg mL1 small and large NPs. In all
cases, 60% to 70% of positive cells and an increased SSC/FSC
signal could be detected aer 24 h. The results indicate that the
used media have no inuence on the cellular uptake.
Dependency of cellular uptake on the incubation time
The size of the NPs showed no inuence on the cytotoxicity and
cellular uptake aer 24 h incubation at a NP concentration of
50 mg mL1 as described above. To gain a deeper understanding104 | Soft Matter, 2013, 9, 99–108of the cellular uptake, a time-dependent cellular uptake was
evaluated. In these experiments, HeLa cells were incubated with
p(MMA-stat-MAorange) NPs for 30 min up to 24 h, and MFI as
well as SSC/FSC were analyzed by ow cytometry. In Fig. 2B, the
cellular uptake is presented as relative MFI and SSC/FSC of
treated cells to non-treated cells. It could be observed that all
the NPs were taken up by the cells in a time-dependent manner.
In detail, small NPs < 100 nm reached a relative MFI of around 4
and an increase of SSC/FSC of around 2 aer 24 h at 50 mgmL1.
This is in agreement with the results observed by the concen-
tration-dependent uptake in Fig. 2A. A signicant increase (p <
0.01) in granularity (relative SSC/FSC) was detectable aer 4 h
incubation. The highest relative SSC/FSC was found aer 12 h
incubation. This was also the case for medium and large sized
NPs (medium NP: MFI 8.5, SSC/FSC 3.5; large NP: MFI 7.5–8,
SSC/FSC 3.5). Furthermore, no signicant diﬀerences were
detected between medium and large NPs aer 4 to 24 h incu-
bation (p > 0.05). The internalization of all NPs reached a
plateau aer 8 h, as indicated by the lack of further signicant
increase in uorescence and granularity (p > 0.05). A diﬀerence
in the cellular uptake of the diﬀerently sized NPs was, however,
observed at early time points. In detail, small NPs < 100 nm and
large NPs > 300 nm showed no increase in granularity for 2 h
and 1 h, respectively (p > 0.05). In contrast to this, an increase in
granularity was detectable with medium sized NPs (p < 0.01),This journal is ª The Royal Society of Chemistry 2013
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View Article Onlinewhich can be due to diﬀerent reasons. First of all, the eﬀect may
be caused by diﬀerent endosomal pathways. The delayed
cellular uptake of small NPs can also be explained by a slower
sedimentation of the NPs compared to the larger ones. This
could lead to a later contact between the membrane of cells and
NPs, and an eventual delayed cellular uptake. Besides, a
decrease in relative SSC/FSC was observed at 24 h compared to
that at 12 h in particular with medium and large sized NPs. This
could not be observed by uorescence. The reason for this
decrease in granularity is not understood by now and requires
further investigations.
In conclusion, medium NPs of 100 to 200 nm were found to
have the fastest cellular uptake in HeLa cells compared to
smaller and larger ones. A fast cellular uptake of medium sized
NPs could be due to fast sedimentation and fast internalization
into cells, indicating an endosomal pathway. Large NPs were
taken up very slowly despite fast sedimentation, indicating a
macropinocytotic uptake, because endosomal pathways like
clathrin- or caveolin-dependent endocytosis are faster
compared to macropinocytosis.47Fig. 3 Confocal microscope images of HeLa cells incubated with NPs. Cells were
seeded at a density of 105 cells per mL for 24 h in medium before particle incu-
bation. NPs with diﬀerent sizes and labels (A: small NPgreen; B: mediumNPorange; C:
large NPred) were added at 50 mgmL1 simultaneously and incubated for 24 h. (D)
Cell nuclei were stained with Hoechst 33342. (E) Overlay of small NPgreen and
large NPred. (F) Overlay image of labeled NPs and cell nuclei. (G) Pearson’s
correlation coeﬃcient of labeled NPs. The scale bars indicate 20 mm.Intracellular localization study of diﬀerently sized NPs
The cellular uptake mechanisms of HeLa cells were investigated
by CLSM. For this purpose, the intracellular distribution of NPs
aer 24 h incubation was studied in living cells. Small NPgreen,
medium NPorange and large NPred suspensions were used at
50 mg mL1 each. The nuclei of the cells were stained with
Hoechst 33342. A representative NP distribution in HeLa cells is
presented in Fig. 3. Cells containing NPs of diﬀerent sizes are
plotted separately (Fig. 3A–C) as well as the corresponding cell
nuclei (Fig. 3D). In addition, two overlays are presented. The
overlay of all channels is presented in Fig. 3F. No NPs could be
observed in the cell nuclei. The intracellular distribution of
small and medium sized NPs is comparable. In detail, a peri-
nuclear localization was observed (compare Fig. 3A and B) in the
cytoplasm. Hence, a strong co-localization was found with NPs
below 200 nm. In contrast, the intracellular localization of small
and large NPs is diﬀerent, as presented in Fig. 3A and C, and
merged in Fig. 3E. Co-localizations between small and large
sized NPs would be indicated by yellow signals. Here, only a few
yellow signals were detectable indicating only some co-locali-
zation. This could also be observed in Fig. 3F, where the
observed cyan staining indicates a co-localization of small and
medium sized NPs, whereas only a few purple (co-localization of
medium and large NPs) and yellow signals could be found.
Furthermore the co-localization was quantied by Pearson’s
correlation coeﬃcient (PCC) (Fig. 3G). The PCC between the
small and medium sized NPs showed the highest value, sug-
gesting that the small and medium sized NPs might have a
similar cellular uptake pathway. To exclude the possibility that
this cellular distribution is caused by the dye, other NPs with
comparable sizes but diﬀerent dyes were investigated (e.g. small
NPorange and large NPgreen). This combination of NPs was also
incubated with HeLa cells and treated as described before.
Thereby, the intracellular distribution shows no dependency on
the dye and, thus, indicates no inuence of the chemical natureThis journal is ª The Royal Society of Chemistry 2013of dyes used on the uptake behavior of HeLa cells. Additionally,
HeLa cells incubated with small, medium, and large NPs at 4 C
revealed no uorescence inside the cells (ESI, Fig. S6†). This
indicates anactive cellular uptakemechanismof all sizedNPs via
endocytosis. Hence, a diﬀerent intracellular distribution of large
NPs (>300 nm) compared to small (<100nm) andmedium (100 to
200 nm) sized NPs was clearly proven. This indicates a diﬀerent
internalization of NPs below 200 nm compared to larger ones.
Furthermore, the microscopy data support the results observed
by ow cytometry, where diﬀerences in time-dependent uptakeSoft Matter, 2013, 9, 99–108 | 105
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View Article Onlinecould be found with regard to the NP size. Although, medium
and large sized NPs sediment faster onto the cells, the large NPs
were not internalized within the rst hour, whereas medium
sized NPs were detected in cells aer 30 min.
Investigation of cellular pathways
The intracellular localization and the cellular uptake kinetics of
NPs showed strong dependency on size (Fig. 2B and 3). To
further elucidate this observation, the intracellular localization
was investigated by using LysoTracker, a well known substance
for staining acidic late endosomes and lysosomes. As NPs
<200 nm showed the same cellular localization in all experi-
ments, only medium (100 to 200 nm) NPs are presented here.
They show a stronger uorescence signal and could be detected
more easily compared to small NPs, due to more labeled poly-
mers inside theNPs. In Fig. 4, the stained lysosomes (A),medium
NPs (B), large NPs (C), and cell nuclei (D) are presented. More-
over, the overlay of lysosomes and largeNPs (E) and the overlay of
all dyes used (F) are shown. Again, no NPs were found in the
nuclei. It should be noted that almost allmedium sizedNPswere
detected in the late endosomes or lysosomes indicated by a high
PCC of 0.61 and a cyan staining in Fig. 4F due to the merging of
medium sized NPorange (plotted in blue) with LysoTracker (A). An
adverse intracellular localization was found by using large NPsFig. 4 Confocal microscope images of HeLa cells incubated with particles. Cells we
incubated for 30 min. NPs at diﬀerent sizes and labels (B: medium NPorange; C: larg
LysoTracker Greenwas added 10min before microscopic analysis and incubated at 37
Hoechst 33342. (E) Overlay of stained lysosomes and large NPred. (F) Overlay image
106 | Soft Matter, 2013, 9, 99–108showing little co-localization with medium sized NPs and a PCC
of 0.19, as described before. Furthermore, little co-localization
was observed with late endosomes or lysosomes, indicated by
slight yellow signals in Fig. 4E and a PCC of only 0.15.
The large NPs were taken up by the cells, but the internali-
zation or the cellular pathway seems to be diﬀerent to the
medium ones. Whereas smaller NPs revealed a fate in late
endosomes or lysosomes, the cellular uptake mechanism of
larger NPs is not fully understood. It can be postulated that NPs
smaller than 200 nm were internalized via endocytosis and
ended up in the late endosomes or lysosomes. The missing co-
localization of larger NPs > 300 nm with late endosomes or
lysosomes indicates an uptake mechanism that does not end in
the lysosomes at the investigated time points, as a release of
NPs into the cytoplasm is not supported.
Inhibition of endocytic pathways
To investigate the cellular uptake mechanism of diﬀerently sized
NPs, internalization routes were inhibited. Chlorpromazine was
used for inhibition of clathrin-dependent and lipin III for inhi-
bition of caveolin-dependent endocytosis. It was described in the
literature that NPs < 200 nm are predominantly taken up by these
pathways.18,48 In contrast to smaller NPs, larger NPs can be taken
up by macropinocytosis or phagocytosis and were inhibited byre seeded at a density of 105 cells per mL for 24 h. The medium was changed and
e NPred) were added at 50 mg mL1 simultaneously and incubated for 24 h. (A)
C to stain acidic late endosomes and lysosomes. (D) Cell nuclei were stained with
of labeled NPs, lysosomes and cell nuclei. The scale bars indicate 20 mm.
This journal is ª The Royal Society of Chemistry 2013
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View Article OnlineEIPA.18,48 The NP internalization was analyzed by ow cytometry
(ESI, Fig. S7†). Inhibition of cellular uptake was investigated with
small and large sized NPs, as it was shown that the intracellular
localization of small and medium sized NPs is comparable. As
mentioned above, the MFI and the SSC/FSC showed no strong
increase aer 2 h (Fig. 2), because the NP concentration in cells
has an inuence on the signal intensity of SSC/FSC and MFI. As
the cells internalize only a few NPs aer 2 hours, the SSC/FSC and
MFI could not be used in this case. Therefore, the percentage of
cells taking up NPs was used (ESI, Fig. S7†). In the case of using
small NPs and the three diﬀerent inhibitors, it was found that NPs
< 200 nm were excluded not by lipin III and EIPA but by chlor-
promazine, indicating an uptake via clathrin-dependent endocy-
tosis. To prove this result, CLSM studies were also performed. In
Fig. S8 (ESI†), medium sized NPs (green) were not detectable in
cells incubated with chlorpromazine (A) but detectable in cells
incubated with lipin III. As controls, polystyrene (PS) beads of
150 nm were used (blue emission). These PS beads could be
excluded by lipin III, indicating an uptake via caveolin-depen-
dent endocytosis, as also conrmed in the literature.18 This
suggests that surfactants, which are usually necessary to prepare
commercial NPs, have an inuence on the uptake in cells. By
using inhibitors, it can be assumed that NPs < 200 nm internalize
via clathrin-dependent endocytosis, in particular the 100 nm NPs
used in this study. In the case of internalization of large NPs, an
exclusion could be observed by using EIPA, but not when chlor-
promazine and lipin III are used (ESI, Fig. S7†), indicating an
uptake of larger NPs via macropinocytosis. As already reported in
the literature,49 EIPA caused also a weak inhibition of small sized
NPs. These blocking study of diﬀerently sized NPs showed that
dened small p(MMA-stat-MAA) NPs were predominantly taken
up by clathrin-dependent endocytosis, whereas larger ones were
predominantly taken up by macropinocytosis.Conclusion
The preparation of a diﬀerently labeled p(MMA-stat-MAA)
copolymer and its nanoprecipitation into dened NPs with
various sizes (<100 nm, 100 to 200 nm, and >300 nm) without
the usage of surfactants were demonstrated. These tailor-made
NPs are promising for studying the inuence of the surface,
charge or size of the NPs on their internalization into cells, as
no stabilizers were used, which have an inuence on cellular
uptake. We showed that the size itself of the NPs has a strong
inuence on the uptake in HeLa cells. This is further inuenced
by the concentration used and incubation time. The medium
sized NPs were taken up faster compared to small and large
ones. All NPs were found inside the cells, whereas small and
medium sized NPs showed the same cellular distribution and
were detectable in lysosomes. In contrast, large NPs showed less
co-localization with smaller NPs and were not detectable in the
lysosomes. By using inhibitors, we have shown that clathrin-
dependent endocytosis is the predominant pathway for smaller
NPs < 200 nm, whereas macropinocytosis is responsible for
larger NPs. In further studies, the inuence of the zeta potential
and of the additional functional groups on the particle surface
will be studied, again in the absence of surfactants.This journal is ª The Royal Society of Chemistry 2013Acknowledgements
The nancial support from the Thuringian Ministry for
Education, Science and Culture (grant #B514-09051, Nano-
ConSens), the Deutsche Forschungsgemeinscha (Japan-Ger-
many exchange program, DFG and JSPS), the Carl-Zeiss
Foundation (JCSM Strukturantrag), the Funding Program for
World-Leading Innovative R&D on Science and Technology
(FIRST Program, JSPS), and the Core Research Program for
Evolutional Science and Technology (CREST) from the Japan
Science and Technology Corporation (JST) is gratefully
acknowledged. We express our gratitude to Steﬃ Stumpf, EMZ
Jena, for assistance in the SEM investigations, Melanie Niko-
lajski, University of Jena, for help with the pH dependent zeta
measurements, Tomoya Suma, the University of Tokyo, for help
with FC studies, and Dr Xueying Liu, the University of Tokyo, for
the CLSM measurements.References
1 K. Riehemann, S. W. Schneider, T. A. Luger, B. Godin,
M. Ferrari and H. Fuchs, Angew. Chem., Int. Ed., 2009, 48,
872.
2 N. Sanvicens and M. P. Marco, Trends Biotechnol., 2008, 26,
425.
3 J. Fang, H. Nakamura and H. Maeda, Adv. Drug Delivery Rev.,
2011, 63, 136.
4 K. Miyata, T. Nomoto, H. Takemoto, H. J. Kim,
Y. Matsumoto, M. Oba, N. Nishiyama and K. Kataoka,
Abstr. Pap. Am. Chem. Soc., 2010, 110, 178.
5 Y. Liu, H. Miyoshi and M. Nakamura, Int. J. Cancer, 2007,
120, 2527.
6 X. A. Wu and H. M. Mansour, Int. J. Nanotechnol., 2011, 8,
115.
7 G. Oberdorster, V. Stone and K. Donaldson, Nanotoxicology,
2007, 1, 2.
8 J. A. Kim, C. Aberg, A. Salvati and K. A. Dawson, Nat.
Nanotechnol., 2012, 7, 62.
9 V. Mailander and K. Landfester, Biomacromolecules, 2009, 10,
2379.
10 L. E. Euliss, J. A. DuPont, S. Gratton and J. M. DeSimone,
Chem. Soc. Rev., 2006, 35, 1095.
11 F. Alexis, E. Pridgen, L. K. Molnar and O. C. Farokhzad, Mol.
Pharmacol., 2008, 5, 505.
12 M. Mahmoudi, I. Lynch, M. R. Ejtehadi, M. P. Monopoli,
F. B. Bombelli and S. Laurent, Chem. Rev., 2011, 111, 5610.
13 J. Wang, J. D. Byrne, M. E. Napier and J. M. Desimone, Small,
2011, 7, 1919.
14 G. M. Whitesides, Nat. Biotechnol., 2003, 21, 1161.
15 M. Gaumet, R. Gurny and F. Delie, Eur. J. Pharm. Sci., 2009,
36, 465.
16 J. P. Best, Y. Yan and F. Caruso, Adv. Healthcare Mater., 2012,
1, 35.
17 G. Sahay, D. Y. Alakhova and A. V. Kabanov, J. Controlled
Release, 2010, 145, 182.
18 J. Rejman, V. Oberle, I. S. Zuhorn and D. Hoekstra, Biochem.
J., 2004, 377, 159.Soft Matter, 2013, 9, 99–108 | 107
Soft Matter Paper
D
ow
nl
oa
de
d 
on
 2
4 
F
eb
ru
ar
y 
20
13
P
ub
li
sh
ed
 o
n 
16
 O
ct
ob
er
 2
01
2 
on
 h
tt
p:
//
pu
bs
.r
sc
.o
rg
 | 
do
i:
10
.1
03
9/
C
2S
M
26
92
8G
View Article Online19 H. J. Gao, W. D. Shi and L. B. Freund, Proc. Natl. Acad. Sci.
U. S. A., 2005, 102, 9469.
20 S. Zhang, J. Li, G. Lykotratis, G. Bao and S. Suresh, Adv.
Mater., 2009, 21, 419.
21 S. E. A. Gratton, P. A. Ropp, P. D. Pohlhaus, J. C. Lu,
V. J. Madden, M. E. Napier and J. M. DeSimone, Proc. Natl.
Acad. Sci. U. S. A., 2008, 105, 11613.
22 N. Doshi and S. Mitragotri, PLoS One, 2010, 5, 1.
23 J. Dausend, A. Musyanovych, M. Dass, P. Walther,
H. Schrezenmeier, K. Landfester and V. Mailander,
Macromol. Biosci., 2008, 8, 1135.
24 A. Musyanovych, J. Dausend, M. Dass, P. Walther,
V. Mailaender and K. Landfester, Acta Biomater., 2011, 7,
4160.
25 S. Lorenz, C. P. Hauser, B. Autenrieth, C. K. Weiss,
K. Landfester and V. Mailander, Macromol. Biosci., 2010,
10, 1034.
26 M. Gaumet, R. Gurny and F. Delie, Int. J. Pharm., 2010, 390,
45.
27 W. Jiang, B. Y. S. Kim, J. T. Rutka and W. C. W. Chan, Nat.
Nanotechnol., 2008, 3, 145.
28 Arnida, M. M. Janat-Amsbury, A. Ray, C. M. Peterson and
H. Ghandehari, Eur. J. Pharm. Biopharm., 2011, 77, 417.
29 W.-K. Oh, S. Kim, M. Choi, C. Kim, Y. S. Jeong, B.-R. Cho,
J.-S. Hahn and J. Jang, ACS Nano, 2010, 4, 5301.
30 P. Decuzzi, B. Godin, T. Tanaka, S. Y. Lee, C. Chiappini,
X. Liu and M. Ferrari, J. Controlled Release, 2010, 141, 320.
31 Z. Popovic, W. Liu, V. P. Chauhan, J. Lee, C. Wong,
A. B. Greytak, N. Insin, D. G. Nocera, D. Fukumura,
R. K. Jain and M. G. Bawendi, Angew. Chem., Int. Ed., 2010,
49, 8649.
32 W. Zauner, N. A. Farrow and A. M. R. Haines, J. Controlled
Release, 2001, 71, 39.
33 O. Lunov, T. Syrovets, C. Loos, J. Beil, M. Delecher, K. Tron,
G. U. Nienhaus, A. Musyanovych, V. Mailander,
K. Landfester and T. Simmet, ACS Nano, 2011, 5, 1657.108 | Soft Matter, 2013, 9, 99–10834 C. He, Y. Hu, L. Yin, C. Tang and C. Yin, Biomaterials, 2010,
31, 3657.
35 Y.-L. Chiu, Y.-C. Ho, Y.-M. Chen, S.-F. Peng, C.-J. Ke,
K.-J. Chen, F.-L. Mi and H.-W. Sung, J. Controlled Release,
2010, 146, 152.
36 T.-G. Iversen, T. Skotland and K. Sandvig, Nano Today, 2011,
6, 176.
37 S. K. Sahoo, J. Panyam, S. Prabha and V. Labhasetwar,
J. Controlled Release, 2002, 82, 105.
38 M. Feng and P. Li, Acta Pharm. Sinica, 2005, 40, 893.
39 K. M. Ho, W. Y. Li, C. H. Wong and P. Li, Colloid Polym. Sci.,
2010, 288, 1503.
40 P.-J. Lou, W.-F. Cheng, Y.-C. Chung, C.-Y. Cheng, L.-H. Chiu
and T.-H. Young, J. Biomed. Mater. Res., Part A, 2009, 88, 849.
41 A. Vollrath, D. Pretzel, C. Pietsch, I. Perevyazko, S. Schubert,
G. M. Pavlov and U. S. Schubert, Macromol. Rapid Commun.,
2012, DOI: 10.1002/marc.201200329.
42 J. Pauli, T. Vag, R. Haag, M. Spieles, M. Wenzel, W. A. Kaiser,
U. Resch-Genger and I. Hilger, Eur. J. Med. Chem., 2009, 44,
3496.
43 S. Schubert, J. T. Delaney and U. S. Schubert, So Matter,
2011, 7, 1581.
44 I. Y. Perevyazko, A. Vollrath, S. Hornig, G. M. Pavlov and
U. S. Schubert, J.Polym. Sci., Part A: Polym. Chem., 2010, 48,
3924.
45 J. Brandrup, E. H. Immergut and E. A. Grulke, in Polymer
Handbook, Wiley-Interscience, 4th edn, 1999.
46 A. Palecanda and L. Kobzik, Methods, 2000, 21, 241.
47 C. S. S. R. Kumar, “Nanocomposites, Nanomaterials for Life
Sciences”, in Nanocomposites, Wiley-VCH, 1st edn, 2010,
p. 466.
48 S. Grosse, Y. Aron, G. Thevenot, M. Monsigny and I. Fajac,
J. Controlled Release, 2007, 122, 111.
49 M. Fretz, J. Jin, R. Conibere, N. A. Penning, S. Al-Taei,
G. Storm, S. Futaki, T. Takeuchi, I. Nakase and A. T. Jones,
J. Controlled Release, 2006, 116, 247.This journal is ª The Royal Society of Chemistry 2013
Supporting information 
 
A toolbox of differently sized and labeled PMMA nanoparticles for 
cellular uptake investigations 
Antje Vollrath,a,b Anja Schallon,a,b Christian Pietsch,a,b Stephanie Schubert,b,c Takahiro Nomoto,d Yu 5 
Matsumoto,e Kazunori Kataoka,d,e,f,g* Ulrich S. Schuberta,b* 
Received 20th August 2012, Accepted 25th September 2012 
DOI: 10.1039/c2sm26928g 
 
Notes and references 10 
a Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstrasse 
10, 07743 Jena, Germany; e-mail: ulrich.schubert@uni-jena.de 
b Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, Philosophenweg 7, 07743 Jena, Germany 
c Institute of Pharmacy, Department of Pharmaceutical Technology, Friedrich Schiller University Jena, Otto-Schott-Str. 
41, 07745 Jena, Germany 15 
d Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 
Tokyo 113-8656, Japan 
e Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 
Hongo, Bunkyo-ku, Tokyo 113-0033, Japan 
f Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-20 
ku, Tokyo 113-8656, Japan 
g Center for NanoBio Integration (CNBI), The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan; e-
mail: kataoka@bmw.t.u-tokyo.ac.jp 
 
 25 
Experimental part 
 
Size exclusion chromatography (SEC) 
SEC were recorded using a Shimadzu SCL-10A system controller, a LC-10AD pump, a RID-10A refractive 
index detector and a PSS SDV column with chloroform:triethylamine:2-propanol (94:4:2) as eluent. The 30 
column oven was set to 40 °C with a flow rate of 1 mL · min-1. Furthermore, an Agilent 1200 Series system 
equipped with an isocratic pump G1310A, a G1329A auto sampler, a G1362A refractive index detector and 
both a PSS Gram30 and a PSS Gram1000 column in series was used for SEC with DMA containing 
0.21 mmol LiCl as eluent with a flow rate of 1 mL · min-1 at 40 °C. The systems were calibrated with narrow 
dispersity PMMA standards. 35 
1H NMR and 13C NMR spectroscopy 
Spectra were recorded in CDCl3 on a Bruker Avance 250 MHz or 300 MHz spectrometer. Chemical shifts are 
given in ppm relative to signals from the NMR solvents. 
Electronic Supplementary Material (ESI) for Soft Matter
This journal is © The Royal Society of Chemistry 2012
Elemental analysis (EA) 
EA was carried out at an Elementaranalysator Vario EL III CHNS from Elementar Analysensysteme GmbH, 
Hanau, Germany.  
UV/VIS spectroscopy 
Measurements were performed on a Specord 250 (Analytik Jena GmbH). The emission spectra of the dyes 5 
and polymers were recorded in acetone using the FP 6500 from Jasco. The particle suspensions were 
measured in water.  
Statistical analysis 
Data sets are reported as mean ± SD. To determine the significance of more than two groups of data, ANOVA 
was used.  10 
 
  
Figure S1.  Fluorescence spectra of labeled p(MMA-stat-MAdye) copolymers for the labeled copolymers p(MMA-
stat-MAgreen, orange, red) (A,B,C). (D) SEC traces of the final copolymers measured in DMAc/LiCl using PMMA
standards (dashed line - p(MMA-stat-MAgreen); solid line - p(MMA-stat-MAorange); dotted line - p(MMA-stat-MAred)).
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Figure S2. SEC traces of the final copolymers measured in CHCl3/triethylamine/2-propanol (94:4:2) using RI and UV 
detector (at 590 nm); A: P(MMA-stat-MAgreen) and B: P(MMA-stat-MAred). 
 
Figure S3. Z average values and corresponding PDIP of the p(MMA-stat-MAdye) particles in water titrated against HCl 
and NaOH in a pH range of 4 to 10.  
 
 5 
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Figure S4. Cytotoxicity test of particles at different sizes and labels in L929 cells. The relative viability is expressed as 
percentage to control cells not treated with particles. Data represent mean ± SD, n ≥ 12. 
 
 5 
 
 
 
 
Figure S5. (A) Flow cytometry data show a time-dependent uptake of particles by an increase in SSC. (B) and (C) 10 
Histograms of non treated cells (black) and cells incubated with small (light blue), medium (blue), and large (dark blue) 
NPorange. (B) Increase in fluorescence measured in PI (orange fluorescence) detector. (C) Increase in SSC signal. 
 
 
 15 
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Figure S6. (A) Flow cytometry data show analysis of HeLa cells incubated with particles. Cells were seeded at a density 
of 105 cells · mL-1, after 24 h medium was replaced with OptiMEM. NPorange at different sizes were added at 50 µg · mL-1 5 
each and incubated for 24 h at 4 °C and 37 °C. No uptake at 4 °C was detectable in SSC/FSC or MFI compared to non 
treated cells (p > 0.05). Data represent mean ± SD, n ≥ 3. (B) Confocal microscope images of HeLa cells incubated with 
50 µg · mL-1 of each NP (small NPgreen; medium NPorange; large NPred; 150 nm latexblue) for 18 h in OptiMEM. The scale 
bars indicate 20 µm.  
 10 
 
 
Figure S7: Flow cytometry analysis of HeLa cells incubated with particles. Cells were seeded at a density of 
105 cells · mL-1, after 24 h medium was replaced with OptiMEM supplemented with indicated inhibitors. NPorange at 
different sizes were added at 50 µg · mL-1 each and incubated for 2 h. * indicates statistical significance (t-test, p < 0.05). 15 
 
 
 
(A) (B) 
* * 
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Figure S8: Confocal microscope images of HeLa cells incubated with NPs and inhibitors. Cells were seeded at a density 
of 105 cells · mL-1 for 24 h, medium was replaced with OptiMEM supplemented with chlorpromazine (A) and filipin (B). 
NPs with different sizes and labels (medium NPgreen; large NPred) were added at 50 µg · mL-1 each simultaneously and 
incubated for 5 h. The scale bars indicate 20 µm.  5 
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Christoph Biskup, Ulrich S. Schubert*Chain length, size, composition, surface charge, and other properties of polymeric materials
affect their recognition and uptake by cells and must be optimized to deliver polymers
selectively to their target. However, it is often not possible to precisely modify selected
properties without changing other parameters. To overcome these difficulties, well-defined
poly(pentafluorostyrene)-based polymers are prepared that can be grafted via thiol/para-
fluorine ‘‘click’’ reaction with 1-thio-b-D-glucose and 1-thio-b-D-galactose. Fluorescence micro-
scopy and flow cytometry show that nanoparticles are taken up by HepG2 cells to a higher
degree than the respective water-soluble
polymers, and that internalization of both
galactosylated homo- and nanoprecipi-
tated block copolymers is enhanced.1. Introduction
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www.mbs-journal.debiocapture analysis, in clinical diagnostics, as well as
in targeted drug delivery systems.[3] They represent a
highly versatile tool allowing the precise modification of
their material and biological traits for the synthesis
of various, cell (organ)-targeting systems. Modern poly-
merization techniques enable the adjustment of the
polymeric backbone composition and to control in this
way the solubility behavior of the material as well as
offer the possibility to introduce responsiveness to
stimuli such as a change of temperature or pH values.[4]
Since the carbohydrate units act as ligands for a broad
spectrum of receptors, glycopolymers that actively target
specific cells or organs can be obtained by selecting
appropriate types of sugar moieties.[5] Recognition by
cell type specific receptors is significantly enhanced by
multivalent representation of the carbohydrate ligand
along the polymeric backbone, exploiting the cluster
glycoside effect.[6,7]
By introducing a hydrophobic block into an otherwise
water soluble glycopolymer, materials that aggregate
in water to nanoparticles (NPs) can be created. Their
significance in biomedical fields for the delivery of drugs,
genes as well as imaging agents has been thoroughly
reviewed.[8,9] Adjustment of the formulation conditions
during the preparation of NPs allows a tuning of the
physicochemical properties (size, charge, and surface
properties) over a wide range and in a high-throughput
manner.[10] By fine-tuning ofmacromolecular composition
and processing parameters, biodistribution and pharma-
cokinetics ofparticulate carriers canbemodified to reachan
enhanced accumulation within specific tissues.[11] NPs
have also been used in the treatment of liver diseases.[12]
In order to successfully target liver the particles should
efficiently pass through the liver sinusoidal endo-
thelium.[12] To be biocompatible they should not interact
with serum proteins, avoid mechanical entrapment by the
capillaries in the lung and the body, and evade uptake
by macrophages or provoke immune responses. Glyco-
polymers have revealed some protein repellant properties,
therefore, their interaction with serum can be minimized
and formation of agglomerates that are captured in
capillaries can be avoided.[13,14]
In order to study the interaction between polymers and
cells well-defined and characterized materials are essen-
tial.[15] Chain length, composition, and topology are the
factors that influence the spatial distribution of sugars on
the backbone of the macromolecule, thus, affecting their
recognition by cells.[16] The synthesis of glycopolymers can
be performed via the polymerization of glycosylated
monomers or the grafting of sugar moieties onto a
preformedpolymeric backbone.[17] In this study, the second
approach was applied. Utilizing controlled polymerization
techniques in combination with a highly efficient intro-
duction of carbohydrate moieties, for example, by ‘‘clickwww.MaterialsViews.com
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 2012 WILEY-VCH Verlag Gmbchemistry,’’ ensures a precise control over the structure of
the glycosylated product.[18]
Poly(pentafluorostyrene)-based glycopolymers reveal
high thermal stability (up to 220 8C) and do not decompose
under acidic conditions.[19,20] In addition, the carbohydrate
attachment via S-glycosidic bonds offers resistance toward
enzymatic degradation.[21] Previously, the glucosylated,
fluorescently labeled, water soluble, pentafluorostyrene
(PFS)-based homopolymers were applied as coating for
superparamagnetic iron oxide NPs.[20] It was shown that
they act as an appropriate stabilizing agent without any
cytotoxicity towards 3T3 fibroblasts. Furthermore, films
prepared from the water insoluble polystyrene block
copolymers were proven as synthetic biocompatible coat-
ings on poly(propylene) (PP) substrates for culturing 3T3
fibroblasts andMC3T3-E1 preosteoblasts.[22] Both cell types
showed stable adhesion and proliferation on the glyco-
polymer-coated surfaces.
In order to confirm that the cellular recognition of
carbohydrates, attached via thiol/para-fluorine ‘‘click’’
reaction to poly(pentafluorostyrene) (PPFS), is maintained,
we report in this contribution the interactions of a HepG2
humanhepatocellular carcinoma cell (HCC) linewithwater
soluble homopolymers as well as nanoprecipitated poly-
styrene block copolymers, carrying b-D-thioglucose or b-D-
thiogalactose moieties. Internalization of fluorescently
labeled water soluble compounds and NPs by a hepato-
carcinoma cell line is studied by confocal laser scanning
microscopy (CLSM) as well as flow cytometry (FC).2. Experimental Section
2.1. Materials
Styrene (99%, Aldrich), PFS (99%, Aldrich) and BlocBuilder1
(Arkema) were used as received. 2,3,4,6-Tetra-O-acetyl-1-thio-b-D-
glucopyranose (>99%) was purchased from Glycon Biochem.
GmbH, triethylamine (TEA) from Merck (for synthesis, 99%),
N,N-dimethylformamide (99.5%) and N,N-dimethylacetamide
(DMA) from Fluka and methanol (anhydrous 99.8%) from Aldrich.
2,3,4,6-Tetra-O-acetyl-1-thio-b-D-galactopyranosewas synthesized
as previously reported.[23] Fluorescein 5(6)-isothiocyanate (FITC,
Sigma) and dry N,N-dimethylformamide (DMF) from Fluka
were used for labeling. For nanoprecipitation of the polymers,
distilled water and THF from Aldrich was utilized. Wheat germ
agglutinin (WGA) coupled to Alexa Fluor 633nm, which was
applied to stain the cellmembrane, was purchased fromMolecular
Probes/Invitrogen. For embedding fixed cells Moviol 4–88 solution
containing 625mg 1,4-diazabicyclo-(2,2,2)octane from Roth, was
used.2.2. General Methods and Instrumentation
1Hand13CNMRspectrawere recordedonaBrukerAvance300MHz
spectrometer, and 19F NMR spectra on a Bruker Avance 200MHz2, 12, 1190–1199
H & Co. KGaA, Weinheim 1191
1192
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K. Babiuch et al.spectrometer in deuterated DMF. The chemical shifts were
calibrated with respect to residual DMF peaks. Size-exclusion
chromatography (SEC) was measured on an Agilent Technologies
1200 Series SEC system equipped with a G131A isocratic pump, a
G1329Aautosampler, a G1362A refractive index detector, and both
a PSS Gram 30 and a PSS Gram 1000 columns in series. 2.1% LiCl
solution in DMA was used as eluent at 1mL min1 flow rate at a
column oven temperature of 40 8C. The reported number-average
molar masses were determined by using polystyrene standards.
Thermogravimetric analyses were performed on a Netzsch TG 209
F1 Iriswith 10 8Cmin1 heating rates fromroomtemperatureup to
900 8C under nitrogen flow. Dynamic light scattering measure-
ments (DLS) were performed on a Zetasizer Nano ZS device from
Malvern Instruments (Worcestershire, UK). In these measure-
ments, a 633nm He/Ne laser beam was used and scattered light
was detected at an angle of 1738. Scanning electron microscopy
(SEM) images were recorded on a LEO-1450 VP SEM (Leo,
Oberkochen, Germany), operating at 10 kV. For platinum coating
of the sample a BAL-TEC SCD005 sputtering device (Balzers,
Lichtenstein) was used, applying a current of 60mA for 80 s.
Cryo-TEM images were recorded using a Technai G2 Sphera (FEI)
transmission electron microscope (TEM) with an acceleration
voltage of 200kV. Fluorescence excitation and emission spectra
of the polymers and NPs were obtained with a Cary Eclipse
fluorescence spectrofluorometer (Varian, Darmstadt, Germany)
using Hellma quartz cuvettes. The slit width of the emission and
excitation monochromator was adjusted such that the resulting
resolution was 5nm. Excitation spectra were recorded at an
emission wavelength of 515nm. The emission spectra were
measuredbyexciting thepolymersat488nm.Fluorescence images
were obtainedwith confocal laser-scanningmicroscopes (LSM 510
MetaandLSM710, Zeiss, Jena, Germany), usinga Plan-Apochromat
63 oil immersion objective (NA 1.4, Zeiss) and a C-Apochromat
40 water immersion objective (NA 1.2, Zeiss). FITC was excited
with the 488nm line of the argon laser. The emitted fluorescence
was collected with a 505nm longpass filter (LSM510) or with the
built-in grating in the 505–550nmwavelength range (LSM710). To
excite theWGAAlexaFluor633membranestain, theHe/Ne633nm
laserwasused. Fluorescencewasrecorded in the640–700nmrange
using the built-in grating (LSM710). To allow a comparison, all
images of a series were captured under identical conditions and
instrument settings (laser power, pinhole diameter and detector
gain). Quantitative image analysis was performed on grayscale
converted images using the ImageJ software. FC was measured
on a Beckmann Coulter Cytomics FC-500 equipped with Uniphase
Argon ion laser, 488nm, 20mW output and analyzed with the
Cytomics CXP software.2.3. Glycopolymer Synthesis
The glycopolymers were synthesized as previously reported.[22]
Briefly, acetylated carbohydrate thiols were grafted onto a PPFS
or a polystyrene-block-PPFS backbones, which were prepared by
nitroxide-mediated, living, radical polymerization.[19] The reaction
was carried out in DMF in presence of TEA yielding polymers
with high degrees of functionalization (90% of substitution). The
glycopolymers were obtained by subsequent deprotection of the
acetyl groups, using sodium methoxide as base.Macromol. Biosci. 201
 2012 WILEY-VCH Verlag Gmb2.4. Glycopolymer Labeling
Labeling was achieved by an analogous method to the previously
reported for glucosylated homopolymers.[20] In an oven-dried,
round bottom flask, glycopolymer and FITC (0.5mol equiv. per
polymer chain) were weighed in and dried for 1 h under vacuum.
DMF (10mL)was added, and the sealedmixturewas stirred for 24h
in the dark. The reaction was quenched by dropping the mixture
into ethanol. The precipitated polymers were centrifuged and
washed at least six times with ethanol until the fluorescence in
the supernatant disappeared completely as shown by thin-layer
chromatography (TLC) monitoring.2.5. Nanoprecipitation Procedure
8mg of the labeled polystyrene block glycopolymers were
dissolved in a mixture of 1mL THF and 1mL of distilled water.
After 10min stirring, 7mL water were added dropwise to cause
nanoprecipitation of the materials. THF was evaporated at 60 8C
under reduced pressure and the solution was sterile filtered using
a 2mm filter.2.6. Characterization of Nanoparticles
2.6.1. DLS Characterization
Dynamic light scattering was used to determine the size and zeta
potentials of the particles. For this purpose, 20mL of the suspension
were added to 1mL of demineralized, filtered water (pH¼ 6.0) and
this solution was transferred into a polycarbonate zeta cell. For
size measurements, three runs were applied for 150 s, and for the
zeta potential three runs for 10 s.
2.6.2. SEM Characterization
For the SEM measurements one droplet (15–20mL) of the
suspension was placed on a mica surface and lyophilized for 3 h.
Finally, the sample was sputtered with platinum applying a
current of 60mA for 80 s.
2.6.3. Cryo-TEM Characterization
Samples for cryo-TEM were prepared using a FEI Vitrobot system.
3mL of the sample solution were transferred onto a Quantifoil
(R2/2) grid, and blotting was performed at 3mm and 3.5 s of
blotting time. Samples were rapidly transferred into liquid ethane
and stored in liquid nitrogen until the measurements were
performed using a Gatan cryo holder.2.7. Measurements of Fluorescence Spectra
To measure the fluorescence by the spectrofluorometer (Varian,
Darmstadt, Germany), the water soluble homopolymers were
dissolved in phosphate-buffered saline (PBS), pH¼ 7.4, at the
indicated concentrations. The aqueous suspensions of the NPs,
obtained from the block copolymers, were diluted to the indicated
concentrations with PBS.2, 12, 1190–1199
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2.8.1. Cell Culture
The human hepatocarcinoma cell line HepG2was purchased from
theGermanCollection ofMicroorganisms andCell Cultures (DSMZ,
Braunschweig, Germany). For uptake studies, 8104 cells were
initially seeded into 6 well plates in 4mL of RPMI medium
supplemented with 10% fetal calf serum (FCS), 100U mL1
penicillin, and 100mg mL1 streptomycin (all components from
Biochrom, Berlin, Germany). To assess the polymer uptake in
adherent HepG2 cell monolayers by CLSM, cells were seeded on
sterileglasscoverslips.Thecellsweregrownat37 8Cinahumidified
atmosphere containing 5 vol% CO2 for 48h until 75% confluency
was reached and then subjected to incubation with the polymers.
2.8.2. Incubation of Cells With Polymers
The cells were incubated separately with different concentrations
(0.10, 1.00, and 10.00mg mL1, respectively) of the sugar contain-
ing polymers for 24 h at 37 8C under 5% CO2 atmosphere. Control
cells were incubated with fresh culture medium. After incubation,
the solutions were aspirated from the wells and any unbound
conjugates were removed by washing the cell layer three times
with PBS. Subsequently, the cells were subjected to further
treatment for CLSM and FC analysis.
2.8.3. Analysis of Glycopolymer and Nanoparticle Uptake
by CLSM
After incubation with the sugar containing polymers, the cells
were fixed directly onto the glass coverslips for 10min at room
temperature using 4% paraformaldehyde (PFA) dissolved in PBS
and subsequently washed twice with PBS. The glass coverslips
were mounted on glass slides using 25mL Moviol 4-88 solution
containing 625mg 1,4-diazabicyclo-(2,2,2)octane. After 24h CLSM
images were recorded using a Carl Zeiss 510. Quantification of
the cell-associated fluorescence signal was performed using 8 bit,
grayscale-converted images and ImageJ software. The cell bound-
aries were identified by the user and the average fluorescence
intensity per pixel was obtained. Values from at least 100 cells
were averaged.
2.8.4. Proof of Glycopolymer and Nanoparticle
Internalization by CLSM
To show that the fluorescence resulted from internalized polymers
and not frommaterials bound to the cell membrane, an aliquot of
enzymatically detachedandfixed cellswas stained for 10minwith
a solution of 5mg WGA coupled to Alexa Fluor 633nm in 1mL
phosphate-bufferedsaline (PBS). Thecellswere thencentrifugedfor
5min at 1500 rpm and resuspended in 400mL PBS. The suspension
was transferred into a custom built microscope chamber and
allowed to sediment. CLSM images were recorded on a Carl Zeiss
710. The emitted fluorescence was collected in the 505–550nm
wavelength range.
2.8.5. FC Analysis
After detaching the adherent cells by trypsin treatment, the cell
suspension was washed twice with PBS supplemented with 10%www.MaterialsViews.com
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labeled with a propidium iodide (PI) staining for 15min at
room temperature using 100mg PI mL1 PBS. The cells were then
incubated with 4% PFA dissolved in PBS for 10min at room
temperature and subsequently washed twice with PBS. A total of
2104 cells were resuspended and subjected to FC using gates of
forward and side scatters to exclude debris and cell aggregates.3. Results and Discussion
3.1. Glycopolymer Synthesis and Labeling
Theglycopolymersweresynthesizedaspreviously reported
(Scheme 1).[22] In brief, glucosylated (hGlc) and galacto-
sylated (hGal) homopolymers as well as the respective
polystyrene block copolymers, bGlc and bGal, were
obtained by post-polymerization modification using
the thiol/para-fluorine ‘‘click’’ reaction to graft acetylated
1-thio-b-D-glucopyranose and 1-thio-b-D-galactopyranose
onto a homopolymer of PFS as well as onto a block
copolymer of styrene and PFS (PS-b-PFS). Subsequent
deprotection of the carbohydrate moieties yielded well-
defined, glucose- or galactose-modified polymers. The
obtained glycopolymers were stable up to 220 8C, as
confirmed by thermogravimetric analysis (see the Support-
ing Information). The post-polymerization modification
approach, unlike the polymerization of glycosylated
monomers, ensures that the materials investigated in this
study are of the same degree of polymerization, since the
grafting stepwasperformedon the samebatchesof PFSand
PS-b-PFS. In addition, the monomers used in the backbone
synthesis are commercially available and thoroughly
studied. Consequently, the synthetic problems connected
with polymerization of unknown, sterically hindered
carbohydrate containing units can be avoided.[24] The
lengths of the obtained starting polymerswere determined
from 1H NMR spectra, by integration of the signals derived
from the initiator and the backbone (see Supporting
Information) and SEC measurements. Furthermore, this
method reduces the practical complications connected
with the characterization of glycopolymers caused by
the bulky carbohydrate moieties, which result in hydro-
dynamic diameter values that significantly deviate from
the commonly applied SEC standard polymers (Table 1). In
order to precisely determine the amount of attached
carbohydrate moieties, after thiol/para-fluorine ‘‘click’’
reaction, 19F NMR spectroscopy was used (Supporting
Information).[19] The deprotected glycopolymers exhibited
narrow molar mass distributions and carried equal
amounts of carbohydrate units. Synthesis and character-
ization details for the obtained glycopolymers can be
found in ref. [22] as well as in the Supporting Information
(1H, 13C, and 19F NMR spectroscopy).2, 12, 1190–1199
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Scheme 1. Schematic representation of the synthesis of the glucosylated and galactosylated homo and block copolymers.
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K. Babiuch et al.Subsequently, the glycopolymers were labeled with
FITC, as reported previously.[20] In order to ensure that the
bioactivity of the carbohydratemoieties is maintained and
the label is equally distributed, 0.5 equivalents of FITC
per one polymeric chain were used for the labeling. SEC
analysesof thefluorescentpolymers (Figure1)didnot show
any significant differences in the molar masses of the
respective Glc and Gal derivatives. The low polydispersity
index values were maintained for the labeled glycopoly-
mers, indicating no coupling reactions of the polymeric
backbone or its decomposition. Furthermore, the SEC traces
showthat the labeledhomopolymersandblock copolymers
have the same molar masses and distributions as the
respective non-labeled substrates. Successful introduction
of the fluorescent label was further confirmed by the
fluorescencespectra (Figure2). For thesameconcentrations,
the fluorescence of glucosylated polymer was 1.4 timesTable 1. Selected characterization data for the obtained glycopolyme
Name Structure Carbohydrate
amounta)
[mol%]
PFS PPFS35 0
hGlc PTFSGlcOH 100
hGal PTFSGalOH 99
PS-b-PFS PS54-b-PPFS33 0
bGlc PS-b-PTFSGlcOH 90
bGal PS-b-PTFSGalOH 94
a)Calculated from 19F NMR spectroscopy; b)Calculated according to poly
Macromol. Biosci. 201
 2012 WILEY-VCH Verlag Gmbhigher than for the galactosylated one. This can be
attributed to different amounts of FITC attached to the
glycopolymers and has to be taken into account when
interpreting the FC and CLSM measurements.3.2. Preparation and Characterization of
Nanoparticles
For the preparation of NPs the nanoprecipitation technique
was chosen. The process of NP formation by solvent
displacement method, i.e., mixing of the polymer solution
with an anti-solvent that is miscible with the solvent, has
already been applied for various synthetic polymers and
biopolymers.[25–28] Important advantages are the fast
and easy preparation and no necessity of surfactants. In
particular, the absence of surface active agents like
poly(vinyl alcohol) is essential for this study, as theirrs.
Mn theo
[g mol1]
Mn, SEC
b)
[g mol1]
Mw=Mn
b)
7200 5700 1.06
13 300 20 600 1.10
13 200 19 300 1.06
12 400 14 300 1.16
17 600 40 000 1.13
17 900 39 900 1.10
styrene standards (PSS) using 2.1% LiCl solution in DMA as eluent.
2, 12, 1190–1199
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Figure 1.Normalized SEC traces of the FITC-labeled glycopolymers
using 2.1% LiCl solution in DMA as eluent.
Figure 3. Volume size distributions of the fluorescent glycosylated
nanoparticles, obtained by DLS.
Uptake of Well-Defined, Highly Glycosylated, Pentafluorostyrene-Based . . .
www.mbs-journal.depresence may affect the cell uptake of the particles.[29] The
particles for the cell study were obtained by dissolving
the amphiphilic block glycopolymers in a water/THF
mixture (1:1) and subsequent precipitation by successive
dropwise addition of water to this solution (the homo-
polymers were water soluble and could, therefore, not be
nanoprecipitated). THF provides good solubility for the PS
block of themacromolecule andwater is a good solvent for
the glycosylated part, as shown for the homo-glycopoly-
mers. Therefore, this solvent mixture gave visibly clear
solutions of the amphiphilic block copolymers. The further
addition of water caused the collapse of the polystyrene
block, because of the water insolubility, and self-assembly
of these hydrophobic parts into NPs. The resulting NP
suspensions were characterized by DLS and the measure-
ment of the zeta potential. The volume size distributions
obtained by DLS are displayed in Figure 3. Both, glucosy-Figure 2. Fluorescence emission spectra of the FITC-labeled, water
soluble glycopolymers.
www.MaterialsViews.com
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 2012 WILEY-VCH Verlag Gmblated and galactosylated particles revealed the same
hydrodynamic diameters of 20nm. The zeta potentials of
the particle suspensions (pH¼ 6) were determined to be
15mV for bGlcNPs and30mV for bGalNPs. The negative
zeta potential values can be attributed to the presence of
electron rich hydroxyl groups of the sugar units as well as
fluorine atoms, since the NPs prepared from unmodified,
hydrophobic PS-b-PFS also revealed strongly negative
(below 30mV) values.[19] Apart from DLS investigations,
the particles were characterized by electron microscopy
techniques such as SEM and cryo-TEM (Figure 4). In the
displayed images very small and spherical particles with
diameters of 15–40nm are visible, confirming the DLS
results. The apparent larger sizes for glucosylated NPs
result from the sample preparation technique and particle
agglomeration during the drying process. Additional SEM
images can be found in Supporting Information (Figure S7).
In order to prove the long-term stability of the particles the
suspensions were stored at 5 8C in the dark for twelve
months. DLSmeasurements of these particles did not show
any significant change in the size distribution. Further-
more, no aggregation or sedimentation of the particles
was observed, confirming a very good stability of these
glycosylated NPs in suspension. It is very important that
the average diameters and size distributions are similar for
bothglycopolymers, in order to excludeany influenceof the
particle size on the cellular uptake.[30] Moreover, the shape
of the particle as well as the morphology also affects its
uptake.[31] The investigated NPs were all spherical with
smooth surfaces; hence, the differences in their uptake can
only result from the type of attached carbohydrate. The
fluorescence of the particles at different concentrations in
PBSwasexamined (Figure5). Thefluorescence intensities of
the glucosylated NPs were, similarly to the water soluble
glycopolymers, approximately 1.4-fold higher than of
the galactose-functionalized NPs (also in this case the2, 12, 1190–1199
H & Co. KGaA, Weinheim 1195
Figure 4. SEM (left) and cryo-TEM (right) images of the glycosylated nanoparticles, which
reveal small and spherical particles with sizes between 15 and 40nm.
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K. Babiuch et al.differencehas tobe taken intoaccountwhenevaluating the
results of uptake studies performed by CLSM and FC).3.3. Investigation of PFS-Based Glycopolymer Uptake
by HepG2 Cells
3.3.1. CLSM Investigation of Uptake Dependence on
Polymer Concentration and Type of Carbohydrate
Hepatocellular carcinoma HepG2 cells were seeded on
sterile glass coverslips and incubated with the sugar
containing polymers in order to investigate their interac-
tionasdescribed in theexperimental section. Subsequently,Figure 5. Fluorescence emission spectra of the FITC-labeled,
glucosylated, and galactosylated nanoparticles.
Macromol. Biosci. 2012, 12, 1190–1199
 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinhthe cells were fixed, using PFA, and the
coverslips were mounted onto glass
slides formicroscopyobservations. Repre-
sentative CLSM micrographs of the cells
are shown in Figure 6, left. The results
reveal an increase of intracellular fluor-
escence after incubation with both,
water soluble polymers and polymeric
NPs in a concentration-dependent
manner, confirming the uptake of the
polymers by the HepG2 cells. To quantify
the uptake, images were subjected
to quantitative analysis using ImageJ
software determining the mean fluor-
escence intensity per cell. At a concentra-
tion of 1mg mL1 a clear increase of
the fluorescence was observed for the
internalized galactosylated, but not for
the glucosylated materials (Figure 6,
right). At higher concentrations the fluor-
escence resulting from the internalized
NPs was much higher than from the
water soluble homo-glycopolymers, butstill galactosylated compounds were taken up to a higher
degree than glucosylated ones.
3.3.2. Proof of Internalization by CLSM Investigations
To confirmthat theparticles aswell as the soluble polymers
did not adsorb to the outer leaflet of the plasmamembrane
butwere truly internalized by theHepG2 cells, an aliquot of
the cells was investigated by CLSM (Figure 7). To delineate
the cell membrane, cells were stained with WGA con-
jugated to Alexa Fluor 633. WGA is a lectin (carbohydrate-
binding protein), which selectively binds to the glycocalyx
of cellular membranes. The overlay of the fluorescence
originating from the labeled polymers (green) and the red
stained membrane clearly shows that all particles are
located inside the cells. This is further confirmedby z-stacks
anda3Dreconstructionof thecells (seemovie inSupporting
Information). Both water-soluble polymers and NPs were
accumulated in HepG2 cells.
3.3.3. Flow Cytometric Investigations of the Uptake
The uptake of the fluorescent labeled glycopolymeres was
further quantified by FC measurements. For this purpose,
cells were incubated with different concentrations (0.10,
1.00, and10.00mg mL1)of thematerials for24h.Unbound
polymers were removed by washing with PBS, and the
cells were trypsinized, fixed with PFA and subjected to
FC analysis. The mean fluorescence intensities per cells
increased with increasing concentrations of the com-
pounds. Since the intrinsic fluorescence intensities of the
glucosylated compounds were 1.4 times higher than of
the galactosylated materials (Figure 2 and 5), the resultseim www.MaterialsViews.com
Figure 6. Confocal fluorescence microscopy images (left) of HepG2 cells after incubation
with the water soluble polymers (hGlc and hGal) and polymeric nanoparticles (bGlcNP
and bGalNP) for 24 h at 37 8C (left). Cells incubated with polymer free culture medium
served as control. All images were obtained with identical instrument settings. Results
from quantitative image analysis (right) of confocal fluorescence micrographs (left).
Values for the mean fluorescence intensity per a HepG2 cell were assessed from
grayscale-converted images using ImageJ software. A color version of this figure is
available in the Supporting Information.
Uptake of Well-Defined, Highly Glycosylated, Pentafluorostyrene-Based . . .
www.mbs-journal.dewere normalized by this factor in order to enable an
accurate comparison of the carbohydrate-specific uptake.
Thehistogramplots (Figure8) clearly showaconcentration-
dependent increase of the fluorescence intensity distribu-
tions (observable as a shift to the right) for all types of
the polymers from a concentration of 1.0–10.0mg mL1.
The results, depicted in the bar chart, for the mean
fluorescence intensities of the analyzed cell populationsFigure 7. Representative CLSM micrographs of cells incubated
with 10mg mL1 of polymeric nanoparticles from bGal for 24 h
at 37 8C. The cells were detached and stained with WGA con-
jugated to Alexa Fluor 633 to mark the plasma membrane.
Fluorescence originating from the labeled polymers was collected
in the FITC channel (1st column) whereas fluorescence originating
from the plasma membrane was collected in the Alexa 633
channel (2nd column). The overlay of both channels (3rd column)
clearly shows that the particles are located inside the cells. A color
version of this figure is available in the Supporting Information.
www.MaterialsViews.com
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 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinhdistinctly reveal the preferential uptake
of the galactosylated compounds and
confirm the results obtained from the
image analysis of the CLSM micrographs
(Figure 6). Furthermore, the fluorescence
of the internalizedglucose- andgalactose-
modified particles at concentration of
10mg mL1 was much higher than of
the respective homopolymers pointing to
some additional uptake mechanism.
Additionally, FC investigation of cellu-
lar membrane integrity with PI exclusion
assays showed that the analyzed materi-
als did not affect the cell membrane
integrity confirming the findings from
CLSM experiments (see Supporting Infor-
mation).[22]
The obtained results confirm the
enhanced internalization of galactosy-
lated PFS-based polymers and NPs. They
are in good correlation with the previous
studies, where both galactosylated and
glucosylated materials show differences
in their uptake via the asialoglycoproteinreceptors (ASGPR).[32] Poly(N-p-vinylbenzyl-O-b-D-galacto-
pyranosyl-[1!4]-D-gluconamide) (PVLA) was previously
employed as amodel ligand for ASGPR in order to examine
theeffectof thedensityof thecarbohydratesattachedto the
polymeric backbone on binding and internalization of
fluorescent polystyrene NPs by hepatocytes.[33] The uptake
of particles (500nm), coated with various concentrations
of water soluble PVLA and non-galactosylated poly(vinyl-
benzyl-D-gluconamide), by rat hepatocytes,was found tobe
proportional to the galactose content.
These findings can be exploited to target liver cells
selectively. So far, amphiphilic, galactose-functionalized
polycarbonate block copolymers, prepared by ring opening
polymerization, have been already employed to prepare
doxorubicin-loadedmicelles with diameters below 100nm
and narrow size distributions.[34] The micelles were taken
up selectively by an ASGPR-expressing HepG2HCC cell line
and had a significantly higher cytotoxicity of the drug
as compared to the ASGPR-negative HEK293 cell line.
Herein, the fluorescence intensities of hGal and bGalNP,
internalized by the HepG2 cells, are distinctly higher, at
the concentration of 1.0mg mL1, than the cellular
autofluorescence (control) as well as the fluorescence of
cells cultured with the glucosylated materials (Figure 6).
Therefore, the galactosyl moieties attached to PFS back-
bones via thiol-p-fluorine ‘‘click’’ reaction retain their
hepatocyte-uptake enhancing properties.
On the other hand, the uptake of glucosylated polymers
and NPs was higher than expected, when comparing with
similar glucose-modified glycopolymers having a hydro-eim 1197
Figure 8. Histogram plots from flow cytometry on the uptake of water soluble polymers
(hGlc and hGal) and polymeric nanoparticles (bGlcNP and bGalNP) by HepG2 cells after
24 h incubation at 37 8C. Cells incubated with polymer free culture medium served as
control. The fluorescence intensity on the x-axis is plotted against the number of events
on the y-axis. A shift of the histogram toward the right side demonstrates an increasing
amount of FITC-labeled polymers/nanoparticles attached to or taken up by the cells. The
bar charts depict the results for the mean fluorescence intensities, obtained from flow
cytometry of the analyzed cell populations. Various polymer concentrations, physical
forms (water soluble: hGlc and hGal; nanoparticles: bGlcNP and bGalNP), as well as
carbohydrate moieties, are taken up to a different degree.
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K. Babiuch et al.phobic polystyryl backbone, namely poly[N-p-vinylbenzyl-
O-a-D-glucopyranosyl-[1!4]-D-gluconamide] (PVMA) and
poly[3-N-p-vinyl-benzyl-D-glucose] (PVG).[35] These poly-
mers carry glucose substituted at C-1 and C-3, respectively,
and did not show any clear interaction with hepatocytes.Macromol. Biosci. 2012, 12, 1190–1199
 2012 WILEY-VCH Verlag GmbH & Co. KGaA, WeinhHowever, hepatocytes took up the poly-
mer with the carbohydrate attached
via C6 (poly[N-p-vinylbenzyl-D-glucuron-
amide], PV6Gna) but to a lower degree
than galactosylated PVLA.[36] It has to be
taken into account that not only the type
of sugarbutalso the rotational restriction,
stiffness and hydrophobicity can influ-
ence the glycopolymer/hepatocyte inter-
actions, as was shown for chitosan
beads functionalized with lactonamide
units.[37] Our observation concerning the
higher uptake (at the concentration of
10mg mL1) of nanoparticulate materi-
als, as compared to the soluble homo-
polymers, is in line with studies on the
interactionofpoly(ethyleneglycol)-block-
poly(e-caprolactone) block copolymeric
micelles with HepG2. They have shown
that even non-targeted particulated
materials were taken up by hepatocellu-
lar carcinoma cells following 24h of
incubation.[38] Thisuptakewasattributed
to unspecific interactions and non-recep-
tor-mediated endocytosis. The ratio
between internalized non-glycosylated
and galactosylated micelles, in ref.,[38]
corresponds well to the ratio between
bGlcNPs and bGalNPs taken up by the
cells in this work.4. Conclusion
Throughnanoprecipitationofwater-inso-
luble galactosylated or glucose-modified
compounds NPs of the same sizes and
similar morphologies were obtained. As
a consequence, an influence of the poly-
meric architecture as well as of the
particle diameter and shape on the
interaction with cells could be excluded.
Fluorescent labeling of the water soluble
polymers and particles facilitated the use
of CLSM and FC to confirm the carbohy-
drate specific uptake of the water soluble
galactosylated polymer as well as of the
NPs prepared from galactose-modified
polystyrene block copolymer and showthat internalization of galactosylated homo- and nano-
precipitated block copolymers is enhanced as compared to
the respective glucose substituted compounds. NPs are
taken up to a higher degree than respective water soluble
polymers.Allmaterialsdidnotshowanyacutecytotoxicity.eim www.MaterialsViews.com
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www.mbs-journal.deSince these results revealed that the preferential inter-
nalization of b-D-galactose by HepG2 cells is maintained
upon grafting onto PPFS-based polymers, these glycopoly-
mers can find a multitude of potential applications in, for
example, liver tumor-targetedchemotherapy, imaging, and
as extracellular matrices for hepatocytes. Additionally, the
PPFS-based glycopolymers can be modified with other
thiolated glycosides for lectin-mediated drug targeting as
reported for other classes of carbohydrate-containing
polymers.Acknowledgements: We thank the Thuringian Ministry for
Education, Science, and Culture (grant #B514-09051, NanoCon-
Sens) and the Dutch Polymer Institute (DPI, Technologic Area HTE)
for funding and Dr. Stephanie Hoeppener for the cryo-TEM
measurements.
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1. Selected data of the polymer characterization 
1.1.  
 
Figure S1. Details from the 1H NMR spectra (300 MHz, DMF-d7) of the galactosylated 
homopolymers (left) and the galactosylated block copolymers (right). 
 
 
Figure S2. 1H NMR spectra (300 MHz, DMF-d 7) of the glu cosylated and deacetylated 
homopolymers (left) and block copolymers (right). 
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1.2. 
 
Figure S3. Details from the 13C NMR spectra (300 MHz, DMF-d7) of the  galactosylated 
homopolymers (left) and block copolymers (right). 
1.3. 
 
Figure S4. 19F NMR spect ra (200 MH z, DMF-d7) of the galactosylated and dea cetylated 
homopolymers (left) and block copolymers (right). 
 
    
10.1002/mabi.201200024 - 4 - 
 
Figure S5. 19F NMR spect ra (200 MHz, DMF-d7) of the  glucosylated and dea cetylated 
homopolymers (left) and block copolymers (right). 
 
1.4. 
 
Figure S6. Thermogravimetric analysis of glucose-carrying block copolymers. 
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2. Additional SEM images of the obtained particles 
Block Glc NP:  
Block Gal NP:  
Figure S7. SEM images of the obtained nanoparticles. 
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3. Flow cytometric analysis of the HepG2 viability (PI exclusion) 
 
Figure S8: Flow cytometry analysis demonstrated an exclusion of propidium  iodide as 
exemplarily shown for cells incubated with FITC labeled bGalNPs (10 µg/mL). Fluorescence 
channel FL1 detects the FITC labeled cells (98.8%), whereas FL3 determines dead cells after 
inclusion of PI staining (0.7%). 
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4.  
Movie S1: Stack of CLSM micrographs of a cell incubated with 10 µg/mL of poly meric 
nanoparticles from bGal for 24 h at 37 °C. The cells were stained with wheat germ agglutinin 
(WGA) conjugated to A lexa Fluor 633 to m ark the plasma membrane. Fluorescence 
originating from the labeled polymers was collected in the FITC channel and is displayed in 
green color, whereas fluorescence originating from the plasma membrane was collected in the 
Alexa 633 channel and is displayed in red color. The pinhole w as adjusted such that each 
cross section has a thickness of 1 µm. The movie shows an overlay of both channels and starts 
with a confocal cross section close to the bottom of the cell. The focus is then shifted by steps 
of 0.5 µm to the top of the ce ll, and the re spective cross sections are s hown. The z-stack 
shows that almost all partic les (except for thos e sticking to the surface of the c overslip) are 
located inside the cells. Only few particles are sticking to the outer surface of the membrane. 
((Typesetter: Please insert movie mabi.201200024_Movie_S1.avi here)) 
 
5. Color versions of Figures 6 and 7 
 
Figure S9: Color version of Figure 6. 
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Figure S10: Color version of Figure 7. 
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Dextran-graft-linear poly(ethylene imine)s for gene delivery: 
Influence of linking strategies on physicochemical and biological 
properties 
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Abstract 
Two low molar mass linear poly(ethylene imine)s (lPEI) with 20 and 40 repeating units were synthesized by acidic hydrolysis of 
poly(2-ethyl-2-oxazoline) and grafted onto dextran via different synthesis routes aiming at the evaluation of structure-property 
relationships of dextran-graft-linear poly(ethylene imine) (dex-g-lPEI) conjugates for gene delivery applications. Using reductive 
amination of oxidized dextran and 1-ethyl-3-(3-dimethylamino-propyl) carbodiimide (EDC) promoted coupling of lPEI to 
carboxymethylated dextran resulted in various derivatives with altered linkers. Beside the molar mass of lPEIs and the linker unit, 
also the degree of functional groups (CHO, COOH) per anhydroglucose unit within the dextran precursors and the content of lPEI 
in the final polymeric vectors were varied. The synthesized dextran modifications were characterized by an enhanced 
complexation and stabilization of DNA against enzymatic degradation with increasing DS and molar mass of lPEI as well as with 
rising polymer nitrogen to DNA phosphate (N/P) ratio. All derivatives formed complexes with DNA of about 100 nm in highly 
purified water and revealed positive zeta potentials. The transfection efficiency of dex-g-lPEIs was increased compared to free 
lPEI and revealed a dependency of the used linking strategy as determined by luciferase assay using chinese hamster ovary (CHO-
) K1 cells. Whereas in a cell viability assay all complexes of DNA and dex-g-lPEIs were found to be nontoxic, for free polymers 
the synthesis route revealed a strong impact on the aggregation of red blood cells. In conclusion, the linking strategy of lPEI to 
dextran has a high influence on physicochemical characteristics of DNA/polymer complexes, the biocompatibility as well as on 
the resulting transfection properties. 
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Introduction  
 
Dextrans, natural hydrophilic, biodegradable polysaccharides 
based of mainly α-1-6-linked D-glucose units, have widely 
been used in medical, pharmaceutical and drug delivery 
applications.1 More than 50 years of clinical use provided an 
impressive proof of their safety in parenteral and oral 
administration, e.g. as lubricant in ophthalmic solutions, 
creams, and ointments or as coating material for diagnostic 
nanoparticles.2, 3 Additionally, many modern drug delivery 
systems containing dextran are under preclinical development, 
for instance bioadhesive microspheres, nanoparticles or 
hydrogels.4 In the field of gene therapy, dextran itself has not 
been found to be suitable as non-viral vector system due to the 
missing positive charge that is required for the electrostatic 
interaction with negatively charged nucleic acids. 
Consequently, several attempts have been made to selectively 
modify dextran to introduce cationic moieties such as 
diethylaminoethyl,5 spermine,6, 7 protamine,8 poly(L-lysine),9 
poly(ethylene imine) (PEI)10-14 or 2,3-epoxypropyl-
trimethylammonium chloride15 in order to improve the 
formation of polyelectrolyte complexes. PEI was thereby one 
of the most favored cationic polymers applied for conjugation 
to dextran owing to its excellent transfection efficiency.  
Several studies have evaluated dextran-graft-poly(ethylene 
imine) (dex-g-PEI) conjugates as promising gene delivery 
systems in recent years. Three different strategies for 
conjugation were followed: (i) Low molar mass dextrans 
(1,500 to 10,000 g · mol-1) were covalently grafted onto high 
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molar mass PEIs (e.g. 25,000 g · mol-1 branched or linear PEI) 
in order to mask the cationic charge of PEI, decrease its 
cytotoxicity and enhance the complex stability.10, 16 The 
biocompatible, uncharged dextran decreased the charge effects 
of salts and proteins present in the extracellular environment as 
also observed for stealth polymers like poly(ethylene glycol) 
(PEG).17 Depending on the molar mass of dextran and the 
degree of grafting used, transfection efficiencies of dex-g-PEI 
were reported to be comparable or lower than that of the 
unmodified high molar mass PEI. This finding was ascribed to 
a steric hindrance of protonation of PEI after conjugation and 
decreased buffering capacity dependent on the molar mass of 
the dextran.18 (ii) The grafting of branched PEIs (bPEI) of low 
molar masses (800 to 2,000 g · mol-1) onto large dextran 
backbones (15,000 to 200,000 g · mol-1) was investigated. Due 
to the conjugation the cytotoxicity was lower compared to high 
molar mass bPEI, whereas the transfection could be enhanced 
compared to 25,000 g · mol-1 bPEI by increasing the degree of 
substitution (DS) of low molar mass bPEIs conjugated to 
dextran or the N/P ratio of DNA/dextran-g-bPEI complexes or 
using serum containing media.11, 12, 14 (iii) Dextran 
nanoparticles were formed by crosslinking of 40,000 g · mol-1 
dextran and grafted in different extents with 25,000 g· mol-1 
bPEI by reductive amination. In this way, the steric hindrance 
of the dextran molecules to form stable complexes of PEI and 
plasmid could be decreased and the transgene expression as 
well as cell viability were enhanced compared to unconjugated 
25,000 g · mol-1 bPEI and lipofectamine.19 
Several linking strategies have been reported to covalently bind 
PEI to dextrans. A commonly used approach is the conjugation 
by primary amines, for which the following strategies were 
described: Tseng et al. synthesized cationized dextrans by 
conjugation of 25,000 g · mol-1 PEI to oxidized 1,500 g · mol-1 
dextran (reductive amination) demonstrating improved 
complex stability, lower cytotoxicity and higher or comparable 
transfection efficiency than 25,000 g · mol-1 PEI dependent on 
the DS of grafted dextran.16 This oxidation process followed by 
conjugation represent a convenient method to form irreversible 
linkages in aqueous solution, but it yields adverse products 
with undefined chemical structures due to the occurrence of 
various chain scission reactions during the oxidation reaction 
of dextran. To keep the dextran structure intact and avoid 
undesired changes of the biocompatibility, Sun et al. 
functionalized dextrans with hexamethylene diisocyanate 
(HMDI).11 The HMDI linkage was found to be advantageous 
since the functionalization reaction could be conducted fast and 
effectively without addition of any catalyst owing to the high 
reactivity of the isocyanate. Furthermore, the urea and urethane 
bonds in the final product are hydrolytically stable. A 
disadvantage of this linker might be the occurrence of 
crosslinking as a result of the multivalence of both, dextran and 
bPEI. Dextran structure can also be maintained by grafting of 
PEI to carboxymethylated dextran (CM-dex). However, by 
application of this method negatively charged carboxyl groups 
are introduced into the molecule what might result in different 
properties of the polymer.12  
Since so far the influence of the different linker strategies on 
biocompatibility, transgene expression and DNA binding 
characteristics have received only little attention, in the present 
study a direct comparison was performed. To this end, dextran 
with a molar mass of 60,000 g · mol-1 typically used in medical 
and pharmaceutical applications, was functionalized with low 
molar mass PEI. In contrast to previously published studies, 
linear PEI (lPEI) was chosen because it could be synthesized in 
a controlled manner with low molar mass distributions and 
well-defined structures as well as with tailored end groups.20, 21 
Two well-defined lPEIs with molar masses of 860 g ∙ mol-1 and 
1,720 g ∙ mol-1, consistent with 20 (lPEI20) and 40 repeating 
units (lPEI40), respectively, were synthesized and subsequently 
grafted onto different dextran-precursors, namely dextran 
aldehyde (CHO-dex), carboxymethylated dextran (CM-dex), 
and 4-nitrophenyl carbonate-substituted dextran (NPCF-dex). 
The degree of the functional groups (CHO, COOH) per 
anhydroglucose unit (AGU) of dextran as well as the DS and 
molar mass of conjugated lPEI were varied. Subsequently, the 
influence of the type of linkage, the DS and the molar mass of 
lPEI of the various dex-g-PEI conjugates was examined 
regarding the interaction with DNA, the complex formation 
and the cell- and hemocompatibility as well as transgene 
expression. 
 
Materials and Methods: see supporting information 
 
Results and discussion 
 
Synthesis of dextran-graft-poly(ethylene imine) polymers 
 
To create a library of various dextran-graft-linear 
poly(ethylene imine)s (dex-g-lPEI), which enables the analysis 
of structure-property relationships, diverse dex-g-lPEIs 
copolymers were synthesized containing different dextran-
precursors with varying linkers as well as type and degree of 
functional groups. In detail, three synthesis strategies were 
utilized to graft lPEIs to dextran: (i) Reductive amination of 
aldehyde functionalized dextran (CHO-dex), (ii) EDC 
promoted coupling of lPEI to carboxymethylated dextran (CM-
dex), and (iii) carbamate formation via reaction of 4-
nitrophenyl carbonate-substituted dextran (NPC-dex) with lPEI 
(Scheme 1).7, 12, 22 The reductive amination method was 
selected since it is known as very efficient conjugation 
technique and provides the benefit that no coupling agents are 
required. By application of the coupling reaction with EDC, 
dextran remains non-oxidized and adverse side-reactions which 
appear by the oxidation of dextran do not occur. Due to the 
beneficial fact that 4-nitrophenyl carbonate-substituted dextran 
reacts with amines without any coupling agent or catalysts and 
introduces no additional functional groups or structural 
changes to the dextran backbone during the reaction, this 
conjugation method was selected as third synthesis route. In 
preliminary studies (data not shown) these synthesis routes 
were examined with regard to their capability to enable a 
straightforward reaction of the primary amino functionality of 
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lPEI with the respective active groups introduced to dextran. It 
was found that the reductive amination and the EDC coupling 
are well-suited techniques for the synthesis of various dex-g-
lPEIs. Contrary, the carbamate formation method was not 
qualified as adverse crosslinking occurred during reaction of 4-
nitrophenyl carbonate-activated dextran with lPEIs resulting in 
insoluble products for higher DS (data not shown).  
To evaluate the influence of the linker unit, but also of the DS 
and molar mass of lPEI, various lPEIs were reacted in various 
ratios with dextran-precursors. To this end, well-defined, 
proton initiated poly(2-ethyl-2-oxazoline)s (PEtOx) were 
synthesized and subsequently hydrolyzed to lPEI under acidic 
conditions (Scheme S1). LPEIs with a molar mass of 
Mn = 860 g ∙ mol
-1 (lPEI20) and 1,720 g ∙ mol
-1 (lPEI40) were 
obtained, which both carried an active primary amino group at 
one polymer chain end that was utilized for subsequent 
conjugation to the dextran (Table S1, Scheme S1). A detailed 
characterization of the LPEIs is published elsewhere.20, 21 
 
Reductive amination 
 
For the attachment of lPEI to dextran via reductive amination, 
CHO-dextran precursors were prepared by oxidation of 60,000 
g · mol-1 pharmaceutical grade dextran from Leuconostoc 
mesenteroides (Mw= 65,900 g ∙ mol
-1) with potassium 
periodate (KIO4). The molar mass of 60,000 g · mol
-1 was 
selected, since it was most frequently applied in previous 
studies as well as in preclinical and clinical applications.2, 12 
For the oxidation, two different ratios of KIO4 per 
anhydroglucose unit (AGU) (1:3 and 1:10, respectively) were 
chosen to react with dextran. The final degree of oxidation 
(degree of aldehyde groups per AGU) of the products (after 
purification by dialysis against water at 25 °C) was determined 
to be 0.51 (CHO-dex0.5) and 1.09 (CHO-dex1.0), as examined 
by hydroxylamine chloride titration according to Zhao et 
al.,1991.23 Further investigations by SEC exhibited a slight 
decrease in the molar mass due to chain degradation. In 
comparison to unmodified dextran, the oxidized CHO-dex 
samples revealed molar masses with Mw = 55,100 g ∙ mol
-1 for 
CHO-dex0.5 and
 Mw = 52,500 g ∙ mol
-1 for CHO-dex1.1, 
respectively (Table S2). As expected, the final molar mass was 
thereby influenced by the amount of KIO4 used for the 
oxidation. With increasing amount of KIO4 applied per AGU, 
the degree of oxidation also increased, whereas the molar mass 
of the dextran decreased due to few unavoidable chain 
scissions. The final products were further characterized by 1H 
NMR spectroscopy and elemental analysis (Table S2, Figure 
S3). In the 1H NMR spectra, the signals at 3.4 ppm to 4.1 ppm 
can be assigned to the protons of the AGU, and the peak at 5.2 
ppm to 5.3 ppm is attributed to the anomeric proton (Figure 
S3). Additionally, the 1H NMR spectra showed several 
distinctive signals in the region of 4.0 ppm to 6.0 ppm that 
were not present in the original dextran 1H NMR spectrum 
indicating the structural changes due to the oxidation reaction 
(hints for different C-C bond breaking reactions as well as the 
formation of various hemiacetals).24-26  
Subsequently, the two aldehyde containing precursors were 
converted each with lPEI20 and lPEI40 by reductive amination 
reaction in water at a temperature of 60 °C (Scheme 1A). To 
reduce aminolysis side reactions caused by a fast conjugation 
rate, the pH value of the lPEI solution was adjusted to pH 6, 
which additionally improved the solubility of the lPEI. The DS 
of conjugated lPEIs per AGU was aimed to be highest 0.5 and, 
thus, the molar ratio of NH2-lPEI to CHO was set to 1:2 for the 
higher oxidized sample CHO-dex1.0 and 1:1 for the lower 
oxidized dextran CHO-dex0.5. After subsequent reduction with 
sodium borohydride (NaBH4), all obtained dex-g-lPEIs (A 
series, A1-A4) were purified by extensive dialysis against 
water at 60 °C, lyophilized and investigated by 1H NMR 
spectroscopy, elemental analysis as well as SEC measurements 
(Table S3, Figure S4). In the 1H NMR spectra, the signals of 
the CHO-dex samples are still detectable (protons of AGU = 
3.4 ppm – 4.1 ppm; anomeric proton = 5.2 ppm – 5.3 ppm). 
The additional peaks at 3.1 ppm to 3.3 ppm corresponds to the 
protons of the lPEI backbone and confirms the successful 
covalent conjugation of the lPEI to the CHO-dex. Furthermore 
various DS of lPEI per AGU were obtained with values 
between DS = 0.13 to 0.38 as calculated from the nitrogen 
content found in the elemental analysis (Table 1). SEC 
measurements showed an increasing molar mass of the 
synthesized CHO-dex-g-lPEIs with increasing DS of lPEI. The 
molar mass ranged from Mw = 24,000 g ∙ mol
-1 for CHO0.5-dex-
g-lPEI20 up to Mw = 36,500 g ∙ mol
-1 for the CHO1.0-dex-g-
lPEI40 (SI, Table S3). However, these results are not reliable as 
a result of the dramatic rise in charge density of the polymers, 
which leads to a considerable change in the elution behavior 
from the column. 
 
EDC coupling 
 
For the second synthetic strategy, carboxylic moieties, which 
are able to react with the primary amino groups of the lPEIs, 
were introduced in the 60,000 g · mol-1 dextran backbone by 
carboxymethylation. The derivatization of dextran to CM-dex 
was performed using monochloroacetic acid (MCA) under 
basic conditions according to literature.12, 27 In order to obtain 
different CM-dex precursors with varying DS of carboxylic 
groups, the ratios of the reagents (dextran-AGU:MCA:NaOH = 
2.2:1:1 or 1:5:10) as well as the reaction times (90 or 300 min) 
were altered. After purification by dialysis against water at 
25 °C, the lyophilized samples were characterized with regard 
to their content of the carboxymethyl groups according to a 
HPLC procedure described by Heinze et al..28, 29 Three degrees 
of carboxymethyl functionalization per AGU were found, 
namely 0.32 (CM0.3-dex), 0.54 (CM0.5-dex), and 1.60 (CM1.6-
dex) (Table S4). Furthermore, all CM-dex samples were 
characterized by SEC and 1H NMR spectroscopy 
measurements (Table S4, Figure S5). The 1H NMR spectra 
(600 MHz, D2O) of the products showed the expected 
methylene peak of the carboxymethyl group in the CM-dex at 
4.1 ppm to 4.3 ppm, and the proton signals of the AGU 
(3.4 ppm – 4.1 ppm ) as well as the anomeric proton peak at 
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5.2  ppm to 5.3 ppm. SEC data revealed increasing molar 
masses with increasing attachment of the carboxymethyl 
groups, ranging from Mw = 51,100 g ∙ mol
-1 for CM0.3-dex up 
to 60,100 g ∙ mol-1 for CM1.6-dex.  
The subsequent grafting of lPEI20 and lPEI40 to the various 
CM-dex samples was performed in water in the presence of N-
hydroxysulfosuccinimide (sulfo-NHS, Sigma Aldrich) and 
EDC (Sigma Aldrich). Both reagents are frequently used in 
peptide chemistry and assure efficient coupling reactions.12 
Similar to the reductive amination, several CM-dex-g-lPEIs 
with altered DS were targeted. Both CM-dex0.3 and CM-dex0.5 
were allowed to react with a slight excess of lPEI 
(COOH:NH2 = 1:1.2), whereas the COOH:NH2 ratio was 
reduced to 3:1 for CM-dex1.6. After purification by extensive 
dialysis against water at 60 °C and lyophilization, the products 
(B series, B1-B6) were characterized by 1H NMR 
spectroscopy, SEC and elemental analysis measurements. In 
agreement with the literature data, the chemical shifts of the 
protons of the lPEI backbone are detected at 3.1 to 3.3 ppm 
confirming the successful binding of the lPEIs to the CM-
dextrans.12, 30 The resulting DS of lPEI per AGU was as well as 
the reductive amination samples calculated from the nitrogen 
content obtained by the elemental analysis and found to be in 
the range between 0.06 to 0.18 (Table 1). Furthermore, SEC 
analysis revealed a change in the elution volume with 
increasing chain length and DS of lPEI, indicating an increase 
of molar mass due to attachment of the lPEIs to the CM-dex. 
Like the results of the A series, the molar mass values 
presented are not absolute values due to the drastic difference 
in the charge density of the polymers that lead to an 
unpredictable elution behavior from the column. 
By comparing the strategies applied for the grafting of lPEI to 
dextran, it is apparent that both ways enabled the synthesis of 
various dex-g-lPEIs with different DS of lPEI in a 
straightforward manner. Although the reductive amination 
method reached considerably higher DS values, this technique 
has the drawback that the required oxidization of dextran led to 
ring opening reactions of the glucose, chain degradation and 
other adverse side-reactions, which resulted in hardly 
predictable chemical structures and biophysicochemical 
characteristics. In contrast, during dextran activation via 
carboxymethylation the glucose units of the dextran kept their 
ring structure and no chain degradation occurred. However, 
dex-g-lPEIs prepared by EDC coupling additionally contained 
carboxylic acid functionalities (COOH) in the dextran 
backbone, which resulted in polyelectrolyte structures 
including both cationic and anionic charges that might 
influence the physicochemical and the biological properties as 
well.  
 
Binding and protection of DNA 
 
Based on electrostatic interactions between the cationic carrier 
material and the anionic DNA, nanoassemblies can be formed 
spontaneously by masking the anionic charge of the DNA. This 
is necessary to protect DNA against enzymatic digestion as 
well as to enable cell uptake. To study the DNA binding 
properties, complexes of modified dextrans were formed with 
herring testes DNA as model DNA31 applying different 
N/P ratios (0.5 to 40) and analyzed by agarose gel 
electrophoresis (Figure S7, the N/P ratios of 0.5 to 10 are 
shown). The analysis of the free DNA as control (left lane of 
each gel), which was detected by ethidium bromide 
intercalation, revealed a broad fluorescent band corresponding 
to its broad molar mass distribution. Free polymers were used 
as controls (data not shown) to exclude unspecific interactions 
between polymer and dye and exhibited no signal. Free 60,000 
g · mol-1 dextran was not able to interact with DNA due to the 
missing charge since the bands showed the same signal as the 
DNA control (data not shown). 
All cationic dextrans spontaneously formed 
interpolyelectrolyte complexes with the DNA as a result of 
cooperative electrostatic interactions depending on the N/P 
ratio. As the cationic dextran concentration increased, the 
amount of DNA migrating into the gel with unchanged 
electrophoretic mobility decreased indicating that the 
complexes were larger in size and/or less negatively charged 
than free DNA. The influence of the N/P ratio on the stability 
and complex size has been described by several authors for 
many cationic polymers.31, 32 Anyway, it was explored that all 
dex-g-lPEIs prepared by reductive amination (A1-A4) fully 
complexed herring testes DNA already at a N/P ratio of 1 
(Figure S7) indicating charge balance. The complexation was 
found to be slightly increased with higher molar mass of lPEI 
coupled to CHO-g-dex. Comparable observations were 
reported for low molar mass branched PEI conjugated to 15 
and 100 to 200 kDa dextran where the increase of molar mass 
branched PEI resulted in a higher binding capacity independent 
of the degree of grafting.14 For comparison, both linear PEIs 
(20 and 40 monomers) also fully retarded the DNA at a N/P 
ratio 1 in accordance with the data of Lungwitz et al.32 
Furthermore, dex-g-lPEIs prepared by EDC coupling (B1-B4) 
were found to completely retard DNA migration into the gel at 
a N/P ratio 2, which indicates a weaker complexation ability 
than free lPEIs and CHO-dex-g-lPEI samples. This may be 
attributed to the lower nitrogen content and to the presence of 
the anionic charges that could interfere with lPEI and, 
therefore, might decrease the interactions with DNA. This 
assumption is supported by polymer B5, which contained the 
highest number of anionic charges and demonstrated the lowest 
interaction with DNA with a total complexation earliest at a 
N/P ratio 5. The negative “charge effect” on DNA binding can 
be balanced by a higher DS and molar mass of lPEI grafted on 
the CM-dex backbone as demonstrated for sample B6. It was 
characterized by the highest nitrogen content in the B series 
and complexed DNA already at a N/P ratio 1. Again a slight 
trend to higher compaction with increasing the molar mass of 
lPEI could be observed. Sun et al. reported comparable effects 
with an improved binding capability of CMD-g-PEI to DNA 
with increasing DS for 800 g · mol-1 bPEI grafted to 60,000 to 
90,000 g · mol-1 dextran.12 
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Compaction of plasmid DNA (pDNA) by cationized dextrans 
should substantially hinder the access of enzymes to the pDNA 
by physical or electrostatic barriers and, thus, increase the 
stability.19 To study the integrity of pDNA after enzymatic 
treatment by gel electrophoresis (Figure 1), pDNA/cationized 
dextran complexes of different N/P ratios were treated with 
DNase I for 45 min. After inactivation of the enzyme by heat 
and release of the plasmid by dissociation of the complex using 
dextran sulfate, free pDNA was detected on agarose gels. 
Intact plasmid revealed two major fluorescent bands 
corresponding to the supercoiled and open circular form 
(Figure 1 a-c, lane 1, “untreated”). Free plasmid was rapidly 
degraded after DNase I incubation at 37 °C already after 5 min 
(data not shown). Thus, the characteristic bands disappeared 
due to degradation to lower molar mass products (Figure 1 a-
c, lane 3, “DNase I”). Plasmid treated by the same procedure 
but without enzyme remained stable and served as control to 
exclude nonspecific degradation (Figure 1 a-c, lane 2, 
“treated”).  
Although a full pDNA complexation by cationic dextrans 
already occurred at low N/P ratios, higher N/P ratios were 
selected for physicochemical analysis based on later 
transfection results. The results of the stability assay indicated 
that the efficiency to stabilize DNA by electrostatic 
interactions was increased with increasing N/P ratio of 
complexes, higher molar masses and DS of lPEI. The trend to a 
higher protection of plasmid against enzymatic degradation by 
complexes of N/P ratio 50 compared to that with N/P ratio 25 
could be shown for lPEI and all dex-g-lPEI derivatives 
independent of the type of linker. The stabilization of plasmids 
against enzymatic and mechanical destruction with increasing 
amount of the cationic component was described for many 
different polycations and correlated to a higher compaction of 
DNA.31 For free lPEI, a molar mass dependent interaction with 
pDNA could be observed (Figure 1, lanes 8 and 10). The 
higher the molar mass of free lPEI, the more effective was the 
stabilizing effect of the complex. This effect could also be 
observed for the dex-g-lPEIs, but was more pronounced for the 
copolymers than for the free lPEIs. In particular, at N/P ratio 
25 the stability increased with rising molar mass which might 
be related to the increase in charge density within the 
macromolecules.  
In the A series the stabilization effect was most obvious for A1 
and A3 since they revealed at a N/P ratio 25 a different pattern 
of DNA bands than the other CHO-dex-g-PEI complexes. 
Changes in the topology of the plasmids were observed as 
reported in many other studies, e.g. after enzymatic treatment 
of DNA complexes with PEI derivatives or 
poly(diallyldimethylammonium chloride).31, 33 A2 and A4 
(both conjugated with lPEI40) protected the plasmid better than 
their lPEI20 counterparts, since at N/P ratio 25 no degradation 
product was visible and just a weak fluorescent band between 
the expected supercoiled and the open circular band appeared 
(Figure 1 a lanes 8 and 10). At N/P ratio 50 for both 
conjugates even a low fluorescent supercoiled plasmid band is 
still visible (Figure 1 a, lanes 9 and 11). The CM-dex-g-lPEIs 
protected the plasmid against enzymatic degradation in an lPEI 
molar mass dependent matter as well. The conjugates with 
lPEI20 (B1, B3 and B5) were not able to protect the pDNA as 
good as their lPEI40 counterparts. B1 with the lowest DS of 
lPEI and, thus, the lowest nitrogen content demonstrated at N/P 
ratio 25 a high plasmid damaging effect. In contrast for B2 and 
B4, both substituted with lPEI40, a certain amount of 
supercoiled plasmid could be conserved. In accordance to the 
finding of the low DNA binding efficiency described above, 
B5 was not able to stabilize plasmid DNA even at N/P ratio 50, 
whereas for B6 characterized by a higher percentage of 
nitrogen a protective effect could be observed.  
Comparing the polymers with the aspect of two different linker 
strategies, for both series a stabilization of plasmid could be 
obtained depending on the molar mass of lPEI and the N/P 
ratio of the complexes. In contrast to the B series, all 
conjugates of the A series were able to achieve a certain 
protection at the chosen N/P ratios. This might be attributed to 
the higher DS of the lPEIs (0.13 to 0.38). Additionally, as also 
observed in the binding study above, the negative charges of 
the B series might hinder the interaction with pDNA and, 
consequently, its tight compaction. In the literature, crosslinked 
dextran nanoparticles were conjugated to bPEI and the DNA 
was shielded against DNase I for at least 2 h of treatment. This 
was observable for one of the conjugates with a medium 
percentage of grafting (7%) of the dextran onto bPEI.19 
Likewise, dextran-spermine protected plasmid against 
enzymatic digestion just in a certain way that only a slight 
decreased fluorescence of the plasmid band was observable. 
Unfortunately, the plasmid was not released from the complex 
after stopping the DNAse I incubation and, hence, the integrity 
of the plasmid was not shown.34 Therefore, it can be concluded 
that neutral and negatively charged polymers conjugated to 
positively charged polymers are able to shield complexed 
nucleotides against nucleases. For the combination of 
negatively and positively charged copolymers a certain content 
of polycation is required for protection of the complexed 
pDNA. 
 
Size and zeta potential of complexes 
 
The efficiency of the dex-g-lPEI-mediated cellular DNA 
delivery will also be determined by the size and the surface 
charge of the complexes formed, because both might be one of 
the limits for an adequate cellular uptake. A positive surface 
charge represents a prerequisite to stabilize the included 
nucleic acid against enzymatic degradation in small sized 
complexes, which are able to interact with the negatively 
charged cell membrane for an effective endocytosis into 
cellular compartments.35 Complexes were prepared with two 
different N/P ratios (25 and 50) in bidistilled water and studied 
by laser light scattering with regard to the effect of the 
functional groups (CH2OH, COOH) on the final size and 
surface charge without any influence of the ionic strength of 
the solvent.  
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All dex-g-lPEI/pDNA assemblies revealed sizes in water in the 
range of 70 to 113 nm with monomodal size distributions 
(polydispersity indices (PDI) 0.13 to 0.31, data not shown) 
(Figure 2 a), which were comparable to the sizes obtained for 
the DNA complexes with lPEI20 and lPEI40. Since an excess of 
polymer was used, no major differences could be observed 
between N/P ratio 25 and 50. For polymer B5, a relatively high 
hydrodynamic diameter of 113 nm could be measured at N/P 
ratio 50. The insufficient DNA binding and stabilization of 
DNA by B5 observed in the electrophoresis experiments 
correlated with a lower DNA compaction, and consequently, 
higher complex size. A similar trend could be observed for B1 
at N/P ratio 25 (hydrodynamic diameter = 110 nm). 
Moreover, all complexes were positively charged with zeta 
potentials between +15 and +35 mV due to the excess of the 
cationic component with comparable results for N/P ratios 25 
and 50 (Figure 2 b). This finding was in accordance with the 
results of Jiang et al. and Tseng et al.14, 16 
In the A series, an increase of zeta potential with higher molar 
mass of lPEI could be detected, which correlated well with the 
observations of the enzymatic stability testing. In the B series 
for B1-B4 nearly comparable surface charges were measured 
for the polymers except for B1 with lower zeta potentials of 
20.7 and 19.8 mV at N/P ratio 25 and 50, respectively. 
Polymer B5 reached also only a zeta potential of 20 mV at N/P 
ratio 50. The low zeta potentials of B1 and B5 correlated with 
the large particle sizes ascribed above and supported the 
hypothesis of an incomplete DNA compaction. Compared to 
the free lPEIs, the zeta potential of the dex-g-lPEIs decreased 
when lPEI was covalently attached to dextran, which can be 
explained by the shielding effect of the dextran backbone and 
was also observed for other dextran-PEI conjugations in earlier 
studies.16, 19  
Additionally, complexes were prepared in 50 mM NaCl 
solution at pH 7.4 (data not shown). All complexes of the A 
series prepared with N/P ratio 25 tended to aggregate in 50 
mM NaCl solution as indicated by formation of complexes 
with hydrodynamic diameters larger than 800 nm with broad 
and multimodal size distributions. Such large assemblies were 
also reported earlier.12, 36 In contrast, at N/P 50 smaller sized 
complexes were obtained with diameters of about 170 to 
320 nm due a more intense compaction of the plasmid by the 
modified dextrans. In comparison to free lPEI20/40, pDNA 
complexes with CHO-dex conjugated lPEIs revealed a 
decrease in complex size, thus demonstrating a positive impact 
of dextran on the complex formation. Measurements of 
complexes of the B series with pDNA in 50 mM NaCl did not 
lead to evaluable results due to strong aggregation, forming 
complexes larger 1 µm with multimodal size distributions (data 
not shown).  
 
Transfection mediated by pDNA/dex-g-lPEI complexes 
 
CHO-K1 cells were transfected with complexes of the 
cationized dextrans and the plasmid pGL3 at different 
N/P ratios for 4 h. Based on preliminary experiments, N/P 
ratios 25 and 50 were found to be suitable and were selected 
for the following experiments. Luciferase expression was 
presented by normalizing the measured relative light units 
(RLU) to the total protein mass of the cells per culture well. 
For all tested samples cytotoxicity-related effects as the reason 
for the declining transfection efficiencies were unlikely, since 
the protein concentrations in cell lysates (determined by a BCA 
assay), an indicator for cell growth, when treated with the 
different polymers were very similar (data not shown). Free 
plasmid itself revealed only a limited ability to transfect cells. 
Unmodified 60,000 g · mol-1 dextran was tested in 
concentrations up to 25 µg · µg-1 pGL3 plasmid in a 
preliminary study and failed to produce any detectable level of 
transgene expression (data not shown). Also lPEI20 and lPEI40, 
which were found before to be too small to form small and 
fully stabilized complexes, were characterized by a low 
transgene expression. The dependency of the transfection 
efficiency on the molar mass could slightly be observed at N/P 
ratio 25 and 50 as described before.37  
The transfection efficiency obtained for the samples prepared 
by reductive amination (A1-A4) was higher than for the 
corresponding free lPEIs, but lower than for the cationized 
dextrans prepared by EDC coupling (B1-B4), which 
demonstrated the highest activity (Figure 3). The covalent 
binding of the lPEIs to the dextran backbone may increase the 
cationic charge density and, conclusively, the electrostatic 
interaction with and protection of pDNA (as seen in the 
stability tests). As observed before in the physicochemical 
characterization, for the CHO-dex-g-lPEI polymer the 
transgene expression increased with higher molar mass of the 
lPEIs and N/P ratio. Similar results were reported by Jiang et 
al.14 For the CM-dex-g-lPEIs the transfection rate increased 
from B1 to B3 at a N/P ratio 25, whereas for B4 a decrease 
could be observed (Figure 3 a). It has to be highlighted that 
B1, B3 and B4 at N/P ratio 50 (1.8 to 2.3 · 106 RLU/µg 
protein, Figure 3 b) showed transfer efficiencies that were 
comparable to that of a commercially available linear 
2,500 g · mol-1 PEI at N/P ratio 25 (2.55 · 106 RLU/µg protein, 
data not shown). A similar effect could be observed earlier for 
CM-dex-PEIs.12 Unexpected was the observation of 
transfection by the CM-dex-g-lPEI40 conjugates. It was 
estimated that B2 and B4 would induce higher transfection 
rates than B1 and B3, as it is known from the higher molar 
mass dex-g-bPEI conjugates14 and what was also shown by the 
A series. But a contrary effect was revealed for B4 at N/P ratio 
25 and B2 at N/P ratio 50, since an approximately 1/3 lower 
transfection could be observed compared to their lPEI20 
counterparts. This could be due to higher interactions between 
the longer lPEI chain and COOH groups of the CM-dex than 
with the pDNA. From the results shown in Figure 3, it can be 
concluded that B3 provides the best gene delivery properties in 
this study at both N/P ratios, what might be related to the ratio 
of cationic charges to anionic charges per monomer (Table 1). 
Additionally, the lower efficiency of the dextrans of the A 
series may be attributed to the higher DNA complexation 
efficiency of the polymer and, therefore, lower ability to 
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release pDNA from the complexes compared to the polymers 
of the B series as shown by the electrophoresis assays. 
Dissociation of DNA from the complexes is one of the critical 
steps in the biological process, since only released and intact 
DNA can be transcribed. The observed trends are in line with 
the results of the physicochemical experiments: As uptake of 
complexes into cells imposes certain size and stability 
requirements on the endocytosed material, it is necessary for a 
successful gene transfer that the cation in polyplexes not only 
bind DNA, but also compact it. Since the condensation of 
DNA is also known to protect the genetic material from 
enzymatic degradation,38 the decrease of transfection ability of 
the complexes formed by polymers B5 and B6 could result 
from the insufficient interactions with pDNA based on the 
highest number of anionic charges. 
 
In vitro biocompatibility testing 
 
Biocompatibility testing has been performed with respect to 
cyto- and hemotoxicity. The in vitro cytotoxicity of the non-
viral vectors was evaluated by the 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay representing 
the metabolic activity of cells (Figure 4). L929 mouse 
fibroblasts were selected since they were recommended as 
target cells for in vitro toxicity testing by many standard 
institutions.39 The same conditions as in the transfection 
experiments were used. Independent of the N/P ratio (N/P 25 
and 50), complexes with the two linear PEIs did not cause any 
cytotoxic effect, which is supported by results from earlier 
studies demonstrating the low cytotoxicity of complexes 
formed with low molar mass lPEIs.37, 40, 41 Taking the DIN ISO 
10993-5 guideline39 into consideration which defines a 
reduction of cell viability lower than 30% as nontoxic, all 
tested dex-g-lPEI/DNA complexes were found to be highly 
compatible (84 to 110%) at N/P ratios 25 and 50 under the 
transfection conditions applied. The compatibility was thereby 
independent of the linker technique, the DS and the selected 
N/P ratios (Figure 4). For comparison, the positive control 
thiomersal solution (0.02%) reduced the mean cell viability to 
0.6% (data not shown). Consequently, cytotoxic effects could 
be excluded for the variations in transfection efficiency which 
were described above. The results of the MTT assay correlated 
well with the observation of the BCA assay (data not shown) in 
the transfection experiments. Similar results were reported in 
earlier studies as well.12, 14 
Furthermore, the compatibility of non-viral vectors with blood 
indicates their suitability for administration directly into the 
systemic circulation. The hemolytic behavior of the free 
polymers was tested as worst case scenario and classified 
according to the ASTM F756-08 standard (data not shown).42 
According to this standard, neither free lPEIs nor dex-g-lPEIs 
did show any detectable disturbance of the red blood cell 
membranes (hemolysis < 2%) up to 1 mg · mL-1 under the 
chosen conditions. In agreement with the results of Moreau et 
al., the observed behavior was attributed to the low DS and the 
low molar mass of the cationic polymers.43 For comparison 
dextran itself showed up to 16 mg · mL-1 with 0.2% hemolytic 
activity no erythrocyte membrane disturbance.44 Conclusively, 
under the chosen conditions no polymer structure related 
differences could be detected concerning the hemolytic 
potential of the cationic dextrans and were comparable to the 
negative control (RBC in PBS buffer, 0% hemolysis). 
To avoid clinical complications like thrombosis and embolism 
by systemic use of the dextran-based vectors, their potential to 
aggregate red blood cells was investigated by qualitative light 
microscopy (Figure 5 a-b) and classified into three stages 
(Figure 5 b) as well as quantitatively by UV-Vis spectroscopy 
(Figure 5 c). Both methods gave comparable results and 
displayed a concentration-dependent red blood cell aggregation 
behavior of the polymers up to 50 µg · mL-1. Applying the 
three stage classification system as described in the supporting 
information, in microscopic experiments the negative control 
did not show any signs of cluster formation (stage 1), whereas 
the positive control (25,000 g · mol-1 bPEI, 15 µg · mL-1) 
caused the formation of large aggregates (stage 3) as described 
before (Figure 5a).45 Additionally, the ΔAbsmax value was 
introduced, meaning the difference of the highest reduction in 
absorbance to the negative control absorbance. 
Correspondingly to the microscopic data, the highest ΔAbsmax 
value (0.12) was calculated for 25,000 g · mol-1 bPEI as 
positive control attributed to the formation of large clusters 
(Figure 5 c). In contrast to the high molar mass bPEI, lPEI20 
was well tolerated and classified as stage 1 (ΔAbsmax = 0.026), 
whereas an increase in molar mass (lPEI40) initiated rouleaux 
formation only at the highest tested concentration of 50 µg · 
mL-1 (stage 2, ΔAbsmax = 0.04). The molar mass and 
concentration dependent effects of PEIs on red blood cell 
aggregation were described by several authors.17, 46 Correlated 
to the increasing number of charges with size, the interactions 
with negatively charged cell membranes increase as well. In 
accordance to the results obtained for the free lPEIs, also for 
the dex-g-lPEIs an increase of red blood cell aggregation could 
be observed with higher molar mass of lPEI (Figure 5). 
In the A series erythrocyte aggregation could be observed 
starting at concentrations of 6.25 and 25 mg · mL-1 for A3, A4 
and A2, respectively. In contrast, A1 did not show any signs of 
interaction up to the highest tested concentration of 50 µg · 
mL-1 (Figure 1 b). Therefore, interactions with negatively 
charged cell membranes of the red blood cells were found to 
increase with the molar mass of lPEI; this observation 
correlated well with the percentage nitrogen content of the A 
series polymers. While A1 (N = 15.8%) did not induce 
aggregation of erythrocytes (stage 1, ΔAbsmax = 0.03), A2 
(N = 19.1%) reached stage 2 at 25 µg · mL-1 and ΔAbsmax of 
0.04. A3 and A4 demonstrated nearly comparable aggregation 
results (stage 3 at 12.5 and 25 µg · mL-1, ΔAbsmax = 0.08) due 
to the similar percentage of nitrogen contents of about 21%. In 
general, the conjugates synthesized by reductive amination 
demonstrated a higher red blood cell aggregation potential 
compared to the modified dextrans prepared by EDC. The CM-
dex-g-lPEIs B2, B3 and B4 reached only stage 2 with 
maximum ΔAbsmax values of 0.06, even at the highest 
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concentration of 50 µg · mL-1. Again, for the lPEI40-containing 
polymers B2 and B4 the aggregation effects were more 
pronounced than for the lPEI20-based polymers (B1 and B3). 
The higher compatibility of the B series polymers compared to 
the A series may be ascribed to the polyelectrolyte nature of 
the CM-Dex-g-lPEIs since they contain both positive and 
negative charges. This was particularly demonstrated by the 
polymer B6, that possess a higher number of anionic charges 
and revealed the lowest effects on red blood cells (stage 1 at 
50 µg · mL-1, ΔAbsmax= 0.02). Hence, the high number of 
anionic charges within the CM-dex-g-lPEI polymers seems to 
interfere with the electrostatic interactions between the anionic 
cell membranes and the cationic polymers resulting in a 
decreased cell aggregation. De facto, for polyelectrolytes (e.g. 
zwitterionic polymers) a higher resistance to non-specific 
protein adsorption and blood cell interactions, which lead to a 
prolonged half life time in blood circulation, have been 
shown.47 
 
Conclusion 
 
With the objective to evaluate the influence of the linking 
strategy of lPEI to dextran, several dextran-g-lPEIs were 
prepared. For this purpose, different lPEIs (M = 860 and 
1720 g ∙ mol-1) were synthesized and conjugated to dextran via 
two altered routes, namely reductive amination or EDC 
coupling. For a detailed study of structure-activity 
relationships, the content of functional groups (CHO, COOH) 
within the dextran precursors and the DS of lPEI were varied 
as well. Subsequently, the final dex-g-lPEI samples were 
investigated with regard to their physicochemical properties 
(DNA binding and stabilization, complex size and surface 
charge), transfection efficiency as well as biocompatibility and, 
in the end, compared to each other as well as to free lPEIs. The 
investigations were performed in terms of dependency on the 
linking strategy, the molar mass of conjugated lPEIs and the 
N/P ratio of the formed DNA/dex-g-lPEI complexes. 
Independent from the linking strategy, DS and molar mass of 
lPEI, it was observed that almost all conjugates formed with 
DNA complexes stable against enzymatic degradation in the 
range of 100 nm (in water) at N/P ratio 25 and 50 and revealed 
a positive surface charge. Differences between the types of 
conjugation were visible when lPEI was conjugated with 
CM1.6-dex (B5): The binding capacity was reduced, as well as 
the stability and the zeta potential which was attributed to the 
higher content of COOH groups along the dextran backbone. 
Moreover, cell viability studies revealed the good 
cytocompatibility of the resulting dex-g-lPEI/DNA complexes 
under the chosen conditions since cell viabilities of 84 to 110% 
were observed with no crucial influence of the synthesis route 
or the DS and molar mass of lPEI. Instead, a remarkable effect 
of these parameters was detected on the transfection efficiency, 
since the cationic dextrans prepared by EDC coupling showed 
a more than one order of magnitude increased transgene 
expression compared to the A series despite much lower lPEI 
content. Nevertheless, the dex-g-lPEI obtained by reductive 
amination still showed higher transfection values than the free 
lPEIs. The efficiency was found to be dependent on the molar 
mass and DS of conjugated lPEI as well as on the N/P ratio: 
With increasing these parameters also the transfection 
efficiency was enhanced. The transfection efficiencies of the 
CM-dex-g-lPEIs might depend additionally on the ratio of 
positive to negative charges of the molecules. However, further 
investigations would be necessary for deeper insights and final 
conclusions. It was also explored that both polymer series 
induced higher red blood cell aggregation compared to 
unconjugated lPEIs, while CHO-dex-g-lPEIs showed a 
stronger erythrocyte aggregation activity than CM-dex-g-lPEIs. 
In conclusion, the variation of the linking strategy of cationic 
polymers to dextran affects the biological properties, while the 
physicochemical properties were affected only marginal which 
was ascribed due to the high excess of polymer used for the 
experiments. Furthermore, for the grafting of low molar mass 
lPEIs to dextran the EDC coupling was more suitable as 
linking strategy compared to the polymers obtained by 
reductive amination, since the conjugates showed improved 
hemocompatibility and enhanced transfection efficiencies. 
 
Associated content 
Supporting Information 
Materials and Methods: Instrumentation, methods of synthesis 
of the conjugates, methods of biological studies. Scheme of 
cationic ring-opening polymerization of pEtOxs (Scheme S1), 
tables of analytical data of the synthesized polymers and the 
conjugates (Table S1-S5), kinetics of cationic ring-opening 
polymerization of pEtOx (Figure S1), SEC traces of pEtOx 
(Figure S2), 1H NMR spectra of the synthesized conjugates 
(Figure S3-S6), DNA binding capacity of the dex-g-lPEIs and 
free lPEIs (Figure S7) and references affiliated to the methods. 
This material is available free of charge via the Internet at 
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Figures and Tables 
 
 
Scheme 1. Schematic representation of the functionalization of dextran by (a) oxidation, (b) carboxymethylation and 
(c) 4-nitrophenyl carbonate-activation with subsequent reaction with lPEIs via (a) reductive amination, (b) EDC 
coupling and (c) carbamate formation. 
 
 
a) Calculated cationic charge/molar mass of monomer unit  
b) Calculated anionic charge/molar mass of monomer unit 
Table 1. Overview about the DS and nitrogen content of all synthesized dex-g-lPEI samples. 
P dex-g-lPEIs 
CHO/ 
COOH: 
NH2 [mol] 
DS [lPEI/ 
AGU] 
N 
[%] 
Cationic 
charge/MMonomer
a 
Anionic 
charge/MMonomer
b 
A Reductive amination      
A1 CHODS=0.5-dex-g-lPEI20 1:0.5 0.18 15.78 0.0114 - 
A2 CHODS=0.5-dex-g-lPEI40 1:0.5 0.13 19.12 0.0135 - 
A3 CHODS=1.0-dex-g-lPEI20 1:0.5 0.38 21.45 0.0156 - 
A4 CHODS=1.0-dex-g-lPEI40 1:0.5 0.19 21.73 0.0156 - 
B EDC coupling      
B1 CMDS=0.3-dex-g-lPEI20 1:1.2 0.06 6.73 0.0052 0.0013 
B2 CMDS=0.3-dex-g-lPEI40 1:1.2 0.07 12.80 0.0093 0.0010 
B3 CMDS=0.5-dex-g-lPEI20 1:1.2 0.07 7.96 0.0056 0.0020 
B4 CMDS=0.5-dex-g-lPEI40 1:1.2 0.1 14.83 0.0110 0.0014 
B5 CMDS=1.6-dex-g-lPEI20 3:1 0.11 8.16 0.0063 0.0046 
B6 CMDS=1.6-dex-g-lPEI40 3:1 0.18 18.38 0.0127 0.0028 
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(a) 
 
  
(b) 
 
(c) 
 
 
Figure 1: Stability of dex-g-lPEI/plasmid complexes against 
enzymatic degradation (DNase I, 37 °C, 45 minutes) at N/P 
ratio 25 and 50: (a) dex-g-lPEIs by reductive amination; 
(b + c) dex-g-lPEIs by EDC-coupling, (c) lPEIs. Controls: 
lane 1: untreated free plasmid; lane 2: free plasmid treated in 
the same way as complexes but without enzyme; lane 3: free 
plasmid treated with enzyme. 
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(a) 
 
 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: (a) Hydrodynamic diameter and (b) zeta 
potential of dex-g-lPEI and lPEI complexes with 
plasmid DNA at N/P ratio 25 and 50 measured in water. 
Results are shown as mean of six measurements ± SD. 
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a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Transfection efficiency of dex-g-lPEIs and free lPEIs complexed with plasmid pGL3 at (a) 
N/P ratio 25 and (b) N/P ratio 50 in CHO-K1 cells determined by luciferase assay; in comparison to 
the control naked plasmid (DNA). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Viability of L929 mouse fibroblasts 
treated with dex-g-lPEI/DNA and lPEI/DNA 
complexes at N/P ratio 25 and 50 for 24 h, 
determined by MTT assay. Complexes were 
formed with herring testes DNA as model DNA. 
Results are shown as mean of seven values ± SD. 
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(a) (b)
 
(c) 
 
 
 
 
 
 
 
 
 
 
Figure 5: Aggregation of sheep red blood cells after treatment with free dex-g-lPEI and lPEI 
polymers incubated at 37 °C for 2 h. (a) Representative pictures of microscopic observation at 50 µg · 
mL-1 (negative control = PBS; positive control = 15 µg · mL-1 bPEI 25,000 g · mol-1) with 
magnification 200×. (b) Stages of sheep blood erythrocyte aggregation of dex-g-lPEIs and lPEIs at 
concentrations up to 50 µg ∙ mL-1. Classification: 1 = no aggregation of erythrocytes, 2 = moderate 
aggregation with rouleau formation, 3 = strong aggregation with cluster formation. (c) ΔAbsmax of 
polymers. The RBC aggregation experiments were performed with n = 2 and repeated once (mean ± 
SD). 
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Material and Methods 
 
1. Instrumentation 
 
Size exclusion chromatograms (SEC) of poly(2-ethyloxazoline) was measured on an 
Agilent Technologies 1200 Series gel permeation chromatography system equipped with a 
G1310A isocratic pump, a G1329A autosampler, a G1362A refractive index detector, and 
both a PSS Gram 30 and a PSS Gram 1000 column placed in series. A 0.21% lithium chloride 
(LiCl, ACROS Organic, New Jersey, USA) solution in N,N-dimethylacetamide (DMA, 
HiPerSolv CHROMANORM, VWR Prolabo, Darmstadt, Germany) was used as eluent at 
1 mL ∙ min-1 flow rate and a column oven temperature of 40 °C. The molar masses were 
calculated against poly(ethylene glycol) (PEG, Polymer Standards Service, Mainz, Germany).  
The dextran aldehyde and carboxymethylated dextran were investigated on a Jasco SEC 
system composed of a DG-2080-53 degasser, a PU-980 pump and a RI-930 refractive index 
detector running in dimethyl sulfoxide (DMSO, ROTIPURAN 99.8%, Carl-Roth GmbH, 
Karlsruhe, Germany) containing 0.5% lithium bromide (LiBr, Riedel-de Haën, Seelze, 
Germany) at 0.5 mL ∙ min-1 at 65 °C. The samples were separated on PSS NOVEMA 3000 
and 300 Å columns and their molar masses calculated against narrow distributed dextran 
standards (Polymer Standards Service, Mainz, Germany). 
Moreover, all dextran-graft-linear poly(ethylene imine)s were measured on a Jasco SEC 
system equipped with a PU-980 pump, a AS-1555 autosampler, a DG-980-50 degasser, a RI-
930 refractive index detector, and a PSS SUPREMA-MAX column. As eluent, a solution of 
0.1% trifluoroacetic acid (TFA, Uvasol, MERCK, Darmstadt, Germany) and 0.05 M NaCl 
(Sigma Aldrich, Deisenhofen, Germany) in water (pH 2), running at a flow rate of 
1 mL ∙ min-1 and a column oven temperature of 60 °C, was used. The molar masses were 
calculated against pullulan (Polymer Standards Service, Mainz, Germany). 
 
1H NMR and 13C NMR spectra were recorded in deuterated water (D2O, Eurisotop, Gif sur 
Yvette Cedex, France) or deuterated dichlormethane (CD2Cl2, Eurisotop, Gif sur Yvette 
Cedex, France) on a Bruker Avance 250 MHz or 300 MHz spectrometer. Chemical shifts are 
given in ppm relative to signals from the NMR solvents. Conversions were calculated from 
1H spectra using anisole as an internal standard. 
 
Elemental analysis (EA) was carried using an the Elementaranalysator Vario EL III CHNS 
from Elementar Analysensysteme GmbH, Hanau.  
 
2. Synthesis 
 
Synthesis of poly(2-oxazolines) (pEtOx) 
The pEtOxs used in this study as starting materials for the preparation of linear polyethylene 
imines (lPEIs) were synthesized according to literature procedures.1, 2 Briefly, poly(2-ethyl-2-
oxazoline)s (pEtOx) with monomer-to-initiator ratios of 20 and 40 were synthesized under 
microwave irradiation. In order to obtain solely proton initiated chains p-toluene sulfonic acid 
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(Sigma Aldrich) was used as initiator for the cationic ring-opening polymerization 
(Scheme S1). Polymerization kinetics revealed a linear increase of ln([M]0/[M]t) with time 
demonstrating a constant concentration of propagating species indicative of a living 
polymerization mechanism. The resulting first-order kinetic plot is shown in Figure S1, left. 
The linear increase in the molar mass with conversion as well as low polydispersity index 
(PDI) values (< 1.3) further support the living character of the polymerization (Figure S1, 
right). Based on these results two large batches of pEtOx20 and pEtOx40 were synthesized. 
The molar mass determined by 1H NMR spectroscopy was in accordance with the feed ratio 
(pEtOx20: 2,000 g ∙ mol
-1, pEtOx40: 4,000 g ∙ mol
-1) and SEC measurements revealed 
reasonable molar mass distributions with low PDI values (PEtOx20: 3,530 g ∙ mol
-1, PDI = 
1.14; PEtOx40: 5,900 g ∙ mol
-1, PDI = 1.2) (Figure S2). 
 
Synthesis of linear poly(ethylene imines) (lPEI) 
The lPEI synthesis was performed according to a modified procedure described in literature.2 
Briefly, corresponding pEtOx (30 g) was dissolved in 6 M HCl (400 mL, Sigma Aldrich) and 
heated for 24 h at 150 °C. The solvent was removed under reduced pressure. The residue was 
dissolved in water (500 mL) and 3 M NaOH (Sigma Aldrich) was added until precipitation 
occurred. The precipitate was filtered off and recrystallized from water (600 mL). After 
filtration the lPEI was dissolved in methanol (200 mL, Mineralöl Albert, Jena, Germany) and 
precipitated into ice-cold diethyl ether (1,300 mL, Mineralöl Albert). The white precipitate 
was filtered off and dried under reduced pressure at 40 °C for 5 d. The purity and degree of 
hydrolysis of the resulting lPEI were determined by 1H NMR spectroscopy.2, 3 
 
Table S1. Analytical data of poly(2-ethyloxazoline) and the resulting linear 
poly(ethylene imine)s. 
 Mn
a [g ∙ mol-1] PDI 
PEtOx20 3,550
 a 1.14 a 
PEtOx40 5,900
 a 1.20 a 
lPEI20 860
b - 
lPEI40 1,720
b - 
a SEC, DMA, b theoretical values caluclated from the PEtOx precursor 
 
 
Scheme S1. Scheme of the cationic ring-opening polymerization of pEtOxs followed by the 
subsequent acidic hydrolysis to lPEI. 
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Figure S1. Kinetics of the cationic ring-opening polymerization of pEtOx: Resulting first-order 
kinetic plot of ln([M]0/[M]t) (left) linear increase in the molar mass with conversion as well as low 
polydispersity index (PDI) values (right). 
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Figure S2. SEC traces of pEtOx20 and pEtOx40 using DMA as eluent. 
 
 
Synthesis of dextran aldehyde (CHO-dex) 
Pharmaceutical grade dextran with an average molar mass of 65,900 g ∙ mol-1 
(Pharmacosmos, Holbaek, Denmark) (5 g, 0.0136 mol per anhydroglucose unit (AGU)) was 
dissolved in 20 mL distilled water, and the adequate amount (0.0045 or 0.00136 mol) of 
potassium periodate (KIO4, Sigma Aldrich) was added. After stirring in the dark at room 
temperature for 24 h, the products were dialyzed for 5 days (10 times exchange of water) and 
were transferred into tare glass vials and lyophilized in an Alpha 1-2/LD Plus freeze dryer 
(Martin Christ, Osterode Germany) at a pressure of 0.006 mbar for 72 h (yield 90%). The 
final CHO-dextrans were characterized by elemental analysis, SEC (Table S2) as well as 1H 
NMR spectroscopy (Figure S3, a, b).  
The degree of oxidation in the CHO-dex was determined according to the hydroxylamine 
chloride titration after Zhao et al. in distilled water.4 CHO-dex samples (100 mg) were 
dissolved in 25 mL of 0.25 M hydroxylamine hydrochloride solution (Sigma Aldrich). After 
2 h incubation at room temperature, the solution was titrated against 1 N NaOH solution. 
Thereby, the degree of substitution (DS) of CHO was calculated based on the sample weights 
(formula) and subscripted as CHOX-dex. 
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Table S2. Overview of analytical data of the oxidation of dextran with KIO4. 
 
 
KIO4:AGU 
[mol] 
[CHO/AGU]a 
Mw
  
[g ∙ mol-1]b 
PDIb 
C 
[%] 
H 
[%] 
N 
[%] 
Dextran - - 65,900 1.86 40.49 6.79 - 
CHO0.5-dex 1:10 0.51 55,100 2.51 42.34 6.39 - 
CHO1.0-dex 1:3 1.09 52,500 2.35 41.43 6.25 - 
a Determined by hydroxylamine chloride titration 
b SEC were performed in DMSO containing 0.5 % LiBr using pullulan as standard  
 
 
a) b) c) 
8 7 6 5 4 3 2 1 0
(ppm)
 
8 7 6 5 4 3 2 1 0
(ppm)
 
8 7 6 5 4 3 2 1 0
(ppm)
 
Figure S3. 1H NMR spectra of (a) dextran, (b) CHO0.5-dex and (c) CHO1.0-dex prepared by oxidation 
with KIO4. The 
1H NMR spectra were measured at 25 °C in D2O.  
 
Synthesis of CHO-dex-g-lPEI 
 
For the synthesis of various dextran conjugated lPEIs, 200 mg (0.0012 mol AGU) CHO0.5-dex 
and CHO1.0-dex as well as the desired amount of lPEI (CHO:NH2-PEI ratio = 1:1 or 1:0.5) 
were dissolved in water at 60 °C. After mixing both solutions, the color turned to yellow 
indicating an imine bond formation. The mixture was stirred for 24 h at 60 °C following the 
slow addition of a 5 times excess of sodium borohydride (NaBH4, Sigma Aldrich). The 
solutions became colorless due to the reduction of the imine bond to an amine formation and 
were stirred for 2 days at room temperature. Subsequently, the product was purified from 
uncoupled lPEI and NaBH4 residues by extensive dialysis against water at 60 °C. The water 
was exchanged at least 10 times within 5 days until the pH of the dialysis water was neutral 
(pH 6-7). The product was lyophilized in an Alpha 1-2/LD Plus freeze dryer (Martin Christ) 
at a pressure of 0.006 mbar for 72 h reaching 30 to 40% overall yield. The absence of 
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unbound lPEI was proven by 1H NMR measurement (600 MHz, D2O, 60 °C) of the collected 
dialysis water and the final DS of lPEI was calculated by the nitrogen content obtained from 
elemental analysis (Table S3). The polymers were further characterized by SEC 
measurements (in H2O, 0.1% TFA) and
 1H NMR spectroscopy (600 MHz, D2O, 60 °C) 
(Figure S4).  
 
Table S3.
 
Overview of analytical data of the dex-g-lPEI samples obtained by reductive amination. 
Products 
CHO: 
NH2-lPEI 
[mol] 
DSa 
[lPEI/ 
AGU] 
C 
[%] 
H 
[%] 
N 
[%] 
Mw 
[g ∙ mol-1]b 
PDIb 
CHO0.5-dex-g-lPEI20 1:1 0.18 41.95 9.75 15.78 24,000 1.21 
CHO0.5-dex-g-lPEI40 1:1 0.13 43.00 10.38 19.12 27,600 1.26 
CHO1.0-dex-g-lPEI20 2:1 0.38 43.74 10.58 21.45 31,300 1.20 
CHO1.0-dex-g-lPEI40 2:1 0.19 43.62 10.45 21.73 36,500 1.20 
a Calculated from the nitrogen content N [%] of the elemental analysis 
b
 SEC measurements were performed in H2O containing 0.1% TFA and 0.05 M NaCl (pH 2) using 
pullulan as standard. 
 
 
a) b) 
8 7 6 5 4 3 2 1 0
(ppm)  
8 7 6 5 4 3 2 1 0
(ppm)  
c) d) 
8 7 6 5 4 3 2 1 0
(ppm)  
8 7 6 5 4 3 2 1 0
(ppm)  
 
Figure S4. 1H NMR spectra of dex-g-lPEI samples obtained by reductive amination. The 1H NMR 
spectra were measured at 60 °C in D2O. (a) CHO0.5-dex-g-lPEI20, (b) CHO0.5-dex-g-lPEI40 (c) CHO1.0-
dex-g-lPEI20, (d) CHO1.0-dex-g-lPEI40. 
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Synthesis of carboxymethyl dextran (CM-dex) 
 
Pharmaceutical grade dextran with an average molar mass of 65,900 g ∙ mol-1 
(Pharmacosmos) (5 g, 0.0136 mol per AGU) was dissolved in 50 mL water and stirred for 
20 minutes at room temperature. The desired amount of 15 M NaOH was added dropwise, 
and the reaction mixture stirred for further 60 minutes. Subsequently, the desired amount of 
monochloracetic acid (Sigma Aldrich) was added dropwise and the temperature was increased 
to 60 °C. The reaction was stopped after 90 minutes or 300 minutes by neutralization with 
acetic acid (pH 6-7, Sigma Aldrich). After precipitation in 1.5 L of cold methanol (Mineralöl 
Albert), the solid product was filtered off over a G3 frit and washed (at least 3 times) with 
methanol. After dialysis (5 times exchange of water, 3 days) the products were obtained in 
80% yield by lyophilization in an Alpha 1-2/LD Plus freeze dryer (Martin Christ) at a 
pressure of 0.006 mbar for 72 h. The DS of carboxymethyl groups was determined according 
to the HPLC procedure described by Wotschadlo et al.5 Furthermore, the products were 
characterized by 1H NMR spectroscopy (600 MHz, D2O), SEC (in DMSO) and EA 
measurements (Table S4).  
 
Table S4. Overview of analytical data of the CM-dex samples obtained by reductive amination.   
 AGU:ClCH2COOH 
:NaOH [mol] 
DSa [CH2COOH 
/AGU] 
Mw 
[g ∙ mol-1]b 
PDIb 
CM0.3-dex 2.2:1:1 (90 minutes) 0.32 51,100 2.36 
CM0.5-dex 2.2:1:1 (300 minutes) 0.54 54,400 2.37 
CM1.6-dex 1:5:10 (300 minutes) 1.6 60,100 2.04 
a Determined by HPLC measurement 
b SEC were performed in DMSO containing 0.5 % LiBr using pullulan as standard 
 
 
a) b) c) 
8 7 6 5 4 3 2 1 0
(ppm)  
8 7 6 5 4 3 2 1 0
(ppm)  
8 7 6 5 4 3 2 1 0
(ppm)
 
Figure S5. 1H NMR spectra of (a) CM0.3-dex, (b) CM0.5-dex and (c) CM1.6-dex obtained by 
carboxymethylation with monochloroacetic acid. The 1H NMR spectra were measured at 25 °C in 
D2O. 
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Synthesis of CM-dex-g-lPEI 
 
The reactions of the CM-dex with the lPEIs were performed using 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC, Sigma-Aldrich) as coupling reagent. Firstly, 
300 mg of each CM-dex and the desired amount of lPEI (NH2:COOH = 1.2:1) were dissolved 
in distilled water at 60 °C to ensure complete dissolution of the lPEIs. Subsequently, the pH 
value of the solution was adjusted to 6.0 by 1 M HCl solution. After 20 minutes stirring at 60 
°C EDC (COOH:EDC = 1:1) and N-hydroxysulfosuccinimide (sulfo-NHS, Sigma Aldrich) 
(EDC:sulfo-NHS = 1:1) were added. The reaction mixture was stirred for 24 h at 60 °C, and 
the product was purified by extensive dialysis (at least 10 times exchange of water within 
5 days) at 60 °C. The products were obtained by lyophilization (Alpha 1-2/LD Plus freeze 
dryer, Martin Christ) at a pressure of 0.006 mbar for 72 h in 30 to 40% overall yield. The 
absence of free unbound lPEI was proven by 1H NMR (600 MHz, D2O) measurement of the 
collected dialysis water. Furthermore, SEC analyses (in H2O, 0.1% TFA) as well as 
1H NMR 
spectroscopy (600 MHz, D2O, 60°C) and elemental analysis investigations of the products 
were performed. The final DS of lPEI was calculated by the nitrogen content obtained from 
elemental analysis (Table S5). 
 
 
Table S5. Overview of analytical data of the dex-g-lPEI samples obtained by EDC coupling. 
Products 
COOH:EDC:
NH2-lPEI 
DSa 
[lPEI 
/AGU]b 
Mw 
[g ∙ mol-1]b 
PDIb 
C 
[%] 
H 
[%] 
N 
[%] 
CM
0.3
-dex-g-lPEI
20
 1:1.2 0.06 22,900 1.06 40.91 7.35 6.73 
CM
0.3
-dex-g-lPEI
40
 1:1.2 0.07 36,500 1.09 38.91 8.07 12.80 
CM
0.5
-dex-g-lPEI
20
 1:1.2 0.07 25,000 1.07 40.55 7.11 7.96 
CM
0.5
-dex-g-lPEI
40
 1:1.2 0.1 36,000 1.09 37.89 8.51 14.83 
CM1.6-dex-g-lPEI20 3:1 0.11 15,600 1.14 43.29 7.09 8.16 
CM1.6-dex-g-lPEI40 3:1 0.18 17,200 1.18 33.91 8.57 18.38 
a Calculated from the nitrogen content N [%] of the elemental analysis  
b
 SEC measurements were performed in H2O containing 0.1% TFA and 0.05 M NaCl (pH 2) using 
pullulan as standard 
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a) b) 
8 7 6 5 4 3 2 1 0
(ppm)
 
8 7 6 5 4 3 2 1 0
(ppm)  
c) d) 
8 7 6 5 4 3 2 1 0
(ppm)
 
8 7 6 5 4 3 2 1 0
(ppm)
 
 
Figure S6. Representative 1H NMR spectra of dex-g-PEI samples obtained by EDC coupling of CM-
dex and lPEI: (a)  CM0.3-dex-g-lPEI20 (b) CM0.3-dex-g-lPEI40 (c) CM0.5-dex-g-lPEI20 (d) CM0.5-dex-g-
lPEI40. The 
1H NMR spectra were measured at 60 °C in D2O. 
 
 
3. Biological studies 
 
DNA preparation 
Luciferase reporter gene encoding plasmid pGL3 (Promega, Madison, WI, USA) was 
transferred to competent E. coli TG1 (kind gift of Hans-Knoell-Institute, Jena) and isolated 
with the plasmid Maxi kit according to manufacturer’s protocol (E.Z.N.A®, OMEGA bio-tek, 
Norcross, GA, USA). Herring testes DNA Type XIV (Sigma Aldrich) was used as model 
DNA. 
 
Preparation of polymer/DNA complexes 
Stock solutions of dextran derivatives and lPEIs were prepared in highly purified water at a 
concentration of 1 mg ∙ mL-1, and pH was adjusted to 7.4. The solutions were sterile filtered 
(0.2 µm, VWR international, Darmstadt, Germany). Polymer concentrations after filtration 
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were quantified as copper(II) (Cu2+) complexes according to Perrine et al. (1967)6 by 
measurement of the absorbance at 645 nm in 96-well plates (Greiner Bio-One, Frickenhausen, 
Germany) with a microplate reader (Fluostar OPTIMA, BMG Labtech, Offenburg, Germany) 
using a calibration curve of the corresponding derivatives. The complexes were formed 
according to Fischer et al. (1999)7 and Tseng et al. (2003).8 The N/P ratio was calculated by 
the molar ratio of the nitrogen (N) (determined by elemental analyses) of each dex-g-lPEI 
sample to phosphorus (P) in the DNA. Five µg DNA and the appropriate amount of polymer 
solution were each diluted in 125 µL 150 mM NaCl (Roth, Karlsruhe, Germany) pH 7.4 and 
vortexed for 10 minutes. Afterwards, the polymer solution was added to the DNA solution, 
vortexed for 10 seconds and incubated at room temperature for 10 minutes. 
 
Horizontal gel retardation assay 
A 50 µL aliquot (containing 1 µg herring testes DNA type XIV) of the complex dilution was 
mixed with 5 μL loading buffer (40 mM Tris, 50% (v/v) glycerol 85%, 1 mM EDTA, pH 7.4, 
all from Roth). Subsequently, 5 µL dilution was applied on a 1% agarose gel (PeqGold 
Universal agarose, Peqlab Biotechnology GmbH, Erlangen, Germany). Electrophoretic 
separation was carried out in TAE running buffer (40 mM Tris, 1% acetic acid, 1 mM 
EDTA, all from Roth) in a horizontal electrophoresis chamber (Biometra, Goettingen, 
Germany) at 80 V for 1 h. For DNA detection, the fluorescence of intercalated ethidium 
bromide (Roth) was determined using a UV transilluminator (Intas GmbH, Goettingen, 
Germany) at 312 nm. Photographs were taken with a gel documentation system (Digit Store 
UNO, Intas GmbH). 
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Complex stability against enzymatic degradation 
Complexes were prepared as described above with 4 µg pGL3 plasmid in a total volume of 
200 µL 150 mM NaCl solution. DNase I (2.5 Kunitz units/µL, Applichem, Darmstadt, 
Germany) diluted in 150 mM NaCl and 20 mM MgCl2 pH 7.4 with an activity of 1.5 Kunitz 
units/µg plasmid was added to the complex solution, gently mixed and incubated for 45 
minutes in a water bath at 37 °C. The enzyme was inactivated in a water bath at 70 °C for 
30 minutes. Subsequently, plasmid was released from the complexes by incubation with 
10 µL dextran sulfate solution (5,000 g ∙ mol-1, 10 mg ∙ mL-1, Sigma) per µg plasmid at 37 °C 
for 20 minutes. Naked plasmid treated with DNase I, untreated plasmid, as well as plasmid 
incubated in the same way like complexes but without enzyme were used as controls. An 
aliquot of 50 µL complex solution (containing 1 µg plasmid) of each sample were mixed with 
5 µL TAE loading buffer and electrophoresed as described above.  
 
Complex size measurement and zeta potential 
Size and zeta potential of complexes with N/P ratios of 25 and 50 with 2 µg plasmid were 
measured with the Zetasizer Nano ZS (Malvern Instruments, Herrenberg, Germany) in 
50 mM NaCl and highly purified water. Photon correlation spectroscopy was carried out in a 
minimal volume cuvette ZEN 0040 (BRAND GmbH, Wertheim, Germany) with a laser beam 
at 633 nm and a scattering angle of 173° at 25 °C. The viscosity (0.89 mPa ∙ s) and refractive 
index (1.33) of purified water at 25 °C were used for data analysis. Results are shown as the 
mean of Z-average of 6 runs ± standard deviation (SD) and calculated with the “General 
purpose” (normal resolution) algorithm using the Malvern software 6.20. Zeta potential of the 
complexes was performed in a zetasizer cuvette (DTS1060, Malvern Instruments) by 
measuring the electrophoretic mobility at 25 °C. The results were calculated with the Malvern 
software 6.20 and shown as the mean of 6 runs ± SD. All measurements were repeated once. 
 
Cell culture 
L929 mouse fibroblasts (German Collection of Microorganisms and Cell Cultures, DSMZ, 
Braunschweig, Germany) were cultured in Roswell Park Memorial Institute 1640 (RPMI 
1640) culture medium supplemented with 2 mM L-glutamine and 10% fetal bovine serum 
gold (FBS) (all PAA, Pasching, Austria). CHO-K1 (Chinese hamster ovary cells, DSMZ) 
cells were cultured in Ham’s F12 (PAA) supplemented with 1 mM L-alanyl-L-glutamine and 
10% FBS (PAA). Cells were subcultured once a week and incubated at 37 °C, 5% CO2 and 
95% relative humidity. To test the absence of squirrel monkey retrovirus, DNA of the cells 
was isolated (QIAamp® DNA Mini kit, Qiagen, Hilden, Germany) and regularly screened by 
PCR (polymerase chain reaction). Absence of mycoplasma in the cells was periodically tested 
with a standard test kit (Venor® GeM, Minerva Biolabs, Berlin, Germany). 
 
Cytotoxicity of complexes 
In vitro cytotoxicity of complexes was tested by the 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay as described by Mosman9 and Fischer et al..10 
Briefly, complexes were prepared as described above with 3.2 µg herring testes DNA (in 10 
mM Tris buffer) and the appropriate amount of polymer to receive N/P ratios of 25 and 50. 
Afterwards, RPMI 1640 culture medium was added to each complex solution up to 1,210 µL. 
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L929 mouse fibroblasts (8500/well) were seeded in 96-well plates (Greiner Bio-One, 
Frickenhausen, Germany) and incubated for 24 h. Afterwards, culture medium was replaced 
by 110 µL complex dilution/well. Cells were incubated with the complexes for 4 h. 
Afterwards the test solution was removed and replaced by 200 µL RPMI 1640 medium 
followed by incubation for further 20 h. The following MTT assay procedure was performed 
as described before. Absorbance (A) of the samples was measured in a microplate reader 
(Fluostar OPTIMA) at 570 nm. As blank control culture medium without cells was used. 
Negative control (100% viability) was determined using cells treated only with culture 
medium. The positive control (0% viability) was obtained by treatment of the cells with 
0.02% thiomersal solution (Synopharm, Barsbüttel, Germany). Relative cell viability was 
calculated as follows: 
 
                       
              
                        
       
 
Relative cell viability < 70% was regarded as cytotoxic according to DIN ISO 10993-5.11 All 
experiments were run with n = 7 and repeated once. 
 
Aggregation of erythrocytes 
To investigate the erythrocyte aggregation of the polymers a modified method of Ogris et al.12 
was applied. Polymers were tested in phosphate buffered saline (PBS) [8 mM disodium 
hydrogen phosphate, 1.5 mM potassium dihydrogen phosphate, 137 mM sodium chloride and 
2.7 mM potassium chloride (all from Roth)] pH 7.4 at concentrations of 0.024 to 50 µg ∙ mL-1. 
Sheep blood was collected in heparinized tubes and the serum was removed by centrifugation 
at 2,880 g for 7 minutes (Eppendorf Centrifuge 5804R, Eppendorf, Hamburg, Germany). The 
pellet was washed three times with PBS by centrifugation at 2,880 g for 7 minutes and was 
resuspended in PBS to the initial volume. The red blood cell suspensions were used within 24 
h after collection. Erythrocyte suspension (100 µL) containing 20 × 106 erythrocytes/mL was 
mixed with 100 µL test compound in a 96-well plate (Greiner Bio-One). The plates were 
incubated under vigorous shaking at 37 °C for 2 h. Afterwards, erythrocyte aggregation was 
evaluated by microscopic observations (Leica DM IL, Achromat 10/0.20 Phaco 1a objective, 
200fold magnifications, Wetzlar, Germany) and the results were classified in three stages. In 
stage 1 the erythrocytes stay discrete in suspension, no aggregation is detectable. At stage 2 
the majority of red blood cells stays separate and shows only a moderate aggregation with 
rouleau formation. In stage 3 almost all erythrocytes are aggregated in clusters. As negative 
control for the determination of stage 1, erythrocytes were treated with PBS. As stage 3 
(positive control), erythrocytes were treated with a 15 µg ∙ mL-1 solution of 25,000 g ∙ mol-1 
branched poly(ethylene imine) (bPEI, a kind gift of BASF corporation, Ludwigshafen, 
Germany). Additionally, the aggregation of erythrocytes was analyzed by quantitative 
measurement of total absorbance at 645 nm with a microplate reader (Fluostar OPTIMA) 
according to Bauer et al.13 To quantify the erythrocyte aggregation the calculation of ΔAbsmax 
was established by using the following equation according to Florian Schlenk (personal 
communication):  
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The experiments were run in duplicate and repeated once. The results are shown as the mean 
of two experiments (n = 4) ± SD. 
 
Hemolysis of erythrocytes 
According to Bauer et al.13 the hemolytic activity of the dex-g-lPEIs was determined. The 
erythrocytes were isolated as described in the previous section. Polymers were tested in PBS 
buffer with concentrations of 0.125 to 1 mg ∙ mL-1. They were mixed with the erythrocyte 
dilution and incubated on a shaker (Heidolph Instruments Titrimax 100, Schwabach, 
Germany) at 450 rpm at 37 °C for 1 h. Hemoglobin release was determined by 
spectrophotometric analysis of 100 µL supernatant at 544 nm with a microplate reader 
(Infinite® M200 PRO, Tecan, Maennedorf, Switzerland) after centrifugation at 2,250g for 5 
minutes (Eppendorf Centrifuge 5804R). As positive control 0.05% Triton X-100 solution 
(Ferak, Berlin, Germany) was used. Erythrocytes treated with PBS provided the negative 
control. Percentage hemolysis was calculated according to the following equation:  
 
              
                                           
                        
       
 
Hemolytic activity of the polymers was evaluated with the limit values of the ASTM F756-08 
standard.14 A hemoglobin release of 0%–2%, 2%–5%, or >5% of the total hemoglobin release 
was classified as non-hemolytic, slightly hemolytic, or hemolytic, respectively. Experiments 
were run in duplicate and repeated once. The results are shown as the mean of the two 
experiments ± SD. 
 
Transfection 
CHO-K1 cells (50,000/well) were seeded in 12-well plates (Greiner bio one) and incubated 
for 24 h. Afterwards, culture medium and complex solution (200 µL/well) prepared as 
described above containing 4 µg pGL3 plasmid at N/P ratios 25 and 50 were added to the 
wells. Cells were incubated with complexes for 4 h. As controls were used cells treated with 
200 µL physiological saline, free plasmid as well as complexes formed with 2,500 g ∙ mol-1 
lPEI (Polysciences Europe GmbH, Eppelheim, Germany) N/P 25. Culture medium was 
changed, and the cells were incubated for further 44 h. Cells were washed twice with PBS 
buffer. Lysis of cells and luciferase assay were carried out according to manufacturer’s 
protocol (Luciferase assay system, Promega). Protein mass was quantified with a standard 
BCA assay kit (Thermo Scientific, Rockford, USA) according to manufacturer’s protocol 
with minor modifications: cell lysate (25 µL) was incubated with 10 µL 0.05 M iodacetamide 
solution (Applichem) to inactivate dithiothreitol (DTT) of the lysis reagent at 37 °C for 20 
minutes. The transfection efficiency was calculated as RLU/μg protein and presented as the 
mean of a duplicate testing ± SD. The experiment was repeated twice. 
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Abstract Within the last years, high-throughput (HT) turned into a keyword in polymer 
research. In this study we present a novel HT workflow for the investigation of cationic polymers 
for gene delivery applications. For this purpose, various poly(ethylene imine)s (PEI) were used as 
representative vectors and investigated via HT-assays in a 96-well plate format starting from the 
polyplex preparation up to the examination of the transfection process. In detail, polyplex 
preparation, complex size determination, DNA binding affinity, polyplex stability, cytotoxicity, 
and transfection efficiency were performed in the well plate format. Usually, biological studies 
are time consuming and, thus, only a few polymers can be investigated under altered conditions 
(such as pH value, buffer systems, concentration). But with the presented approach, manifold 
parameters can be tested, and different polymers can be screened in terms of their transfection 
properties. The HT-workflow represents a great facilitation to gain deeper insights into 
physiochemical properties as well as biological parameters of polyplexes, like transfection 
efficiency and cytotoxicity. 
Introduction  
Beside the evolutionary qualified and very efficient viral gene delivery, non-viral gene delivery 
(transfection) is of high interest. In particular, the strategy of using cationic polymers as non-viral 
vectors to form complexes (polyplexes) with the negatively charged plasmid DNA (pDNA) was 
discovered as promising concept with increased safety and control.
[1, 2]
 For the evaluation of 
polymers as transfection agents, two main aspects must be considered: The efficiency of the gene 
delivery with subsequent reporter gene expression as well as the resulting cytotoxicity.
[3]
 
Biophysical properties, such as polyplex size and surface charge of the polyplexes play thereby a 
crucial role for the required cellular uptake.
[4, 5]
 In addition, the interaction between the polymer 
and the genetic material (binding affinity) has a critical impact since the binding within the 
interelectrolyte complex of polymer and pDNA has to be strong enough to protect the pDNA, but 
at the same time must be reversible to release the pDNA inside the cells.[6, 7] Although strenuous 
effort was performed to understand the chemical nature as well as the biological function of 
polymers and the resulting polyplexes, there is still an insufficient knowledge how polymers 
should be constructed to be highly efficient gene vectors. Certainly, some demands on ideal 
polymers have already been proposed: (i) Efficient binding and protection of genetic material 
during delivery, (ii) efficient cellular uptake, (iii) high biocompatibility and (iv) high transfection 
efficiency.
[8, 9]
 However, general synthesis rules for the construction of efficient polymers are 
missing as a result of too diverse methods and polymer classes applied in the published studies. 
For instance, the transfection protocols differ notably in the used cells and media. Also for the 
preparation of the polyplexes often different polymer solutions and buffers were used leading to 
results that are hard to compare.
[10, 11]
 Up to now, no polymer based transfection agent reached 
the marketing approval, although they were used for in vitro application and in biotechnology 
since decades.
[12-14]
  The high-throughput (HT) synthesis and characterization of cationic 
polymers represents thereby no obstacle, since nowadays manifold polymers can be prepared 
quasi overnight by synthesis robots.
[15-20]
 Using this synthetic approach, polymer properties, e.g., 
molar mass, functional groups, architecture, or the combination of different monomers in statistic 
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or block copolymers can be altered, yielding systematic polymer libraries, which enable the 
elucidation of structure-property relationships.
[15-23]
 But unfortunately, the subsequent biological 
evaluation is still time consuming and limited regarding a combinatorial HT workflow.
[24]
 Thus, 
the biological outcome must be increased to gain deeper insights into the transfection mechanism 
to allow tailor-made synthesis rules for polymers aimed to be used as transfection vectors. A 
combinatorial HT workflow, which combines analytic and biological methods, would help to 
understand how the polymers should be designed specifically to their task.
[25-27]
 Biological 
studies such as binding affinity and polyplex stability are commonly performed via agarose gel 
electrophoresis, but are not recommended for HT screenings. However, in recent years, HT 
experiments using assays in a 96-well plate format have been established to study the binding 
affinity by usage of an intercalating dye.
[28]
 Also transfection as well as cytotoxicity assays are 
performed in 96-well plates, but with repeating samples to reduce measurement mistakes. 
Moreover, HT screening of a wide range of polymers as transfection agents were described by 
Langer and coworkers with regard to synthesis and transfection efficiency.
[29]
 Massing and 
coworkers presented a HT screening for lipofection reagents also concerning transfection 
efficiency and toxicity.
[30]
 
With the aim to solve the bottle-neck in the biological screening of various polymers regarding 
their complexation behavior with pDNA, a combinatorial high-throughput workflow was 
developed and is presented herein. The HT workflow starts with the automated polyplex 
preparation via pipetting robots and continues with a parallel and HT analysis of analytical and 
biological properties like size, binding affinity, stability, transfection, and toxicity. Therefore, 
poly(ethylene imine) (PEI), the most prominent cationic polymer and most efficient transfection 
agent for pDNA in vitro, was used.
[31]
 It is a well known system and was studied in detail with 
regard to the polyplex properties and the transfection efficiency since the 90ies. Thus, it 
represents an excellent model polymer to be investigated in a HT manner in order to allow a 
comparison to results described in literature.
[14]
 In detail, linear PEI synthesized of poly(2-ethyl-
2-oxazoline)s of different molar masses, was chosen.
[32, 33]
 By application of automated 
microwave synthesizers, poly(2-ethyl-2-oxazoline)s can be obtained within 10 minutes and 
converted into “pharma-grade” PEI within 1 hour by acidic hydrolysis. The cationic PEI 
polymers offer the advantage to be molecularly designed in a highly reproducible manner for 
specific applications in pharmacy or biotechnology. In addition, also commercial branched PEI 
completed this study. The demonstrated novel workflow is applicable for versatile polymer 
systems as well as conditions and allows a fast and efficient screening in terms of important 
vector parameters, such as polyplex formation, pDNA release, cytotoxicity and transfection. 
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Results and Discussions 
Evaluation of an appropriate buffer system 
The polyplex formation of cationic polymers and anionic genetic material is driven by 
electrostatic interactions and a gain of entropy.
[34]
 Thus, the ionic strength, the pH value and the 
final polyplex concentration in the buffer system applied have a major impact on the 
complexation behavior and the resulting polyplex size.
[35, 36]
 For the ex cellular characterization, 
polyplexes are often prepared in high ionic strength buffers, such as 150 mM sodium chloride 
(NaCl) or buffer systems using phosphate (PBS) or TRIS (TBS). It was reported that the high 
ionic strength of the media has a negative impact on particle size as well as stability and leads to 
fast aggregation of the polyplexes.
[36]
 Thus, a low ionic strength 20 mM HEPES buffer with 5% 
glucose for physiological osmolarity (HBG buffer) was examined for the polyplex preparation. 
Preliminary studies with linear PEI600 revealed that smaller polyplexes were formed in HBG.
[35]
 
A lower tendency to aggregate over time compared to physiological salt solutions (150 mM 
NaCl) was observed if the polyplexes were prepared in HBG.
[37-39]
 To confirm the decreased 
aggregation tendency, the sizes of the polyplexes in HBG prepared by the conventional polyplex 
preparation methods were compared to the polyplexes prepared using the pipetting robots. No 
tendency to aggregate or differences in polyplex size were observed (data not shown). 
Furthermore, the polyplexes in HBG revealed no aggregation or particle growth before and after 
the addition to serum containing culture media.
[36, 37, 40]
 This prevents misinterpretation of 
physicochemical properties as size and biological investigations regarding the cellular uptake 
behavior. Also convincing is the fact that HBG buffer can be used for zeta potential 
measurements in this concentration range as well as for electron microscopic evaluations, where 
salts cause electrophoresis or artifacts, respectively. Consequently, HBG was selected as best 
appropriate buffer system for the HT approach and was used for all polyplex preparations and its 
analytical investigations, showing improved potential for structure properties studies.  
Polyplex preparation using pipetting robots 
For an automated preparation of polyplexes formed of cationic polymers and DNA liquid 
handling robots, which were usually utilized in peptide chemistry and recently discovered to be 
also beneficial for the production of polymeric nanoparticles, were used.[41] The benefit of such 
pipetting systems is the ability to systematically alter different parameters individually, such as 
polymer concentration, pH value or buffer system.
[42] The HT polyplex preparation was realized 
by automatic deposition of a buffered pDNA solution into wells that contain various buffered 
cationic polymer solutions with the desired concentrations. Although the preparation via pipetting 
robots differs from the conventional preparation methods
[1]
 (pipetting polymer to DNA solution, 
vortexing after polymer addition), it was evaluated that similar results could be observed in 
previous experiments with lPEI600 and bPEI600 (see methods). 
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Scheme 1. Workflow of the high-throughput transfection studies for structure-property 
evaluations concerning molar ratio, size, polyplex formation, polyplex stability, release, 
transfection efficiency and cytotoxicity. 
 
 
In order to evaluate the dependency of the polyplex properties on different polymers and 
preparation conditions, various linear and branched cationic poly(ethylene imine) (LPEI and 
BPEI, respectively) with varied degree of polymerization (DP = 20, 200 and 600) were used to 
form polyplexes with pDNA. Besides the molar mass and architecture, also several nitrogen 
(polymer) to phosphate (DNA) ratios (N/P = 2.5, 5, 10 and 20) were applied. To this end, a 
dilution series of previously prepared polymer solutions was provided by using the pipetting 
robot. Afterwards, pDNA solution was added to each polymer solution, and the resulting 
suspensions were directly mixed by repetitive suction and release. After the polyplex formation, 
the prepared polyplex suspensions were distributed each automatically into different well plates 
for subsequent parallel analysis studies. Although it was reported that a reverse order of pipetting 
(polymer to pDNA solution) results in higher transfection results,
[43]
 we observed no influence of 
the pipetting order. This could be explained by more reversible interelectrolyte formation in the 
low ionic strength buffer HBG compared to high ionic strength buffer (150 mM NaCl) commonly 
used. 
Investigation of polyplex size and stability 
The polyplex size allows a first hint regarding the polymer capability to be used as transfection 
agent, since it is known that polyplexes larger than 500 nm show a decreased uptake.[44] For this 
purpose, dynamic light scattering (DLS) was applied as first analysis technique to determine the 
dependency of aggregation of the polyplexes on the conditions used for the complex 
formation.
[45]
 To evaluate the polyplex formation with regard to the preparation procedure, in first 
experiments the polyplex sizes were measured manually using the Zetasizer (Malvern). 
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Polyplexes for all N/P ratios and all PEIs revealed thereby radii between 40 to 100 nm with 
polydispersities in a range of 0.09 to 0.50 (data not shown). Additionally, selected polyplexes 
were studied over 2 h and revealed no change in their size (data not shown), which further 
confirmed the formation of stable polyplexes by utilization of the pipetting robot.  However, in 
order to realize the analysis of the polyplex size in an automatic HT manner, a DLS plate reader 
was applied. As displayed in Figure 1, all polyplexes revealed here a radius of less than 270 nm, 
whereby in particular polyplexes with N/P ratios above 5 showed radii below 250 nm. The 
smallest radius of 70 nm was obtained for the BPEI200. It is obvious that higher radii with 
increased standard deviations were detected by the HT-DLS device. This could be explained by 
the altered preparation procedure as well as by the different devices and settings. Although HT-
DLS results should be always considered with care by application of the HT-DLS device 
information about the tendency of the polyplexes to aggregate can be obtained and conclusions 
about the polyplex stability in comparison to standard polymer controls are possible. According 
to these data, three tendencies were found, also reported in literature: (i) With increasing N/P 
ratio smaller polyplexes were observed (ii) BPEI with higher DPs showed a stronger size 
dependency compared to LPEI and (iii) BPEI condensed DNA into smaller particles compared to 
LPEI.
[31]
 An influence of the degree of polymerization or the molar mass could not be observed 
under the chosen conditions.  
 
 
Figure 1. Hydrodynamic radii of polyplexes prepared using they pipetting robot. The values 
represent the mean (n ≥ 3) of each polymer at different N/P ratios.  
Fluorescence displacement assay 
Besides the polyplex size, also the determination of the binding affinity of the polymers to the 
genetic material is of vital importance for the interpretation of the transfection results. As 
mentioned before, an optimal polyplex binding is a compromise of a strong, but also reversible 
interaction in order to protect and transport the genetic material as well as to release the DNA 
inside the cell. Moreover, by determination of the binding affinity the N/P ratio at which the 
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polyplexes are formed, could be estimated. This can either be investigated by usage of gel 
retardation assays or by application of intercalating dyes, such as ethidium bromide (EB) or Pico 
Green. As the gel retardation method is not suitable for a HT screening in a 96-well plate format, 
the fluorescence displacement assay with EB was chosen. It is generally known that the binding 
of EB with the pure pDNA leads to a high fluorescence signal. However, if the pDNA form 
interelectrolyte complexes with the polymers, the dyes are displaced leading to decreased 
fluorescence signals. For the investigation of the binding affinity via an EB assay, 100 µL of the 
polyplex suspension were mixed with EB in each well and analyzed using a fluorescence plate 
reader. In Figure 2, the fluorescence signals (RFU) of all investigated PEI polymers with 
increasing N/P ratio are shown. It was found that BPEI200 and BPEI600 reached a comparable 
RFU of around 30.5 ± 1.4% (p > 0.5) indicating a strong DNA binding. Furthermore, BPEI20 as 
well as the higher molar mass LPEIs (LPEI200 and LPEI600) revealed comparable RFUs in the 
range of 37.1 ± 6.2% (p > 0.1), whereas the weakest binding was obtained by LPEI20 showing 
further a strong N/P dependency. In detail, polyplexes formed at N/P -20 revealed a mediate RFU 
of 48.7 ± 8% (p > 0.5) compared to 73.8 ± 8.5% at N/P 5. The obtained results demonstrate that 
the binding affinity depends on the molar mass and the architecture of the polymer as well as on 
the N/P ratio applied. A proportional increase of the binding affinity was observed with 
increasing molar mass of the polymer. Furthermore, a higher binding affinity of branched 
structures (BPEI) was detected in comparison to linear architectures.
[8, 31]
 Additionally, in the 
case of LPEI20 it can be seen that the binding affinity correlates with the N/P ratio until a plateau 
is reached (here at N/P 10). These trends were also reported in literature and confirm the 
possibility of polyplex analysis by this HT assay.
[46, 47]
 It should be noted that already at this stage 
of the workflow, after performing size measurements and binding affinity assays, it is possible to 
exclude polymers non-suitable as transfection agents, which showed undesired interaction like 
aggregation or no polyplex formation, respectively.  
 
Figure 2. Fluorescence displacement assay using LPEI and BPEI with varying DP. The RLU 
of single pDNA represent 100% RLU. N/P ratios of 2.5 up to 20 were studied using EB as 
intercalating agent. The values represent the mean ± S.D., n ≥ 3, # indicate significant statistical 
difference (ANOVA, p < 0.05). 
strong 
binding 
# 
medium 
binding 
weak 
binding 
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DNA release 
After determination of the binding affinity, the release of the pDNA from the polyplexes was 
investigated using the heparin assay. Heparin is a polyanion and was explored to be a good 
competitor to the negatively charged pDNA.
[47]
 Thus, it is able to form interelectrolyte complexes 
with the cationic polymers and, as a result of this polymer-heparin interaction, the pDNA is 
released and able to interact with the EB as intercalating dye leading to increased fluorescence 
intensities. The heparin study is often performed via gel retardation assays or using one single 
N/P ratio, which might lead to misinterpretations due to the fact that the given N/P ratio does not 
represent the molar ratio at each step of the transfection procedure. In particular for in vitro 
cultivations of adherent cells, the concentration at the cell membrane differs between the 
beginning of the transfection and after incubation due to the polyplex sedimentation process.
[8, 48, 
49]
 In order to determine the critical heparin concentration at different N/P ratios for a more 
reliable conclusion, all polyplex suspensions were titrated against two heparin stock solutions 
(c = 10 U mL
-1 
and 200 U mL
-1
) in the fluorescence plate reader at 37 °C. With this approach, a 
high range of heparin concentrations (20) can be tested for one sample. The results obtained from 
the performed assay are displayed in Figure 3. A detailed fluorescence plot for N/P ratios up to 
20 for LPEI600 is shown in Figure 3 A, whereas a summary of all is presented in Figure 3 C.  
As expected, the release of pDNA detected by RFU was dependent on the heparin 
concentration. Moreover, it was explored that higher N/P ratios required an increased amount of 
heparin to reach a full pDNA release. This effect was detected for all investigated polymers 
(Figure 3 C) and is explained by the fact that at high N/P ratios the amount of free polymer is 
increased, whereas the amount of complexed polymer remains constant.
[50]
 Thus, by adding 
heparin to the polyplex suspensions with high N/P ratios, first all free polymers complex with the 
heparin and no pDNA is released. Only above a critical concentration the pDNA is released, and 
an increase of RFU can be detected. For an improved comparability, the inflection point of the 
titration curves in Figure 3 A was defined as the critical heparin concentration (HC50) and 
implemented as representative value of the concentration at which usually 50% of the complexed 
pDNA were released. 
9 
 
 
 
A B 
  
C D 
  
 
Figure 3. The pDNA release of polyplexes after titration with heparin. Release of pDNA was 
measured by incubation of polyplexes with increasing heparin concentrations. A) RFU of 
polyplexes prepared from LPEI600 at different N/P ratios and increasing heparin concentrations. 
B) Slope of RFU of LPEI600 polyplexes at different N/P ratios. C) RFU of all polyplexes at 
different N/P ratios and increasing heparin concentrations. Color represents the RFU. D) Slope of 
RFU of all polyplexes at different N/P ratios. Color represents the slope. The values represent the 
mean ± S.D., n ≥ 3.  
A detailed example of RFU plots of the LPEI600 polyplexes is shown in Figure 3 B, and an 
overview of the HC50 values of all studied polyplex samples is displayed in Figure 3 D. The 
correlation between the N/P ratio and the heparin concentration was obvious and confirmed 
already published trends, which are also based on the complex formation of heparin with PEI 
polymers. However, beside the influence of the N/P ratio, it was observed that the architecture of 
PEI plays a role in the kinetic of the release. Polyplexes prepared from branched polymers 
RFU / % 
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showed higher HC50 values (indicated by larger purple areas in particular at N/P 2.5 and 5, Figure 
3 C and D) in comparison to the linear polycations. Furthermore, the polyplexes prepared with 
the LPEI20 showed an early release of the pDNA at low heparin concentrations in comparison to 
its branched counter piece (BPEI20), but also compared to the linear PEIs with higher molar 
masses (LPEI200 and LPEI600). These results correlate well to the weak binding affinity obtained 
with the fluorescence displacement assay (Figure 2). 
Cytotoxicity  
To study the cytotoxicity of the polyplexes, HEK cells were seeded in 96-well plates and 
incubated for 24 h with the prepared polyplex suspensions. In order to measure the viability of 
the cells, they were washed after the incubation and stained with Hoechst 33324, a dye that 
crosses the cell membrane and stains the chromosomal DNA of attached cells. Subsequently, the 
fluorescence was measured utilizing the fluorescence plate reader. The obtained RFU signals of 
Hoechst of all treated cells are presented in Figure 4 A. No indication for cytotoxic effects of the 
polyplexes was found since the detected values are comparable to non-treated cells (ANOVA, 
p > 0.05). The polyplexes exhibited a lower cytotoxicity than the single polymers due to 
neutralized cationic groups. Polyplex toxicity at N/P 20 would be a knock out criteria. However, 
for a comprehensive analysis, the polymers were also screened with regard to their toxicity using 
polymer concentrations up to 72 µg mL
-1
, which is equal to N/P 500 in this case (data not 
shown). With increasing DP of the cationic polymers a higher cytotoxicity was observed, though 
no significant difference between linear and branched PEI could be detected.
[31]
 Interestingly, the 
polymers with the lowest DP showed no cytotoxicity at all investigated concentrations. 
 
Figure 4. Investigation of cytotoxicity. The viability of cells after incubation of the polyplexes 
up to N/P 20. Non-treated cells served as controls and gave comparable results. The bottom of 
96-well plates were measured at Em350/Ex461 (Hoechst 33324).  
 
Transfection efficiency 
 
To allow conclusions about the transfection efficiency of the polymeric vectors, the expression 
of reporter genes was visualized by fluorescence using an EGFP reporter encoded plasmid. 
Usually, this expression system is analyzed by flow cytometry analysis. But as this technique is 
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not suitable for the HT screening approach presented here the transfection efficiency was studied 
using a microscope and a fluorescence plate reader. To this end, cells were seeded in 96-well 
plates, incubated with polyplexes for 24 h, stained with Hoechst 33324 and, subsequently, studied 
with regard to the amount of green fluorescent cells by automatically scanning the wells with the 
microscope. In Figure 5 A, a representative overview of the cells transfected with LPEI600 is 
displayed. Since a simple microscopic analysis is not sufficiently efficient for a rapid HT 
screening with regard to the data processing and does not allow a direct comparison of the 
samples, the mean fluorescence in each picture was measured and calculated. The obtained 
values are presented in Figure 5 B. In order to study the capability for the quantification of EGFP 
using a fluorescence plate reader, which would be more efficient and faster, the well plates were 
additionally screened with this technical device regarding their fluorescence. As demonstrated in 
Figure 5 B, a good correlation between the microscopic analysis and the fluorescence plate reader 
results was found, proving the capability to screen the EGFP amount in a fast and easy manner. 
In general it can be stated that there are some decent advantageous of a fluorescence screening 
with a plate reader compared to luciferase or galactose based assays, namely: (1) An easy and 
cheap detection, (2) the possibility to perform single cell analysis by flow cytometry or 
microscope afterwards of the same cells, and (3) the fact that EGFP is a more stable reporter 
protein. 
The expression of EGFP for all investigated PEI polymers is presented in Figure 5 C. The 
following order of high to low transfection efficiency was obtained: LPEI600 > LPEI200 > BPEI200 
> BPEI600 > BPEI20 > LPEI20. Obviously, the standard deviation was increased compared to flow 
cytometry measurements. However, the HT investigation showed clearly trends confirming that 
the method is suitable to elucidated high potential candidates, which should be investigated 
subsequently in more detail. LPEI20 revealed no transfection efficiency, while LPEI600 shows the 
highest one. In between, also branched and linear PEI200 reached high transfection efficiencies. 
The most efficient N/P ratio seemed to be dependent on the specific cationic polymer. While N/P 
5 and N/P 10 were optimal for the linear PEIs, BPEI200 showed the highest transfection efficiency 
at N/P 2.5. The results obtained from the screening of the EGFP expression were comparable 
with non HT transfection procedures, using vortexed polyplexes and flow cytometry (data not 
shown). This observation further confirms the potential of such a HT screening of the transfection 
efficiencies of polymers using a fluorescent plate reader.
12 
 
 
A 
 
B C 
 
 
Figure 5. Transfection efficiency by microscopic evaluation and fluorescence intensity 
measurements. A) HEK cells transfected with EGFP coding pDNA and LPEI600 at N/P 10. Cell 
nuclei were stained with Hoechst 33324 (blue). Scale bare indicates 500 µm. B) Correlation of 
the microscopic evaluation of EGFP content determined (RFUmicroscope) and bottom measurements 
using a plate reader (RFUplate reader). Three control wells, where cells were not transfected, as well 
as cells only incubated with the polymer at concentrations correspond N/P 20 (N20) showed no 
RFU. C) Transfection efficiency and number of cells transfected with a pipetting robot in a 96-
well plate. Values represent the mean ±  S.D., n ≥ 3. 
 
Conclusion 
 
Since HT synthesis and characterization of polymers could be managed by synthetic robots and 
microwave synthesizers combined with the subsequent characterization of the molecular 
properties using fast and automated characterization tools, polymer libraries for biological 
applications can be prepared with a high variety of parameters in a rapid manner.
[15-20]
 However, 
an efficient and fast HT screening of these polymers for gene delivery purposes regarding 
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structure-property relationship was up to now not possible. In this contribution, a solution for the 
biological screening bottleneck has been found for gene delivery applications. The discussed HT 
workflow enables a rapid analysis of polymer vectors in an automated way with respect to 
important polymer characteristics, such as molar mass, architecture, and N/P ratio used for the 
pDNA binding and release. By its application it is possible to identify and evaluate reams of 
polymers with regard to their capability to realize an efficient complexation, protection and 
transfection of pDNA. For instance, the described heparin assay can be used for 23 polymers at 
four different N/P ratios resulting in 92 samples plus controls (n = 1).
[15-20]
 By using only one N/P 
ratio, a further increase in polymer samples up to 30 (triplicate), 46 (duplicate), or 94 (single) is 
possible. This enables a possible screening of around 360 polymers (one N/P ration, triplicate or 
three N/P ratios, single) or 1100 polymers (one N/P ration, single) within 24 h. Furthermore, it 
was demonstrated that the screening of the cytotoxicity and the transfection efficiency of the 
polyplexes is also possible in a HT manner. As expected, the study of the different PEI model 
polymers revealed that linear and branched PEI are non-cytotoxic at the investigated 
concentrations, but that with rising molar mass and polymer concentration the cytotoxic effect 
was increasing. The polymeric architecture itself showed thereby no influence on the cell 
viability. At low molar masses the DNA binding affinity is influenced by the polymeric 
architecture, since BPEI20 revealed a stronger pDNA binding than LPEI20. The obtained results 
indicated that PEIs with branched architectures and small molar masses have the highest potential 
to be used as gene vectors, as they offer the advantage of low cytotoxicity combined with high 
pDNA binding affinity. Although having relatively high binding affinities, the best transfection 
results were obtained for LPEI600 and the BPEI200. 
It could be proven that the developed workflow is applicable for polymer systems and 
conditions enabling a fast and efficient screening in terms of important vector parameters, such as 
polyplex formation, transfection and release. The possible screening of polymer libraries for the 
best transfection candidate will help to elucidate main polymer characteristics and to understand 
why some polymers are high performers and others not. Thus, an enhanced development of more 
efficient polymers and polyplexes can be realized.  
 
Experimental section  
Material 
Ethidium bromide solution 1% was purchased from Carl Roth (Karlsruhe, Germany). 
AlamarBlue was obtained from Life Technologies (Darmstadt, Germany). If not otherwise stated, 
cell culture materials, cell culture media, and solutions were obtained from PAA (Pasching, 
Austria). Plasmid pEGFP-N1 (4.7 kb, Clontech, USA) was isolated using Qiagen Giga plasmid 
Kit (Hilden, Germany). All other chemicals were purchased from Sigma Aldrich (Steinhausen, 
Germany) and are of analytical grade or better and used without further purification. Linear PEI 
was synthesized according to procedure described in literature.
[32]
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Synthesis of LPEI 
LPEIs were synthesized from the corresponding poly(2-ethyl-2-oxazoline)s (PEtOx) by acidic 
hydrolysis as described in literature.
[32, 33]
 Briefly, PEtOx (2 g) was dissolved in 6 M aqueous 
hydrochloric acid (15 mL) and heated at 130 °C for 1 h in a Initiator Sixty single-mode 
microwave synthesizer from Biotage, equipped with a noninvasive IR sensor (accuracy: ± 2%). 
The acid was removed under reduced pressure. The residue was dissolved in water and 3 M 
aqueous NaOH was added until precipitation occurred. The precipitate was filtered off, 
recrystallized from water, filtered, dissolved in methanol, and precipitated into ice-cold diethyl 
ether. Subsequently, the LPEI was dried for 3 day at 40 °C. The degrees of hydrolysis were 
determined by 
1
H NMR spectroscopy and found to be 99% for all LPEIs. A detailed 
characterization of the short LPEI20 can be found elsewhere. 
[32, 33, 51]
 1H NMR (300 MHz, CD3OD): 
δ = 3.65 (t, CH2-OH), 2.73 (br., N-CH2), 2.39 (s, CH3-N). IR (FT-IR): ν = 3217 (NH), 2 873 (CH3), 2804 
(CH), 1 446 (CH2/CH3), 1330 (C-N), 1134 (C-N), 1103 (C-N) cm
-1 
 
Table 1. SEC-Data of the PEtOx precursors.  
PEtOx precursor Repeating units
a)
 Mn (g/mol)
b)
 PDI
b)
 
PEtOx20 20 3,600 1.11 
PEtOx200 200 58,200 1.14 
PEtOx600 600 40,600 1.79 
a)
Calculated from 
1
H NMR; 
b)
Determined by size exclusion chromatography (solvent: 
chloroform/triethylamine/ iso-propanol [94/4/2]; calibration standard: PS) 
Polyplex preparation using pipetting robot 
For an automated polyplex preparation, 100 μL buffered DNA solution (c = 15 μg mL-1) were 
injected into wells that contain 300 μL of the desired polymer solution. As cationic polymers, 
linear PEI with a DP of 20, 200, and 600 as well as branched PEI with a DP of 20, 200, and 600 
were applied. In order to achieve different polymer to DNA ratios (N/P ratios), a dilution series in 
HBG of four different polymer concentrations (N/P ratio 2.5, 5, 10, 20) was prepared using a 
pipetting robot from a polymer stock solution of c = 72 µg mL
-1
. After addition of the DNA 
solution, the polyplex suspension was mixed five times by suction and release using 200 μL tips 
and incubatedat least 20 min. Subsequently, 100 μL of each polyplex suspension were transferred 
into three different well plates for a detailed analysis studies. The following assays were 
performed up to 2 h after polyplex preparation. 
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Table 2. Hydrodynamic diameter of polyplexes prepared by conventional preparation 
(vortexed for 10sec, incubated for at least 15 min) and pipetting. Radii were measured with 
Zetasizer Nano ZS (Malvern Instruments, Herrenberg, Germany).  
 METHOD 
PEI  
(µL) 
DNA  
(µL) 
HB  
(µL) 
Z Avg 
(nm) 
PDI 
lPEI600 
pipetted 3x mix 100 50 50 160 0.40 
vortexed 10s 100 50 50 158 0.38 
bPEI600 
pipetted 3x mix 100 50 50 135 0.23 
vortexed 10s 100 50 50 150 0.43 
 
Investigation of polyplex size and stability 
For first studies, the polyplex sizes were studied by utilization of a Zetasizer Nano ZS (Malvern 
Instruments, Herrenberg, Germany). The measurements were carried out in a minimal volume 
cuvette ZEN 0040 (BRAND GmbH, Wertheim, Germany) with a laser beam at 633 nm and a 
scattering angle of 173° at 25 °C. The viscosity (0.89 mPa s) and refractive index (1.33) of 
purified water at 25 °C were used for data analysis. 40 μL of polyplex suspensions were 
measured five times for 20 sec. The mean particle size was approximated as the effective 
(Z average) diameter and calculated with the General purpose (normal resolution) algorithm 
using the Malvern software 6.20. For the polyplex size analysis by dynamic light scattering, a 
DynaPro Plate Reader Plus (Wyatt Technology Corporation, Santa Barbara, CA) equipped with a 
60 mV linearly polarized gallium arsenide (GaAs) laser of λ = 832.5 nm and operating at an 
angle of 156° was utilized. Again, the viscosity (0.89 mPa s) and refractive index (1.33) of 
purified water at 25 °C were used for data analysis. The data were analyzed with the Dynamics 
software ver. 6.10 by the method of cumulants as previously described for nanoparticle 
analysis.
[42]
 The measurement time was set to 10 seconds per run and 10 acquisitions were 
collected five times per well and repeated 3 times in independent experiments. 
Binding affinity 
The polyplex formation and binding affinity responsible for complexation of pDNA and 
polymers were detected by quenching of the ethidium bromide (EB) fluorescence as described 
previously.
[52]
 After the polyplex preparation via pipetting robot, 100 µL of the polyplex solution 
were incubated with EB (0.4 µg mL
-1
) for 10 min at room temperature in black 96-well plates 
(Nunc, Langenselbold, Germany). The fluorescence was measured using a Tecan Genios Pro 
fluorescence microplate reader (Tecan, Crailsheim, Germany) with excitation and emission 
wavelength at 525 and 605 nm, respectively. A sample containing only pDNA and EB was used 
to calibrate the device to 100% fluorescence. The percentage of dye displaced upon polyplex 
formation was calculated using equation (1): 
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        (1) 
Here, RFU is the relative fluorescence. Fsample and FsiRNA are the fluorescence intensities of a 
given sample and the EB intercalated into pDNA alone. 
DNA release by heparin 
To investigate the release of pDNA from polyplexes, the heparin dissociation assay was used. 
For this purpose, 100 µL of polyplex solution were incubated for 10 min with EB (0.4 µg mL
-1
) 
in a black 96-well plate. After transferring into the Tecan Genios Pro fluorescence microplate 
reader, heparin solutions were automatically added at the indicated concentrations. Therefore, 20 
cycles of the following procedure were used: 5 µL of heparin stock solutions (10 U mL
-1
 or 
200 U mL
-1
) were dropped to each well. Afterwards the plate was shaked (orbital, 10 sec, 2 mm) 
and incubated for 5 min at 37 °C. After each cycle, the fluorescence of EB was measured, and the 
percentage of intercalated EB was calculated as described before (1). 
Cell Culture  
HEK-293 (CRL-1573, ATCC) cells were maintained in RPMI 1640 culture medium, L929 
(CCL-1, ATCC) in DMEM culture medium. Both media were supplemented with 10% fetal calf 
serum (FCS), 100 µg/mL streptomycin, 100 IU mL
-1
 penicillin, and 2 mM L-glutamine. Cells 
were cultivated at 37 °C in a humidified 5% CO2 atmosphere.  
The cytotoxicity of the single polymers was tested with L929 cells, as this cell line is 
recommended by ISO10993-5. In detail, cells were seeded at 10
4
 cells per well in a 96-well plate 
and incubated for 24 h. No cells were seeded in the outer wells. Afterwards, polymers at the 
indicated concentrations were added, the plates were slued, and incubated at 37 °C for further 
24 h. Subsequently, the medium was replaced by PBS and AlamarBlue as recommended by the 
supplier. After incubation for 4 h, the fluorescence was measured at Ex 570 / Em 610 nm, with 
untreated cells on the same well plate serving as controls (2).  
       (2) 
Here, viability is the relative fluorescence and Fsample, F0, and Fcontrol are the fluorescence 
intensities of a given sample, the blank wells without cells, and the control cells without polymer 
treatment. 
For transfection experiments, HEK cells were seeded at a density of 10
4
 cells per well in 96-
well plates 24 h before transfection. In order to avoid any misleading measurement results and to 
prevent a systematic mistake, the polyplexes were always placed and measured at different 
positions in the 96-well plate to avoid alterations due to differences in the gas exchange between 
outer and inner wells and 25 measuring points per well were taken. One hour prior transfection, 
cells were washed with PBS and supplemented with 100 µL OptiMEM (Life Technologies). 
Polyplex solutions were added (10 µL) to the cells and the plates were slued and incubated for 4 
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h at 37 °C. Afterwards, the supernatant was replaced by 100 µL of fresh growth medium 
(RPMI1640 based), and the cells were further incubated for 20 h. Before analysis, the cells were 
incubated with 1 µg mL
-1
 Hoechst 33324 for 10 min at 37 °C, washed twice with PBS, and the 
plates were transferred to the plate reader. The expression of EGFP fluorescence (Ex 475 nm / 
Em 509 nm) and viability (Hoechst, Em 350 nm / Ex 461 nm) was quantified by using the 
fluorescence measured from the bottom of the plates. The transfection efficiency was calculated 
relative to cell number and control cells using the following equation (3), where and EGFPsample, 
EGFPcontrol, Hoechstsample, Hoechstcontrol are the fluorescence signal of EGFP and Hoechst of 
treated (sample) and non treated (control) cells, respectively. Experiments were repeated 3 times 
independently.  
    (3) 
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Figure 2.1. Important parameters for the design of polymeric nanoparticles.  Moreover, for in vivo applications an active targeting strategy of the nanoparticles is beneficial to ensure a controlled accumulation in the desired tissue.[38] The idea is to conjugate ligands, such as antibodies, peptides, nucleic acids and other small molecules to the nanoparticle surface, which bind specifically to antigens or receptors that are only expressed on the target cells.[39] Manifold studies demonstrated that the attachment of targeting units, in particular in combination with a PEG surface modification, significantly increased the accumulation of the nanoparticles in the tumor tissue.[40,41] The undesired accumulation in healthy organs, such as liver, spleen, heart and lung was thereby decreased, which is beneficial in terms of enhanced cancer detection and unknown long-time consequences that might be accompanied with the application of fluorescent nanoparticles. In the past few years a great progress in the development of polymer based nanoscale agents could be observed and many promising studies demonstrated the large potential of targeted fluorescent particles for selective imaging. However, in order to realize the usage of polymeric nanoparticles in clinical applications it is certainly required to gain deeper knowledge about their production and design, in vivo stability, circulation behavior and their interactions with blood, proteins and cells as well as their definite faith.    
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Figure 3.1. Left: Overview about the nanoprecipitation methods (a) of dialysis and (b) dropping technique. Right: Tuning possibilities of the size and shape of the nanoparticles by variation of (c) initial polymer concentration and (d) dropping method.  Stimulated by the successful application of nanoprecipitation for various synthetic polymers, the dropping technique was accomplished in a high-throughput (HT) manner via utilization of pipetting robots, in order to facilitate a faster, reproducible, and more in-depth exploration of process-property relationships of the materials. In particular, for the development of improved particle formulations for drug delivery or systematic biotechnological studies, the HT-nanoprecipitation represents a highly suitable tool. In a first set of experiments, the biocompatible polymers poly(methyl methacrylate-stat-methylacrylic acid) (p(MMA-stat-MAA)0.66:0.33), poly(lactide-co-glycolide)0.5:0.5 (PLGA) and acetal-derivatized dextran (ac-dex) were chosen to be processed via HT-nanoprecipitation (Figure 3.2a). The interplay of the manufacture process and the resulting characteristics of the nanoparticles was thereby investigated by alteration of the initial polymer concentration and the solvent-to-non-solvent ratio (Figure 3.2b). For this purpose, a dilution series of the respective polymer solution with concentrations ranging from 1 mg · mL-1 up to 12 mg · mL-1 was created and combined with different proportions of water, in a way that the solvent (acetone) to non-solvent (water) ratios varied from 0.1 to 0.5 (v/v). After each polymer solution was added dropwise into water, the net result was an array of 96 different formulations, which exhibits a visually observable trend in appearance, following the changes made in the nanoprecipitation process (Figure 3.2b).  The fabricated plates of the different nanoparticle formulations were subsequently characterized with regard to their particle size distribution in an automated manner using a high-throughput dynamic light scattering (HT-DLS) device (Figure 3.2c). The HT-DLS measurements confirmed the dependency of the final average particle sizes on the polymer concentration (Figure 3.3a-c). At diluted polymer concentrations, the nanoprecipitation process yielded small nanoparticle sizes below 100 nm with monomodal and narrow size distributions for all polymers. But with rising concentration, the particle diameters 
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increased, which was indicated before by the increased turbidity of the suspensions. In detail, 60 nm to 290 nm sized nanoparticles were obtained by nanoprecipitation of the p(MMA-stat-MAA)0.66:0.33 polymer within a concentration range from 1 mg · mL-1 to 12 mg · mL-1 (Figure 3.3a). The sizes of the PLGA nanoparticles varied from 40 nm for 1 mg · mL-1 to 170 nm for 10 mg · mL-1, while ac-dex particles revealed increasing sizes from 80 nm to 140 nm for the same range of concentrations (Figure 3.2b,c).  
Figure 3.2.  HT-experimental set-up: (a) HT-nanoprecipitation of polymers a pipetting robot. (b) Layout of a 96 well plate after nanoprecipitation. The concentration of the polymer is varied along the x-axis and the ratio of solvent/non-solvent solution along the y-axis. (c) The final well plates of different nanoparticle formulations were characterized using HT-DLS. For all examined polymers the tendency of a growth of the mean particle diameter as a function of initial polymer concentration was detected. This effect was expected since with higher concentration of the polymer in the organic phase more polymer molecules per unit volume of solvent are present. A comparatively small effect on the nanoparticle sizes exhibited the solvent to non-solvent ratio in the studied region. Merely a slight decline in the mean nanoparticle diameter with increasing solvent/non-solvent ratio was observed. Furthermore, the polymer characteristics itself revealed a high impact on the nanoparticle size as well. Regarding to its hydrophobicity and molar mass, a difference in the particle formation for the different polymers is the consequence. By HT-DLS investigations, an exponential growing in the particle size was observed for the p(MMA-stat-MAA)0.66:0.33 copolymer, while the sizes of the ac-dex particles increase less considerably, and the concentration dependence tends to play a minor role (Figure 3.3d). The tendency obtained for PLGA-nanoparticles is located between the p(MMA-stat-MAA)0.66:0.33 and ac-dex, and it also tends to show a linear correlation between concentration and size, contrary to the exponential one of the p(MMA-stat-MAA)0.66:0.33 copolymer. To evaluate the influence of the polymers and the manufacturing parameters on the resulting surface charge of the nanoparticles, zeta potential (ζ) measurements were performed of selected samples. As mentioned in Chapter 2, the zeta potential provides vital information about the nanoparticle stability and affects the cellular internalization as well as the biodistribution in vivo.[17,45] p(MMA-stat-MAA)0.66:0.33 particles revealed values between ζ = ‒17  to ‒65 mV, while a lower 
surface charge of ζ = ‒14  to ‒22 mV was obtained for ac-dex and PLGA particles. A correlation of the zeta potential and particle size was evident due to the fact that the surface charge was increasing with higher polymer concentrations, whereas with varying solvent/non-solvent ratio the measured zeta potential remained unchanged. 
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Figure 3.3. (a) P(MMA-stat-MAA)0.66:0.33, PLGA, and ac-dex applied for HT-nanoprecipitation and (b) corresponding 3-D representation of the size distribution obtained by HT-DLS as a function of initial polymer concentration and solvent to non-solvent ratio. The particle suspensions were prepared by dropping the polymer acetone solution into water.   Additional studies were addressed to extend the understanding of the effect of the molar mass of the polymer on the nanoparticle formation. For this purpose, a homologous series of a poly(methyl methacrylate) (PMMA) polymer with molar masses ranging from 3,000 g · mol-1 to 278,000 g · mol-1 was applied for the HT-nanoprecipitation process. In first studies identical to previous experiments, the polymer concentration and the solvent to non-solvent ratio were altered. HT-DLS measurements revealed that with increasing molar mass of the PMMA polymer the range of particle sizes was rising as well, while the critical polymer concentration for aggregation was decreased (Figure 3.4). For instance, PMMA with a molar mass of 38,000 g · mol-1 showed an aggregation of the particles already at an initial concentration above 10 mg · mL-1, whereas PMMA with a molar mass of 6,000 g · mol-1 formed stable nanoparticles up to a concentration of c = 30 mg · mL-1.   
Figure 3.4. 3D-Representation of a size distribution obtained by DLS of PMMA polymers with different molar masses: (a) Mw = 6,000 g · mol-1, (b) Mw = 18,000 g · mol-1, and (c) Mw = 38,000 g · mol-1.  The particles were prepared by dropping polymer acetone solution in water. 
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 It was explored that the small p(MMA-stat-MAy)0.97:0.03 particle batches (S1 and S2) revealed similar average sizes and size distributions proving the superior qualification of the nanoprecipitation to prepare narrow, defined nanoparticles in a straightforward manner. Contrary, for the larger particles (L1 and L2) diverging sizes were obtained ranging from 400 up to 600 nm, depending on the characterization method applied. Although no remarkable discrepancy in the size plots of the differently prepared particle suspensions could be observed by DLS (Figure 4.2a), the distributions obtained by AUC already illustrate broader size distribution for the samples prepared by nanoprecipitation (Figure 4.2b). This was further confirmed by a detailed analysis of the SEM images, in which the fractionated samples were obviously more uniform in their size than the initial, non-fractionated samples (Figure 4.2c). Yet, it is difficult to predict if a fractionation process by PUC is actually more efficient than using a defined nanoprecipitation process. The precipitation method convinces due to its fast and easy applicability. Furthermore, it already led to monomodal and narrow size distributions for the small nanoparticles. In contrast, for the large particles prepared by nanoprecipitation a broader size distribution was observed (as revealed by AUC and SEM measurements) indicating that the effort to use PUC for more distinct size distribution might be profitable.  
 
Figure 4.2. Characterization of small and large nanoparticles of p(MMA-stat-MAy)0.97:0.03 prepared by nanoprecipitation and fractionation via PUC. Size distributions of the particles in water determined by DLS (a) and AUC (b) as well as SEM images of the particle suspensions (c). 
Table 4.2. Summary of the size distributions of the nanoparticles based on p(MMA-stat-MAy)0.97:0.03.  Sample Preparation method dDLS [nm] PDIP dSEM [nm] dAUC [nm] 
S1  Nanoprecipitation 118 0.10 111 120 
L1 Nanoprecipitation 488 0.03 696 503 
S2 PUC fractionation 120 0.26 131 97 
L2 PUC  fractionation 597 0.19 502 381 
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synthesize a range of dextran-graft-linear poly(ethylene imine)s (dex-g-lPEI): (1) Reductive amination of aldehyde functionalized dextran (CHO-dex), (2) 1-ethyl-3-(3-dimethylamino-propyl) carbodiimide (EDC) coupling of carboxymethylated dextran (CM-dex) and (3) carbamate formation via reaction of 4-nitrophenyl carbonate-substituted dextran (NPC-dex) (Scheme 6.1).[31,80,83] 
 
Scheme 6.1. Schematic representation of the functionalization of dextran by (a) oxidation, (b) carboxymethylation and (c) 4-nitrophenyl carbonate-activation with subsequent reaction with lPEIs 
via (a) reductive amination, (b) EDC coupling and (c) carbamate formation. 
 To study further the impact of the degree of substitution (DS) of the dextran with lPEI as well as the lPEI chain length, two lPEIs consisting of n = 20 and 40 monomer units (lPEI20 and lPEI40) were allowed to react in various ratios with the different dextran precursors. For the grafting of lPEI to the dextran via reductive amination, aldehyde enriched dextrans were prepared by oxidation of dextran from Leuconostoc mesenteroides with different amounts of potassium periodate (KIO4). Subsequently, the aldehyde containing precursors were each converted with the lPEI20 and lPEI40, whereas the DS of conjugated lPEIs per AGU was aimed to be at maximum 0.5. After subsequent reduction with sodium borohydride (NaBH4) and purification by dialysis, the successful binding of the lPEI to the CHO-dex was confirmed by 1H NMR spectroscopy measurements. The resulting DS of lPEI was calculated from the nitrogen content observed in the elemental analysis and determined to be between 0.13 to 0.38 per AGU (A series, A1-A4, Table 6.1).  For the EDC coupling strategy, dextran was first derivatized to CM-dex to introduce carboxylic moieties into the polymer. The carboxymethylation was performed under basic conditions using altered ratios of monochloroacetic acid (CH2ClCOOH) and altered reaction times.[84] The final degree of functionalization was determined according to the HPLC procedure described by Heinze et al. (Table 6.1).[85] The subsequent grafting of lPEI20 and lPEI40 to the carboxymethylated carbohydrates was performed with usage of 
N-hydroxysulfosuccinimide (sulfo-NHS) and EDC owing to their well-known coupling 
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In order to investigate the dependency of the nanoparticle properties on different polymers and preparation conditions, several N/P ratios (2.5, 5, 10 and 20) were applied next to various PEIs. To this end, a dilution series ranging of previously produced polymer stock solutions was provided by using the pipetting robot. Afterwards, a DNA solution was added to each polymer solution, and the resulting suspensions were directly mixed by repetitive suction and release. After the nanoparticle formation, the nanosuspensions were distributed automatically into different well plates for subsequent parallel characterization studies (Scheme 6.2).  Since the complex size allows a first conclusion regarding the polymer capability to be used as transfection agent, DLS was applied as first analysis technique to determine the dependency of aggregation of the PEI/DNA assemblies on the conditions used for the complex formation.[62] In order to realize the analysis of the complex size in an automatic HT-manner, a DLS platereader was used. As displayed in Figure 6.1, all PEI/DNA nanoassemblies revealed diameters less than 600 nm. The smallest diameter of 140 nm was obtained for the bPEI200. In comparison to previously performed manual size measurements, where complex sizes in a range of 80 to 200 nm were obtained, larger diameters with increased standard deviations were detected by the HT-DLS device. This could be explained by the different devices and settings for the DLS measurements. Although the HT-DLS results should be always considered with care, by application of the HT-DLS device information about the tendency of the polyplexes to aggregate can be obtained and conclusions about the polyplex stability in comparison to standard polymer controls are possible. According to these data, three tendencies were found: (i) With increasing N/P ratio, smaller complexes were formed; (ii) the bPEI revealed a stronger size dependency with higher molar masses in comparison to the lPEI, and (iii) the bPEI condensed the DNA into smaller particles compared to the lPEI (as also reported in literature).[90] An influence of the degree of polymerization or the molar mass could not be observed under the chosen conditions. 
 
Figure 6.1 Hydrodynamic diameters of PEI/DNA complexes prepared by the pipetting robot. Values represent the mean, n ≥ 3. 
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Fluorescence imaging of cancer tissue based on metal-free polymeric 
nanoparticles - Review
Antje Vollrath,a Stephanie Schubert,b,c Ulrich S. Schuberta,b* 
 
Abstract  5 
 
The utilization of fluorescent nanoparticles (FNPs), which consist of organic fluorophores embeded into a polymer matrix, seems to be 
a promising concept for in vivo cancer imaging showing good biocompatibility, biodegradability, and low toxicity of the agents. 
Polymeric nanoparticles as fluorescent nanocarriers can be systematically designed with regard to the requested task, i.e., specific 
accumulation in the tumor tissue. Versatile organic fluorophores can be entrapped into polymers with fine-tuned properties, which 10 
were synthesized via polymerization techniques. Moreover, the formulation of the nanoparticles can be adjusted, and passive as well as 
active targeting strategies can be employed. Despite their evident benefits, fluorescent polymeric nanoparticles are still not in clinical 
application for cancer detection due to a still existing lack in the understanding of their in vivo interactions as well as their reproducible 
production. This review focuses on cancer imaging based on organic dyes and metal-free polymeric fluorescent nanoparticles 
highlighting recent interesting reports about their design and application as well as their limitations.  15 
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emerging matrix. The covalent attachment can be realized by 
copolymerization of original and dye-functionalized monomers. 
 
Figure 1. Common preparation techniques of polymeric FNPs. 5 
 
To obtain FNPs via the single emulsion technique, the labeled 
polymer units (covalent method) or a mixture of the polymer 
and the hydrophobic dye molecules (non-covalent method) are 
dissolved in a water-immiscible organic solvent (e.g. ethyl 10 
acetate, dichloromethane). Subsequently, the organic phase is 
emulsified in water with usage of appropriate surfactants 
(poly(vinylalcohol), polysorbate 20) to stabilize the particles, 
following the evaporation of the organic solvent. Hydrophilic 
dyes can be encapsulated by the double emulsion process.[101,102] 15 
In this approach, the dye is dissolved in a small volume of an 
aqueous phase and emulsified in an organic phase that contains 
the polymer. The mixture is emulsified again in a larger amount 
of aqueous media. Comparable to emulsion polymerization, the 
particle size and degree of dye loading can be influenced by the 20 
type of polymer and solvents, concentrations, surfactants, 
emulsification time, and other formulation conditions.  
Polymeric NPs are further produced by the nanoprecipitation 
method (also called solvent displacement) (Figure 1).[97,103-105] 
This method presents an alternative, easy, low cost as well as 25 
time efficient way to produce polymeric NPs and can be realized 
in a high-throughput manner.[106,107] Thereby, particles are 
readily constructed by exposure of a polymer solution (organic 
phase) to a non-solvent (water). The major advantages of the 
nanoprecipitation process over the emulsification procedures are 30 
the non-requirement of surfactants and that no additional energy 
for sonification is required. Moreover, by variation of the initial 
conditions, such as the solvent/non-solvent ratio and the 
concentration of the polymer solution, the NP sizes can be tuned 
from a few nanometers up to 1 µm.[106] For the dye labeling, the 35 
dye molecules are mixed with the polymer in the organic phase 
prior precipitation, and the dyes are encapsulated during the 
collapse or arrangement of the polymer molecules; not included 
dyes can be removed by washing procedures.   
To achieve FNPs via a covalent procedure, active groups, such 40 
as carboxylic groups, amine functionalities or entities that may 
perform click reactions, are introduced into the polymer 
backbone for reaction with the dye molecules. Likewise, the 
dyes also have to provide at least one functionality that can react 
with the polymer without changing the fluorescence properties. 45 
By usage of coupling agents, high conversions can be reached, 
though very often a low degree of dye substitution (e.g. few dye 
molecules per polymer chain) is sufficient as the particles 
contain multitudes of polymer molecules. 
 50 
3.4 Design of smart NPs 
 
Manifold biophysicochemical parameters are the key for NPs 
fate in vivo, which emphasizes that NP characteristics, such as 
size, shape, surface properties, and target unit, should be 55 
adjusted very carefully with regard to the final application of the 
nanocarriers.[108-111] By implementation of targeting concepts, 
NPs can be directed to desired active sites (tumors) without 
adverse effects such as fast clearance by the macrophagocytotic 
system (MPS) or accumulation in healthy tissue. For improved 60 
diagnostic it is essential that the FNPs accumulate, but to a great 
extend, only in the target site to avoid interferences and to 
achieve high signal-to-background ratios for refined tumor 
detection. 
 65 
 
Figure 2. Important parameters for the design of polymeric NPs.  
 
3.4.1 Passive targeting 
 70 
 Size 
One of the most important parameters in the NP design is the 
size. It is evident that particles aimed for intravenous injection 
should be in a size range not larger than 1 m in order to ensure 
long-term in vivo circulation without causing any thrombolytic 75 
reactions.[1] In contrast, particles administered to the lung by 
aspiration of an aerosol can be in the range of several 
micrometers, and for GI tract imaging the particle size is 
supposed to be even less important.[112] In literature, 
controversial size specifications are found for NPs to be used for 80 
in vitro and in vivo applications.[107,110-114] The data range 
thereby from small particles below 10 nm up to 500 nm sized 
NPs. While NP with a diameter approximately below 30 nm 
show an efficient cell uptake, they are also rapidly cleared by 
glomerular filtration in the kidney. Contrary, larger NPs 85 
(> 200 nm) show a decreased internalization into cells and 
increased accumulation in spleen and liver.[110] The optimal NP 
diameter is expected to be in the range of 30 to 200 nm, since 
NPs in that size range benefit from the enhanced permeation and 
retention (EPR) effect.[115] The EPR effect exploits that the 90 
tumor tissue exhibits different structural features compared to 
normal cells, such as leaky vessels with enlarged gap functions 
Electronic supplementary information 
Instrumentation 
Sedimentation velocity experiments. 
The raw sedimentation data were evaluated by the program Sedfit using continuous c(s), which is based on the numerical resolution of 
the Lamm equation. It allows the least-squares boundary modeling ls – g*(s), which describes sedimentation of a non–diffusing species, 5
and to determine the average frictional ratio (f/fsph) of the particles.
1,2 The partial specific volume υ was determined by the density 
variation method, i.e., by sedimentation velocity experiments on the nanoparticle suspensions, using in parallel H2O and D2O. The partial 
specific volume was found to be υ = (0.78 ± 0.01) cm3·g-1. Molar masses of the particles were estimated applying the modified Svedberg 
equation: 
  10
where NA is the Avogadro’s number, υ the partial specific volume and [s] is the intrinsic sedimentation coefficient which is 
defined as:  
 
where s0 is the sedimentation coefficient at zero concentration, η0 the dynamic viscosity of the solvent, and ρ0 the density of 
the solvent. The diameters were calculated from the Stokes approximation for a sphere: 15
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Fig. 1 Chemical structure of the polymers. A - p(MMA-stat-MAA)2:1, B - poly(lactic-co-glycolic acid) (50:50), C - dextran acetal (DS = 2.17). 
 
Fig. 2 Size distributions of the nanoparticles at different solvent/non-solvent ratios. The distributions were obtained by sedimentation velocity analysis. 
The values of the solvent/non-solvent ratio were 0.280 (A), 0.157 (B), and 0.099 (C). The polymer concentration was 3.57 mg·mL-1. The particles were 5
prepared by dropping the polymer solution into water. 
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Fig. 3 SEM images of nanoparticles prepared from A) ac-dex and B) PLGA at different polymer concentrations. The particles were prepared by dropping 
the polymer solution into water. 
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 1. Introduction 
 Recent progress in the area of nanosciences enabled the 
development of various nanoparticle (NP) devices as pow-
erful tools in the pharmaceutical area for drug delivery 
systems, but also in other scientiﬁ c ﬁ elds, for example, 
chemistry, biology, and electronics. [ 1–3 ] In particular for 
diagnostic applications, like live cell imaging, the inves-
tigation of labeled nanosystems (1 to 1000 nm) is rapidly 
expanding. [ 4–8 ] Such nanodevices can consist of various 
materials, such as silica, carbon, metal oxides, pure metals, 
and polymers. [ 6 , 9,10 ] In particular, quantum dots have revo-
lutionized the biological research with their fascinating 
light-emitting properties, though still having safety issues 
due to the liberation of heavy metals. [ 2 , 11 ] The use of fl uo-
rescent polymeric NP represents a suitable alternative 
to avoid the obstacle of the potential toxicity of metal-
based NP. A diversity of biocompatible polymers, such as 
poly(lactide- co -glycolide) and poly( ε -caprolactone), are used 
for formulation. [ 12–14 ] The incorporation of dyes into the 
polymer shell during NP preparation or the use of labeled 
polymer systems provides a protection against external 
infl uences while keeping their spectral properties, which 
are essential for the subsequent analysis of particle–cell 
interactions via confocal laser scanning microscopy. [ 7 , 13 , 15 ] 
A further beneﬁ t of polymeric NP is the variety of formu-
lation techniques such as emulsiﬁ cation–solvent diffusion, 
 Methacrylate monomers were functionalized with a 4-hydroxythiazole chromophore and copo-
lymerized with methyl methacrylate via RAFT. Nanoparticles of 120 and 500 nm in size were 
prepared without using stabilizers/surfactants. For comparative studies, preparative ultracen-
trifugation was applied for the separation into small and large 
particle fractions. All suspensions were characterized by DLS, 
AU C, and SEM and tested regarding their stability during cen-
trifugation and re-suspension, autoclavation, and incubation 
in cell culture media. In vitro studies with mouse ﬁ broblast 
cell line and differently sized NP showed a particle uptake into 
cells. Biocompatibility, non-toxicity, and hemocompatibility 
were demonstrated using a X TT assay, a live/dead staining, 
and an erythrocyte aggregation and hemolysis assay. 
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all suspensions were characterized comprehensively by 
dynamic light scattering (DLS), scanning electron micro-
scopy (SEM), and analytical ultracentrifugation (AU C) to 
allow a detailed characterization of the NPs. [ 43 ] The sta-
bility of the resulting nanosuspensions after long-time 
storage, autoclavation, and incubation in cell culture 
media was studied by measurements of size and zeta 
potential. The internalization of the differently sized nan-
oparticles into adherent cells was monitored by confocal 
laser scanning microscopy (CLSM). The biocompatibility 
of the particle suspensions in terms of their non-toxicity 
was proven by X TT cytotoxicity assay and microscopic 
evaluation of viability after a live/dead staining. Compat-
ibility with blood was analyzed by checking the induction 
of hemolysis and aggregation of erythrocytes. 
 2. Results and D iscussion 
 2.1. Synthesis of P(MMA- stat -MA Y ) 
 The yellow light-emitting thiazole-dye 3-((5-(4-(dimethyl-
amino)phenyl)-2-(pyridin-3-yl)thiazol-4-yl)oxy)propan-1-ol 
was attached to the methacrylate monomer by an esteri-
ﬁ cation reaction. The non-classical 4-hydroxy-1,3-thiazole 
chromophore structure is similar to the luciferin dye of 
ﬁ refl ies and shows excellent fl uorescent properties. [ 44 ] The 
resulting dye-functionalized methacrylate MA y was copo-
lymerized statistically with MMAs using the RAFT polym-
erization methodology (Scheme  1 ). [ 31–33 ] The reaction was 
carried out using AIBN as a radical initiator, toluene as a 
solvent, and 2-cyano-2-propyl dithiobenzoate (CPDB) as 
a chain transfer agent. The ratio of MMA to the dye-func-
tionalized monomers was 69:1, leading to a ﬁ nal conver-
sion rate of 70%  of the copolymers with a DP of 100. The 
dye-functionalized methacrylates were statistically distrib-
uted in the polymer backbone due to the same reactivity 
of both monomers. [ 29 ] The low degree of labeling (1 to 3% ) 
ensured the preservation of the properties of the PMMA 
nanoprecipitation, spray drying, salting out, and milling 
processes. [ 16–18 ] By using the appropriate conditions for 
formulation, speciﬁ c drugs can be encapsulated resulting 
in labeled drug carriers of desired sizes and with suitable 
charges. [ 16 , 18,19 ] 
 In the herein presented study, polymethylmethacrylate 
(PMMA) copolymers were chosen as a model system to 
demonstrate that functional PMMA-based nanoparticles 
are well suitable for diagnostic applications such as the 
imaging of cells. The biocompatibility of PMMA micro-
spheres enables their use in many biomedical applica-
tions, for example, as injectable dermal ﬁ llers, as PMMA-
based NPs for in vitro gene delivery approaches, and also 
for orthopedic bone reconstruction. [ 20–28 ] For the design 
of labeled nanosystems, a luciferin-based 4-hydrox-
ythiazole derivative was incorporated into the PMMA 
polymer backbone, showing beneﬁ ts as high fl uores-
cence at room temperature with high quantum yields, 
easy adjustment of the fl uorescent properties, and excel-
lent stability. [ 29,30 ] For this purpose, methacrylates were 
functionalized with the thiazole chromophore (MA y ) and 
then copolymerized with methyl methacrylate (MMA) 
using the reversible addition–fragmentation chain 
transfer (RAFT) polymerization technique. [ 29 , 31–33 ] For the 
NP preparation, nanoprecipitation (solvent-evaporation) 
was chosen as a simple, fast, reliable, and cost-effective 
method. [ 34–36 ] Different particle sizes were obtained by 
varying the initial conditions of the formulation. Addi-
tionally, preparative ultracentrifugation (pU C) was uti-
lized for the fractionation of particles into discretely 
sized NP suspensions. It provides another dimension of 
physical control of the size distribution of particles on 
the nanoscale. [ 14 , 37–39 ] 
 Since the size strongly infl uences the biodistribution 
of NPs and the way of internalization into target cells, it 
is imperative to have well-deﬁ ned particles with narrow 
size distributions. Unf ortunately, it is a matter of fact 
that in literature the accuracy of particle size determina-
tion is disputable. [ 40–42 ] Consequently, in this distribution, 
 Scheme  1 .  Schematic representation of the synthesis of p(MMA- stat -MA y ). 
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suspension with a broad size distribution was separated by 
pU C into fractions  S2 and  L2 . DLS and AU C measurements 
indicated particle sizes of  d S2  = 120 nm (PDI P  = 0.29) and  d L2  = 
600 nm (PDI P  = 0.19, Table  1 ). The small increase of the 
PDI P values of  S2 and  L2 compared with  S1 and  L1 might 
be caused by a slight agglomeration of the NP during the 
pU C treatment. The zeta potential of all suspensions were 
in the same range ( ζ  =  − 32 to  − 36 mV ) and thereby testiﬁ ed 
a good stability of the NP in suspension. SEM investiga-
tions were performed to obtain further information about 
the size and shape of the particles (Figure  1 ). The small 
particles  S1 and  S2 revealed more irregular shapes than 
the larger ones ( L1 and  L2 ), which might be caused by the 
preparation technique, that is, dropping acetone in water, 
which is characterized by the fast exchange of the solvent 
against the non-solvent environment. [ 34,35 ] For the small 
particles, the calculated diameters were in good agreement 
with the DLS results ( d S1  = 111 nm,  d S2  = 131 nm), whereas 
the large particle samples were characterized by slightly 
increased sizes in the particle fractions ( d L1  = 696 nm,  d L2  = 
502 nm, Table  1 ). Complementary, the analysis of the sam-
ples by AU C revealed diameters of  d S1  = 120 nm and  d L1  = 
503 nm as well as  d S2  = 97 nm and  d L2  = 381 nm, respec-
tively. In order to exclude the occurrence of bulk precipita-
tion and Ostwald ripening even over a long period of time, 
the nanosuspensions were stored at 5  ° C for 6 months and 
examined again regarding their zeta potential and size dis-
tribution. No signs of instability of the initial nanosuspen-
sions were found in terms of agglomeration or creaming 
up. It should be mentioned that no surfactants were added 
to inhibit particle aggregation. In addition, samples of the 
initial NP suspension were analyzed by DLS and SEM after 
centrifugation at 24.650 g for 20 min, autoclavation, lyophi-
lization, and subsequent resuspension. Neither the size 
distributions nor the zeta potential values changed, which 
ensured the high stability of the p(MMA- stat -MA y ) nano-
particles. The absorption and emission spectra of the nano-
suspensions in comparison to the monomer were equal 
within the range of the measurement errors ( ± 5 nm). This 
implies that the fl uorescence properties of the monomers 
were unaffected by polymerization and NP formation. 
 2.3. Biological Experiments 
 In order to prove the efﬁ cient internalization of the par-
ticles into cells, mouse ﬁ broblasts L929 were incubated 
with 120 and 500 nm sized nanosuspensions prepared 
by nanoprecipitation and pU C separation, respectively. 
The internalization of the NP into the cells was moni-
tored by CLSM (representative micrographs are shown in 
Figure  2 ). On the basis of the relative size distribution of 
their corresponding fl uorescence signal, a clear discrimi-
nation of small and large particles was possible. Further-
more, a concentration-dependent internalization of all 
homopolymer. As determined by SEC, the ﬁ nal p(MMA-
 stat -MA y ) revealed a molar mass ( M— n ) of 8500 g mol  − 1 with 
a polydispersity index value of 1.19 (Table S1, Supporting 
Information). Similar molar mass distributions recorded by 
both RI and U V  detector clearly demonstrate that the thia-
zole dye was incorporated into the copolymer. The ratio of 
the MMA units and the thiazole dye in the copolymer was 
determined to be 2.9 mol%  by  1 H  NMR spectroscopy. The 
ﬁ nal copolymer showed the same absorbance and emis-
sion behavior like the monomeric thiazole chromophore 
(solvent acetonitrile;  λ Abs  = 413 nm,  λ Em  = 557 nm, Stoke-
shift 6259 cm  − 1 , Figure S1, Supporting Information) with a 
quantum yield of  Φ PL  = 0.29. 
 2.2. Nanoparticle Preparation and Characterization 
 The so-called nanoprecipitation or solvent evaporation 
process was found to be a suitable method for the prepa-
ration of differently sized NPs. Therefore, this simple, fast, 
and cost effective technique was applied for the prepara-
tion of p(MMA- stat -MA y ) NPs. [ 34 , 45 ] The ﬁ nal particle size 
was tuned by variation of the initial polymer concentra-
tion in the organic phase and/or by changing the drop-
ping method (polymer solution into water or water into 
polymer solution). [ 46 ] In order to obtain small particles ( S1 ), 
a polymer solution with a concentration of 4 mg mL  − 1 was 
dropped into water. For larger particles ( L1 ), water was 
dropped into the polymer solution with a concentration 
of 3 mg mL  − 1 . In general, a solvent/non-solvent ratio of 
0.25 was used and continuous stirring was applied. After 
evaporation of the acetone, the particle sizes were exam-
ined by DLS. The Z-average diameter for the nanoparticles 
suspensions  S1 and  L1 was determined to be  d S1  = 118 nm 
(PDI P  = 0.10) and  d L1  = 488 nm (PDI P  = 0.03), respectively 
(Table  1 ). The resulting size distributions were monomodal 
(Figure  1 ). In addition to nanoprecipitation, preparative 
ultracentrifugation (pU C) [ 47 ] in a density gradient was used 
for the separation of deﬁ ned NP. For pU C, a thin layer of 
a particle suspension to be fractionated is layered on the 
top of a solution containing the density gradient. When a 
centrifugal ﬁ eld is applied, the various components move 
through the gradient at different rates depending on their 
sizes, densities, and shapes. [ 37–39 , 48 ] In this respect, a particle 
 Table  1.  Summary of the size distributions of the nanoparticles 
based on p(MMA- stat -MA y ). 
Sample  d D LS 
[nm]
PD I particle  d SEM 
[nm]
 d AU C 
[nm]
 ξ 
[mV ]
 S1 118 0.10 111 120  − 36
 L1 488 0.03 696 503  − 35
 S2 120 0.26 131 97  − 32
 L2 597 0.19 502 381  − 33
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 It is known that PMMA particles are phagocytosable 
and it can be assumed that the cellular uptake of PMMA 
particles in the size range studied is presumable medi-
ated in a similar fashion via an endocytotic pathway. [ 27 ] 
The negative surface charge of the PMMA NP does not 
alter the cellular uptake and most probably yields to a 
reduction of the non speciﬁ c binding of anionic proteins 
present in the cell culture medium and also in the body 
fl uid, for example, in the blood, thus rendering opportuni-
ties for in vivo administration of NP. [ 26 ] 
 For diagnostic applications, the biocompatibility and 
non-toxicity of the nanosuspensions are important 
fl uorescent NP into the cytoplasm in the range of  c  = 
0.1 to 10  μ g mL  − 1 was observed. The more particles added 
for incubation with adherent cells, the more particles 
were consequently found in the cytoplasm. It was further 
obvious that the pU C prepared samples  S2 and  L2 were 
internalized to a higher degree than the particles  S1 and 
 L1 . This might be due to traces of sucrose attached to the 
particle surface. As described in literature, carbohydrate 
moieties can act as ligands for diverse receptors. H ence, 
their appearance on the particle surface could lead to an 
enhanced cellular recognition and internalization of the 
particle  S2 and  L2 . [ 49–51 ] 
 Figure  1 .  Size distributions of the particles in w ater ( c  = 0. 5 mg mL  − 1 ) obtained by DLS and AUC as w ell as SEM images of the particle 
suspensions. 
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of FDA in cytoplasm) (Figure S3, Supporting Informa-
tion). In addition, the interaction of NP suspensions with 
blood cells was investigated in terms of their potential 
to induce hemolysis (membrane damage and cell dis-
ruption) and/or aggregation of erythrocytes, one of the 
major cellular blood components. Whereas the treatment 
of erythrocytes with 1% Triton X -100 as positive control 
led to a complete disruption of the erythrocytes and sub-
sequent release of the incorporated hemoglobin, none of 
the NP suspensions nor the PBS-treated negative control 
showed any hemolytic activity, indicating the absence of 
any harmful effect on the erythrocyte membrane integ-
rity (Figure S4, Supporting Information). Furthermore, 
prerequisites. The in vitro cytotoxicity experiment was 
performed on the basis of the X TT assay using L929 mouse 
ﬁ broblasts, according to the G erman standard institution 
guideline DIN ISO 10993-5 as a reference for biomaterial 
testing. After 24 h of incubation with different NP concen-
trations ( c  = 0.1–10  μ g mL  − 1 ), the metabolic activity of cells 
treated with test-samples was found to be on the level of 
untreated controls, which proves the absence of a toxic 
effect mediated by the NPs (Figure S2, Supporting Infor-
mation). A detailed live/dead microscopy study of cells 
that were treated with NP conﬁ rmed the cell-membrane 
integrity (exclusion of red fl uorescent PI from cell nuclei) 
and their excellent viability (strong green fl uorescence 
 Figure  2 .  Confocal ß uorescence images of L929 cells after 24 h incubation w ith polymeric p(MMA- stat -MA y ) nanoparticles. Cells 
incubated w ith polymer free culture medium served as control (not show n). All images w ere obtained w ith identical instrument settings 
(scale bars 10  μ m). 
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PMMA particles surface, also a speciﬁ c binding to biomol-
ecules can be mediated, thereby enabling approaches like 
speciﬁ c cell targeting. [ 55 ] 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library 
or from the author. 
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the capability of NP suspensions to induce a formation 
of erythrocyte aggregates as an unwanted sign of blood 
incompatibility was studied microscopically and photo-
metrically. None of the NP suspensions induced any red 
blood cell aggregation, even at the highest concentration 
of 10  μ g mL  − 1 (Figure S5 and S6, Supporting Information). 
In contrast, the treatment with 25 kDa bPEI as positive 
control caused the clear formation of aggregates, whereas 
PBS-treated samples used as negative control did not 
yield in any aggregate formation. This observed absence 
of any nanoparticle-mediated blood incompatibility is 
in line with clinical evaluations of PMMA membranes 
dedicated for the use in blood dialysis. [ 26 ] It is reported 
that due to their relatively hydrophobic and anionic sur-
face PMMA particles show less nonspeciﬁ c protein and 
peptide binding, and, thereby reduce the initial steps of 
opsonization leading to cell recognition/binding and pos-
sible immunological reactions. [ 52 ] It is known that PMMA 
NP may be ingested and most probably can pass through 
the epithelial barrier and will likely end up in the blood-
stream. Large particles are usually trapped by the liver, [ 53 ] 
while smaller pass on and are captured by the kidneys. [ 54 ] 
H owever, because of the very low toxicity documented for 
PMMA NPs, even in view of a chronic/continuous disease 
treatment in,vivo, the possibility of obtaining sustain-
able effects by using PMMA NPs is presumably realistic. 
In addition, the good stability of the nanoparticles during 
autoclavation, centrifugation, and lyophilization/resus-
pension is basic requirements for the possible adminis-
tration of lyophilized, resuspended/reconstituted, and 
autoclaved particles. 
 3. Conclusion 
 Consequently, the 4-hydroxythiazole-functionalized PMMA 
NPs are suitable for fl uorescence-based long-term studies of 
biological processes at the molecular level. On the contrary 
to traditional fl uorophores, the PMMA NPs combine small 
size and high photostability, and, in contrast to widely used 
quantum dots, they do not contain hazardous components, 
which need to be shielded by protective layers. The bio-
analytical applications based on functionalized polymeric 
PMMA NPs are of emerging interest and provide oppor-
tunities like minimal-invasive intracellular monitoring 
of key components like pH  value and oxygen content as 
well as ions like calcium, potassium or sodium. They can 
be combined with state-of-the-art imaging techniques 
like fl ow cytometry, fl uorescence microscopy, and sophis-
ticated imaging approaches, such as confocal imaging 
providing the opportunity for 3D analysis. In combination 
with dyes emitting in the near-infrared wavelength range, 
it offers an optical window for in vivo tissue imaging into 
several mm depth. By the immobilization of ligands to the 
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Polymer characterization 
Table S1. Characterization data of the copolymer p(MMA-stat-MAy).  
[MMA]: 
[dye] 
[M]: 
[CTA]: 
[AIBN] 
Conv.  
MMAa 
(%) 
Mn, theo 
(g/mol) 
Mn, SEC  
(RI)b 
(g/mol) 
PDISEC  
(RI)b 
DPSEC  
(RI)b 
Dye content  
(NMR)c 
(%) 
138:2 140:1:0.25 68 9,900 8,500 1.19 81 2.9 
a) Calculated from vinyl integrals of 1H NMR spectra using anisole as internal standard. 
b) Calculated from SEC (CHCl3), PMMA calibration. 
c) Calculated from integrated areas of aromatic dye signals and the methyl signals of MMA. 
 
 
A) B) 
  
Figure S1. A) Fluorescence emission spectra of p(MMA-stat-MAy) in acetonitrile (excited at 
 = 418 nm). B) SEC measurements (CHCl3) of p(MMA-stat-MA
y). The refractive index 
trace (--) and the UV trace at 310 nm (-) of the labeled polymer occur at the same retention 
time confirming the covalent attachment. 
 
 
 
 
 
10 
 
 
Figure S3. Representative fluorescence microscopy micrographs of Hoechst 33342/FDA/PI 
stained L929 mouse fibroblast cells cultured for 24 hours in the presence of the small (S1/S2) 
and large (L1/L2) polymeric p(MMA-stat-MAy) nanoparticles up to 10 g · mL-1 for 24 
hours. Blue fluorescent Hoechst dye labels nuclei of all cells present, green fluorescent FDA 
dye indicates cytoplasm of vital cells, red fluorescent PI signals tag nuclei of dead cells. Left: 
10 g · mL-1particle suspension added (small (S1); same results for small (S2) and large 
(L1/L2) particle suspensions), right: control culture without particles. 
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Figure S4. Representative micrographs of red blood cell aggregation after 2 h incubation at 
37 °C with small polymeric p(MMA-stat-MAy) nanoparticles (S1, 10 g · mL-1). Same results 
as for S1 were obtained for S2/L1/L2. 25 kDa bPEI (50 g · mL-1) served as positive and PBS 
as negative control. Magnification 320 ×.  
 
 
S1 
(10 µg · mL-1 ) 
Positive control 
(bPEI, 50  µg · mL-1 ) 
Negative control 
(PBS) 
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Correction
DOI: 10.1002/marc.201300030
DOI: 10.1002/marc.201200329
The authors regret that there were important omissions in the above article. The synthesis of the yellow light-emitting 
thiazole-dye 3-((5-(4-(dimethylamino) phenyl)-2-(pyridin-3-yl)thiazol-4-yl)oxy)propan-1-ol as well as the corresponding 
methacrylate monomer was not described in reference 29 of the manuscript or in reference 1 of the Supporting Informa-
tion (in this publication only the related blue emitting monomer is described). The resulting yellow and blue polymers 
were both investigated – however, due to the non-visibility of the blue polymer only the yellow one was continued in the 
published study. In order to allow an exact reproduction of the monomer synthesis, a detailed description has been added 
as Supporting Information of this Correction.
In the original version of the above article, three co-authors’ names (Roberto Menzel, Dieter Weiß, and Rainer Beckert) 
were missing from the byline and afﬁ liation. The correct author byline is as follows:
Antje Vollrath, David Pretzel, Christian Pietsch, Igor Perevyazko, 
Roberto Menzel, Stephanie Schubert, George M. Pavlov, Dieter Weiß, 
Rainer Beckert, Ulrich S. Schubert*
Finally, the Acknowledgments section in the above article should be replaced with the following paragraph.
The Thüringer Ministerium für Bildung, Wissenschaft und Kultur (TMBWK, ProExzellenz-Programm NanoConSens) is ack-
nowledged for ﬁ nancial support. We gratefully thank Stefﬁ  Stumpf and Dr. Frank Steininger, EMZ Jena, for assistance in 
the SEM investigations.
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Figures and Tables 
 
 
Scheme 1. Schematic representation of the functionalization of dextran by (a) oxidation, (b) carboxymethylation and 
(c) 4-nitrophenyl carbonate-activation with subsequent reaction with lPEIs via (a) reductive amination, (b) EDC 
coupling and (c) carbamate formation. 
 
 
a) Calculated cationic charge/molar mass of monomer unit  
b) Calculated anionic charge/molar mass of monomer unit 
Table 1. Overview about the DS and nitrogen content of all synthesized dex-g-lPEI samples. 
P dex-g-lPEIs 
CHO/ 
COOH: 
NH2 [mol] 
DS [lPEI/ 
AGU] 
N 
[%] 
Cationic 
charge/MMonomer
a 
Anionic 
charge/MMonomer
b 
A Reductive amination      
A1 CHODS=0.5-dex-g-lPEI20 1:0.5 0.18 15.78 0.0114 - 
A2 CHODS=0.5-dex-g-lPEI40 1:0.5 0.13 19.12 0.0135 - 
A3 CHODS=1.0-dex-g-lPEI20 1:0.5 0.38 21.45 0.0156 - 
A4 CHODS=1.0-dex-g-lPEI40 1:0.5 0.19 21.73 0.0156 - 
B EDC coupling      
B1 CMDS=0.3-dex-g-lPEI20 1:1.2 0.06 6.73 0.0052 0.0013 
B2 CMDS=0.3-dex-g-lPEI40 1:1.2 0.07 12.80 0.0093 0.0010 
B3 CMDS=0.5-dex-g-lPEI20 1:1.2 0.07 7.96 0.0056 0.0020 
B4 CMDS=0.5-dex-g-lPEI40 1:1.2 0.1 14.83 0.0110 0.0014 
B5 CMDS=1.6-dex-g-lPEI20 3:1 0.11 8.16 0.0063 0.0046 
B6 CMDS=1.6-dex-g-lPEI40 3:1 0.18 18.38 0.0127 0.0028 
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(a) 
 
  
(b) 
 
(c) 
 
 
Figure 1: Stability of dex-g-lPEI/plasmid complexes against 
enzymatic degradation (DNase I, 37 °C, 45 minutes) at N/P 
ratio 25 and 50: (a) dex-g-lPEIs by reductive amination; 
(b + c) dex-g-lPEIs by EDC-coupling, (c) lPEIs. Controls: 
lane 1: untreated free plasmid; lane 2: free plasmid treated in 
the same way as complexes but without enzyme; lane 3: free 
plasmid treated with enzyme. 
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(a) (b)
 
(c) 
 
 
 
 
 
 
 
 
 
 
Figure 5: Aggregation of sheep red blood cells after treatment with free dex-g-lPEI and lPEI 
polymers incubated at 37 °C for 2 h. (a) Representative pictures of microscopic observation at 50 µg · 
mL-1 (negative control = PBS; positive control = 15 µg · mL-1 bPEI 25,000 g · mol-1) with 
magnification 200×. (b) Stages of sheep blood erythrocyte aggregation of dex-g-lPEIs and lPEIs at 
concentrations up to 50 µg ∙ mL-1. Classification: 1 = no aggregation of erythrocytes, 2 = moderate 
aggregation with rouleau formation, 3 = strong aggregation with cluster formation. (c) ΔAbsmax of 
polymers. The RBC aggregation experiments were performed with n = 2 and repeated once (mean ± 
SD). 
 
 
 
 
 
A
1
A
2
A
3
A
4
B
1
B
2
B
3
B
4
B
6
lP
E
I 20
lP
E
I 40
P
os
iti
ve
co
nt
ro
l0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14

A
bs
m
ax
Polymer
 
 
  
 
- 
11
 -
 
 
F
ig
ur
e 
S
7.
 D
N
A
 b
in
di
ng
 c
ap
ac
ity
 o
f 
lP
E
I 2
0/
40
 a
nd
 d
ex
-g
-l
P
E
Is
 a
t 
di
ff
er
en
t 
N
/P
 r
at
io
s 
in
 c
om
pa
ri
so
n 
to
 f
re
e 
D
N
A
, 
de
te
rm
in
ed
 b
y 
ag
ar
os
e 
ge
l e
le
ct
ro
ph
or
es
is
. 
16 
 
        (1) 
Here, RFU is the relative fluorescence. Fsample and FsiRNA are the fluorescence intensities of a 
given sample and the EB intercalated into pDNA alone. 
DNA release by heparin 
To investigate the release of pDNA from polyplexes, the heparin dissociation assay was used. 
For this purpose, 100 µL of polyplex solution were incubated for 10 min with EB (0.4 µg mL
-1
) 
in a black 96-well plate. After transferring into the Tecan Genios Pro fluorescence microplate 
reader, heparin solutions were automatically added at the indicated concentrations. Therefore, 20 
cycles of the following procedure were used: 5 µL of heparin stock solutions (10 U mL
-1
 or 
200 U mL
-1
) were dropped to each well. Afterwards the plate was shaked (orbital, 10 sec, 2 mm) 
and incubated for 5 min at 37 °C. After each cycle, the fluorescence of EB was measured, and the 
percentage of intercalated EB was calculated as described before (1). 
Cell Culture  
HEK-293 (CRL-1573, ATCC) cells were maintained in RPMI 1640 culture medium, L929 
(CCL-1, ATCC) in DMEM culture medium. Both media were supplemented with 10% fetal calf 
serum (FCS), 100 µg/mL streptomycin, 100 IU mL
-1
 penicillin, and 2 mM L-glutamine. Cells 
were cultivated at 37 °C in a humidified 5% CO2 atmosphere.  
The cytotoxicity of the single polymers was tested with L929 cells, as this cell line is 
recommended by ISO10993-5. In detail, cells were seeded at 10
4
 cells per well in a 96-well plate 
and incubated for 24 h. No cells were seeded in the outer wells. Afterwards, polymers at the 
indicated concentrations were added, the plates were slued, and incubated at 37 °C for further 
24 h. Subsequently, the medium was replaced by PBS and AlamarBlue as recommended by the 
supplier. After incubation for 4 h, the fluorescence was measured at Ex 570 / Em 610 nm, with 
untreated cells on the same well plate serving as controls (2).  
       (2) 
Here, viability is the relative fluorescence and Fsample, F0, and Fcontrol are the fluorescence 
intensities of a given sample, the blank wells without cells, and the control cells without polymer 
treatment. 
For transfection experiments, HEK cells were seeded at a density of 10
4
 cells per well in 96-
well plates 24 h before transfection. In order to avoid any misleading measurement results and to 
prevent a systematic mistake, the polyplexes were always placed and measured at different 
positions in the 96-well plate to avoid alterations due to differences in the gas exchange between 
outer and inner wells and 25 measuring points per well were taken. One hour prior transfection, 
cells were washed with PBS and supplemented with 100 µL OptiMEM (Life Technologies). 
Polyplex solutions were added (10 µL) to the cells and the plates were slued and incubated for 4 
17 
 
h at 37 °C. Afterwards, the supernatant was replaced by 100 µL of fresh growth medium 
(RPMI1640 based), and the cells were further incubated for 20 h. Before analysis, the cells were 
incubated with 1 µg mL
-1
 Hoechst 33324 for 10 min at 37 °C, washed twice with PBS, and the 
plates were transferred to the plate reader. The expression of EGFP fluorescence (Ex 475 nm / 
Em 509 nm) and viability (Hoechst, Em 350 nm / Ex 461 nm) was quantified by using the 
fluorescence measured from the bottom of the plates. The transfection efficiency was calculated 
relative to cell number and control cells using the following equation (3), where and EGFPsample, 
EGFPcontrol, Hoechstsample, Hoechstcontrol are the fluorescence signal of EGFP and Hoechst of 
treated (sample) and non treated (control) cells, respectively. Experiments were repeated 3 times 
independently.  
    (3) 
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